Paradoxically	O
,	O
loop	O
3i	O
from	O
the	O
M1Ach	B
-	I
muscarinic	I
receptor	I
also	O
maximally	O
inhibited	O
GnRH	B
agonist	O
-	O
stimulated	O
cAMP	O
accumulation	O
and	O
PRL	B
release	O
by	O
40	O
%	O
(	O
both	O
effects	O
mediated	O
through	O
activation	O
of	O
the	O
Gs	B
protein	I
)	O
.	O

Oligomers	O
corresponding	O
to	O
the	O
region	O
of	O
the	O
mlc-1	B
/	I
3	I
enhancer	I
,	O
which	O
encompasses	O
this	O
conserved	O
sequence	O
,	O
bound	O
MEF-2	B
and	O
competed	O
for	O
its	O
binding	O
to	O
the	O
mck	B
enhancer	O
.	O

Overall	O
graft	O
and	O
patient	O
survival	O
after	O
HAT	O
were	O
33.3	O
%	O
and	O
75	O
%	O
,	O
respectively	O
.	O

E2A	B
-	O
HLF	B
-	O
mediated	O
cell	O
transformation	O
requires	O
both	O
the	O
trans	O
-	O
activation	O
domains	O
of	O
E2A	B
and	O
the	O
leucine	O
zipper	O
dimerization	O
domain	O
of	O
HLF	B
.	O

One	O
patient	O
exhibited	O
a	O
non	O
-	O
sense	O
mutation	O
(	O
codon	O
388	O
)	O
,	O
which	O
changed	O
a	O
glutamine	O
codon	O
(	O
CAG	O
)	O
to	O
a	O
stop	O
codon	O
(	O
TAG	O
)	O
.	O

Comparison	O
of	O
the	O
encoded	O
ERCC3Dm	B
protein	I
with	O
the	O
homologous	O
proteins	O
of	O
mouse	O
and	O
man	O
shows	O
a	O
strong	O
amino	O
acid	O
conservation	O
(	O
71	O
%	O
identity	O
)	O
,	O
especially	O
in	O
the	O
postulated	O
DNA	O
binding	O
region	O
and	O
seven	O
'	B
helicase	I
'	I
domains	I
.	O

Previous	O
data	O
suggested	O
a	O
subtle	O
increase	O
in	O
serum	O
P	O
at	O
the	O
time	O
of	O
hCG	B
injection	O
without	O
LH	B
surge	O
reduces	O
the	O
PR	O
of	O
women	O
having	O
oocyte	O
retrievals	O
for	O
IVF	O
;	O
this	O
study	O
compared	O
PRs	O
of	O
recipients	O
in	O
a	O
shared	O
oocyte	O
program	O
according	O
to	O
the	O
donors	O
'	O
pre	B
-	I
hCG	I
P	O
level	O
.	O

Scleraxis	B
overexpression	O
enhanced	O
expression	O
of	O
the	O
aggrecan	B
gene	I
,	O
which	O
is	O
not	O
normally	O
expressed	O
at	O
high	O
levels	O
in	O
these	O
osteoblastic	O
cells	O
.	O

A	O
29.425	O
kb	O
segment	O
on	O
the	O
left	O
arm	O
of	O
yeast	O
chromosome	O
XV	O
contains	O
more	O
than	O
twice	O
as	O
many	O
unknown	O
as	O
known	O
open	O
reading	O
frames	O
.	O

Ultimobranchial	O
body	O
and	O
parathyroid	O
glands	O
of	O
the	O
freshwater	O
snake	O
Natrix	O
piscator	O
in	O
response	O
to	O
vitamin	O
D3	O
administration	O
.	O

Given	O
a	O
rapid	O
induction	O
of	O
Egr-1	B
on	O
stimulation	O
with	O
growth	O
factors	O
or	O
injury	O
,	O
these	O
findings	O
may	O
represent	O
at	O
least	O
one	O
of	O
the	O
molecular	O
mechanisms	O
underlying	O
phenotypic	O
modulation	O
of	O
smooth	O
muscles	O
after	O
vascular	O
injury	O
.	O

Soluble	O
recombinant	O
RI	B
and	O
soluble	O
recombinant	O
C	B
alpha	I
can	O
associate	O
in	O
vitro	O
and	O
be	O
activated	O
by	O
cyclic	O
AMP	O
.	O

A	O
31-year	O
-	O
old	O
man	O
with	O
primary	O
myelofibrosis	O
initially	O
received	O
low	O
dose	O
Ara	O
C.	O

The	O
factors	O
defective	O
in	O
groups	O
A	O
(	O
CIITA	B
)	O
,	O
C	O
(	O
RFX5	B
)	O
and	O
D	O
(	O
RFXAP	B
)	O
have	O
been	O
identified	O
.	O

Our	O
results	O
are	O
consistent	O
with	O
TCOF1	B
mutations	I
leading	O
to	O
the	O
Treacher	O
Collins	O
syndrome	O
phenotype	O
.	O

Acute	O
spontaneous	O
subdural	O
haematoma	O
.	O

Ultra	O
-	O
energy	O
(	O
UHE	O
)	O
imaging	O
is	O
usually	O
performed	O
in	O
simultaneous	O
F-18	O
FDG	O
/	O
Tc-99	O
m	O
MIBI	O
studies	O
.	O

The	O
effect	O
of	O
betamethasone	O
on	O
duodenal	O
calcium	O
absorption	O
and	O
1,25-dihydroxy	O
vitamin	O
D3	O
production	O
in	O
the	O
chick	O
.	O

Fluctuations	O
of	O
the	O
measured	O
ECF	O
energy	O
-	O
related	O
substances	O
corresponded	O
to	O
various	O
clinical	O
events	O
presumably	O
involving	O
hypoxia	O
/	O
ischemia	O
.	O

We	O
have	O
demonstrated	O
that	O
a	O
putative	O
HOX	B
cofactor	I
,	O
PBX1A	B
,	O
participates	O
in	O
cooperative	O
DNA	O
binding	O
with	O
HOXA-1	B
and	O
the	O
Deformed	B
group	O
protein	O
HOXD-4	B
.	O

The	O
effect	O
of	O
iron	O
on	O
the	O
toxigenicity	O
of	O
Vibrio	O
cholerae	O
.	O

Although	O
there	O
is	O
evidence	O
that	O
cone	O
ratios	O
do	O
determine	O
colour	O
appearance	O
under	O
many	O
conditions	O
,	O
the	O
site	O
or	O
sites	O
of	O
their	O
computation	O
is	O
unknown	O
.	O

In	O
an	O
effort	O
to	O
identify	O
factors	O
involved	O
in	O
the	O
expression	O
of	O
this	O
important	O
erythroid	O
-	O
specific	O
regulatory	O
protein	O
,	O
we	O
have	O
isolated	O
the	O
mouse	B
EKLF	I
gene	I
and	O
systematically	O
analyzed	O
the	O
promoter	O
region	O
.	O

RESULTS	O
:	O
All	O
primary	O
tumors	O
were	O
positive	O
for	O
CAM5.2	B
.	O

Moreover	O
,	O
since	O
the	O
integrated	O
transforming	O
DNA	O
was	O
not	O
altered	O
or	O
lost	O
expression	O
of	O
the	O
RbcS2::aadA::RbcS2	B
gene	B
(	I
s	I
)	I
appears	O
to	O
be	O
repressed	O
.	O

In	O
one	O
trial	O
,	O
116	O
subjects	O
with	O
transfusion	O
-	O
related	O
chronic	O
hepatitis	O
C	O
were	O
treated	O
with	O
lymphoblastoid	B
interferon	I
(	O
5	O
MU	O
/	O
m2	O
three	O
times	O
a	O
week	O
for	O
2	O
mo	O
,	O
then	O
3	O
MU	O
/	O
m2	O
three	O
times	O
a	O
week	O
for	O
4	O
or	O
10	O
mo	O
)	O
.	O

Instead	O
,	O
the	O
large	O
difference	O
in	O
ssDNA	O
-	O
binding	O
affinities	O
reflects	O
the	O
loss	O
of	O
hexamerization	O
ability	O
by	O
uvsY	B
,	O
suggesting	O
that	O
a	O
form	O
of	O
intrahexamer	O
synergism	O
or	O
cooperativity	O
between	O
binding	O
sites	O
within	O
the	O
uvsY	B
hexamer	I
leads	O
to	O
its	O
high	O
observed	O
affinity	O
for	O
ssDNA	O
.	O

Sox8	B
maps	O
to	O
the	O
t	B
complex	I
on	O
mouse	O
chromosome	O
17	O
and	O
to	O
human	O
chromosome	O
16p13.3	O
,	O
a	O
region	O
associated	O
with	O
the	O
microphthalmia	O
-	O
cataract	O
syndrome	O
CATM	O
and	O
the	O
alpha	O
-	O
thalassemia	O
/	O
mental	O
retardation	O
syndrome	O
ATR-16	O
.	O

Evaluation	O
of	O
the	O
effects	O
of	O
chelation	O
therapy	O
with	O
time	O
following	O
strontium	O
exposure	O
to	O
mice	O
.	O

To	O
better	O
understand	O
the	O
relationship	O
between	O
expression	O
of	O
an	O
oncogene	O
and	O
genetic	O
instability	O
,	O
we	O
have	O
studied	O
a	O
cell	O
line	O
expressing	O
an	O
activated	B
human	I
Ha	I
-	I
ras	I
under	O
the	O
control	O
of	O
bacterial	B
lactose	I
operon	I
regulatory	I
elements	I
for	O
changes	O
in	O
methotrexate	O
resistance	O
and	O
dihydrofolate	B
reductase	I
(	O
dhfr	B
)	O
gene	O
amplification	O
following	O
mutant	B
Ha	I
-	I
ras	I
induction	O
.	O

The	O
aim	O
of	O
this	O
work	O
was	O
to	O
organize	O
chemical	O
data	O
in	O
a	O
client	O
-	O
server	O
environment	O
using	O
Database	O
Management	O
System	O
and	O
Web	O
fashion	O
for	O
the	O
client	O
interface	O
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
exhibits	O
95.3	O
and	O
76.1	O
%	O
identity	O
with	O
the	O
CAD	B
sequences	I
of	I
hamster	I
and	I
Squalus	I
acanthias	I
.	O

The	O
sulfur	O
species	O
could	O
be	O
separated	O
within	O
less	O
than	O
4	O
min	O
by	O
CZE	O
with	O
a	O
pyromellitic	O
acid	O
electrolyte	O
at	O
pH	O
3.5	O
to	O
5.0	O
.	O

Because	O
of	O
the	O
structural	O
similarities	O
the	O
new	O
gene	O
will	O
be	O
termed	O
scERV2	B
from	O
now	O
on	O
.	O

Analysis	O
of	O
the	O
DNA	O
sequence	O
upstream	O
of	O
the	O
narQ	B
gene	I
,	O
which	O
encodes	O
the	O
second	O
nitrate	O
-	O
responsive	O
sensor	O
-	O
transmitter	O
protein	O
in	O
Escherichia	O
coli	O
,	O
revealed	O
an	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
whose	O
product	O
shows	O
a	O
high	O
degree	O
of	O
similarity	O
to	O
a	O
number	O
of	O
iron	B
-	I
sulfur	I
proteins	I
as	O
well	O
as	O
to	O
the	O
beta	O
subunit	O
of	O
glutamate	B
synthase	I
(	O
gltD	B
)	O
of	O
E.	O
coli	O
.	O

In	O
CYP7A1	B
transgenic	O
mice	O
,	O
livers	O
contained	O
approximately	O
3-fold	O
more	O
sterol	B
response	I
element	I
-	I
binding	I
protein-2	I
mRNA	I
.	O

A	O
total	O
of	O
10,763	O
men	O
and	O
3,118	O
women	O
has	O
been	O
studied	O
,	O
of	O
whom	O
97	O
%	O
and	O
89	O
%	O
,	O
respectively	O
,	O
have	O
been	O
traced	O
and	O
36	O
%	O
and	O
16	O
%	O
have	O
died	O
.	O

One	O
of	O
them	O
is	O
its	O
limited	O
sensitivity	O
to	O
weak	O
interactions	O
,	O
which	O
are	O
common	O
in	O
the	O
mammalian	O
cerebral	O
cortex	O
.	O

Cefminox	O
shows	O
greater	O
in	O
vivo	O
activity	O
than	O
that	O
expected	O
for	O
the	O
MICs	O
,	O
excellent	O
efficacy	O
and	O
safety	O
.	O

We	O
have	O
previously	O
demonstrated	O
that	O
pyrene	O
in	O
diesel	O
-	O
exhaust	O
particles	O
(	O
DEP	O
)	O
has	O
an	O
adjuvant	O
activity	O
on	O
immunoglobulin	B
E	I
(	O
IgE	B
)	O
antibody	O
production	O
in	O
mice	O
immunized	O
with	O
Japanese	O
cedar	O
pollen	O
allergen	O
(	O
JCPA	O
)	O
or	O
ovalbumin	B
(	O
OA	B
)	O
intraperitoneally	O
.	O

The	O
corresponding	O
tetrapeptide	O
sequences	O
SSPD	O
and	O
SATD	O
for	O
human	B
and	I
mouse	I
PKC	I
-	I
epsilon	I
,	O
respectively	O
,	O
are	O
unusual	O
for	O
caspase-3	B
.	O

A	O
poly	O
(	O
ortho	O
ester	O
)	O
designed	O
for	O
combined	O
ocular	O
delivery	O
of	O
dexamethasone	O
sodium	O
phosphate	O
and	O
5-fluorouracil	O
:	O
subconjunctival	O
tolerance	O
and	O
in	O
vitro	O
release	O
.	O

Regardless	O
of	O
muscle	O
tensioning	O
or	O
marination	O
treatments	O
,	O
aging	O
of	O
the	O
carcass	O
for	O
24	O
h	O
(	O
T1	O
,	O
T2	O
,	O
and	O
T3	O
)	O
produced	O
meats	O
with	O
lower	O
shear	O
values	O
than	O
those	O
from	O
hot	O
-	O
boned	O
carcasses	O
(	O
T4	O
and	O
T5	O
)	O
.	O

This	O
effect	O
was	O
stronger	O
after	O
multiple	O
predoses	O
of	O
sertraline	O
,	O
when	O
imipramine	O
Cmax	O
and	O
AUC	O
(	O
0-infinity	O
)	O
were	O
increased	O
by	O
39	O
%	O
and	O
68	O
%	O
,	O
respectively	O
.	O

It	O
is	O
pathogenetically	O
proved	O
to	O
use	O
antithrombin	B
III	I
concentrate	O
preparations	O
with	O
anti-	O
and	O
dysaggregatory	O
properties	O
,	O
fibronectin	B
preparations	O
,	O
trasylol	O
or	O
its	O
analogs	O
during	O
complex	O
preoperative	O
preparation	O
of	O
patients	O
.	O

LV	O
compliance	O
was	O
determined	O
from	O
the	O
slope	O
of	O
the	O
LV	O
end	O
-	O
diastolic	O
pressure	O
(	O
LVEDP	O
)	O
vs.	O

The	O
ARE	O
is	O
loosely	O
defined	O
as	O
the	O
five	O
-	O
nucleotide	O
sequence	O
AUUUA	O
embedded	O
in	O
a	O
uracil	O
-	O
rich	O
region	O
.	O

A	O
regulatory	O
element	O
of	O
the	O
empty	B
spiracles	I
homeobox	O
gene	O
is	O
composed	O
of	O
three	O
distinct	O
conserved	O
regions	O
that	O
bind	O
regulatory	O
proteins	O
.	O

Together	O
with	O
previous	O
work	O
our	O
results	O
suggest	O
that	O
C	B
/	I
EBP	I
may	O
be	O
a	O
general	O
cooperation	O
partner	O
for	O
v	B
-	I
Myb	I
in	O
myelomonocytic	O
cells	O
.	O

This	O
bud	O
morphology	O
results	O
at	O
least	O
in	O
part	O
from	O
a	O
cell	O
cycle	O
delay	O
imposed	O
by	O
the	O
Cdc28p	B
-	O
inhibitory	O
kinase	O
Swe1p	B
.	O

Nonlethal	O
sec71	B
-	I
1	I
and	O
sec72	B
-	I
1	I
mutations	I
eliminate	O
proteins	O
associated	O
with	O
the	O
Sec63p	B
-	O
BiP	B
complex	O
from	O
S.	O
cerevisiae	O
.	O

Analytical	O
scanning	O
isoelectrofocusing	O
.	O

In	O
the	O
future	O
,	O
transoesophageal	O
echocardiography	O
may	O
be	O
used	O
to	O
measure	O
variations	O
in	O
wall	O
thickness	O
which	O
change	O
the	O
global	O
loading	O
conditions	O
in	O
the	O
basal	O
midwall	O
compartments	O
of	O
the	O
left	O
ventricle	O
.	O

Thus	O
,	O
d	O
-	O
delta3-carene	O
was	O
about	O
four	O
times	O
more	O
potent	O
as	O
a	O
sensory	O
irritant	O
than	O
I	O
-	O
beta	O
-	O
pinene	O
,	O
whereas	O
the	O
difference	O
with	O
I	O
-	O
alpha	O
-	O
pinene	O
was	O
more	O
marked	O
;	O
as	O
a	O
sensory	O
irritant	O
,	O
I	O
-	O
alpha	O
-	O
pinene	O
is	O
almost	O
inactive	O
.	O

Sodium	O
dodecylsulfate	O
polyacrylamide	O
gel	O
electrophoresis	O
(	O
SDS	O
-	O
PAGE	O
)	O
showed	O
two	O
bands	O
of	O
about	O
the	O
same	O
intensity	O
with	O
apparent	O
molecular	O
masses	O
of	O
24.5	O
and	O
22.5	O
kDa	O
.	O

However	O
,	O
at	O
the	O
time	O
of	O
salvage	O
treatment	O
,	O
the	O
mean	O
serum	B
PSA	I
levels	O
were	O
9.1	O
and	O
1.1	O
ng	O
/	O
mL	O
for	O
the	O
salvage	O
RP	O
and	O
salvage	O
RT	O
groups	O
,	O
respectively	O
(	O
P	O
=	O
0.0001	O
)	O
.	O

Uncoupling	O
gene	O
activity	O
from	O
chromatin	O
structure	O
:	O
promoter	O
mutations	O
can	O
inactivate	O
transcription	O
of	O
the	O
yeast	B
HSP82	I
gene	I
without	O
eliminating	O
nucleosome	O
-	O
free	O
regions	O
.	O

Maximal	O
exercise	O
duration	O
and	O
peak	O
oxygen	O
consumption	O
were	O
not	O
changed	O
.	O

Real	O
-	O
time	O
two	O
-	O
dimensional	O
echocardiographic	O
studies	O
of	O
the	O
mitral	O
valve	O
in	O
short	O
-	O
axis	O
view	O
were	O
obtained	O
from	O
10	O
normal	O
subjects	O
.	O

More	O
important	O
,	O
ligand	O
-	O
activated	O
insulin	B
and	O
IGF	B
-	I
I	I
receptors	I
phosphorylate	O
SHC	B
proteins	I
in	O
vitro	O
,	O
indicating	O
that	O
SHC	B
proteins	I
could	O
be	O
direct	O
substrates	O
for	O
insulin	B
and	O
IGF	B
-	I
I	I
receptors	I
.	O

To	O
test	O
for	O
progesterone	B
receptor	I
-	O
mediated	O
activation	O
of	O
transcription	O
in	O
yeast	O
,	O
reporter	O
plasmids	O
were	O
constructed	O
to	O
transform	O
yeast	O
cells	O
expressing	O
PRB	B
or	O
C1C2	B
receptors	I
.	O

TAF-1	B
activates	O
transcription	O
constitutively	O
and	O
was	O
mapped	O
to	O
the	O
first	O
32	O
amino	O
acids	O
of	O
the	O
A	O
-	O
region	O
.	O

We	O
have	O
used	O
the	O
chloramphenicol	B
acetyltransferase	I
(	O
CAT	B
)	O
reporter	O
gene	O
system	O
to	O
study	O
the	O
effect	O
of	O
T	B
on	O
the	O
long	O
terminal	O
repeats	O
(	O
LTRs	O
)	O
of	O
a	O
large	O
family	O
of	O
human	O
endogenous	O
retrovirus	O
-	O
like	O
sequences	O
,	O
RTVL	O
-	O
H.	O

They	O
contain	O
a	O
large	O
(	O
0.9	O
X	O
10	O
(	O
3	O
)	O
to	O
1.88	O
X	O
10	O
(	O
3	O
)	O
base	O
-	O
pairs	O
)	O
intron	O
in	O
the	O
middle	O
of	O
the	O
gene	O
and	O
are	O
further	O
interrupted	O
close	O
to	O
the	O
5	O
'	O
end	O
of	O
the	O
gene	O
.	O

Primer	O
extension	O
experiments	O
using	O
dbcAMP	O
-	O
differentiated	O
U937	O
RNA	O
indicated	O
a	O
single	O
transcriptional	O
initiation	O
site	O
.	O

On	O
a	O
variety	O
of	O
fronts	O
,	O
chronic	O
bacterial	O
infection	O
is	O
being	O
found	O
to	O
be	O
significantly	O
associated	O
with	O
the	O
development	O
of	O
atherosclerosis	O
and	O
the	O
clinical	O
complications	O
of	O
unstable	O
angina	O
,	O
myocardial	O
infarction	O
,	O
and	O
stroke	O
.	O

025	O
)	O
.	O

Although	O
the	O
energy	O
-	O
based	O
DFT	O
was	O
not	O
affected	O
by	O
isoproterenol	O
(	O
from	O
6.1	O
+	O
/-	O

1.5	O
to	O
6.0	O
+	O
/-	O

1.7	O
J	O
)	O
,	O
it	O
was	O
decreased	O
to	O
3.7	O
+	O
/-	O

1.6	O
J	O
in	O
the	O
third	O
stage	O
by	O
infusion	O
of	O
E4031	O
and	O
isoproterenol	O
(	O
p	O
<	O
0.01	O
vs.	O
baseline	O
and	O
vs.	O
isoproterenol	O
)	O
.	O

In	O
cases	O
of	O
intracapsular	O
prostatic	O
cancer	O
the	O
level	O
of	O
prostatic	B
acid	I
phosphatase	I
(	O
PAP	B
)	O
measured	O
by	O
radioimmunoassay	O
was	O
1.4	O
+	O
/-	O

0.8	O
micrograms	O
/	O
l	O
.	O

CONCLUSIONS	O
:	O
The	O
number	O
of	O
Spanish	O
articles	O
published	O
in	O
Anesthesiology	O
,	O
BJA	O
,	O
and	O
Anesth	O
Analg	O
is	O
low	O
,	O
although	O
the	O
comparison	O
of	O
our	O
productivity	O
with	O
that	O
of	O
other	O
EU	O
countries	O
in	O
function	O
of	O
GNPpc	O
places	O
us	O
in	O
an	O
intermediate	O
position	O
.	O

Neonatal	O
hyperthyroidism	O

Serum	O
prolactin	B
rapidly	O
decreased	O
after	O
institution	O
of	O
treatment	O
,	O
with	O
actual	O
normalization	O
(	O
less	O
than	O
20	O
ng	O
/	O
ml	O
)	O
by	O
the	O
3rd	O
month	O
.	O

Three	O
high	O
-	O
amylose	O
rice	O
varieties	O
,	O
IR42	O
,	O
IR36	O
,	O
and	O
IR62	O
,	O
with	O
similar	O
chemical	O
composition	O
including	O
amylose	O
content	O
(	O
26.7	O
-	O
27.0	O
%	O
)	O
,	O
were	O
cooked	O
under	O
the	O
same	O
conditions	O
and	O
tested	O
for	O
in	O
vitro	O
digestibility	O
as	O
well	O
as	O
blood	O
glucose	O
and	O
insulin	B
responses	O
in	O
healthy	O
human	O
volunteers	O
.	O

This	O
indicates	O
changes	O
in	O
postvaccination	O
allergy	O
to	O
BCG	O
.	O

Between	O
the	O
RNA	O
initiation	O
site	O
and	O
the	O
coding	O
region	O
is	O
a	O
GC	O
-	O
rich	O
hairpin	O
structure	O
followed	O
by	O
8	O
T	O
residues	O
that	O
looks	O
like	O
a	O
rho	B
-	I
independent	I
transcription	I
terminator	I
.	O

The	O
term	O
Kartagener	O
syndrome	O
applies	O
to	O
this	O
syndrome	O
when	O
accompanied	O
by	O
infertility	O
and	O
dextrocardia	O
or	O
situs	O
inversus	O
.	O

The	O
ferric	B
uptake	I
regulation	I
(	O
fur	B
)	O
gene	O
product	O
participates	O
in	O
regulating	O
expression	O
of	O
the	O
manganese-	O
and	O
iron	O
-	O
containing	O
superoxide	B
dismutase	I
genes	I
of	I
Escherichia	I
coli	I
.	O

On	O
average	O
these	O
maximum	O
potency	O
estimates	O
were	O
within	O
one	O
order	O
of	O
magnitude	O
of	O
the	O
inverse	O
maximum	O
dose	O
tested	O
.	O

Furthermore	O
,	O
CL100	B
suppresses	O
the	O
[	O
val12	O
]	O
ras	B
-	O
induced	O
activation	O
of	O
MAP	B
kinase	I
in	O
a	O
cell	O
-	O
free	O
system	O
from	O
Xenopus	O
oocytes	O
.	O

Static	O
and	O
dynamic	O
MRI	O
of	O
the	O
normal	O
and	O
pathological	O
female	O
pelvic	O
floor	O

Mutation	O
of	O
K14	O
in	O
H3	B
,	O
which	O
serves	O
as	O
the	O
major	O
target	O
of	O
recombinant	B
Gcn5p	I
acetylation	O
in	O
vitro	O
,	O
confers	O
a	O
strong	O
,	O
synthetic	O
growth	O
defect	O
in	O
gcn5	B
cells	O
.	O

Medical	O
management	O
of	O
early	O
-	O
stage	O
breast	O
cancer	O
.	O

Upon	O
incubation	O
of	O
the	O
most	O
highly	O
purified	O
fractions	O
with	O
Mn	O
-	O
ATP	O
or	O
Mg	O
-	O
ATP	O
,	O
p40	B
was	O
the	O
only	O
protein	O
phosphorylated	O
on	O
tyrosine	O
.	O

CLINICAL	O
FEATURES	O
:	O
This	O
30-yr	O
-	O
old	O
gravida	O
V	O
para	O
0	O
woman	O
presented	O
to	O
the	O
anaesthesia	O
consultation	O
clinic	O
at	O
37-wk	O
gestation	O
to	O
discuss	O
pain	O
relief	O
options	O
for	O
labour	O
and	O
delivery	O
.	O

Judge	O
Christian	O
Byk	O
renders	O
service	O
to	O
the	O
Steering	O
Committee	O
on	O
Bioethics	O
of	O
the	O
Council	O
of	O
Europe	O
(	O
CDBI	O
)	O
by	O
proposing	O
a	O
draft	O
of	O
the	O
protocol	O
destined	O
to	O
fill	O
in	O
a	O
gap	O
in	O
international	O
law	O
on	O
the	O
status	O
of	O
the	O
human	O
embryo	O
.	O

The	O
human	O
protein	O
is	O
encoded	O
by	O
a	O
900-base	O
pair	O
-	O
long	O
mRNA	O
that	O
is	O
expressed	O
in	O
the	O
glandular	O
epithelial	O
cells	O
of	O
the	O
endometrium	O
in	O
a	O
cyclic	O
manner	O
;	O
in	O
addition	O
,	O
it	O
is	O
found	O
in	O
the	O
mucosal	O
epithelial	O
cells	O
of	O
the	O
fallopian	O
tubes	O
.	O

We	O
conclude	O
that	O
a	O
0.25	O
mg	O
dose	O
of	O
triazolam	O
does	O
not	O
effectively	O
counteract	O
a	O
posture	O
-	O
induced	O
sleep	O
disturbance	O
,	O
but	O
induces	O
changes	O
in	O
the	O
EEG	O
spectra	O
which	O
are	O
typical	O
for	O
benzodiazepine	B
receptor	I
agonists	O
.	O

Northern	O
blot	O
analysis	O
of	O
liver	O
,	O
muscle	O
,	O
fat	O
,	O
and	O
pituitary	O
RNA	O
from	O
normal	O
(	O
DwDw	O
)	O
chickens	O
shows	O
a	O
major	O
transcript	O
of	O
4.3	O
kilobases	O
(	O
kb	O
)	O
and	O
three	O
minor	O
transcripts	O
(	O
0.8	O
,	O
1.7	O
,	O
and	O
3.2	O
kb	O
)	O
,	O
which	O
correspond	O
to	O
the	O
cGHR	B
.	O

The	O
procedure	O
was	O
technically	O
successful	O
in	O
12	O
of	O
14	O
(	O
86	O
%	O
)	O
stenoses	O
in	O
the	O
fibromuscular	O
dysplasia	O
subgroup	O
but	O
in	O
only	O
one	O
of	O
five	O
(	O
20	O
%	O
)	O
lesions	O
in	O
the	O
neurofibromatosis	O
subgroup	O
.	O

Amplitude	O
of	O
late	O
surface	O
(	O
P2	O
and	O
N2	O
)	O
and	O
depth	O
(	O
B	O
and	O
C	O
)	O
components	O
significantly	O
decreased	O
when	O
patients	O
shifted	O
from	O
SWS	O
IV	O
to	O
PS	O
and	O
increased	O
from	O
PS	O
to	O
W2	O
.	O

We	O
then	O
supplemented	O
these	O
spliceosomes	O
with	O
purified	O
proteins	O
or	O
yeast	O
extract	O
fractions	O
as	O
a	O
functional	O
assay	O
for	O
second	O
-	O
step	O
splicing	O
factors	O
.	O

We	O
discuss	O
the	O
possibility	O
that	O
DNA	O
-	O
protein	O
interactions	O
at	O
homologous	O
nucleotide	O
sequences	O
like	O
those	O
identified	O
in	O
PII	O
are	O
part	O
of	O
a	O
regulatory	O
gene	O
cascade	O
that	O
participates	O
in	O
timing	O
fla	B
gene	I
expression	O
in	O
the	O
C.	O
crescentus	O
cell	O
cycle	O
.	O

Nramp2	B
contains	O
a	O
classical	O
iron	O
responsive	O
element	O
in	O
the	O
3	O
'	O
untranslated	O
region	O
that	O
confers	O
iron	O
dependent	O
mRNA	O
stabilization	O
.	O

When	O
a	O
longer	O
-714	O
to	O
+	O
78	O
fragment	O
of	O
the	O
PBGD	B
promoter	I
is	O
used	O
,	O
the	O
-70	O
GATA	O
mutant	O
still	O
displays	O
erythroid	O
-	O
specific	O
activity	O
and	O
is	O
cis	O
-	O
activated	O
by	O
the	O
5'HS-2	B
enhancer	I
,	O
while	O
the	O
-100	O
CCACC	O
mutant	O
is	O
completely	O
inactive	O
in	O
the	O
absence	O
or	O
in	O
the	O
presence	O
of	O
the	O
5'HS-2	B
enhancer	I
.	O

The	O
Robert	O
Wood	O
Johnson	O
Foundation	O
:	O
billion	O
dollar	O
force	O
for	O
health	O
-	O
care	O
change	O
.	O

Constant	O
slowing	O
of	O
median	O
MNCV	O
and	O
SNCV	O
and	O
ulnar	O
SNCV	O
without	O
changes	O
in	O
morphology	O
,	O
amplitude	O
and	O
duration	O
of	O
MAP	O
and	O
SAP	O
have	O
been	O
observed	O
in	O
92	O
patients	O
,	O
with	O
persistent	O
abnormalities	O
in	O
64	O
cases	O
after	O
six	O
months	O
.	O

Studies	O
with	O
and	O
without	O
attenuating	O
media	O
were	O
performed	O
,	O
and	O
myocardium	O
-	O
to	O
-	O
defect	O
count	O
ratios	O
and	O
defect	O
sizes	O
from	O
dual	O
-	O
isotope	O
SPECT	O
images	O
were	O
compared	O
to	O
myocardium	O
-	O
to	O
-	O
defect	O
count	O
ratios	O
and	O
defect	O
sizes	O
from	O
single	O
-	O
isotope	O
(	O
201Tl	O
and	O
99mTc	O
)	O
SPECT	O
images	O
.	O

The	O
N1-P2	O
amplitudes	O
of	O
the	O
AEP	O
decreased	O
with	O
increasing	O
strength	O
of	O
muscular	O
innervation	O
.	O

Measurements	O
in	O
rats	O
given	O
a	O
dose	O
of	O
propranolol	O
that	O
partially	O
inhibited	O
the	O
NA	O
-	O
induced	O
increase	O
in	O
Q	O
to	O
IBAT	O
indicated	O
that	O
the	O
decline	O
in	O
ENAIBAT	O
was	O
attributable	O
primarily	O
to	O
the	O
increase	O
in	O
Q	O
rather	O
than	O
to	O
increasing	O
saturation	O
of	O
uptake	O
mechanisms	O
.	O

The	O
role	O
of	O
NUT1	B
and	O
regulation	O
of	O
nitrogen	O
metabolism	O
in	O
the	O
disease	O
process	O
was	O
evaluated	O
by	O
pathogenicity	O
assays	O
.	O

This	O
study	O
tests	O
the	O
hypothesis	O
that	O
O2	O
is	O
a	O
critical	O
component	O
in	O
myocardial	O
protection	O
afforded	O
by	O
BCP	O
.	O

An	O
ICU	O
length	O
of	O
stay	O
shorter	O
than	O
24	O
h	O
was	O
not	O
related	O
to	O
the	O
frequency	O
of	O
group	O
C	O
errors	O
.	O

Injection	O
of	O
horseradish	B
peroxidase	I
(	O
HRP	B
)	O
into	O
the	O
cerebellar	O
flocculus	O
of	O
the	O
rat	O
was	O
employed	O
to	O
identify	O
neurons	O
in	O
the	O
abducens	O
nucleus	O
that	O
project	O
to	O
the	O
flocculus	O
.	O

The	O
enzyme	O
encoded	O
by	O
the	O
cloned	O
fragment	O
is	O
equally	O
active	O
on	O
pyruvate	O
and	O
hydroxypyruvate	O
,	O
indicating	O
that	O
the	O
enzyme	O
has	O
both	O
D	B
-	I
lactate	I
and	I
D	I
-	I
glycerate	I
dehydrogenase	I
activities	O
.	O

In	O
a	O
subsequent	O
phase	O
-	O
II	O
clinical	O
trial	O
safety	O
and	O
efficacy	O
of	O
transrectal	O
HIFU	O
as	O
a	O
novel	O
minimally	O
invasive	O
treatment	O
modality	O
for	O
patients	O
with	O
symptomatic	O
benign	O
prostatic	O
hyperplasia	O
(	O
BPH	O
;	O
n	O
=	O
102	O
)	O
was	O
determined	O
.	O

Taking	O
into	O
account	O
certain	O
well	O
defined	O
conditions	O
(	O
frequent	O
feedings	O
,	O
no	O
supplementary	O
feeding	O
before	O
4	O
-	O
6	O
months	O
,	O
method	O
only	O
to	O
be	O
used	O
in	O
the	O
absence	O
of	O
menstruation	O
)	O
,	O
LAM	O
can	O
be	O
relied	O
on	O
for	O
contraceptive	O
protection	O
for	O
up	O
to	O
1	O
year	O
post	O
partum	O
.	O

Our	O
data	O
suggest	O
that	O
the	O
ZF	B
-	I
HD	I
class	O
of	O
homeodomain	B
proteins	I
may	O
be	O
involved	O
in	O
the	O
establishment	O
of	O
the	O
characteristic	O
expression	O
pattern	O
of	O
the	O
C4	B
PEPCase	I
gene	I
.	O

Although	O
the	O
only	O
authoritative	O
way	O
to	O
determine	O
the	O
effect	O
of	O
diet	O
on	O
urinary	O
pH	O
is	O
a	O
feeding	O
trial	O
,	O
there	O
is	O
no	O
universally	O
accepted	O
protocol	O
for	O
measuring	O
urinary	O
pH.	O

In	O
stage	O
I	O
,	O
histochemistry	O
for	O
copper	O
was	O
positive	O
in	O
11	O
out	O
of	O
21	O
cases	O
:	O
6	O
cases	O
were	O
T+	O
;	O
1	O
case	O
R+	O
and	O
2	O
cases	O
O+	O
;	O
2	O
cases	O
were	O
T+	O
,	O
R+	O
,	O
O+	O
.	O

A	O
24-year	O
-	O
old	O
pregnant	O
woman	O
started	O
to	O
have	O
hyperemesis	O
gravidarum	O
6	O
weeks	O
before	O
admission	O
.	O

Biopsy	O
of	O
the	O
lesion	O
revealed	O
granulomatous	O
inflammation	O
and	O
numerous	O
septate	O
hyphae	O
.	O

Mating	O
response	O
,	O
ovulation	O
rate	O
,	O
follicle	O
and	O
corpus	O
luteum	O
size	O
,	O
gestation	O
length	O
,	O
pregnancy	O
rate	O
,	O
lambing	O
rate	O
,	O
and	O
lamb	O
birth	O
weight	O
were	O
recorded	O
.	O

A	O
biopsy	O
specimen	O
taken	O
from	O
the	O
frontal	O
branch	O
of	O
the	O
right	O
superficial	O
artery	O
revealed	O
segmental	O
intimal	O
thickening	O
consistent	O
with	O
intimal	O
fibroplasia	O
type	O
FMD	O
upon	O
histological	O
examination	O
.	O

Reduced	O
risk	O
of	O
upper	O
gastrointestinal	O
ulcer	O
complications	O
with	O
celecoxib	O
,	O
a	O
novel	O
COX-2	B
inhibitor	O
.	O

The	O
DW	O
directions	O
uniformly	O
sampled	O
the	O
diffusion	O
ellipsoid	O
surface	O
.	O

Recent	O
,	O
highly	O
visible	O
reviews	O
on	O
the	O
subject	O
have	O
clearly	O
pointed	O
out	O
that	O
little	O
is	O
known	O
about	O
the	O
cellular	O
mechanisms	O
through	O
which	O
inhaled	O
asbestos	O
fibers	O
cause	O
the	O
well	O
known	O
,	O
debilitating	O
lung	O
disease	O
-	O
asbestosis	O
(	O
i.e.	O
interstitial	O
pulmonary	O
fibrosis	O
)	O
.	O

The	O
Rep78	B
protein	I
of	O
adeno	O
-	O
associated	O
virus	O
(	O
AAV	O
)	O
contains	O
amino	O
acid	O
sequence	O
motifs	O
common	O
to	O
rolling	B
-	I
circle	I
replication	I
(	I
RCR	I
)	I
initiator	I
proteins	I
.	O

METHODS	O
:	O
Two	O
patients	O
developed	O
cervical	O
myelopathy	O
or	O
radiculopathy	O
after	O
spinal	O
manipulation	O
therapy	O
,	O
and	O
magnetic	O
resonance	O
imaging	O
showed	O
herniated	O
cervical	O
discs	O
at	O
C4-C5	O
and	O
C6-C7	O
,	O
respectively	O
.	O

Isolates	O
of	O
B.	O
burgdorferi	O
from	O
humans	O
,	O
rodents	O
,	O
and	O
I.	O
dammini	O
are	O
usually	O
indistinguishable	O
,	O
but	O
strains	O
of	O
B.	O
burgdorferi	O
with	O
different	O
major	O
proteins	O
have	O
been	O
identified	O
.	O

In	O
a	O
pilot	O
study	O
in	O
which	O
two	O
dogs	O
were	O
given	O
parenteral	O
rifampin	O
before	O
and	O
after	O
operation	O
and	O
grafts	O
were	O
preclotted	O
with	O
blood	O
that	O
contained	O
rifampin	O
,	O
it	O
was	O
suggested	O
that	O
there	O
was	O
a	O
slight	O
increase	O
in	O
inhibition	O
at	O
24	O
hours	O
(	O
93	O
%	O
)	O
.	O

To	O
study	O
the	O
mechanisms	O
and	O
the	O
signaling	O
pathways	O
involved	O
,	O
IGF-1R	B
promoter	I
reporter	I
constructs	I
were	O
transiently	O
transfected	O
in	O
CHO	O
-	O
AT1	O
cells	O
that	O
overexpress	O
angiotensin	B
AT1	I
receptors	I
.	O

Gel	O
shift	O
analysis	O
of	O
protein	O
binding	O
from	O
nuclear	O
extracts	O
to	O
these	O
caveolin	B
promoter	I
DNA	I
sequences	I
,	O
together	O
with	O
DNase	B
I	I
footprinting	O
,	O
confirmed	O
nucleoprotein	O
binding	O
to	O
the	O
SRE	O
-	O
like	O
elements	O
as	O
part	O
of	O
the	O
transcriptional	O
response	O
to	O
LDL	B
-	I
FC	I
.	O

Early	O
attempts	O
for	O
modifying	O
growth	O
functions	O
to	O
annual	O
variations	O
dating	O
back	O
up	O
to	O
2	O
decades	O
are	O
recalled	O
together	O
with	O
examples	O
for	O
their	O
application	O
showing	O
rather	O
different	O
degrees	O
of	O
approximation	O
.	O

Indications	O
for	O
therapy	O
using	O
MAO	B
inhibitors	O

Through	O
effective	O
use	O
of	O
laboratory	O
testing	O
database	O
,	O
it	O
will	O
be	O
possible	O
to	O
shift	O
away	O
our	O
vague	O
management	O
of	O
pre	O
-	O
analytic	O
phase	O
of	O
quality	O
control	O
so	O
far	O
to	O
its	O
established	O
system	O
based	O
on	O
objective	O
evaluation	O
.	O

The	O
melanoma	B
growth	I
stimulatory	I
activity	I
/	I
growth	I
-	I
regulated	I
protein	I
,	O
CXCL1	B
,	O
is	O
constitutively	O
expressed	O
at	O
high	O
levels	O
during	O
inflammation	O
and	O
progression	O
of	O
melanocytes	O
into	O
malignant	O
melanoma	O
.	O

The	O
activated	O
glucocorticoid	B
receptor	I
forms	O
a	O
complex	O
with	O
Stat5	B
and	O
enhances	O
Stat5-mediated	B
transcriptional	O
induction	O
.	O

The	O
median	O
levels	O
of	O
t	B
-	I
PA	I
Ag	I
and	O
PAI	B
in	O
plasma	O
were	O
respectively	O
10.7	O
ng	O
/	O
ml	O
(	O
interquartile	O
range	O
8.6	O
ng	O
/	O
ml	O
)	O
and	O
15.7	O
IU	O
/	O
ml	O
(	O
interquartile	O
range	O
12.2	O
IU	O
/	O
ml	O
)	O
.	O

The	O
rice	O
gene	O
consists	O
of	O
four	O
exons	O
.	O

One	O
of	O
the	O
ORFs	O
in	O
the	O
Methanococcus	O
jannaschii	O
genome	O
possesses	O
high	O
similarity	O
to	O
the	O
M.	B
aeolicus	I
ilvB	I
,	O
indicating	O
that	O
it	O
is	O
an	O
authentic	O
AHAS	B
.	O

It	O
differed	O
from	O
cued	O
recall	O
only	O
in	O
the	O
instructions	O
,	O
which	O
directed	O
subjects	O
away	O
from	O
the	O
memory	O
aspects	O
of	O
the	O
test	O
and	O
asked	O
them	O
to	O
complete	O
each	O
three	O
-	O
letter	O
cue	O
with	O
the	O
first	O
word	O
that	O
came	O
to	O
mind	O
.	O

Samarium-153	O
for	O
intravascular	O
irradiation	O
therapy	O
with	O
liquid	O
-	O
filled	O
balloons	O
to	O
prevent	O
restenosis	O
:	O
acute	O
and	O
long	O
-	O
term	O
results	O
in	O
a	O
hypercholesterolemic	O
rabbit	O
restenosis	O
model	O
.	O

We	O
determined	O
that	O
Hop	B
(	I
T42	I
)	I
contains	O
a	O
glutamic	O
acid	O
-	O
to	O
-	O
lysine	O
substitution	O
at	O
amino	O
acid	O
residue	O
695	O
(	O
E695	O
K	O
)	O
.	O

It	O
is	O
suggested	O
that	O
on	O
presentation	O
of	O
tail	O
tip	O
necrosis	O
in	O
kittens	O
a	O
diagnosis	O
of	O
neonatal	O
isoerythrolysis	O
or	O
isoagglutination	O
should	O
be	O
considered	O
.	O

The	O
effects	O
of	O
cefazolin	O
,	O
given	O
into	O
the	O
III	O
cerebral	O
ventricle	O
at	O
different	O
doses	O
were	O
studied	O
on	O
GABA	O
content	O
,	O
GAD	O
and	O
GABA	O
-	O
T	O
in	O
the	O
brain	O
-	O
stem	O
of	O
young	O
chickens	O
(	O
Gallus	O
domesticus	O
)	O
.	O

The	O
amino	B
-	I
terminal	I
gag	I
-	I
encoded	I
region	I
of	O
P140gag	B
-	O
fps	B
contains	O
a	O
phosphotyrosine	O
residue	O
in	O
addition	O
to	O
normal	O
gag	B
phosphorylation	O
sites	O
.	O

The	O
subjects	O
'	O
lungs	O
were	O
ventilated	O
with	O
N2O	O
in	O
O2	O
(	O
FIO2	O
0.3	O
)	O
to	O
the	O
end	O
-	O
tidal	O
CO2	O
present	O
before	O
anesthesia	O
,	O
and	O
then	O
CBF	O
was	O
measured	O
using	O
intravenous	O
133Xe	O
and	O
ten	O
scintillation	O
counters	O
,	O
five	O
over	O
each	O
cerebral	O
hemisphere	O
.	O

Six	O
patients	O
(	O
24	O
%	O
)	O
developed	O
sepsis	O
and	O
only	O
one	O
survived	O
.	O

Diabetic	O
osteopenia	O
,	O
a	O
known	O
chronic	O
complication	O
of	O
diabetes	O
,	O
has	O
been	O
demonstrated	O
with	O
alterations	O
in	O
the	O
calcium	O
-	O
vitamin	O
D	O
endocrine	O
system	O
.	O

In	O
this	O
reconstituted	O
system	O
,	O
RNAP	B
IIA	I
,	O
but	O
not	O
RNAP	B
IIB	I
,	O
can	O
transcribe	O
from	O
the	O
DHFR	B
promoter	I
.	O

Furthermore	O
,	O
the	O
data	O
suggest	O
an	O
immunological	O
non	O
-	O
responsiveness	O
to	O
enterotoxin	B
A	I
in	O
a	O
considerable	O
portion	O
of	O
the	O
patients	O
.	O

In	O
addition	O
,	O
the	O
authors	O
found	O
one	O
an3	B
allele	I
(	O
an3-W138A	B
)	O
in	O
which	O
a	O
dTph1	B
element	I
had	O
inserted	O
30	O
bp	O
upstream	O
the	O
translation	O
start	O
,	O
without	O
inactivating	O
the	O
gene	O
.	O

The	O
right	O
cornea	O
of	O
rats	O
was	O
cauterized	O
by	O
drops	O
of	O
1.5	O
N	O
HC1	O
over	O
30	O
s	O
;	O
the	O
left	O
one	O
served	O
as	O
a	O
control	O
.	O

Secretion	O
of	O
cuticle	O
over	O
and	O
between	O
the	O
domed	O
apical	O
surfaces	O
of	O
these	O
cells	O
leads	O
to	O
a	O
honeycomb	O
-	O
like	O
structure	O
and	O
gives	O
the	O
superficial	O
wart	O
-	O
like	O
phenotype	O
of	O
mitotic	O
clones	O
on	O
the	O
adult	O
.	O

The	O
sequences	O
of	O
two	O
previously	O
known	O
tail	B
genes	I
,	O
R	B
and	O
S	B
,	O
of	O
the	O
temperate	O
bacteriophage	O
P2	O
and	O
the	O
sequence	O
of	O
an	O
additional	O
open	O
reading	O
frame	O
(	O
orf-30	O
)	O
located	O
between	O
S	B
and	O
V	B
,	O
were	O
determined	O
.	O

After	O
a	O
shift	O
to	O
37	O
degrees	O
C	O
,	O
the	O
mutant	O
Rat7	B
-	I
1p	I
/	O
Nup159	B
-	I
1p	I
is	O
lost	O
from	O
the	O
nuclear	O
rim	O
of	O
rat7	O
-	O
1	O
cells	O
and	O
NPCs	O
,	O
which	O
are	O
clustered	O
together	O
in	O
these	O
cells	O
grown	O
under	O
permissive	O
conditions	O
become	O
substantially	O
less	O
clustered	O
.	O

This	O
paper	O
describes	O
a	O
course	O
of	O
therapy	O
with	O
an	O
agoraphobic	O
female	O
patient	O
.	O

The	O
activation	O
of	O
NF	B
-	I
kappaB	I
-	O
dependent	O
reporter	O
gene	O
transcription	O
by	O
E1A	B
was	O
potently	O
suppressed	O
upon	O
coexpression	O
of	O
the	O
E1B	B
19-kDa	I
protein	I
(	I
19	I
K	I
)	I
.	O

We	O
conclude	O
that	O
transcription	O
of	O
both	O
SCD1	B
and	O
SCD2	B
genes	I
is	O
responsive	O
to	O
cellular	O
sterol	O
levels	O
and	O
to	O
the	O
levels	O
of	O
nuclear	O
SREBP	B
/	O
ADD1	B
and	O
that	O
transcriptional	O
induction	O
requires	O
three	O
spatially	O
conserved	O
cis	O
elements	O
,	O
that	O
bind	O
SREBP	B
and	O
NF	B
-	I
Y.	I

BACKGROUND	O
:	O
Recent	O
iterative	O
methods	O
for	O
sequence	O
alignment	O
have	O
indicated	O
that	O
the	O
380	O
kDa	O
motor	O
unit	O
of	O
dynein	B
belongs	O
to	O
the	O
AAA	B
class	I
of	O
chaperone	B
-	I
like	I
ATPases	I
.	O

The	O
vertebrate	B
transcription	I
factors	I
TCF	I
(	O
T	B
cell	I
factor	I
)	O
and	O
LEF	B
(	O
lymphocyte	B
enhancer	I
binding	I
factor	I
)	O
interact	O
with	O
beta	B
-	I
catenin	I
and	O
are	O
hypothesized	O
to	O
mediate	O
Wingless	B
/	O
Wnt	B
signaling	O
.	O

DESIGN	O
:	O
Activating	B
protein-1	I
(	O
AP-1	B
)	O
and	O
Tat	B
-	O
induced	O
transcription	O
were	O
assessed	O
using	O
Jun	B
and	O
hybrid	O
Tat	B
/	O
Jun	B
-	O
expression	O
plasmids	O
and	O
reporter	O
gene	O
constructs	O
which	O
contained	O
AP-1	B
binding	I
sites	I
upstream	O
of	O
the	O
rat	B
prolactin	I
TATAA	I
element	I
or	O
an	O
HIV-1	B
LTR	I
construct	I
in	O
which	O
AP-1	B
binding	I
sites	I
replaced	O
the	O
TAR	O
element	O
.	O

According	O
to	O
the	O
penetration	O
of	O
Ca-45	O
,	O
the	O
microleakage	O
level	O
was	O
scored	O
for	O
each	O
section	O
.	O

KatA	B
,	O
AhpCF	B
,	O
heme	O
biosynthesis	O
enzymes	O
,	O
and	O
MrgA	B
are	O
also	O
induced	O
upon	O
entry	O
into	O
stationary	O
phase	O
under	O
conditions	O
of	O
iron	O
and	O
manganese	O
limitation	O
.	O

Healthy	O
preterm	O
infants	O
of	O
gestational	O
age	O
26	O
-	O
29	O
weeks	O
showed	O
a	O
'	O
mature	O
'	O
pattern	O
of	O
permeability	O
at	O
birth	O
,	O
followed	O
by	O
a	O
temporary	O
period	O
of	O
enhanced	O
permeability	O
after	O
3	O
-	O
4	O
weeks	O
of	O
life	O
.	O

Reproduction	O
and	O
maternal	O
response	O
of	O
the	O
rat	O
when	O
thiamine	O
intake	O
is	O
limited	O
.	O

The	O
formation	O
of	O
tumorlike	O
lesions	O
in	O
the	O
cockroach	O
leucophaea	O
maderae	O
after	O
anal	O
blockage	O
.	O

Promoter	O
,	O
spliced	O
leader	O
,	O
and	O
coding	O
sequence	O
for	O
BICP4	B
,	O
the	O
largest	O
of	O
the	O
immediate	B
-	I
early	I
proteins	I
of	I
bovine	I
herpesvirus	I
1	I
.	O

Effects	O
of	O
prolonged	O
inhibition	O
of	O
labour	O
pains	O
with	O
Th	O
1165a	O
and	O
Isoptin	O
on	O
the	O
heart	O
,	O
circulation	O
,	O
organ-	O
and	O
metabolic	O
parameters	O
of	O
the	O
mother	O

Further	O
studies	O
are	O
warranted	O
to	O
determine	O
whether	O
these	O
findings	O
are	O
idiosyncratic	O
,	O
coincidental	O
,	O
or	O
a	O
more	O
general	O
phenomenon	O
.	O

RESULTS	O
:	O
In	O
men	O
,	O
weight	O
/	O
height2	O
met	O
the	O
criteria	O
for	O
a	O
satisfactory	O
index	O
in	O
that	O
there	O
was	O
a	O
very	O
strong	O
correlation	O
with	O
triceps	O
skinfold	O
,	O
and	O
a	O
negligible	O
correlation	O
with	O
height	O
.	O

Identification	O
of	O
an	O
osteocalcin	B
gene	I
promoter	I
sequence	I
that	O
binds	O
AP1	B
.	O

Sexual	O
adventurism	O
,	O
high	O
-	O
risk	O
behavior	O
,	O
and	O
human	O
immunodeficiency	O
virus-1	O
seroconversion	O
among	O
the	O
Chicago	O
MACS	O
-	O
CCS	O
cohort	O
,	O
1984	O
to	O
1992	O
.	O

It	O
is	O
important	O
to	O
understand	O
the	O
etiology	O
of	O
HITT	O
because	O
of	O
its	O
devastating	O
clinical	O
consequences	O
.	O

New	O
concepts	O
of	O
condyloma	O
acuminata	O
in	O
children	O
.	O

The	O
effect	O
of	O
lung	O
edema	O
on	O
pulmonary	O
vasoactivity	O
of	O
furosemide	O
.	O

Only	O
the	O
native	O
structure	O
of	O
phosphorylated	O
ERK	B
was	O
recognized	O
by	O
VHR	B
and	O
was	O
inactivated	O
with	O
a	O
second	O
-	O
order	O
rate	O
constant	O
of	O
40,000	O
M-1	O
s-1	O
.	O

The	O
Xenopus	B
homeobox	I
gene	I
twin	I
mediates	O
Wnt	B
induction	O
of	O
goosecoid	B
in	O
establishment	O
of	O
Spemann	O
's	O
organizer	O
.	O

Bovine	O
anaplasmosis	O
:	O
susceptibility	O
of	O
seronegative	O
cows	O
from	O
an	O
infected	O
herd	O
to	O
experimental	O
infection	O
with	O
Anaplasma	O
marginale	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
TGFbeta1	B
expression	O
is	O
upregulated	O
in	O
mouse	O
keratinocytes	O
infected	O
with	O
a	O
v	B
-	I
rasHa	I
retrovirus	O
,	O
although	O
the	O
functional	O
significance	O
of	O
this	O
has	O
not	O
been	O
clear	O
.	O

As	O
a	O
member	O
of	O
the	O
uncoupling	B
protein	I
family	I
,	O
UCP2	B
is	O
ubiquitously	O
expressed	O
in	O
rodents	O
and	O
humans	O
,	O
implicating	O
a	O
major	O
role	O
in	O
thermogenesis	O
.	O

In	O
situ	O
localization	O
of	O
PCP	B
-	I
A1	I
transcripts	I
revealed	O
that	O
they	O
accumulate	O
specifically	O
in	O
pollen	O
at	O
the	O
late	O
binucleate	O
/	O
trinucleate	O
stage	O
of	O
development	O
rather	O
than	O
in	O
the	O
tapetum	O
,	O
which	O
previously	O
was	O
taken	O
to	O
be	O
the	O
principal	O
source	O
of	O
the	O
pollen	O
coat	O
.	O

RESULTS	O
:	O
Here	O
,	O
we	O
report	O
the	O
identification	O
of	O
two	O
major	O
and	O
novel	O
Shc	B
tyrosine	O
phosphorylation	O
sites	O
,	O
Y239	O
and	O
Y240	O
.	O

Based	O
on	O
our	O
sequence	O
data	O
,	O
ORF2	O
from	O
most	O
isolates	O
excluding	O
G1	O
encode	O
truncated	O
49	O
aa	O
(	O
pORF2a	O
)	O
because	O
of	O
an	O
in	O
-	O
frame	O
stop	O
codon	O
,	O
although	O
ORF2s	O
from	O
most	O
G1	O
isolates	O
encode	O
202	O
aa	O
(	O
pORF2ab	O
)	O
.	O

Fusions	O
between	O
the	O
GAL	B
DNA	I
binding	I
domain	I
and	O
full	B
-	I
length	I
mSin3	I
were	O
also	O
capable	O
of	O
repression	O
.	O

The	O
method	O
was	O
tested	O
on	O
7	O
rats	O
with	O
48-hr	O
-	O
old	O
myocardial	O
infarction	O
and	O
4	O
sham	O
-	O
operated	O
controls	O
.	O

Disruption	O
and	O
reconstruction	O
:	O
narrative	O
insights	O
into	O
the	O
experience	O
of	O
family	O
members	O
caring	O
for	O
a	O
relative	O
diagnosed	O
with	O
serious	O
mental	O
illness	O
.	O

Thus	O
,	O
an	O
increase	O
in	O
lactate	O
concentration	O
of	O
the	O
magnitude	O
observed	O
during	O
alkali	O
therapy	O
need	O
not	O
indicate	O
a	O
worsening	O
of	O
the	O
metabolic	O
picture	O
in	O
lactic	O
acidosis	O
.	O

A	O
wound	O
model	O
for	O
decubitus	O
and	O
leg	O
ulcers	O
consisting	O
of	O
human	O
dermal	O
fibroblasts	O
in	O
type	B
I	I
collagen	I
dermal	O
""""	O
equivalent	O
""""	O
matrix	O
(	O
DEM	O
)	O
was	O
exposed	O
in	O
vitro	O
to	O
electric	O
fields	O
similar	O
to	O
postulated	O
endogenous	O
fields	O
in	O
wounds	O
.	O

Lastly	O
,	O
several	O
restriction	O
length	O
polymorphisms	O
were	O
identified	O
and	O
mapped	O
within	O
a	O
1	O
kb	O
region	O
located	O
immediately	O
upstream	O
from	O
the	O
JH	B
cluster	I
.	O

Y1	B
,	O
Y2	B
,	O
and	O
Y4	B
/	O
PP1	B
.	O

A	O
case	O
comparison	O
of	O
acquired	O
immune	O
deficiency	O
syndrome	O
(	O
AIDS	O
)	O
in	O
homosexual	O
males	O
with	O
spindle	O
-	O
endothelial	O
cell	O
abnormalities	O
and	O
with	O
recrudescent	O
melioidosis	O
.	O

The	O
significance	O
of	O
these	O
changes	O
in	O
relation	O
to	O
the	O
control	O
of	O
phosphorus	O
balance	O
in	O
ruminants	O
is	O
discussed	O
.	O

UPR	O
elements	O
present	O
in	O
other	O
ER	O
chaperone	O
genes	O
,	O
such	O
as	O
yeast	B
KAR2	I
(	O
BiP	B
)	O
,	O
mammalian	B
GRP78	I
(	O
BiP	B
)	O
,	O
and	O
GRP94	B
,	O
function	O
in	O
an	O
analogous	O
manner	O
to	O
that	O
in	O
FKB2	B
.	O

Acceptability	O
of	O
home	O
monitoring	O
as	O
an	O
aid	O
to	O
conception	O
.	O

The	O
5-HT3	B
antagonist	O
ondansetron	O
reduced	O
alcohol	O
intake	O
in	O
both	O
the	O
medium	O
and	O
high	O
alcohol	O
preferring	O
rats	O
at	O
doses	O
between	O
0.01	O
and	O
0.16	O
mg	O
/	O
kg	O
.	O

In	O
addition	O
,	O
we	O
mapped	O
a	O
putative	O
hnRNP	B
A1	I
binding	I
site	I
in	O
U5	B
RNA	I
and	O
demonstrated	O
that	O
p40CRS	B
(	O
hnRNP	B
A1	I
)	O
binding	O
to	O
that	O
site	O
correlates	O
with	O
CRS	B
function	O
.	O

The	O
gene	O
responsible	O
for	O
multiple	O
endocrine	O
neoplasia	O
type	O
1	O
(	O
MEN1	B
)	O
,	O
a	O
heritable	O
predisposition	O
to	O
endocrine	O
tumours	O
in	O
man	O
,	O
has	O
recently	O
been	O
identified	O
.	O

trans	O
-	O
activation	O
of	O
the	O
HIV-1	B
LTR	I
by	O
the	O
HIV-1	B
Tat	I
and	O
HTLV	B
-	I
I	I
Tax	I
proteins	I
is	O
mediated	O
by	O
different	O
cis	O
-	O
acting	O
sequences	O
.	O

Using	O
green	B
fluorescent	I
protein	I
fusions	O
we	O
demonstrate	O
that	O
the	O
SYT	B
,	O
SSX	B
and	O
the	O
SYT	B
-	O
SSX	B
proteins	O
are	O
nuclear	O
proteins	O
.	O

Similarly	O
,	O
antisense	B
TGF	I
-	I
beta	I
type	I
II	I
receptor	I
oligodeoxynucleotides	I
(	I
40	I
microM	I
)	I
resulted	O
in	O
a	O
58	O
%	O
increase	O
in	O
branching	O
,	O
compared	O
to	O
scrambled	O
and	O
mismatched	O
sequence	O
controls	O
,	O
while	O
TGF	B
-	I
beta	I
,	I
type	I
II	I
receptor	I
mRNA	I
and	O
its	O
protein	O
expression	O
levels	O
were	O
suppressed	O
by	O
95	O
and	O
84	O
%	O
,	O
respectively	O
.	O

This	O
action	O
could	O
be	O
antagonized	O
by	O
aminophylline	O
,	O
a	O
competitive	O
antagonist	O
on	O
P1	B
purinoceptors	I
.	O

A	O
definition	O
of	O
bias	O
founded	O
on	O
the	O
concept	O
of	O
the	O
study	O
base	O
.	O

The	O
use	O
of	O
the	O
two	O
pharmacokinetic	O
parameters	O
,	O
t1	O
/	O
2	O
and	O
Cltp	O
,	O
as	O
indices	O
of	O
drug	O
elimination	O
ability	O
are	O
discussed	O
.	O

In	O
group	O
1	O
,	O
mean	O
z	O
-	O
score	O
for	O
GFR	O
was	O
-0.27	O
(	O
94.6	O
%	O
of	O
normal	O
)	O
and	O
in	O
group	O
2	O
mean	O
z	O
-	O
score	O
was	O
-1.51	O
(	O
72.7	O
%	O
of	O
normal	O
for	O
two	O
kidneys	O
)	O
(	O
P	O
=	O
0.022	O
,	O
Mann	O
-	O
Whitney	O
U	O
-	O
test	O
)	O
.	O

The	O
apparent	O
binding	O
constant	O
of	O
6	O
to	O
calf	O
thymus	O
DNA	O
is	O
1.68	O
X	O
10	O
(	O
5	O
)	O
M-1	O
whereas	O
netropsin	B
under	O
similar	O
conditions	O
gives	O
a	O
value	O
of	O
1.85	O
X	O
10	O
(	O
7	O
)	O
M-1	O
.	O

Neonatal	O
masculinization	O
affects	O
maternal	O
behavior	O
sensitivity	O
in	O
female	O
rats	O
.	O

However	O
,	O
there	O
are	O
some	O
cows	O
that	O
fail	O
to	O
produce	O
adequate	O
1,25-dihydroxyvitamin	O
D	O
at	O
the	O
onset	O
of	O
lactation	O
.	O

We	O
examined	O
the	O
mechanisms	O
by	O
which	O
two	O
different	O
types	O
of	O
photonic	O
radiation	O
,	O
short	O
wavelength	O
UV	O
(	O
UV	O
-	O
C	O
)	O
and	O
gamma	O
radiation	O
,	O
activate	O
transcription	O
factor	O
NF	B
-	I
kappaB.	I

Prenatal	O
diagnosis	O
of	O
genetic	O
diseases	O
.	O

M.	O
,	O
Apps	O
,	O
D.	O

The	O
three	O
OAS	B
genes	I
are	O
flanked	O
by	O
markers	B
WI-10614	I
(	O
cen	B
)	O
and	O
D12S2293	B
(	O
tel	B
)	O
and	O
are	O
contained	O
within	O
three	O
sets	O
of	O
overlapping	O
cosmid	O
clones	O
.	O

5'-Deletion	O
of	O
the	O
Stat	B
-	I
binding	I
sites	I
abolished	O
all	O
promoter	O
-	O
reporter	O
activity	O
in	O
response	O
to	O
PRL	B
.	O

The	O
main	O
new	O
features	O
of	O
this	O
version	O
are	O
that	O
end	O
-	O
tidal	O
PO2	O
instead	O
of	O
inspiratory	O
PO2	O
can	O
be	O
kept	O
constant	O
,	O
and	O
that	O
the	O
correcting	O
activity	O
of	O
both	O
controllers	O
(	O
capnostat	O
and	O
oxystat	O
)	O
is	O
proportional	O
to	O
the	O
magnitude	O
of	O
the	O
difference	O
between	O
the	O
actual	O
and	O
the	O
adjusted	O
end	O
-	O
tidal	O
PCO2	O
or	O
PO2	O
.	O

The	O
MAP	B
kinase	I
kinase	I
kinase	I
MLK2	B
co	O
-	O
localizes	O
with	O
activated	O
JNK	B
along	O
microtubules	O
and	O
associates	O
with	O
kinesin	B
superfamily	I
motor	O
KIF3	B
.	O

Materials	O
are	O
presented	O
of	O
a	O
comparative	O
study	O
of	O
morphological	O
and	O
cultural	O
properties	O
and	O
virulence	O
of	O
liophylized	O
cultures	O
of	O
Leishmania	O
tropica	O
major	O
after	O
their	O
rehydration	O
or	O
after	O
a	O
long	O
passage	O
on	O
the	O
NNN	O
medium	O
.	O

CrkII	B
and	O
CrkL	B
constitutively	O
formed	O
complex	O
with	O
the	O
guanine	B
nucleotide	I
exchange	I
factor	I
C3	B
G	I
,	O
in	O
unstimulated	O
as	O
well	O
as	O
PDGF	B
-	O
stimulated	O
cells	O
.	O

DSIP	O
was	O
found	O
to	O
significantly	O
increase	O
slow	O
-	O
waves	O
(	O
delta	O
sleep	O
)	O
in	O
the	O
sleep	O
EEG	O
.	O

Two	O
courses	O
of	O
chemotherapy	O
(	O
CBCDA	O
+	O
VDS	O
)	O
failed	O
to	O
gain	O
any	O
improvement	O
,	O
and	O
the	O
pain	O
resulting	O
from	O
recurrent	O
bone	O
metastases	O
was	O
managed	O
mainly	O
by	O
the	O
administration	O
of	O
the	O
best	O
supportive	O
care	O
.	O

Thus	O
,	O
the	O
search	O
for	O
genetic	O
and	O
acquired	O
susceptibility	O
to	O
nontuberculous	O
mycobacteria	O
is	O
also	O
a	O
search	O
for	O
susceptibility	O
factors	O
for	O
MTB	O
as	O
well	O
as	O
an	O
opportunity	O
to	O
recognize	O
endogenous	O
pathways	O
that	O
can	O
be	O
exploited	O
therapeutically	O
.	O

This	O
gene	O
is	O
divided	O
into	O
six	O
exons	O
spanning	O
about	O
3	O
kb	O
,	O
and	O
encodes	O
a	O
175	O
amino	O
acid	O
protein	O
with	O
40	O
-	O
52	O
%	O
identity	O
with	O
the	O
other	O
five	O
mouse	B
Reg	I
(	O
regenerating	B
gene	I
product	I
)	O
proteins	O
.	O

Interconversions	O
between	O
haloperidol	O
and	O
reduced	O
haloperidol	O
in	O
schizophrenic	O
patients	O
and	O
guinea	O
pigs	O
:	O
a	O
steady	O
-	O
state	O
study	O
.	O

Bilirubin	O
and	O
red	O
cell	O
metabolism	O
in	O
relation	O
to	O
neonatal	O
jaundice	O
.	O

Minute	B
virus	I
of	I
mice	I
NS1	I
,	O
an	O
83-kDa	O
mainly	O
nuclear	O
phosphoprotein	O
,	O
is	O
the	O
only	O
viral	O
nonstructural	O
protein	O
required	O
in	O
all	O
cell	O
types	O
and	O
it	O
is	O
involved	O
in	O
multiple	O
processes	O
necessary	O
for	O
virus	O
propagation	O
.	O

Pediatric	O
patients	O
--	O
handle	O
with	O
care	O
.	O

K.	O

Protection	O
levels	O
of	O
33.3	O
%	O
,	O
36.6	O
%	O
and	O
37.0	O
%	O
were	O
achieved	O
in	O
groups	O
which	O
had	O
received	O
,	O
respectively	O
,	O
1000	O
20-krad	O
cercariae	O
,	O
1000	O
10-krad	O
cercariae	O
,	O
2000	O
40-krad	O
cercariae	O
and	O
2000	O
60-krad	O
cercariae	O
.	O

Interferon	B
-	I
alpha	I
inducibility	O
of	O
IFI16	B
may	O
be	O
regulated	O
by	O
an	O
interferon	B
-	I
alpha	I
/	I
beta	I
-	O
stimulated	O
response	O
consensus	O
element	O
in	O
the	O
5	O
'	O
UT	O
exon	O
,	O
as	O
a	O
similar	O
motif	O
is	O
conserved	O
in	O
the	O
corresponding	O
position	O
in	O
the	O
related	O
myeloid	B
cell	I
nuclear	I
differentiation	I
antigen	I
gene.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
400	O
WORDS	O
)	O

For	O
the	O
population	O
of	O
patients	O
with	O
melanoma	O
levels	O
III	O
and	O
IV	O
significant	O
differences	O
in	O
survival	O
rate	O
were	O
associated	O
with	O
thickness	O
(	O
less	O
than	O
2	O
mm	O
or	O
greater	O
than	O
or	O
equal	O
to	O
2	O
mm	O
;	O
p	O
less	O
than	O
0,001	O
)	O
,	O
though	O
not	O
with	O
level	O
.	O

However	O
,	O
the	O
in	O
vivo	O
attachment	O
strength	O
of	O
the	O
CSTi-2	O
coating	O
was	O
comparable	O
both	O
to	O
CSTi-1	O
and	O
to	O
an	O
HA	O
-	O
coated	O
control	O
after	O
8	O
weeks	O
.	O

Effects	O
of	O
negative	O
pi	O
mesons	O
on	O
mouse	O
bone	O
marrow	O
cells	O
.	O

The	O
(	O
0	O
0	O
2	O
)	O
diffraction	O
of	O
the	O
synthesized	O
HAp	O
crystals	O
on	O
a	O
Col	O
fiber	O
showed	O
an	O
around	O
60	O
arching	O
angle	O
,	O
while	O
that	O
on	O
a	O
ChS	O
fiber	O
showed	O
just	O
around	O
10	O
degrees	O
.	O

Mutations	O
of	O
SIN4	B
,	O
ROX3	B
,	O
SRB8	B
,	O
SRB9	B
,	O
SRB10	B
,	O
SRB11	B
,	O
and	O
two	O
novel	O
genes	O
,	O
NUT1	B
and	O
NUT2	B
,	O
relieve	O
the	O
requirement	O
of	O
Swi4p	B
for	O
expression	O
of	O
this	O
reporter	O
.	O

In	O
the	O
case	O
of	O
the	O
pT181	O
plasmid	O
,	O
inactivation	O
of	O
the	O
initiator	B
RepC	I
protein	I
occurs	O
by	O
the	O
attachment	O
of	O
an	O
oligonucleotide	O
to	O
its	O
active	O
tyrosine	O
residue	O
.	O

The	O
results	O
of	O
this	O
study	O
demonstrate	O
that	O
release	O
of	O
a	O
single	O
pulley	O
after	O
repair	O
of	O
the	O
tendons	O
in	O
this	O
area	O
improved	O
gliding	O
excursions	O
of	O
the	O
tendons	O
and	O
reduced	O
resistance	O
to	O
motion	O
of	O
the	O
repaired	O
tendons	O
,	O
and	O
provide	O
support	O
for	O
partial	O
A2	O
pulley	O
incision	O
after	O
repair	O
of	O
the	O
tendons	O
in	O
the	O
area	O
of	O
the	O
pulley	O
.	O

Differential	O
transcription	O
of	O
plastome	O
-	O
encoded	O
genes	O
in	O
the	O
mesophyll	O
and	O
bundle	O
-	O
sheath	O
chloroplasts	O
of	O
the	O
monocotyledonous	O
NADP	O
-	O
malic	B
enzyme	I
-	O
type	O
C4	O
plants	O
maize	O
and	O
Sorghum	O
.	O

RESULTS	O
--	O
The	O
maximal	O
early	O
asthmatic	O
response	O
after	O
allergen	O
with	O
placebo	O
treatment	O
was	O
18.4	O
%	O
(	O
SE	O
4.4	O
%	O
)	O
and	O
with	O
WEB	O
2086	O
18.9	O
%	O
(	O
4.4	O
%	O
)	O
.	O

A	O
total	O
of	O
64	O
uncomplicated	O
Type-2	O
diabetic	O
individuals	O
of	O
higher	O
middle	O
class	O
to	O
rich	O
socio	O
-	O
economic	O
status	O
were	O
studied	O
.	O

To	O
investigate	O
the	O
role	O
of	O
this	O
domain	O
in	O
the	O
incorporation	O
of	O
the	O
SIV	B
Env	I
into	O
virions	O
,	O
we	O
generated	O
a	O
series	O
of	O
SIV	B
Env	I
mutants	I
carrying	O
small	O
in	O
-	O
frame	O
deletions	O
within	O
the	O
cytoplasmic	O
domain	O
.	O

Ozone	O
uptake	O
was	O
assessed	O
in	O
awake	O
,	O
spontaneously	O
breathing	O
Fischer-344	O
Sprague	O
-	O
Dawley	O
,	O
and	O
Long	O
-	O
Evans	O
rats	O
and	O
Hartley	O
guinea	O
pigs	O
to	O
provide	O
data	O
on	O
the	O
dosimetry	O
of	O
O3	O
in	O
small	O
laboratory	O
animals	O
.	O

On	O
the	O
3rd	O
day	O
after	O
ischemia	O
of	O
the	O
remained	O
kidney	O
for	O
30	O
min	O
,	O
structural	O
components	O
of	O
the	O
walls	O
of	O
the	O
glomerular	O
arterioles	O
and	O
those	O
of	O
the	O
filtration	O
-	O
reabsorption	O
barrier	O
undergo	O
certain	O
ultrastructural	O
changes	O
,	O
that	O
with	O
time	O
elapsed	O
(	O
7	O
,	O
14	O
days	O
)	O
gradually	O
pass	O
away	O
,	O
and	O
amount	O
of	O
cells	O
with	O
hypertrophic	O
processes	O
increases	O
.	O

Patients	O
with	O
Eales	O
'	O
disease	O
,	O
chorioretinitis	O
,	O
central	O
serous	O
retinopathy	O
,	O
or	O
malignant	O
choroidal	O
melanoma	O
were	O
tested	O
for	O
HLA	B
antigen	O
deviation	O
.	O

Of	O
all	O
YASR	O
syndromes	O
,	O
the	O
highest	O
stability	O
was	O
for	O
the	O
Anxious	O
/	O
Depressed	O
scale	O
.	O

Significant	O
differences	O
were	O
observed	O
in	O
the	O
composition	O
of	O
nuclear	O
transcription	O
factors	O
bound	O
to	O
cis	O
-	O
elements	O
within	O
the	O
LDH	B
/	I
C	I
proximal	I
promoter	I
region	I
in	O
somatic	O
versus	O
germ	O
cells	O
.	O

We	O
conclude	O
that	O
although	O
the	O
G3	O
sequence	O
contains	O
two	O
protein	O
-	O
binding	O
motifs	O
,	O
the	O
organization	O
of	O
the	O
G3	O
enhancer	O
-	O
like	O
element	O
is	O
not	O
bipartite	O
.	O

A	O
preterm	O
formula	O
with	O
a	O
traditional	O
corn	O
oil	O
/	O
MCT	O
blend	O
containing	O
38	O
%	O
MCTs	O
(	O
MCT	O
group	O
)	O
was	O
compared	O
to	O
a	O
new	O
fat	O
blend	O
,	O
designed	O
to	O
resemble	O
human	O
milk	O
more	O
,	O
containing	O
6	O
%	O
MCTs	O
(	O
LCT	O
group	O
)	O
.	O

The	O
existence	O
of	O
a	O
TFIIIB	B
assembly	O
pathway	O
leading	O
to	O
the	O
faithful	O
transcription	O
of	O
natural	O
eukaryotic	O
tRNA	O
genes	O
in	O
the	O
absence	O
of	O
TFIIIC	B
provides	O
novel	O
insights	O
into	O
the	O
functional	O
flexibility	O
of	O
the	O
eukaryotic	O
tRNA	O
gene	O
transcription	O
machinery	O
and	O
on	O
its	O
evolution	O
from	O
an	O
ancestral	O
RNA	B
polymerase	I
III	I
system	O
relying	O
on	O
upstream	O
,	O
TATA-	O
centered	O
control	O
elements	O
.	O

Reasons	O
are	O
presented	O
to	O
support	O
the	O
contention	O
that	O
this	O
increase	O
is	O
in	O
part	O
real	O
.	O

Hypocalcemia	O
is	O
usually	O
due	O
to	O
either	O
a	O
disturbance	O
in	O
the	O
parathyroid	B
hormone	I
-	O
adenylate	B
cyclase	I
system	O
or	O
a	O
disturbance	O
in	O
vitamin	O
D	O
metabolism	O
.	O

Northern	O
blot	O
analysis	O
with	O
GPR37	B
probes	O
revealed	O
a	O
main	O
3.8-kb	O
mRNA	O
and	O
a	O
less	O
abundant	O
8-kb	O
mRNA	O
,	O
both	O
expressed	O
in	O
human	O
brain	O
tissues	O
,	O
particularly	O
in	O
corpus	O
callosum	O
,	O
medulla	O
,	O
putamen	O
,	O
and	O
caudate	O
nucleus	O
.	O

TNF	B
-	I
alpha	I
effect	O
was	O
eliminated	O
by	O
a	O
2-bp	O
substitution	O
mutation	O
in	O
the	O
NF	B
-	I
kappa	I
B1	I
binding	I
half	I
site	I
of	O
the	O
NF	B
-	I
kappa	I
B	I
cis	I
element	I
.	O

The	O
tam	B
A	I
gene	I
of	I
Aspergillus	I
nidulans	I
encodes	O
a	O
739-amino	O
acid	O
protein	O
with	O
similarity	O
to	O
Uga35p	B
/	O
Dal81p	B
/	O
DurLp	B
of	O
Saccharomyces	O
cerevisiae	O
.	O

Glutathione	B
reductase	I
(	O
GR	B
)	O
was	O
purified	O
from	O
the	O
cyanobacterium	O
Anabaena	O
PCC	O
7120	O
.	O

The	O
effects	O
of	O
inoculum	O
size	O
,	O
medium	O
,	O
temperature	O
,	O
and	O
duration	O
of	O
growth	O
on	O
the	O
in	O
vitro	O
susceptibility	O
testing	O
of	O
Aspergillus	O
fumigatus	O
were	O
investigated	O
using	O
broth	O
micro-	O
and	O
macro	O
-	O
dilution	O
techniques	O
.	O

This	O
dynamic	O
nature	O
may	O
be	O
relevant	O
to	O
the	O
ability	O
of	O
E47	B
both	O
to	O
homodimerize	O
and	O
to	O
heterodimerize	O
with	O
MyoD	B
,	O
I	B
d	I
,	O
and	O
Tal1	B
.	O

In	O
spite	O
of	O
the	O
variability	O
of	O
DD95	O
with	O
regard	O
to	O
body	O
weight	O
,	O
the	O
recovery	O
of	O
neuromuscular	O
transmission	O
in	O
the	O
patients	O
of	O
the	O
three	O
groups	O
is	O
comparable	O
.	O

Kerstin	O
takes	O
the	O
abbreviated	O
medical	O
education	O
.	O

An	O
atypical	O
form	O
of	O
juvenile	O
myasthenia	O
gravis	O
associated	O
with	O
severe	O
emaciation	O
,	O
muscle	O
atrophy	O
,	O
ophthalmoplegia	O
,	O
bulbar	O
signs	O
and	O
joint	O
contracture	O

Autophosphorylation	O
on	O
the	O
major	O
phosphorylation	O
site	O
Y1235	O
upregulates	O
the	O
kinase	O
activity	O
of	O
the	O
receptor	O
,	O
increasing	O
the	O
Vmax	O
of	O
the	O
phosphotransfer	O
reaction	O
.	O

Two	O
pharmacokinetic	O
models	O
were	O
compared	O
.	O

The	O
cats	O
with	O
stage-2	O
lymphomas	O
that	O
were	O
FeLV	O
-	O
test	O
negative	O
had	O
the	O
best	O
response	O
to	O
treatment	O
.	O

Reality	O
and	O
clinical	O
application	O
of	O
immunoglobulin	B
preparations	O

Our	O
case	O
,	O
however	O
,	O
had	O
no	O
histologic	O
evidence	O
of	O
malignancy	O
,	O
no	O
serum	B
alpha	I
fetoprotein	I
at	O
7	O
months	O
of	O
age	O
,	O
and	O
no	O
recurrence	O
at	O
1	O
years	O
.	O

We	O
evaluated	O
99mTc	O
-	O
ECD	O
SPECT	O
comparing	O
with	O
rCBF	O
images	O
obtained	O
by	O
PET	O
in	O
12	O
patients	O
with	O
spinocerebellar	O
degeneration	O
(	O
SCD	O
)	O
.	O

Outlook	O
in	O
oral	O
and	O
cutaneous	O
Kaposi	O
's	O
sarcoma	O
.	O

The	O
concepts	O
were	O
developed	O
by	O
Mines	O
and	O
Garrey	O
during	O
the	O
next	O
10	O
years	O
.	O

Maximum	O
overexpression	O
of	O
holoenzyme	O
activity	O
was	O
achieved	O
by	O
the	O
inclusion	O
in	O
such	O
plasmids	O
of	O
Salmonella	O
typhimurium	O
cysG	O
,	O
which	O
encodes	O
a	O
uroporphyrinogen	B
III	I
methyltransferase	I
required	O
for	O
the	O
synthesis	O
of	O
siroheme	O
,	O
a	O
cofactor	O
for	O
the	O
hemoprotein	O
.	O

METHODS	O
:	O
Precision	O
and	O
accuracy	O
were	O
measured	O
using	O
controls	O
and	O
method	O
comparison	O
studies	O
.	O

Residues	O
crucial	O
for	O
Ras	B
interaction	O
with	O
GDP	B
-	I
GTP	I
exchangers	I
.	O

Expression	O
of	O
human	B
complement	I
receptor	I
type	I
2	I
(	O
CR2	B
/	O
CD21	B
)	O
is	O
primarily	O
restricted	O
to	O
mature	O
B	O
cells	O
and	O
follicular	O
dendritic	O
cells	O
.	O

The	O
AtNMT1	B
expression	O
profile	O
indicated	O
ubiquity	O
in	O
roots	O
,	O
stem	O
,	O
leaves	O
,	O
flowers	O
,	O
and	O
siliques	O
(	O
approximately	O
1.7	O
kb	O
transcript	O
and	O
approximately	O
50	O
kDa	O
immunoreactive	O
polypeptide	O
)	O
but	O
a	O
greater	O
level	O
in	O
the	O
younger	O
tissue	O
,	O
which	O
are	O
developmentally	O
very	O
active	O
.	O

Studies	O
in	O
26	O
patients	O
.	O

In	O
addition	O
,	O
mutations	O
within	O
the	O
Ubx	B
unit	I
exons	I
are	O
known	O
and	O
most	O
of	O
these	O
behave	O
as	O
null	O
alleles	O
.	O

However	O
,	O
the	O
molecular	O
mechanisms	O
by	O
which	O
specific	O
cis-	O
and	O
trans	O
-	O
acting	O
factors	O
control	O
activity	O
of	O
the	O
prodynorphin	B
promoter	I
are	O
not	O
as	O
clearly	O
defined	O
.	O

Sesame	O
seed	O
should	O
also	O
be	O
considered	O
a	O
cause	O
of	O
allergic	O
reactions	O
to	O
drug	O
products	O
and	O
cosmetics	O
.	O

In	O
absence	O
of	O
i.m	O
.	O

medication	O
,	O
levels	O
over	O
1,000	O
U	O
must	O
be	O
carefully	O
screened	O
in	O
order	O
to	O
rule	O
out	O
SNM	O
or	O
organic	O
pathology	O
associated	O
.	O

This	O
latter	O
complex	O
reacts	O
with	O
an	O
antibody	O
to	O
serum	B
response	I
factor	I
(	O
SRF	B
)	O
and	O
exhibits	O
the	O
same	O
binding	O
characteristics	O
as	O
purified	O
SRF	B
.	O

After	O
cumulative	O
occlusions	O
of	O
15	O
,	O
30	O
,	O
45	O
,	O
and	O
90	O
min	O
,	O
transmural	O
needle	O
biopsies	O
were	O
taken	O
from	O
the	O
ischemic	O
area	O
to	O
be	O
analyzed	O
for	O
adenine	O
nucleotides	O
,	O
nucleosides	O
,	O
creatine	O
phosphate	O
,	O
and	O
ultrastructural	O
changes	O
.	O

Although	O
indomethacin	O
is	O
useful	O
for	O
examining	O
the	O
role	O
of	O
cyclooxygenase	B
products	I
in	O
asthmatic	O
responses	O
,	O
it	O
should	O
not	O
be	O
considered	O
in	O
the	O
treatment	O
of	O
asthma	O
.	O

Therapeutic	O
iodine	O
125	O
for	O
hyperthyroidism	O
:	O
evidence	O
for	O
a	O
special	O
radiobiological	O
effect	O
on	O
the	O
follicular	O
cell	O
.	O

The	O
biological	O
activity	O
of	O
these	O
mutants	O
was	O
tested	O
by	O
determining	O
their	O
capacity	O
to	O
(	O
i	O
)	O
reconstitute	O
RNA	B
polymerase	I
activity	O
in	O
vivo	O
by	O
cotransfection	O
with	O
proteins	O
NP	B
,	O
PB1	B
,	O
and	O
PA	B
and	O
a	O
virion	O
-	O
like	O
RNA	O
encoding	O
the	O
cat	B
gene	O
into	O
vaccinia	O
virus	O
T7-infected	O
COS-1	O
cells	O
and	O
(	O
ii	O
)	O
complete	O
with	O
the	O
wild	B
-	I
type	I
PB2	I
activity	O
.	O

Menstrual	O
and	O
lunar	O
cycles	O
.	O

A	O
nationwide	O
record	O
linkage	O
of	O
the	O
Finnish	O
Twin	O
Cohort	O
Study	O
(	O
FTCS	O
)	O
with	O
the	O
Hospital	O
Discharge	O
Registry	O
and	O
the	O
Registry	O
of	O
Rights	O
for	O
Free	O
medication	O
is	O
presented	O
.	O

Western	O
blot	O
experiments	O
detected	O
SMBP	B
as	O
a	O
70	O
kDa	O
protein	O
that	O
may	O
be	O
further	O
cleaved	O
into	O
an	O
active	O
34	O
kDa	O
N	O
-	O
terminal	O
polypeptide	O
.	O

On	O
Western	O
blots	O
,	O
the	O
same	O
antibodies	O
recognized	O
the	O
recombinant	O
protein	O
migrating	O
slightly	O
slower	O
on	O
SDS	O
/	O
PAGE	O
than	O
chicken	B
axonin-1	I
.	O

Denaturing	O
gradient	O
gel	O
electrophoresis	O
(	O
DGGE	O
)	O
with	O
sequence	O
analysis	O
showed	O
that	O
PGCL4	B
is	O
a	O
major	O
member	O
in	O
the	O
female	O
mammary	O
gland	O
,	O
and	O
in	O
the	O
submaxillary	O
and	O
lachrymal	O
glands	O
of	O
both	O
sexes	O
,	O
while	O
the	O
counterpart	O
in	O
male	O
liver	O
and	O
the	O
coagulate	O
glands	O
was	O
found	O
to	O
be	O
PGCL1	B
.	O

ATF	O
is	O
formulated	O
from	O
the	O
prothrombin	B
time	O
(	O
PT	O
)	O
,	O
fibrinogen	B
transformation	O
rate	O
(	O
FTR	O
)	O
(	O
a	O
representation	O
of	O
thrombin	B
activity	O
)	O
,	O
and	O
a	O
consideration	O
of	O
the	O
fibrinogen	B
(	O
FBG	B
)	O
content	O
of	O
blood	O
plasma	O
.	O

Protein	O
binding	O
to	O
UAS1MLS1	B
was	O
observed	O
with	O
extracts	O
from	O
derepressed	O
but	O
not	O
from	O
repressed	O
cells	O
,	O
and	O
could	O
be	O
competed	O
for	O
by	O
an	O
excess	O
of	O
the	O
unlabelled	O
CSRE	O
(	O
ICL1	B
)	O
sequence	O
.	O

Recently	O
we	O
have	O
performed	O
a	O
detailed	O
analysis	O
of	O
specific	O
neuronal	O
populations	O
affected	O
by	O
the	O
mutation	O
which	O
shed	O
new	O
light	O
on	O
the	O
role	O
of	O
Krox-20	B
in	O
the	O
segmentation	O
and	O
on	O
the	O
physiological	O
consequences	O
of	O
its	O
inactivation	O
.	O

Further	O
comparative	O
analysis	O
identified	O
an	O
ADNP	B
paralog	O
(	O
33	O
%	O
identity	O
and	O
46	O
%	O
similarity	O
)	O
,	O
indicating	O
that	O
these	O
genes	O
belong	O
to	O
a	O
novel	O
protein	O
family	O
with	O
a	O
nine	O
-	O
zinc	O
finger	O
motif	O
followed	O
by	O
a	O
homeobox	O
domain	O
.	O

Nature	O
and	O
incidence	O
of	O
conditioned	O
responses	O
in	O
a	O
methadone	O
population	O
:	O
a	O
comparison	O
of	O
laboratory	O
,	O
clinic	O
,	O
and	O
naturalistic	O
settings	O
.	O

Fourteen	O
Centers	O
participated	O
in	O
this	O
trial	O
.	O

Northern	O
blot	O
analysis	O
identified	O
retina	O
-	O
specific	O
transcripts	O
of	O
3.0	O
kb	O
for	O
rod	B
G	I
alpha	I
t	I
and	O
2.6	O
kb	O
for	O
cone	B
G	I
alpha	I
t.	I

This	O
interesting	O
exon	O
junction	O
resulted	O
in	O
novel	O
deduced	O
amino	O
terminal	O
open	O
reading	O
frames	O
,	O
which	O
are	O
completely	O
in	O
-	O
frame	O
with	O
sequences	O
located	O
further	O
downstream	O
.	O

We	O
investigated	O
the	O
pattern	O
of	O
evolution	O
of	O
bronchial	O
albumin	B
,	O
IgA	B
,	O
and	O
IgG	B
levels	O
in	O
ventilated	O
ICU	O
patients	O
in	O
relation	O
to	O
nosocomial	O
pneumonia	O
.	O

Membrane	O
depolarization	O
is	O
a	O
critical	O
element	O
of	O
neuronal	O
signaling	O
.	O

Humoral	O
immunity	O
is	O
altered	O
with	O
the	O
drop	O
in	O
IgG	B
levels	O
.	O

(	O
control	O
hearts	O
)	O
.	O

Although	O
several	O
other	O
signal	O
transduction	O
molecules	O
also	O
contain	O
tandemly	O
occurring	O
SH3	B
and	O
SH2	B
domains	I
,	O
the	O
function	O
of	O
these	O
closely	O
spaced	O
domains	O
is	O
not	O
well	O
understood	O
.	O

To	O
investigate	O
this	O
possibility	O
,	O
we	O
conducted	O
split	O
-	O
visual	O
-	O
field	O
studies	O
in	O
which	O
we	O
manipulated	O
stimulus	O
sets	O
,	O
recognition	O
task	O
,	O
and	O
exposure	O
duration	O
.	O

These	O
results	O
indicate	O
that	O
the	O
changes	O
in	O
the	O
patient	O
's	O
thyroid	O
scan	O
and	O
RAIU	O
were	O
attributable	O
to	O
the	O
presence	O
of	O
TSAb	O
.	O

Sequence	O
analysis	O
revealed	O
that	O
Hv	B
-	I
p68	I
belongs	O
to	O
the	O
large	O
family	O
of	O
FAD	B
-	I
dependent	I
glucose	I
methanol	I
choline	I
oxidoreductases	I
and	O
that	O
it	O
shares	O
significant	O
sequence	O
identity	O
(	O
>	O
67	O
%	O
)	O
with	O
the	O
alcohol	B
oxidases	I
of	O
the	O
methylotrophic	O
yeasts	O
.	O

Coronatine	B
(	O
COR	B
)	O
is	O
a	O
plasmid	O
-	O
encoded	O
phytotoxin	O
synthesized	O
by	O
several	O
pathovars	O
of	O
phytopathogenic	O
Pseudomonas	O
syringae	O
.	O

Radioactively	O
labeled	O
microspheres	O
were	O
used	O
to	O
determine	O
and	O
compare	O
the	O
hemodynamic	O
effects	O
of	O
sodium	O
nitroprusside	O
(	O
SNP	O
)	O
,	O
nitroglycerin	O
(	O
NTG	O
)	O
,	O
and	O
deep	O
enflurane	O
anesthesia	O
on	O
oral	O
tissues	O
during	O
controlled	O
hypotension	O
when	O
compared	O
with	O
controls	O
.	O

However	O
,	O
no	O
consensus	O
on	O
indications	O
exists	O
and	O
,	O
according	O
to	O
the	O
literature	O
,	O
results	O
are	O
contradictory	O
.	O

However	O
,	O
studies	O
using	O
the	O
A20	B
promoter	I
demonstrated	O
that	O
LMP1	B
transcriptionally	O
activates	O
the	O
A20	B
gene	I
through	O
cis	O
-	O
acting	O
kappa	B
B	I
sites	I
.	O

Finally	O
,	O
we	O
tested	O
whether	O
activation	O
by	O
either	O
of	O
these	O
factors	O
is	O
dependent	O
on	O
components	O
of	O
the	O
SAGA	B
complex	I
.	O

Recombinant	O
propeptides	O
containing	O
mutations	O
of	O
one	O
of	O
the	O
three	O
tryptophan	O
residues	O
were	O
three	O
orders	O
of	O
magnitude	O
less	O
effective	O
as	O
inhibitors	O
of	O
mature	B
cathepsin	I
S	I
than	O
the	O
wild	O
-	O
type	O
propeptide	O
.	O

AU	O
-	O
rich	O
elements	O
in	O
the	O
3'-untranslated	O
region	O
of	O
a	O
new	O
mucin	B
-	I
type	I
gene	I
family	O
of	O
Trypanosoma	O
cruzi	O
confers	O
mRNA	O
instability	O
and	O
modulates	O
translation	O
efficiency	O
.	O

The	O
repeats	O
are	O
highly	O
conserved	O
both	O
within	O
a	O
given	O
element	O
as	O
well	O
as	O
between	O
different	O
members	O
of	O
the	O
family	O
(	O
less	O
than	O
10	O
%	O
divergence	O
)	O
.	O

The	O
Polycomb	B
group	I
proteins	I
are	O
involved	O
in	O
maintenance	O
of	O
the	O
silenced	O
state	O
of	O
several	O
developmentally	O
regulated	O
genes	O
.	O

Alterations	O
in	O
TCR	B
-	O
MHC	B
contacts	O
subsequent	O
to	O
cross	O
-	O
recognition	O
of	O
class	B
I	I
MHC	I
and	O
singly	O
substituted	O
peptide	O
variants	O
.	O

We	O
also	O
show	O
that	O
the	O
products	O
of	O
both	O
the	O
GIY	B
-	I
YIG	I
ORF	O
and	O
the	O
non	O
-	O
canonical	O
LAGLI	B
-	I
DADG	I
-	I
GIY	I
-	I
YIG	I
ORF	O
,	O
which	O
is	O
generated	O
by	O
its	O
integration	O
,	O
have	O
endonuclease	O
activities	O
which	O
recognize	O
and	O
cut	O
the	O
insertion	O
site	O
of	O
the	O
optional	O
sequence	O
.	O

The	O
pharmacokinetics	O
were	O
best	O
described	O
by	O
a	O
two	O
-	O
compartment	O
open	O
model	O
giving	O
distribution	O
half	O
-	O
lives	O
of	O
0.31	O
h	O
and	O
1.53	O
h	O
,	O
and	O
elimination	O
half	O
-	O
lives	O
of	O
69.7	O
h	O
and	O
60.3	O
h	O
for	O
oxolinic	O
acid	O
and	O
oxytetracycline	O
,	O
respectively	O
.	O

Inhibitory	O
receptors	O
are	O
characterized	O
by	O
the	O
presence	O
of	O
a	O
characteristic	O
sequence	O
known	O
as	O
an	O
immunoreceptor	O
tyrosine	O
-	O
based	O
inhibitory	O
motif	O
(	O
ITIM	O
)	O
in	O
their	O
cytoplasmic	O
tail	O
.	O

Our	O
data	O
suggest	O
that	O
some	O
defects	O
observed	O
in	O
BS	O
,	O
WS	O
or	O
RTS	O
are	O
the	O
consequence	O
of	O
unrestrained	O
recombination	O
.	O

Alternative	O
splicing	O
of	O
the	O
human	B
serotonin	I
transporter	I
gene	I
.	O

Nuclear	O
proteins	O
bound	O
the	O
cad	B
+	I
55	I
/	I
+75	I
element	I
in	O
a	O
cell	O
cycle	O
-	O
dependent	O
manner	O
in	O
electromobility	O
shift	O
assays	O
;	O
antibodies	O
specific	O
to	O
USF	B
and	O
Max	B
blocked	O
the	O
DNA	O
-	O
binding	O
activity	O
of	O
different	O
growth	O
-	O
regulated	O
protein	O
-	O
DNA	O
complexes	O
.	O

The	O
carboxy	O
-	O
proximal	O
regions	O
of	O
the	O
VP1	B
,	O
which	O
contain	O
very	O
low	O
amino	O
acid	O
homology	O
,	O
displayed	O
evidence	O
of	O
conservation	O
in	O
structural	O
features	O
such	O
as	O
a	O
hydrophilic	O
,	O
highly	O
basic	O
domain	O
.	O

Here	O
we	O
show	O
that	O
inhibition	O
occurs	O
with	O
a	O
NS1-Rev	B
chimera	O
in	O
which	O
the	O
78	O
amino	O
-	O
terminal	O
amino	O
acids	O
of	O
the	O
NS1A	B
protein	I
comprising	O
its	O
entire	O
RNA	O
-	O
binding	O
domain	O
is	O
deleted	O
,	O
thereby	O
establishing	O
that	O
this	O
carboxyl	O
portion	O
of	O
the	O
NS1A	B
protein	I
can	O
function	O
as	O
an	O
independent	O
effector	O
domain	O
.	O

Thus	O
integration	B
host	I
factor	I
is	O
required	O
for	O
normal	O
type	B
1	I
fimbriae	I
phase	O
variation	O
in	O
E.	O
coli	O
.	O

Salts	O
of	O
these	O
four	O
metal	O
ions	O
may	O
be	O
added	O
to	O
the	O
growth	O
medium	O
to	O
facilitate	O
selective	O
isolation	O
of	O
Acinetobacter	O
.	O

To	O
examine	O
the	O
effect	O
of	O
the	O
cAMP	O
signal	O
transduction	O
pathway	O
on	O
transcription	O
of	O
the	O
gene	O
encoding	O
the	O
catalytic	O
subunit	O
of	O
glucose-6-phosphatase	B
(	O
G6Pase	B
)	O
,	O
G6Pase	B
-	O
chloramphenicol	B
acetyltransferase	I
(	O
CAT	B
)	O
fusion	O
genes	O
were	O
transiently	O
transfected	O
into	O
either	O
the	O
liver	O
-	O
derived	O
HepG2	O
or	O
kidney	O
-	O
derived	O
LLC	O
-	O
PK	O
cell	O
line	O
.	O

Two	O
plasmids	O
,	O
one	O
containing	O
the	O
amino	O
terminus	O
of	O
P	O
fused	O
to	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
the	O
yeast	O
transactivator	O
,	O
GAL4	B
,	O
and	O
the	O
other	O
containing	O
the	O
amino	O
terminus	O
of	O
NP	B
fused	O
to	O
the	O
herpesvirus	O
transactivator	O
,	O
VP16	B
,	O
were	O
transfected	O
in	O
COS-1	O
cells	O
along	O
with	O
a	O
chloramphenicol	B
acetyltransferase	I
(	O
CAT	B
)	O
reporter	O
plasmid	O
containing	O
GAL4	B
DNA	O
-	O
binding	O
sites	O
.	O

Ultrastructure	O
and	O
toxin	O
formation	O
of	O
Cor	O
.	O

diphtheriae	O
PW-8	O
cultured	O
in	O
the	O
presence	O
of	O
penicillin	O

Ras	B
involvement	O
in	O
signal	O
transduction	O
by	O
the	O
serotonin	B
5-HT2B	I
receptor	I
.	O

The	O
nine	O
subjects	O
were	O
treated	O
in	O
random	O
sequence	O
with	O
cimetidine	O
0	O
-	O
8	O
-	O
1	O
-	O
0	O
g	O
on	O
one	O
day	O
and	O
placebo	O
capsules	O
on	O
the	O
other	O
.	O

The	O
detection	O
limits	O
obtained	O
by	O
using	O
the	O
mixed	O
eluent	O
were	O
0.05	O
-	O
0.13	O
mg	O
/	O
L	O
,	O
several	O
times	O
lower	O
than	O
those	O
obtained	O
by	O
using	O
single	O
KHPh	O
eluent	O
.	O

The	O
effect	O
of	O
buthionine	O
sulfoximine	O
(	O
BSO	O
)	O
and	O
disulfiram	O
(	O
DSF	O
)	O
on	O
the	O
urotoxicity	O
induced	O
by	O
cyclophosphamide	O
(	O
CPA	O
)	O
was	O
examined	O
in	O
mice	O
.	O

One	O
of	O
these	O
clones	O
encodes	O
Xenopus	B
N	I
-	I
ras	I
.	O

Psoriasis	O
on	O
tumor	O
.	O

Flicker	O
thresholds	O
were	O
measured	O
from	O
1	O
to	O
40	O
Hz	O
with	O
a	O
vertical	O
-	O
line	O
target	O
used	O
for	O
the	O
asynchrony	O
thresholds	O
.	O

Buserelin	O
offers	O
an	O
effective	O
alternative	O
medical	O
treatment	O
of	O
carcinoma	O
of	O
the	O
prostate	O
and	O
,	O
apart	O
from	O
impotence	O
,	O
does	O
not	O
have	O
the	O
side	O
effects	O
of	O
oestrogens	O
.	O

Cell	O
sloughing	O
with	O
proparacaine	O
.	O

One	O
hundred	O
cDNA	O
clones	O
were	O
sequenced	O
and	O
8	O
RTKs	B
were	O
identified	O
,	O
as	O
well	O
as	O
12	O
non	O
-	O
RTKs	B
and	O
2	O
serine	B
/	I
threonine	I
kinases	I
.	O

A	O
model	O
for	O
oligomerization	O
-	O
dependent	O
subunit	O
folding	O
.	O

The	O
reporter	O
gene	O
with	O
two	O
copies	O
of	O
the	O
wild	O
-	O
type	O
Repeat	O
2	O
+	O
3	O
sequence	O
was	O
transcribed	O
actively	O
in	O
sterol	O
-	O
deprived	O
cells	O
and	O
was	O
repressed	O
by	O
more	O
than	O
80	O
%	O
when	O
sterols	O
were	O
present	O
.	O

This	O
review	O
chronicles	O
the	O
characteristics	O
of	O
deliberate	O
and	O
accidental	O
mass	O
poisonings	O
that	O
occurred	O
in	O
World	O
Wars	O
I	O
and	O
II	O
,	O
in	O
Bhopal	O
,	O
and	O
in	O
other	O
historical	O
cases	O
up	O
to	O
and	O
including	O
modern	O
wars	O
.	O

Similar	O
to	O
what	O
was	O
observed	O
for	O
P.	O
putida	O
,	O
a	O
psrA	B
null	O
mutant	O
of	O
P.	O
aeruginosa	O
also	O
showed	O
a	O
90	O
%	O
reduction	O
in	O
rpoS	B
promoter	I
activity	O
;	O
both	O
mutants	O
could	O
be	O
complemented	O
for	O
rpoS	B
promoter	I
activity	O
when	O
the	O
psrA	B
gene	I
was	O
provided	O
in	O
trans	O
.	O

psrA	B
mutants	I
of	O
both	O
Pseudomonas	O
species	O
lost	O
the	O
ability	O
to	O
induce	O
rpoS	B
expression	O
at	O
stationary	O
phase	O
,	O
but	O
they	O
retained	O
the	O
ability	O
to	O
produce	O
quorum	O
-	O
sensing	O
autoinducer	O
molecules	O
.	O

Extracellular	B
protein	I
kinase	I
A	I
as	O
a	O
cancer	O
biomarker	O
:	O
its	O
expression	O
by	O
tumor	O
cells	O
and	O
reversal	O
by	O
a	O
myristate	O
-	O
lacking	O
Calpha	O
and	O
RIIbeta	O
subunit	O
overexpression	O
.	O

The	O
KEMAR	O
measurements	O
show	O
that	O
the	O
two	O
models	O
give	O
an	O
improvement	O
of	O
the	O
signal	O
-	O
to	O
-	O
noise	O
ratio	O
of	O
approximately	O
7.5	O
dB	O
in	O
a	O
diffuse	O
sound	O
field	O
.	O

Mutations	O
that	O
extend	O
the	O
specificity	O
of	O
the	O
endonuclease	O
activity	O
of	O
lambda	B
terminase	I
.	O

It	O
is	O
concluded	O
that	O
the	O
new	O
class	O
of	O
competitive	O
NMDA	B
receptor	I
antagonists	O
,	O
exemplified	O
by	O
CGP	O
37849	O
,	O
is	O
the	O
most	O
promising	O
candidate	O
for	O
clinical	O
trials	O
in	O
anxiety	O
disorders	O
.	O

In	O
the	O
fungus	O
Neurospora	O
crassa	O
,	O
nit-2	B
,	O
the	O
major	O
nitrogen	O
regulatory	O
gene	O
,	O
activates	O
the	O
expression	O
of	O
unlinked	O
structural	O
genes	O
that	O
specify	O
nitrogen	O
-	O
catabolic	O
enzymes	O
during	O
conditions	O
of	O
nitrogen	O
limitation	O
.	O

Tetrazepam	O
:	O
a	O
benzodiazepine	O
which	O
dissociates	O
sedation	O
from	O
other	O
benzodiazepine	O
activities	O
.	O

An	O
hcr1	B
null	O
mutant	O
was	O
viable	O
,	O
but	O
showed	O
slight	O
reduction	O
of	O
growth	O
when	O
compared	O
with	O
the	O
wild	O
-	O
type	O
strain	O
.	O

The	O
women	O
in	O
the	O
intermediate	O
calcium	O
group	O
had	O
approximately	O
the	O
same	O
mean	O
BMD	O
values	O
as	O
those	O
in	O
the	O
low	O
calcium	O
group	O
.	O

Serum	B
amyloid	I
A	I
(	O
SAA	B
)	O
is	O
a	O
plasma	O
protein	O
which	O
has	O
been	O
associated	O
with	O
several	O
diseases	O
,	O
including	O
amyloidosis	O
,	O
arthritis	O
,	O
and	O
atherosclerosis	O
,	O
and	O
its	O
abnormal	O
expression	O
,	O
particularly	O
in	O
nonhepatic	O
cells	O
,	O
is	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
these	O
diseases	O
.	O

Convergence	O
of	O
trigeminal	O
input	O
with	O
visceral	O
and	O
phrenic	O
inputs	O
on	O
primate	O
C1-C2	O
spinothalamic	O
tract	O
neurons	O
.	O

A	O
Frank	O
vectorcardiogram	O
was	O
recorded	O
before	O
and	O
every	O
15	O
-	O
30	O
minutes	O
for	O
10	O
hours	O
after	O
the	O
occlusion	O
.	O

When	O
O-2A	O
/	O
c	B
-	I
myc	I
cells	O
underwent	O
terminal	O
differentiation	O
APprog	B
complexes	I
were	O
lost	O
and	O
conventional	O
AP-1	B
DNA	O
-	O
binding	O
activity	O
became	O
evident	O
,	O
particularly	O
in	O
astrocytes	O
.	O

(	O
i	O
)	O
The	O
chimeric	O
gene	O
consisting	O
of	O
the	O
coding	O
and	O
5	O
'	O
nontranslated	O
leader	O
regions	O
of	O
the	O
TK	B
gene	I
fused	O
to	O
portions	O
of	O
the	O
domain	O
of	O
alpha	B
gene	I
0	I
extending	O
largely	O
upstream	O
from	O
the	O
site	O
of	O
initiation	O
of	O
transcription	O
of	O
alpha	B
gene	I
0	I
was	O
regulated	O
in	O
the	O
same	O
fashion	O
as	O
the	O
alpha	B
4-	I
and	I
alpha	I
27-TK	I
chimeras	O
.	O

Torsion	O
of	O
the	O
contralateral	O
testis	O
5	O
years	O
after	O
orchiopexy	O
.	O

Legionella	B
antibodies	I
in	O
domestic	O
animals	O

When	O
transfected	O
into	O
HepG2	O
cells	O
,	O
which	O
lack	O
C	B
/	I
EBP	I
alpha	I
,	O
the	O
mouse	B
ob	I
promoter	I
was	O
only	O
weakly	O
active	O
.	O

When	O
translated	O
in	O
-	O
frame	O
with	O
PKC	B
zeta	I
,	O
a	O
stop	O
codon	O
is	O
located	O
28	O
amino	O
acids	O
towards	O
the	O
N	O
-	O
terminus	O
of	O
the	O
divergence	O
point	O
and	O
the	O
intervening	O
sequence	O
lacks	O
an	O
expected	O
initiating	O
methionine	O
.	O

psi	B
PKC	I
zeta	I
is	O
non	O
-	O
functional	O
in	O
terms	O
of	O
protein	O
synthesis	O
since	O
Western	O
blotting	O
with	O
an	O
antibody	O
directed	O
against	O
the	O
C	O
-	O
terminus	O
of	O
PKC	B
zeta	I
failed	O
to	O
reveal	O
a	O
protein	O
smaller	O
than	O
PKC	B
zeta	I
,	O
and	O
synthetic	O
psi	B
PKC	I
zeta	I
RNA	I
failed	O
to	O
support	O
protein	O
synthesis	O
in	O
a	O
translation	O
system	O
in	O
vitro	O
.	O

Comparative	O
ultrafiltration	O
(	O
UF	O
)	O
studies	O
with	O
BiGG	O
and	O
standard	O
lactate	O
(	O
La	O
)	O
solutions	O
in	O
rabbits	O
showed	O
that	O
net	O
UF	O
with	O
La	O
solution	O
peaked	O
at	O
2	O
h	O
and	O
decreased	O
significantly	O
at	O
4	O
h	O
and	O
6	O
h.	O

JCAHO	O
moves	O
to	O
rewrite	O
many	O
rules	O
to	O
lessen	O
hospitals	O
'	O
regulatory	O
burden	O
.	O

However	O
,	O
it	O
is	O
not	O
easy	O
to	O
establish	O
the	O
diagnosis	O
of	O
thoracic	O
MFH	O
.	O

IGF	B
-	I
I	I
levels	O
were	O
measured	O
in	O
the	O
CSF	O
of	O
11	O
children	O
with	O
autism	O
(	O
4	O
females	O
,	O
7	O
males	O
;	O
mean	O
age	O
3.8	O
years	O
,	O
SD	O
1.1	O
)	O
using	O
a	O
sensitive	O
radioimmunoassay	O
method	O
and	O
compared	O
with	O
levels	O
in	O
11	O
control	O
participants	O
(	O
6	O
females	O
,	O
5	O
males	O
;	O
mean	O
age	O
3.8	O
years	O
)	O
.	O

Forty	O
-	O
five	O
patients	O
with	O
recent	O
-	O
onset	O
hyperthyroidism	O
(	O
<	O
12	O
weeks	O
)	O
were	O
sex	O
and	O
menopause	O
stratified	O
and	O
randomly	O
allocated	O
to	O
treatment	O
with	O
carbimazole	O
(	O
Neotomizol	O
)	O
,	O
carbimazole	O
plus	O
low	O
dose	O
CT	O
(	O
Calsynar	O
;	O
100	O
IU	O
/	O
day	O
,	O
2	O
days	O
/	O
week	O
)	O
,	O
or	O
carbimazole	O
plus	O
high	O
dose	O
CT	O
(	O
Calsynar	O
;	O
100	O
IU	O
/	O
day	O
,	O
14	O
days	O
/	O
month	O
)	O
.	O

We	O
also	O
show	O
that	O
psbH	B
and	O
psbT	B
are	O
transcribed	O
from	O
the	O
upstream	O
psbB	B
gene	I
promoter	I
,	O
and	O
that	O
the	O
psbH	B
mRNA	I
has	O
its	O
own	O
target	O
sequence	O
for	O
Mbb1	B
function	O
.	O

CONCLUSION	O
:	O
Men	O
presenting	O
with	O
urethritis	O
and	O
women	O
presenting	O
with	O
PID	O
both	O
have	O
significantly	O
greater	O
peripheral	O
blood	O
mononuclear	O
cell	O
proliferative	O
responses	O
to	O
the	O
DK20	O
strain	O
of	O
C	O
trachomatis	O
than	O
controls	O
.	O

Our	O
data	O
provide	O
the	O
first	O
evidence	O
that	O
differential	O
splicing	O
in	O
the	O
extracellular	O
region	O
of	O
a	O
receptor	O
gene	O
generates	O
receptor	O
variants	O
with	O
different	O
ligand	O
-	O
binding	O
specificities	O
.	O

Intrathecal	O
injections	O
of	O
small	O
volumes	O
of	O
the	O
alpha	B
2-adrenoceptor	I
agonists	O
,	O
xylazine	O
and	O
clonidine	O
,	O
into	O
the	O
cervical	O
region	O
of	O
the	O
spinal	O
cord	O
of	O
conscious	O
unrestrained	O
sheep	O
produced	O
a	O
dose	O
-	O
dependent	O
analgesia	O
of	O
the	O
forelimbs	O
as	O
measured	O
using	O
a	O
mechanical	O
pressure	O
device	O
.	O

Estrogen	O
has	O
positive	O
effects	O
on	O
mood	O
,	O
sexual	O
function	O
,	O
target	O
end	O
organs	O
and	O
cognitive	O
function	O
,	O
and	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
etiology	O
of	O
Alzheimer	O
's	O
Disease	O
by	O
acting	O
to	O
prevent	O
amyloid	O
plaque	O
formation	O
,	O
oxidative	O
stress	O
,	O
or	O
deterioration	O
of	O
the	O
cholinergic	O
neurotransmitter	O
system	O
.	O

Effect	O
of	O
gentamycin	O
on	O
the	O
kidney	O
functional	O
state	O
in	O
experimental	O
pyelonephritis	O

Nucleocapsid	O
structure	O
and	O
thermostability	O
of	O
the	O
virion	O
,	O
nucleocapsid	O
and	O
polymerase	O
complex	O
.	O

Studies	O
on	O
recurrences	O
in	O
gingival	O
hyperplasia	O

Measurement	O
of	O
protein	O
in	O
natural	O
rubber	O
latex	O
.	O

Maximum	O
likelihood	O
estimation	O
in	O
covariance	O
structure	O
analysis	O
with	O
truncated	O
data	O
.	O

The	O
arterial	O
blood	O
pressure	O
was	O
measured	O
by	O
using	O
bloody	O
method	O
in	O
anesthizied	O
animals	O
.	O

In	O
this	O
study	O
,	O
the	O
subcellular	O
location	O
,	O
domain	O
structure	O
,	O
and	O
biochemical	O
function	O
of	O
metaxin	B
were	O
investigated	O
.	O

There	O
is	O
,	O
however	O
,	O
uncertainty	O
as	O
to	O
how	O
results	O
obtained	O
in	O
recent	O
experiments	O
scale	O
up	O
to	O
landscape	O
and	O
regional	O
levels	O
and	O
generalize	O
across	O
ecosystem	O
types	O
and	O
processes	O
.	O

Chest	O
X	O
-	O
P	O
revealed	O
an	O
abnormal	O
shadow	O
in	O
the	O
left	O
upper	O
lobe	O
.	O

Changes	O
in	O
the	O
size	O
and	O
organisation	O
of	O
the	O
brain	O
in	O
man	O
and	O
his	O
ancestors	O
.	O

K562	O
erythroleukemia	O
cells	O
stably	O
transfected	O
with	O
constructs	O
containing	O
the	O
human	B
Agamma	I
-	I
globin	I
promoter	I
linked	O
to	O
an	O
enhanced	B
green	I
fluorescent	I
protein	I
(	O
EGFP	B
)	O
reporter	O
,	O
with	O
or	O
without	O
HS2	O
,	O
were	O
analyzed	O
for	O
EGFP	B
expression	O
by	O
flow	O
cytometry	O
.	O

Some	O
may	O
affect	O
the	O
folding	O
pathway	O
or	O
the	O
affinity	O
for	O
chaperonins	B
.	O

VBP	B
and	O
a1	B
/	I
EBP	I
could	O
mediate	O
the	O
high	O
rates	O
of	O
ALV	O
and	O
RSV	B
LTR	I
-	O
enhanced	O
transcription	O
in	O
bursal	O
lymphoma	O
cells	O
and	O
many	O
other	O
cell	O
types	O
.	O

The	O
BCL-6	B
POZ	O
domain	O
and	O
other	O
POZ	O
domains	O
interact	O
with	O
the	O
co	O
-	O
repressors	O
N	B
-	I
CoR	I
and	O
SMRT	B
.	O

The	O
traW	B
gene	I
of	I
the	I
Escherichia	I
coli	I
K-12	I
sex	I
factor	I
,	O
F	O
,	O
encodes	O
one	O
of	O
the	O
numerous	O
proteins	O
required	O
for	O
conjugative	O
transfer	O
of	O
this	O
plasmid	O
.	O

Expression	O
of	O
these	O
chemokines	O
is	O
similar	O
in	O
that	O
both	O
require	O
the	O
NF	B
-	I
kappa	I
B	I
element	I
and	O
additional	O
regions	O
such	O
as	O
the	O
CAAT	B
/	I
enhancer	I
binding	I
protein	I
(	O
C	B
/	I
EBP	I
)	O
element	O
of	O
the	O
IL-8	B
promoter	I
.	O

The	O
toxicity	O
of	O
copper	O
to	O
the	O
collembolan	O
Folsomia	O
fimetaria	O
L.	O
was	O
studied	O
in	O
soil	O
incubated	O
with	O
copper	O
sulfate	O
for	O
different	O
periods	O
before	O
the	O
introduction	O
of	O
collembolans	O
,	O
to	O
assess	O
the	O
effect	O
of	O
aging	O
of	O
contamination	O
on	O
the	O
toxicity	O
of	O
copper	O
.	O

Using	O
probes	O
containing	O
C	B
/	I
EBP	I
-	I
binding	I
sites	I
from	O
the	O
iNOS	B
gene	I
revealed	O
further	O
binding	O
of	O
different	O
complexes	O
,	O
all	O
of	O
which	O
were	O
strongly	O
inducible	O
by	O
cAMP	O
and	O
to	O
a	O
lower	O
extent	O
also	O
by	O
IL-1beta	B
.	O

The	O
duration	O
of	O
PGE2	O
and	O
PGF2	O
alpha	O
elevations	O
as	O
well	O
as	O
the	O
peak	O
values	O
were	O
influenced	O
by	O
day	O
of	O
the	O
cycle	O
.	O

RESULTS	O
:	O
Lateral	O
PF	O
OA	O
was	O
more	O
common	O
than	O
medial	O
PF	O
OA	O
(	O
P<0.0001	O
)	O
.	O

Moreover	O
,	O
we	O
show	O
that	O
GATA-1	B
and	O
Sp1	B
synergize	O
from	O
a	O
distance	O
in	O
constructs	O
designed	O
to	O
mimic	O
the	O
architecture	O
of	O
globin	B
locus	I
control	I
regions	I
and	O
downstream	O
globin	B
promoters	I
.	O

The	O
effects	O
of	O
space	O
radiation	O
are	O
partially	O
known	O
on	O
astronauts	O
,	O
but	O
much	O
remains	O
to	O
be	O
discovered	O
.	O

First	O
,	O
the	O
amino	O
-	O
terminal	O
regulatory	O
arm	O
of	O
the	O
GDI	B
binds	O
to	O
the	O
switch	O
I	O
and	O
II	O
domains	O
of	O
Cdc42	B
leading	O
to	O
the	O
inhibition	O
of	O
both	O
GDP	O
dissociation	O
and	O
GTP	O
hydrolysis	O
.	O

In	O
the	O
virus	O
-	O
infected	O
cells	O
,	O
translation	O
of	O
the	O
M1	B
protein	I
was	O
reduced	O
to	O
10	O
to	O
20	O
%	O
of	O
that	O
of	O
the	O
wild	O
-	O
type	O
virus	O
;	O
however	O
,	O
the	O
translation	O
of	O
neither	O
the	O
nucleoprotein	O
nor	O
NS1	B
was	O
significantly	O
interfered	O
with	O
,	O
indicating	O
the	O
important	O
role	O
of	O
NS1	B
in	O
translational	O
stimulation	O
of	O
the	O
M1	B
protein	I
.	O

The	O
results	O
show	O
that	O
while	O
a	O
larger	O
polypeptide	O
substrate	O
carrying	O
the	O
HD1	B
/	I
3C	I
site	I
was	O
processed	O
more	O
efficiently	O
than	O
a	O
polypeptide	O
substrate	O
carrying	O
the	O
POL	B
/	I
Zn	I
site	I
,	O
cleavage	O
of	O
the	O
synthetic	O
peptide	O
substrates	O
containing	O
these	O
two	O
cleavage	O
sites	O
occurred	O
at	O
similar	O
efficiencies	O
.	O

The	O
GST	B
-	O
CBL	B
-	O
LZIP	B
fusion	O
protein	O
contains	O
a	O
binding	O
site	O
for	O
the	O
SH2	B
domain	I
of	O
the	O
p85	B
subunit	I
of	O
phosphatidylinositol	B
3-kinase	I
,	O
which	O
mapped	O
to	O
Tyr731	O
,	O
which	O
is	O
present	O
in	O
the	O
sequence	O
YEAM	O
.	O

The	O
level	O
of	O
transcription	O
generated	O
by	O
all	O
of	O
these	O
activators	O
is	O
greater	O
than	O
the	O
sum	O
of	O
the	O
levels	O
generated	O
by	O
individual	O
factors	O
,	O
a	O
phenomenon	O
designated	O
transcriptional	O
synergy	O
.	O

Growth	B
hormone	I
exerts	O
its	O
effects	O
on	O
the	O
ovarian	O
follicular	O
cycle	O
directly	O
or	O
by	O
local	O
production	O
of	O
insulin	B
-	I
like	I
growth	I
factor	I
1	I
(	O
IGF-1	B
)	O
.	O

The	O
results	O
suggest	O
that	O
the	O
posterior	O
wall	O
is	O
more	O
compliant	O
than	O
the	O
anterior	O
wall	O
(	O
that	O
is	O
,	O
for	O
a	O
given	O
difference	O
in	O
transmural	O
pressure	O
,	O
the	O
local	O
segment	O
length	O
change	O
of	O
the	O
posterior	O
wall	O
was	O
greater	O
)	O
.	O

No	O
consensus	O
binding	O
sequence	O
could	O
be	O
discerned	O
in	O
these	O
fragments	O
and	O
bound	O
factor	O
is	O
in	O
rapid	O
equilibrium	O
with	O
unbound	O
.	O

Sixteen	O
patients	O
(	O
25.4	O
%	O
)	O
encountered	O
rejection	O
while	O
weaning	O
at	O
median	O
period	O
of	O
9.5	O
months	O
(	O
range	O
,	O
1	O
-	O
63	O
months	O
)	O
from	O
the	O
start	O
of	O
weaning	O
.	O

The	O
results	O
in	O
the	O
untreated	O
patients	O
demonstrate	O
the	O
primary	O
importance	O
of	O
bulk	O
reduction	O
at	O
initial	O
laparotomy	O
.	O

Vertebrate	O
U6	B
small	I
nuclear	I
RNA	I
(	O
snRNA	O
)	O
loci	O
exemplify	O
a	O
novel	O
class	O
of	O
polymerase	B
III	I
-	O
transcribed	O
genes	O
that	O
lack	O
an	O
intragenic	O
control	O
region	O
(	O
ICR	O
)	O
.	O

This	O
article	O
focuses	O
on	O
a	O
general	O
approach	O
to	O
the	O
use	O
of	O
ARV	O
agents	O
.	O

Finally	O
,	O
there	O
is	O
now	O
appropriate	O
recognition	O
of	O
the	O
pivotal	O
role	O
of	O
BP	O
reduction	O
in	O
forestalling	O
pressure	O
-	O
related	O
cardiovascular	O
complications	O
,	O
even	O
among	O
high	O
-	O
risk	O
persons	O
with	O
diabetes	O
mellitus	O
and	O
renal	O
insufficiency	O
.	O

Most	O
other	O
differences	O
between	O
these	O
two	O
Leporipoxviruses	O
are	O
located	O
in	O
the	O
telomeres	O
.	O

The	O
Tat	B
protein	I
coded	O
by	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
is	O
a	O
strong	O
activator	O
of	O
viral	O
gene	O
expression	O
from	O
the	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
.	O

Type	O
C	O
units	O
summate	O
the	O
responses	O
to	O
the	O
two	O
-	O
tone	O
stimulus	O
,	O
and	O
show	O
little	O
or	O
no	O
inhibitory	O
influences	O
.	O

19	O
,	O
4967	O
-	O
4973	O
)	O
.	O

Using	O
gel	O
retardation	O
analysis	O
,	O
four	O
binding	O
sites	O
for	O
Rap1p	B
have	O
been	O
identified	O
within	O
the	O
promoter	O
of	O
the	O
RAP1	B
gene	I
.	O

Unlike	O
CSK	B
,	O
the	O
SH3	B
domain	I
of	O
HYL	B
was	O
unique	O
since	O
the	O
ALYDY	O
motif	O
was	O
absent	O
.	O

RESULTS	O
:	O
Although	O
low	O
levels	O
of	O
vIRF-2	B
mRNAs	I
can	O
be	O
detected	O
in	O
the	O
HHV-8-positive	O
BCBL-1	O
tumor	O
cell	O
line	O
,	O
12	O
-	O
0-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
)	O
treatment	O
does	O
not	O
stimulate	O
expression	O
of	O
vIRF-2	B
gene	I
together	O
with	O
primary	O
lytic	O
cycle	O
genes	O
.	O

As	O
anticipated	O
,	O
both	O
intracellular	O
p54-SAPKbeta	B
activation	O
and	O
Bcl-2	B
phosphorylation	O
are	O
blocked	O
by	O
co	O
-	O
transfection	O
with	O
the	O
MAP	B
kinase	I
specific	O
phosphatase	O
MKP3	B
/	O
PYST1	B
.	O

RESULTS	O
:	O
In	O
76	O
trials	O
,	O
5,351	O
patients	O
received	O
24	O
different	O
regimens	O
of	O
droperidol	O
.	O

One	O
new	O
ORF	O
,	O
YBR0224	B
,	O
was	O
detected	O
,	O
coding	O
for	O
a	O
protein	O
with	O
918	O
amino	O
acids	O
.	O

This	O
suggests	O
that	O
the	O
duration	O
of	O
varicocele	O
per	O
se	O
could	O
affect	O
DHT	O
seminal	O
plasma	O
levels	O
.	O

Thus	O
,	O
the	O
cognitive	O
performance	O
of	O
elderly	O
subjects	O
could	O
be	O
trained	O
to	O
a	O
large	O
extent	O
.	O

Two	O
genes	O
from	O
the	O
family	O
encoding	O
mouse	B
ribosomal	I
protein	I
S16	I
were	O
cloned	O
,	O
sequenced	O
,	O
and	O
analyzed	O
.	O

Replacement	O
of	O
a	O
valine	O
(	O
V68	O
)	O
in	O
the	O
ETS	B
domain	O
of	O
SAP1a	B
by	O
aspartic	O
acid	O
(	O
as	O
found	O
in	O
c	B
-	I
Ets-1	I
,	O
Elk-1	B
,	O
and	O
Net	B
)	O
enhanced	O
ternary	O
complex	O
formation	O
by	O
more	O
than	O
60-fold	O
.	O

Tissue	O
-	O
specific	O
gene	O
regulation	O
of	O
eukaryotic	O
organisms	O
is	O
to	O
a	O
large	O
extent	O
mediated	O
by	O
transcription	O
factors	O
that	O
interact	O
with	O
genomic	O
DNA	O
sequences	O
in	O
a	O
sequence	O
-	O
specific	O
manner	O
.	O

As	O
exogenously	O
expressed	O
PKR	B
can	O
form	O
heterodimers	O
with	O
endogenous	B
PKR	I
,	O
the	O
results	O
obtained	O
on	O
the	O
functional	O
characterization	O
of	O
mutant	O
forms	O
of	O
PKR	B
have	O
been	O
taken	O
with	O
caution	O
.	O

Experimental	O
exposure	O
of	O
poults	O
with	O
each	O
of	O
two	O
strains	O
representing	O
the	O
rarely	O
reported	O
capsular	O
group	O
B	O
indicated	O
that	O
both	O
were	O
virulent	O
.	O

Studies	O
on	O
the	O
reaction	O
of	O
cytochrome	B
c	I
with	O
corticosteroids	O
.	O

The	O
results	O
can	O
be	O
summarized	O
as	O
follows	O
.	O

The	O
level	O
of	O
expression	O
of	O
the	O
PDE	B
protein	I
was	O
monitored	O
by	O
immunoblot	O
analysis	O
using	O
two	O
specific	O
cAMP	B
-	I
PDE	I
polyclonal	I
antibodies	I
and	O
by	O
measuring	O
the	O
PDE	B
activity	O
.	O

In	O
response	O
to	O
phosphorus	O
limitation	O
,	O
the	O
fungus	O
Neurospora	O
crassa	O
synthesizes	O
a	O
number	O
of	O
enzymes	O
that	O
function	O
to	O
bring	O
more	O
phosphate	O
into	O
the	O
cell	O
.	O

The	O
Cryotherapy	O
for	O
Retinopathy	O
of	O
Prematurity	O
Study	O
has	O
shown	O
that	O
this	O
number	O
can	O
be	O
halved	O
with	O
treatment	O
.	O

Many	O
of	O
the	O
metabolic	O
effects	O
induced	O
by	O
thiazide	O
diuretics	O
,	O
however	O
,	O
can	O
be	O
limited	O
by	O
the	O
use	O
of	O
low	O
doses	O
.	O

This	O
paper	O
describes	O
a	O
longitudinal	O
study	O
in	O
which	O
clinical	O
parameters	O
and	O
aspartate	B
aminotransferase	I
(	O
AST	B
)	O
in	O
gingival	O
crevicular	O
fluid	O
(	O
GCF	O
)	O
were	O
monitored	O
bimonthly	O
over	O
a	O
6	O
-	O
12	O
months	O
period	O
in	O
970	O
sites	O
from	O
7	O
treated	O
periodontitis	O
patients	O
.	O

Penicillamine	O
-	O
induced	O
myasthenia	O
gravis	O
associated	O
with	O
antibodies	O
to	O
acetylcholine	B
receptor	I
.	O

A	O
mutated	B
ABF1	I
site	I
that	O
displays	O
a	O
very	O
low	O
affinity	O
for	O
ABF1	B
does	O
not	O
functionally	O
replace	O
the	O
ILV1	B
REB1	B
site	I
.	O

1.23	O
)	O
as	O
a	O
PPARalpha	B
-	I
interacting	I
protein	I
.	O

RESULT	O
(	O
S	O
)	O
:	O
A	O
prospective	O
study	O
was	O
conducted	O
with	O
44	O
cycles	O
for	O
34	O
couples	O
with	O
nafarelin	O
acetate	O
(	O
group	O
1	O
)	O
and	O
47	O
cycles	O
for	O
40	O
couples	O
with	O
buserelin	O
acetate	O
(	O
group	O
2	O
)	O
with	O
a	O
long	O
IVF	O
protocol	O
;	O
68	O
cycles	O
for	O
46	O
couples	O
with	O
nafarelin	O
acetate	O
(	O
group	O
3	O
)	O
and	O
56	O
cycles	O
for	O
39	O
couples	O
with	O
buserelin	O
acetate	O
(	O
group	O
4	O
)	O
with	O
a	O
short	O
IVF	O
protocol	O
;	O
39	O
cycles	O
for	O
32	O
couples	O
with	O
nafarelin	O
acetate	O
(	O
group	O
5	O
)	O
and	O
50	O
cycles	O
for	O
30	O
couples	O
with	O
buserelin	O
acetate	O
(	O
group	O
6	O
)	O
with	O
a	O
long	O
ICSI	O
protocol	O
;	O
and	O
87	O
cycles	O
for	O
60	O
couples	O
with	O
nafarelin	O
acetate	O
(	O
group	O
7	O
)	O
and	O
81	O
cycles	O
for	O
61	O
couples	O
with	O
buserelin	O
acetate	O
(	O
group	O
8)	O
with	O
a	O
short	O
ICSI	O
protocol	O
.	O

They	O
are	O
both	O
insensitive	O
to	O
inhibitors	O
of	O
serine	B
and	I
aspartyl	I
proteinases	I
but	O
are	O
sensitive	O
to	O
sulfhydryl	O
reagents	O
and	O
0.5	O
mM	O
ZnCl2	O
.	O

Association	O
between	O
diaphragm	O
use	O
and	O
asymptomatic	O
bacteriuria	O
.	O

We	O
compared	O
these	O
responses	O
for	O
six	O
hatchling	O
and	O
eight	O
adult	O
Chrysemys	O
picta	O
from	O
an	O
Ohio	O
population	O
.	O

INTERNET	O
is	O
literally	O
a	O
world	O
of	O
data	O
,	O
dialogue	O
,	O
and	O
discourse	O
on	O
any	O
topic	O
imaginable	O
,	O
right	O
at	O
your	O
fingertips	O
.	O

We	O
established	O
that	O
,	O
in	O
unstimulated	O
lymphocytes	O
,	O
the	O
Src	B
homology	I
2	I
(	O
SH2	B
)	O
and	O
SH3	B
domain	I
-	I
containing	I
protein	I
Grb2	B
and	O
the	O
p85	B
subunit	O
of	O
phosphatidylinositol	B
3-kinase	I
,	O
associate	O
constitutively	O
with	O
Cbl	B
via	O
their	O
SH3	B
domains	I
.	O

Indirect	O
determination	O
of	O
maximal	O
O2	O
consumption	O
in	O
man	O
.	O

Taken	O
together	O
,	O
these	O
results	O
indicate	O
that	O
ICSBP	B
and	O
PU.1	B
are	O
critical	O
elements	O
for	O
IL-18	B
gene	I
expression	O
.	O

Sequence	O
divergence	O
of	O
approximately	O
16	O
%	O
reduced	O
transformation	O
frequencies	O
by	O
at	O
least	O
10-fold	O
.	O

During	O
subsequent	O
CS	O
-	O
alone	O
trials	O
,	O
the	O
responses	O
of	O
(	O
+	O
)	O
MK-801-injected	O
mice	O
were	O
extinguished	O
as	O
easily	O
as	O
those	O
of	O
saline	O
-	O
injected	O
mice	O
.	O

The	O
kinetics	O
of	O
[	O
14C	O
]	O
NG	O
in	O
the	O
blood	O
of	O
the	O
dosed	O
animals	O
was	O
followed	O
.	O

The	O
data	O
show	O
that	O
processing	O
time	O
as	O
a	O
function	O
of	O
intensity	O
is	O
modified	O
not	O
only	O
at	O
the	O
retina	O
but	O
also	O
at	O
later	O
processing	O
sites	O
.	O

Salt	O
wars	O
.	O

Analysis	O
of	O
domain	O
deletion	O
mutants	O
demonstrated	O
strong	O
synergy	O
between	O
the	O
RRM	O
and	O
a	O
central	O
degenerate	O
RRM	O
repeat	O
in	O
binding	O
to	O
RNA	O
.	O

We	O
used	O
an	O
immobilized	O
template	O
-	O
based	O
assay	O
to	O
examine	O
transcription	O
termination	O
by	O
VA1	B
,	O
7SL	B
,	O
and	O
Alu	B
class	I
III	I
templates	O
and	O
the	O
role	O
of	O
transcript	O
release	O
in	O
the	O
pol	B
III	I
terminator	O
-	O
dependent	O
inhibition	O
of	O
processing	O
of	O
B1-Alu	B
transcripts	O
.	O

Conservation	O
of	O
this	O
zinc	O
finger	O
motif	O
from	O
yeast	O
to	O
mouse	O
and	O
human	O
implies	O
functional	O
importance	O
.	O

The	O
terminal	O
a	O
sequence	O
of	O
the	O
herpes	O
simplex	O
virus	O
genome	O
contains	O
the	O
promoter	O
of	O
a	O
gene	O
located	O
in	O
the	O
repeat	O
sequences	O
of	O
the	O
L	O
component	O
.	O

A	O
simple	O
algorithm	O
fitting	O
the	O
data	O
for	O
the	O
moving	O
192Ir	O
source	O
is	O
proposed	O
.	O

Preventing	O
the	O
heterosexual	O
spread	O
of	O
HIV	O
into	O
this	O
vulnerable	O
population	O
is	O
a	O
formidable	O
public	O
health	O
challenge	O
.	O

Several	O
studies	O
have	O
demonstrated	O
that	O
the	O
corticotropin	B
-	I
releasing	I
factor	I
test	O
(	O
CRF	B
)	O
is	O
useful	O
for	O
the	O
aetiological	O
diagnosis	O
of	O
Cushing	O
's	O
syndrome	O
:	O
in	O
Cushing	O
's	O
disease	O
,	O
as	O
opposed	O
to	O
ectopic	O
ACTH	B
secretion	O
syndrome	O
,	O
the	O
hypothalamus	O
-	O
pituitary	O
-	O
adrenal	O
(	O
HPA	O
)	O
axis	O
can	O
still	O
be	O
stimulated	O
by	O
CRF	B
.	O

The	O
psi	B
zeta	I
gene	I
has	O
a	O
nonsense	O
mutation	O
in	O
exon	O
1	O
but	O
has	O
identical	O
promoter	O
sequence	O
and	O
RNA	O
processing	O
sites	O
to	O
the	O
zeta	B
gene	I
,	O
raising	O
the	O
possibility	O
that	O
both	O
psi	B
zeta	I
and	O
zeta	B
are	O
transcriptionally	O
active	O
.	O

Tax	B
and	O
the	O
active	O
Tax	B
mutants	I
were	O
able	O
to	O
abrogate	O
the	O
G1	O
arrest	O
and	O
apoptosis	O
induced	O
by	O
p53	B
,	O
and	O
this	O
effect	O
does	O
not	O
correlate	O
with	O
an	O
altered	O
localization	O
of	O
nuclear	B
p53	I
or	O
with	O
the	O
disruption	O
of	O
p53-DNA	B
complexes	I
.	O

Chronic	O
,	O
recurrent	O
multifocal	O
osteomyelitis	O
.	O

BACKGROUND	O
:	O
The	O
extract	O
of	O
medicinal	O
plants	O
containing	O
curcumin	O
is	O
traditionally	O
believed	O
to	O
have	O
a	O
positive	O
contraction	O
effect	O
on	O
the	O
human	O
gall	O
-	O
bladder	O
.	O

Moreover	O
,	O
the	O
formation	O
of	O
the	O
complex	O
between	O
IclR	B
and	O
the	O
operator	O
/	O
promoter	O
region	O
has	O
been	O
found	O
to	O
be	O
impaired	O
by	O
phosphoenol	O
pyruvate	O
but	O
insensitive	O
to	O
acetate	O
,	O
acetyl	O
-	O
CoA	O
,	O
pyruvate	O
,	O
and	O
oxaloacetate	O
.	O

Also	O
,	O
the	O
RVW	O
hypertrophy	O
,	O
the	O
IVS	O
hypertrophy	O
,	O
and	O
the	O
RV	O
high	O
pressure	O
load	O
to	O
the	O
LV	O
through	O
the	O
IVS	O
may	O
be	O
related	O
to	O
the	O
small	O
LV	O
,	O
high	O
EF	O
,	O
and	O
abnormal	O
two	O
chamber	O
inflow	O
in	O
the	O
PS	O
group	O
before	O
BV	O
.	O

OBJECTIVE	O
:	O
Respiratory	O
-	O
related	O
electromyographic	O
(	O
EMG	O
)	O
activity	O
of	O
the	O
superior	O
pharyngeal	O
constrictor	O
(	O
SPC	O
)	O
muscle	O
was	O
analyzed	O
during	O
the	O
early	O
stage	O
of	O
forced	O
breathing	O
.	O

Expression	O
,	O
characterization	O
,	O
and	O
genomic	O
structure	O
of	O
carp	B
JAK1	I
kinase	I
gene	I
.	O

Cough	O
-	O
CPR	O
,	O
a	O
deep	O
rhythmic	O
forceful	O
cough	O
repeated	O
30	O
-	O
60	O
times	O
per	O
minute	O
,	O
can	O
be	O
an	O
effective	O
resuscitative	O
technique	O
during	O
emergencies	O
occurring	O
in	O
the	O
cardiac	O
catheterization	O
laboratory	O
.	O

The	O
cause	O
for	O
the	O
increase	O
in	O
plasma	B
ANP	I
levels	O
in	O
the	O
active	O
phase	O
remains	O
to	O
be	O
determined	O
.	O

Further	O
interventions	O
were	O
:	O
nephrectomy	O
(	O
2x	O
)	O
,	O
resection	O
and	O
ligation	O
of	O
the	O
inferior	O
vena	O
cava	O
(	O
1x	O
)	O
,	O
resection	O
and	O
replacement	O
of	O
the	O
left	O
renal	O
vein	O
(	O
1x	O
)	O
.	O

These	O
clones	O
contain	O
most	O
of	O
the	O
exon	O
of	O
cyclin	B
D2	I
except	O
exon	O
5	O
.	O

The	O
odds	O
of	O
atopy	O
(	O
defined	O
as	O
a	O
positive	O
test	O
for	O
at	O
least	O
one	O
of	O
the	O
antigens	O
)	O
were	O
5	O
times	O
higher	O
(	O
odds	O
ratio	O
=	O
7.0	O
;	O
95	O
%	O
confidence	O
interval	O
=	O
1.6	O
-	O
31.1	O
%	O
;	O
p	O
=	O
0.01	O
)	O
in	O
the	O
uninfected	O
group	O
,	O
after	O
taking	O
into	O
account	O
the	O
potential	O
influence	O
of	O
gender	O
and	O
age	O
.	O

Similar	O
immunological	O
disturbances	O
were	O
observed	O
in	O
SCI	O
but	O
not	O
in	O
the	O
PC2	O
subgroup	O
,	O
i.e.	O
patients	O
examined	O
later	O
than	O
6	O
months	O
after	O
injury	O
.	O

In	O
the	O
remaining	O
91	O
patients	O
(	O
group	O
2	O
)	O
,	O
Pseudomonas	O
(	O
18	O
)	O
,	O
coagulase	B
-	O
negative	O
Staphylococci	O
(	O
15	O
)	O
,	O
Staphylococcus	O
epidermidis	O
(	O
23	O
)	O
,	O
Staphylococcus	O
aureus	O
(	O
16	O
)	O
,	O
Corynebacterium	O
species	O
(	O
12	O
)	O
,	O
and	O
others	O
(	O
seven	O
)	O
were	O
isolated	O
.	O

Serum	O
concentrations	O
of	O
hormones	O
in	O
patients	O
classified	O
as	O
C	O
were	O
characteristically	O
and	O
inclined	O
to	O
be	O
hypergonadotropic	O
and	O
hypoestrogenic	O
.	O

We	O
generated	O
""""	O
signature	O
""""	O
oligonucleotides	O
from	O
these	O
CDR3s	B
and	O
probed	O
PCR	O
amplified	O
V	B
kappa	I
products	I
from	O
the	O
synovium	O
and	O
PBLs	O
of	O
the	O
same	O
patient	O
,	O
and	O
from	O
PBLs	O
and	O
spleen	O
of	O
individuals	O
without	O
rheumatic	O
disease	O
.	O

Structure	O
and	O
regulation	O
of	O
KGD2	B
,	O
the	O
structural	O
gene	O
for	O
yeast	B
dihydrolipoyl	I
transsuccinylase	I
.	O

Above	O
this	O
transition	O
temperature	O
the	O
calcium	O
antagonist	O
lowers	O
fm	O
more	O
pronouncedly	O
than	O
below	O
.	O

Solution	O
of	O
the	O
Boltzmann	O
equation	O
in	O
a	O
random	O
magnetic	O
field	O
.	O

These	O
include	O
the	O
genes	O
,	O
undefined	B
1	I
(	O
UD1	B
)	O
,	O
UD2	B
,	O
and	O
UD3	B
,	O
each	O
coding	O
for	O
proteins	O
of	O
unknown	O
function	O
,	O
the	O
ken	B
gene	I
encoding	O
a	O
new	O
Kruppel	B
-	I
like	I
putative	I
transcription	I
factor	I
,	O
the	O
fly	O
homologues	O
of	O
the	O
mammalian	B
mitochondrial	I
trifunctional	I
enzyme	I
(	O
thiolase	B
)	O
,	O
and	O
the	O
TAR	B
DNA	I
-	I
binding	I
protein-43	I
(	O
TBPH	B
)	O
,	O
the	O
first	O
nonvertebrate	O
member	O
of	O
the	O
transmembrane	B
4	I
superfamily	I
(	O
TM4SF	B
)	O
gene	O
,	O
a	O
new	O
homeodomain	B
gene	I
,	O
and	O
a	O
gene	O
coding	O
for	O
a	O
putative	O
nuclear	O
binding	O
protein	O
(	O
PNBP	O
)	O
that	O
is	O
homologous	O
to	O
maleless	B
,	O
and	O
a	O
Copia	B
-	I
like	I
element	I
.	O

We	O
recently	O
described	O
the	O
isolation	O
and	O
characterization	O
of	O
nontoxic	O
PAP	B
mutants	I
,	O
NT123	O
-	O
2	O
,	O
which	O
has	O
a	O
point	O
mutation	O
(	O
E176V	O
)	O
in	O
the	O
active	O
site	O
that	O
abolishes	O
enzymatic	O
activity	O
,	O
and	O
NT124	O
-	O
3	O
,	O
which	O
has	O
a	O
nonsense	O
mutation	O
that	O
results	O
in	O
deletion	O
of	O
the	O
C	O
-	O
terminal	O
25	O
aa	O
(	O
W237Stop	O
)	O
.	O

This	O
ligand	O
-	O
independent	O
pathway	O
can	O
function	O
through	O
another	O
androgen	O
-	O
regulated	O
promoter	O
as	O
shown	O
by	O
the	O
use	O
of	O
the	O
mouse	B
mammary	I
tumor	I
virus	I
MMTV	I
-	I
CAT	I
reporter	I
.	O

Studies	O
on	O
low	O
-	O
dose	O
oral	O
contraceptives	O
:	O
cervical	O
mucus	O
and	O
plasma	O
hormone	O
changes	O
in	O
relation	O
to	O
circulating	O
D	O
-	O
norgestrel	O
and	O
17alpha	O
ethynyl	O
-	O
estradiol	O
concentrations	O
.	O

On	O
the	O
pharmacology	O
of	O
9,10-dihydro-10-	O
(	O
1-methyl-4-piperidylidene	O
)	O
-9-anthrol	O
(	O
WA	O
335	O
)	O
,	O
a	O
histamine	O
and	O
serotonin	O
antagonist	O

This	O
incompatibility	O
phenotype	O
requires	O
the	O
global	O
transcriptional	O
repressor	O
,	O
KorB	B
,	O
and	O
the	O
target	O
for	O
incC	B
-	O
mediated	O
incompatibility	O
is	O
a	O
KorB	B
-	I
binding	I
site	I
(	I
O	I
(	I
B	I
)	I
)	I
.	O

A	O
mean	O
value	O
for	O
HbA1	B
greater	O
than	O
10	O
%	O
was	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
progression	O
of	O
retinopathy	O
and	O
a	O
mean	O
value	O
less	O
than	O
8.7	O
%	O
was	O
associated	O
with	O
a	O
diminished	O
risk	O
.	O

Threefold	O
risks	O
were	O
observed	O
for	O
men	O
with	O
the	O
highest	O
level	O
of	O
intensity	O
and	O
for	O
those	O
with	O
the	O
highest	O
probability	O
of	O
EMF	O
exposure	O
,	O
although	O
women	O
with	O
heavy	O
EMF	O
exposure	O
did	O
not	O
experience	O
increased	O
risk	O
.	O

Early	O
complement	O
components	O
,	O
C1q	B
and	O
C4	B
,	O
and	O
IgA	B
secretory	O
piece	O
were	O
absent	O
.	O

Erdheim	O
-	O
Chester	O
disease	O
:	O
a	O
distinct	O
lipoidosis	O
or	O
part	O
of	O
the	O
spectrum	O
of	O
histiocytosis	O
?	O

Erdheim	O
-	O
Chester	O
disease	O
has	O
always	O
been	O
considered	O
a	O
distinct	O
lipoidosis	O
based	O
on	O
clinical	O
and	O
radiographic	O
criteria	O
.	O

The	O
leader	O
peptide	O
was	O
hypothesized	O
to	O
inhibit	O
ribosome	O
release	O
at	O
the	O
tnaC	B
stop	I
codon	I
,	O
thereby	O
blocking	O
Rho	B
's	O
access	O
to	O
the	O
transcript	O
.	O

In	O
the	O
presence	O
of	O
high	O
concentrations	O
(	O
propofol	O
100	O
microg	O
mL-1	O
,	O
thiopental	O
50	O
microg	O
mL-1	O
)	O
marked	O
relaxation	O
was	O
observed	O
(	O
propofol	O
-32	O
%	O
up	O
to	O
-49	O
%	O
,	O
P	O
<	O
0,05	O
;	O
thiopental	O
-23	O
%	O
up	O
to	O
-67	O
%	O
,	O
P	O
<	O
0.05	O
)	O
.	O

Specifically	O
,	O
we	O
demonstrate	O
that	O
this	O
25-base	O
pair	O
region	O
mediates	O
the	O
up	O
-	O
regulatory	O
effect	O
of	O
TGF	B
-	I
beta	I
on	O
COL1A2	B
promoter	I
activity	O
and	O
allows	O
antagonistic	O
activity	O
of	O
TNF	B
-	I
alpha	I
on	O
the	O
TGF	B
-	I
beta	I
effect	O
.	O

The	O
mouse	O
lactoferrin	B
gene	O
promoter	O
was	O
active	O
in	O
human	O
endometrium	O
carcinoma	O
RL	O
95	O
-	O
2	O
cells	O
and	O
in	O
rat	O
glioma	O
C6	O
cells	O
.	O

Computer	O
analysis	O
revealed	O
that	O
the	O
human	B
protein	I
P1	I
sequence	I
corresponding	O
to	O
amino	O
acid	O
residues	O
within	O
the	O
N	O
-	O
terminal	O
RNA	O
binding	O
domain	O
displays	O
high	O
homology	O
(	O
greater	O
than	O
54	O
%	O
identity	O
;	O
61	O
to	O
94	O
%	O
similarity	O
)	O
with	O
two	O
animal	O
virus	O
proteins	O
which	O
possess	O
RNA	O
binding	O
activity	O
(	O
vaccinia	B
virus	I
E3L	I
;	O
rotavirus	B
VP2	I
)	O
and	O
two	O
proteins	O
of	O
unknown	O
function	O
(	O
murine	B
TIK	I
;	O
rotavirus	B
NS34	I
)	O
,	O
but	O
which	O
are	O
likely	O
RNA	O
binding	O
proteins	O
.	O

Conversely	O
the	O
rate	O
of	O
bioavailability	O
was	O
significantly	O
different	O
,	O
because	O
from	O
the	O
Reference	O
patch	O
the	O
release	O
rate	O
is	O
fast	O
in	O
the	O
first	O
24	O
h	O
,	O
leading	O
to	O
an	O
E2	O
peak	O
at	O
8	O
h	O
and	O
to	O
a	O
Cmax	O
in	O
average	O
at	O
23	O
h.	O

A	O
silica	O
-	O
based	O
,	O
fluoride	O
-	O
free	O
placebo	O
containing	O
NaTPP	O
,	O
and	O
a	O
NaF	O
-	O
containing	O
silica	O
-	O
based	O
USP	O
reference	O
standard	O
toothpaste	O
were	O
used	O
as	O
negative	O
and	O
positive	O
control	O
toothpastes	O
,	O
respectively	O
.	O

The	O
cost	O
and	O
effectiveness	O
of	O
nurse	O
education--1	O
.	O

No	O
significant	O
difference	O
in	O
plasma	O
ET	B
levels	O
was	O
found	O
between	O
cardiac	O
and	O
peripheral	O
sampling	O
sites	O
(	O
pulmonary	O
artery	O
;	O
1.07	O
+	O
/-	O

0.28	O
,	O
right	O
atrium	O
;	O
1.02	O
+	O
/-	O

0.28	O
,	O
peripheral	O
artery	O
;	O
1.12	O
+	O
/-	O

0.23	O
,	O
peripheral	O
vein	O
;	O
1.14	O
+	O
/-	O

0.38	O
fmol	O
/	O
ml	O
:	O
N.S.	O
)	O
,	O
or	O
among	O
patients	O
with	O
uncomplicated	O
MI	O
,	O
unstable	O
angina	O
(	O
1.00	O
+	O
/-	O

0.32	O
fmol	O
/	O
ml	O
)	O
,	O
and	O
healthy	O
subjects	O
(	O
1.01	O
+	O
/-	O

0.29	O
fmol	O
/	O
ml	O
)	O
.	O

Transfer	O
of	O
health	O
care	O
to	O
natives	O
holds	O
much	O
promise	O
,	O
lecturers	O
say	O
.	O

S.	O
aureus	O
leakage	O
into	O
the	O
totally	O
submerged	O
test	O
specimens	O
was	O
detected	O
in	O
1	O
of	O
5	O
samples	O
incubated	O
for	O
4	O
weeks	O
,	O
while	O
no	O
leakage	O
was	O
detected	O
in	O
specimens	O
incubated	O
for	O
3	O
,	O
5	O
,	O
6	O
,	O
7	O
,	O
and	O
8	O
weeks	O
.	O

The	O
Prompt	O
and	O
Praise	O
condition	O
was	O
superior	O
to	O
the	O
other	O
two	O
conditions	O
in	O
encouraging	O
participation	O
in	O
low	O
-	O
interest	O
recreational	O
activities	O
.	O

In	O
the	O
promoters	O
of	O
many	O
immediate	B
early	I
genes	I
,	O
including	O
c	B
-	I
fos	I
,	O
CArG	O
DNA	O
regulatory	O
elements	O
mediate	O
basal	O
constituitive	O
expression	O
and	O
rapid	O
and	O
transient	O
serum	O
induction	O
.	O

Strains	O
lacking	O
a	O
functional	B
RPL16A	I
gene	I
grow	O
as	O
rapidly	O
as	O
wild	O
type	O
,	O
whereas	O
those	O
containing	O
a	O
null	O
allele	O
of	O
RPL16B	B
grow	O
more	O
slowly	O
than	O
wild	O
type	O
.	O

DIC	O
and	O
low	O
grade	O
fibrinolysis	O
may	O
account	O
for	O
the	O
coagulation	O
abnormalities	O
of	O
the	O
syndrome	O
.	O

Overexpression	O
of	O
wild	O
type	O
and	O
SeCys	O
/	O
Cys	O
mutant	O
of	O
human	B
thioredoxin	I
reductase	I
in	O
E.	O
coli	O
:	O
the	O
role	O
of	O
selenocysteine	O
in	O
the	O
catalytic	O
activity	O
.	O

A	O
Meis1	B
cDNA	I
clone	O
that	O
encoded	O
a	O
novel	O
member	O
of	O
the	O
homeobox	B
gene	I
family	I
was	O
identified	O
.	O

Cellular	O
lysates	O
were	O
analyzed	O
for	O
luciferase	B
and	O
beta	B
-	I
galactosidase	I
activities	O
.	O

The	O
protein	O
contains	O
a	O
SHAQKYF	O
amino	O
acid	O
signature	O
motif	O
in	O
the	O
second	O
myb	B
-	I
like	I
repeat	I
,	O
which	O
is	O
highly	O
conserved	O
in	O
a	O
number	O
of	O
recently	O
identified	O
plant	B
myb	I
-	I
related	I
genes	I
,	O
thus	O
defining	O
a	O
new	O
class	O
of	O
plant	O
DNA	O
-	O
binding	O
proteins	O
.	O

The	O
use	O
of	O
aluminum	O
hydroxide	O
was	O
associated	O
with	O
an	O
increase	O
in	O
fecal	O
fluoride	O
excretion	O
and	O
a	O
decrease	O
in	O
net	O
absorption	O
of	O
fluoride	O
regardless	O
of	O
the	O
intake	O
fluoride	O
,	O
calcium	O
,	O
phosphorus	O
,	O
or	O
magnesium	O
.	O

First	O
aid	O
.	O

We	O
have	O
isolated	O
and	O
determined	O
the	O
complete	O
nucleotide	O
sequence	O
of	O
another	O
operon	O
,	O
cpeCD	B
,	O
that	O
encodes	O
the	O
linker	O
proteins	O
associated	O
with	O
phycoerythrin	B
hexamers	I
in	O
the	O
phycobilisome	B
.	O

Here	O
,	O
we	O
describe	O
the	O
results	O
of	O
a	O
detailed	O
study	O
aimed	O
at	O
identifying	O
the	O
gene	O
or	O
genes	O
responsible	O
for	O
the	O
rapid	O
growth	O
-	O
arrest	O
response	O
obtained	O
with	O
human	O
chromosome-9	O
.	O

A	O
novel	O
Cdc42Hs	B
mutant	I
induces	O
cellular	O
transformation	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
mechanism	O
of	O
ribosomal	O
frameshifting	O
at	O
the	O
PVM	O
signal	O
is	O
different	O
from	O
the	O
one	O
described	O
by	O
the	O
'	O
simultaneous	O
slippage	O
'	O
model	O
in	O
that	O
only	O
the	O
string	O
of	O
four	O
adenosine	O
nucleotides	O
represents	O
the	O
slippery	O
sequence	O
involved	O
in	O
a	O
-1	O
P	O
-	O
site	O
slippage	O
.	O

Kluyveromyces	O
lactis	O
,	O
a	O
budding	O
yeast	O
related	O
to	O
Saccharomyces	O
cerevisiae	O
,	O
can	O
grow	O
on	O
a	O
wider	O
variety	O
of	O
substrates	O
and	O
shows	O
less	O
sensitivity	O
to	O
glucose	O
repression	O
than	O
does	O
Saccharomyces	O
cerevisiae	O
.	O

The	O
human	B
Fc	I
gamma	I
receptor	I
gene	I
Fc	B
gamma	I
RIIA	I
is	O
expressed	O
in	O
platelets	O
,	O
neutrophils	O
,	O
monocytes	O
and	O
macrophages	O
.	O

Hence	O
,	O
it	O
is	O
perhaps	O
not	O
necessary	O
to	O
perform	O
spinal	O
puncture	O
if	O
the	O
only	O
purpose	O
is	O
to	O
determine	O
the	O
CSF	O
/	O
serum	O
ratio	O
.	O

Interestingly	O
,	O
VDR	B
was	O
able	O
to	O
bind	O
to	O
VDREs	O
with	O
high	O
affinity	O
and	O
to	O
fully	O
activate	O
transcription	O
in	O
intact	O
yeast	O
cells	O
in	O
the	O
presence	O
of	O
the	O
retinoid	B
X	I
receptor	I
(	O
RXR	B
)	O
.	O

In	O
contrast	O
,	O
the	O
sequences	O
essential	O
for	O
the	O
transcription	O
of	O
EFT1	B
were	O
localized	O
to	O
the	O
region	O
between	O
the	O
start	O
ATG	O
and	O
the	O
stop	O
codon	O
of	O
the	O
VPS17	B
gene	I
that	O
terminates	O
267	O
nt	O
upstream	O
on	O
the	O
same	O
strand	O
.	O

Foreign	O
DNA	O
inserts	O
contained	O
within	O
the	O
fowlpox	O
virus	O
sequence	O
were	O
transferred	O
to	O
the	O
viral	O
genome	O
by	O
homologous	O
recombination	O
occurring	O
in	O
cells	O
infected	O
with	O
a	O
fowlpox	O
virus	O
temperature	O
-	O
sensitive	O
mutant	O
and	O
transfected	O
with	O
both	O
wild	O
-	O
type	O
viral	O
DNA	O
and	O
plasmid	O
DNA	O
.	O

The	O
LT	B
-	I
beta	I
gene	I
is	O
expressed	O
in	O
lymphoid	O
cells	O
and	O
organs	O
,	O
but	O
little	O
is	O
known	O
about	O
its	O
inducible	O
regulation	O
.	O

Genomic	O
organization	O
of	O
the	O
human	B
multidrug	I
resistance	I
(	I
MDR1	I
)	I
gene	I
and	O
origin	O
of	O
P	B
-	I
glycoproteins	I
.	O

Yet	O
IL-2	B
and	O
IFN	B
-	I
gamma	I
production	O
are	O
independently	O
regulated	O
,	O
as	O
demonstrated	O
by	O
their	O
differential	O
expression	O
in	O
certain	O
T	O
cell	O
subsets	O
,	O
suggesting	O
that	O
the	O
regulatory	O
elements	O
in	O
these	O
two	O
genes	O
must	O
differ	O
.	O

Using	O
beta	B
1-AR	I
-	O
luciferase	B
reporter	O
recombinants	O
,	O
we	O
have	O
previously	O
determined	O
that	O
important	O
beta	B
1-AR	I
genetic	O
elements	O
controlling	O
expression	O
within	O
the	O
C6	O
glioma	O
cell	O
line	O
are	O
contained	O
within	O
the	O
region	O
-396	O
to	O
-299	O
,	O
relative	O
to	O
the	O
translational	O
start	O
site	O
.	O

The	O
gene	O
is	O
predicted	O
to	O
encode	O
an	O
880-amino	O
-	O
acid	O
protein	O
which	O
contains	O
two	O
C2H2	O
zinc	O
fingers	O
,	O
a	O
nuclear	O
localization	O
sequence	O
and	O
two	O
transcriptional	O
activation	O
domains	O
.	O

Pathogenesis	O
of	O
fever	O
.	O

In	O
many	O
other	O
contractile	O
protein	O
gene	O
families	O
,	O
genes	O
encoding	O
cardiac	O
isoforms	O
are	O
expressed	O
early	O
in	O
skeletal	O
muscle	O
development	O
and	O
are	O
later	O
repressed	O
.	O

This	O
is	O
the	O
first	O
clinical	O
case	O
report	O
of	O
NIHF	O
due	O
to	O
fetal	O
Kasabach	O
-	O
Merritt	O
syndrome	O
that	O
was	O
prenatally	O
diagnosed	O
by	O
sonography	O
,	O
computerized	O
tomography	O
,	O
and	O
percutaneous	O
umbilical	O
blood	O
sampling	O
.	O

Growth	O
factors	O
promote	O
cell	O
survival	O
through	O
phosphorylation	O
of	O
Bad	B
,	O
resulting	O
in	O
its	O
dissociation	O
from	O
Bcl-2	B
and	O
Bcl	B
-	I
x	I
(	I
L	I
)	I
and	O
its	O
association	O
with	O
14	B
-	I
3	I
-	I
3tau	I
.	O

Developmental	O
regulation	O
of	O
expression	O
of	O
the	O
malate	B
synthase	I
gene	I
in	O
transgenic	O
plants	O
.	O

Of	O
3841	O
serum	O
samples	O
from	O
sows	O
received	O
from	O
the	O
Tennessee	O
State	O
Diagnostic	O
Laboratory	O
in	O
1991	O
-	O
1992	O
,	O
1130	O
were	O
positive	O
for	O
Toxoplasma	B
gondii	I
antibody	I
.	O

An	O
insertion	O
sequence	O
element	O
(	O
IS1170	O
)	O
was	O
identified	O
upstream	O
of	O
the	O
nimC	B
gene	I
.	O

We	O
show	O
that	O
the	O
upstream	O
region	O
of	O
the	O
beta	B
-MyHC	I
gene	I
(	O
-5518	O
to	O
-2490	O
relative	O
to	O
the	O
transcriptional	O
start	O
site	O
)	O
directed	O
high	O
levels	O
of	O
transcriptional	O
activity	O
only	O
when	O
stably	O
integrated	O
,	O
but	O
not	O
when	O
expressed	O
extrachromosomally	O
in	O
transient	O
assays	O
.	O

Similarly	O
,	O
TAM-67	B
reverted	O
the	O
morphology	O
of	O
the	O
AdoMetDC	B
-	I
antisense	I
expressors	I
.	O

Immune	O
and	O
clinical	O
impact	O
of	O
Lactobacillus	O
acidophilus	O
on	O
asthma	O
.	O

To	O
examine	O
the	O
functional	O
relationship	O
between	O
distinct	O
cis	O
-	O
active	O
elements	O
within	O
the	O
distal	O
enhancer	O
region	O
of	O
the	O
rat	B
PRL	I
gene	I
,	O
we	O
have	O
used	O
deletional	O
and	O
mutational	O
analysis	O
of	O
that	O
region	O
in	O
transient	O
transfection	O
studies	O
in	O
GH3	O
pituitary	O
tumor	O
cells	O
.	O

While	O
there	O
is	O
growing	O
evidence	O
that	O
perception	O
and	O
imagery	O
share	O
common	O
neural	O
substrates	O
,	O
the	O
fact	O
that	O
D.F.	O
shows	O
intact	O
visual	O
imagery	O
in	O
the	O
face	O
of	O
a	O
massive	O
perceptual	O
deficit	O
in	O
form	O
vision	O
challenges	O
recent	O
suggestions	O
that	O
these	O
two	O
psychological	O
processes	O
share	O
common	O
input	O
pathways	O
in	O
early	O
vision	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
of	O
the	O
conserved	O
cysteine	O
residue	O
(	O
tom1C3235A	B
)	O
in	O
the	O
hect	B
-	I
domain	I
,	O
supposed	O
to	O
be	O
necessary	O
for	O
thioester	O
-	O
bond	O
formation	O
with	O
ubiquitin	B
,	O
abolished	O
the	O
gene	O
function	O
.	O

The	O
amino	O
acid	O
sequence	O
of	O
the	O
protein	O
encoded	O
by	O
MSK1	B
is	O
homologous	O
to	O
yeast	B
cytoplasmic	I
lysyl	I
-	I
tRNA	I
synthetase	I
and	O
to	O
the	O
product	O
of	O
the	O
herC	B
gene	I
,	O
which	O
has	O
recently	O
been	O
suggested	O
to	O
code	O
for	O
the	O
Escherichia	O
coli	O
enzyme	O
.	O

Joint	O
ultrasonography	O
demonstrating	O
thickening	O
of	O
synoviae	O
and	O
tendons	O
has	O
become	O
a	O
useful	O
non	O
-	O
invasive	O
diagnostic	O
tool	O
,	O
although	O
it	O
is	O
not	O
specific	O
for	O
beta	B
2-M	I
amyloidosis	O
,	O
and	O
results	O
depend	O
on	O
observer	O
experience	O
.	O

Videoanalysis	O
confirms	O
the	O
ballistic	O
character	O
of	O
the	O
initial	O
phase	O
of	O
the	O
reaching	O
movement	O
.	O

Toward	O
this	O
end	O
,	O
we	O
used	O
two	O
cultured	O
colon	O
cancer	O
cell	O
lines	O
;	O
one	O
(	O
RKO	O
)	O
has	O
a	O
transcriptionally	O
activated	O
u	B
-	I
PAR	I
gene	I
,	O
and	O
the	O
other	O
(	O
GEO	O
)	O
overexpresses	O
the	O
receptor	O
only	O
after	O
phorbol	O
ester	O
treatment	O
.	O

Mortality	O
among	O
patients	O
with	O
CAVB	O
is	O
still	O
high	O
and	O
has	O
not	O
declined	O
within	O
the	O
last	O
decade	O
.	O

Serum	O
triglycerides	O
also	O
showed	O
an	O
increase	O
from	O
birth	O
to	O
6	O
months	O
of	O
age	O
,	O
but	O
a	O
decrease	O
from	O
6	O
months	O
to	O
1	O
years	O
of	O
age	O
.	O

In	O
contrast	O
SF	B
,	O
but	O
not	O
GM	B
-	I
CSF	I
or	O
IL-3	B
,	O
induced	O
tyrosine	O
phosphorylation	O
of	O
phospholipase	B
C	I
-	I
gamma	I
(	O
PLC	B
-	I
gamma	I
)	O
.	O

The	O
effects	O
of	O
oxalate	O
-	O
containing	O
products	O
on	O
the	O
exposed	O
dentine	O
surface	O
:	O
an	O
SEM	O
investigation	O
.	O

Up	O
to	O
1988	O
,	O
145	O
cases	O
had	O
been	O
reported	O
in	O
literature	O
and	O
32	O
cases	O
in	O
our	O
country	O
.	O

Disorganization	O
scores	O
of	O
the	O
hypertrophy	O
zone	O
and	O
trabecular	O
bone	O
were	O
low	O
,	O
approaching	O
normal	O
(	O
P	O
<	O
0.05	O
)	O
,	O
for	O
turkey	O
poults	O
fed	O
on	O
diets	O
with	O
phytase	B
supplementation	O
,	O
and	O
tibial	O
abnormality	O
scores	O
were	O
linearly	O
decreased	O
(	O
P	O
<	O
0.001	O
)	O
as	O
nP	O
levels	O
increased	O
(	O
zero	O
score	O
is	O
considered	O
normal	O
)	O
.	O

These	O
results	O
suggest	O
that	O
1a	B
,	O
which	O
also	O
interacts	O
independently	O
with	O
the	O
ER	O
and	O
viral	O
RNA	O
,	O
is	O
a	O
key	O
organizer	O
of	O
RNA	O
replication	O
complex	O
assembly	O
.	O

Here	O
we	O
examine	O
the	O
population	O
of	O
gammaS	B
transcripts	I
in	O
adult	O
human	O
lens	O
and	O
the	O
structure	O
of	O
the	O
human	B
CRYGS	I
genes	I
.	O

Functional	O
importance	O
of	O
a	O
properly	O
folded	O
surface	O
loop	O
covering	O
the	O
catalytic	O
center	O
.	O

This	O
mechanism	O
seems	O
to	O
be	O
involved	O
in	O
VIP	B
-	O
induced	O
PRL	B
gene	I
regulation	O
.	O

A	O
Brassica	O
cDNA	O
clone	O
encoding	O
a	O
bifunctional	O
hydroxymethylpyrimidine	B
kinase	I
/	O
thiamin	B
-	I
phosphate	I
pyrophosphorylase	I
involved	O
in	O
thiamin	O
biosynthesis	O
.	O

When	O
CSF	O
[	O
HCO3-	O
]	O
is	O
shown	O
as	O
a	O
function	O
of	O
CSF	O
PCO2	O
the	O
data	O
of	O
K	O
-	O
depleted	O
rats	O
are	O
no	O
longer	O
displaced	O
when	O
compared	O
to	O
controls	O
but	O
still	O
have	O
a	O
significantly	O
greater	O
slope	O
(	O
1.21	O
+	O
/-	O

0.23	O
vs.	O

In	O
the	O
matched	O
control	O
group	O
the	O
acquisition	O
-	O
rate	O
of	O
both	O
symptomatic	O
and	O
asymptomatic	O
0acteriuria	O
was	O
over	O
12	O
%	O
,	O
a	O
figure	O
similar	O
to	O
the	O
percentage	O
of	O
women	O
present	O
in	O
the	O
practice	O
population	O
during	O
one	O
year	O
with	O
transient	O
,	O
symptomatic	O
,	O
and	O
persistent	O
A.B.	O

In	O
2	O
subjects	O
the	O
phytomitogen	O
reactivity	O
of	O
the	O
lymphocytes	O
was	O
improved	O
after	O
treatment	O
.	O

The	O
maintenance	O
of	O
increased	O
myocardial	O
capillary	O
density	O
required	O
a	O
similar	O
amount	O
of	O
exercise	O
,	O
and	O
at	O
least	O
1	O
h	O
of	O
exercise	O
once	O
a	O
week	O
was	O
necessary	O
to	O
maintain	O
the	O
enlargement	O
of	O
ECA.20	O

These	O
observations	O
have	O
led	O
us	O
to	O
conclude	O
that	O
an	O
elevated	O
VIII	O
-	O
ratio	O
is	O
a	O
very	O
sensitive	O
indicator	O
of	O
intravascular	O
coagulation	O
.	O

The	O
inner	O
ears	O
were	O
exposed	O
by	O
microdissection	O
,	O
and	O
the	O
vestibular	O
sensory	O
regions	O
were	O
either	O
sectioned	O
and	O
studied	O
with	O
light	O
or	O
electron	O
microscopy	O
,	O
or	O
prepared	O
and	O
studied	O
with	O
the	O
surface	O
specimen	O
technique	O
.	O

The	O
matrix	O
surrounding	O
the	O
clusters	O
either	O
showed	O
a	O
normal	O
morphology	O
or	O
a	O
homogeneous	O
appearance	O
,	O
within	O
which	O
faint	O
cross	O
striations	O
but	O
no	O
distinctly	O
fibrillar	O
outlines	O
could	O
be	O
identified	O
.	O

The	O
incidence	O
of	O
DNCB	O
reactions	O
was	O
78	O
per	O
cent	O
for	O
Stage	O
I	O
and	O
II	O
cancers	O
(	O
37	O
patinets	O
)	O
,	O
73	O
per	O
cent	O
for	O
resectable	O
Stage	O
III	O
cancer	O
(	O
22	O
patients	O
)	O
,	O
and	O
66	O
per	O
cent	O
in	O
patients	O
with	O
unresectable	O
or	O
inoperable	O
Stage	O
III	O
cancer	O
.	O

Workers	O
with	O
""""	O
sensitivity	O
""""	O
to	O
toluene	O
diisocyanate	O
(	O
TDI	O
)	O
studied	O
in	O
depth	O
in	O
an	O
attempt	O
to	O
determine	O
mechanisms	O
of	O
bronchial	O
hyperreactivity	O
.	O

Bertioga	O
(	O
Guama	O
group	O
)	O
and	O
Anhembi	O
(	O
Bunyamwera	O
group	O
)	O
,	O
two	O
new	O
arboviruses	O
isolated	O
in	O
Sao	O
Paulo	O
,	O
Brazil	O
.	O

The	O
'	O
field	O
of	O
stress	O
'	O
of	O
the	O
supervisory	O
nurse	O

Williams	O
,	O
2	O
August	O
1977	O
.	O

Disrupted	O
vaccines	O
and	O
whole	O
-	O
virus	O
vaccines	O
containing	O
type	B
B	I
antigen	I
only	O
did	O
not	O
cause	O
significant	O
reactivity	O
.	O

255	O
-	O
61	O
.	O

The	O
maximum	O
period	O
of	O
treatment	O
was	O
73	O
(	O
oral	O
)	O
,	O
73	O
(	O
intraperitoneal	O
)	O
or	O
75	O
(	O
dermal	O
)	O
weeks	O
.	O

Bone	O
marrow	O
transplantation-1979	O
.	O

Inherent	O
hematology	O
of	O
old	O
age	O

Immunologic	O
mechanisms	O
in	O
chronic	O
brucellosis	O
in	O
humans	O
.	O

This	O
expression	O
assumes	O
:	O
(	O
1	O
)	O
a	O
laminar	O
flow	O
regimen	O
during	O
expiration	O
,	O
and	O
(	O
2	O
)	O
a	O
constant	O
CT	O
value	O
over	O
the	O
range	O
of	O
VT	O
.	O

In	O
addition	O
a	O
significant	O
Treatment	O
X	O
Strain	O
interaction	O
was	O
due	O
to	O
the	O
larger	O
defecation	O
numbers	O
displayed	O
by	O
the	O
taurine	O
-	O
injected	O
MR	O
rats	O
relative	O
to	O
the	O
saline	O
-	O
injected	O
MR	O
rats	O
.	O

It	O
has	O
come	O
out	O
that	O
CAEC	O
is	O
between	O
CC	O
and	O
CIEC	O
and	O
that	O
attacks	O
of	O
biliary	O
fever	O
and	O
high	O
levels	O
of	O
alkaline	B
phosphatase	I
and	O
transaminases	O
in	O
the	O
serum	O
are	O
the	O
helpful	O
findings	O
for	O
preoperative	O
diagnosis	O
.	O

The	O
present	O
study	O
examined	O
the	O
dependence	O
of	O
difference	O
tone	O
level	O
[	O
L	O
(	O
f2-f1	O
)	O
]	O
on	O
the	O
following	O
parameters	O
of	O
the	O
two	O
-	O
tone	O
input	O
:	O
f1	O
,	O
f2	O
/	O
f1	O
(	O
f2	O
greater	O
than	O
f1	O
)	O
,	O
L1	O
,	O
L2	O
,	O
and	O
L1	O
=	O
L2	O
.	O

All	O
13	O
patients	O
showed	O
endoscopic	O
evidence	O
of	O
oesophagitis	O
,	O
moderate	O
in	O
4	O
and	O
severe	O
in	O
9	O
.	O

Urinary	O
excretion	O
of	O
oestrone	O
,	O
oestradiol-17	O
beta	O
and	O
oestriol	O
in	O
pregnancies	O
complicated	O
by	O
steroid	B
sulphatase	I
deficiency	O
.	O

When	O
two	O
determinations	O
were	O
performed	O
on	O
12	O
samples	O
of	O
plasma	O
taken	O
from	O
normal	O
adults	O
in	O
October	O
,	O
the	O
values	O
were	O
22.6	O
+	O
/-	O

4.8	O
and	O
21.0	O
+	O
/-	O

3.6	O
(	O
mean	O
+	O
/-	O

SD	O
)	O
ng	O
/	O
ml	O
,	O
respectively	O
.	O

None	O
of	O
the	O
cystometrograms	O
showed	O
uninhibited	O
detrusor	O
contractions	O
.	O

Treatment	O
of	O
Graves	O
'	O
disease	O
.	O

A	O
highly	O
significant	O
correlation	O
was	O
found	O
between	O
the	O
presence	O
of	O
fibrinolytic	O
degradation	O
products	O
(	O
FDP	O
)	O
and	O
the	O
incidence	O
of	O
nephropathy	O
and	O
renal	O
insufficiency	O
,	O
as	O
well	O
as	O
between	O
the	O
presence	O
of	O
fibrin	B
monomers	I
(	O
Godal	O
's	O
ethanol	O
-	O
gelification	O
test	O
)	O
and	O
the	O
evolutive	O
signs	O
of	O
the	O
primary	O
disease	O
(	O
fever	O
,	O
accelerated	O
ESR	O
)	O
.	O

2	O
cases	O
of	O
toxic	O
lymphomononucleosis	O

A	O
one	O
-	O
week	O
ulcer	O
therapy	O
with	O
atropine	O
and	O
Vikalin	O
(	O
Roter	O
)	O
led	O
to	O
a	O
significant	O
(	O
p	O
less	O
than	O
0.01	O
)	O
reduction	O
of	O
the	O
nocturnal	O
proteolytic	O
activity	O
.	O

Action	O
of	O
strontium-90	O
and	O
metaphos	O
on	O
Cyprinus	O
carpio	O

Escherichia	O
of	O
a	O
single	O
sero	O
-	O
anzymatic	O
type	O
(	O
06a6b	O
:	O
K13	O
:	O
H1	O
)	O
were	O
isolated	O
in	O
a	O
group	O
affection	O
.	O

A	O
one	O
-	O
way	O
analysis	O
of	O
variance	O
,	O
performed	O
separately	O
for	O
men	O
and	O
women	O
for	O
differences	O
among	O
the	O
three	O
phobic	O
groups	O
on	O
field	O
dependence	O
,	O
showed	O
significance	O
(	O
rho	O
less	O
than	O
.05	O
)	O
for	O
the	O
females	O
,	O
with	O
the	O
famale	O
agoraphobic	O
being	O
more	O
field	O
dependent	O
than	O
the	O
female	O
simple	O
phobic	O
groups	O
,	O
but	O
not	O
for	O
the	O
males	O
.	O

The	O
results	O
of	O
a	O
quantitative	O
study	O
of	O
vasculosyncytial	O
membranes	O
in	O
123	O
placentas	O
are	O
presented	O
.	O

Platelet	O
serotonin	O
(	O
5-HT	O
)	O
and	O
5-HT	B
releasing	I
factor	I
in	O
plasma	O
of	O
migrainous	O
patients	O
.	O

The	O
vigilance	O
task	O
and	O
the	O
measurement	O
of	O
attentional	O
deficits	O
.	O

Absorption	O
varied	O
between	O
65	O
and	O
95	O
per	O
cent	O
,	O
with	O
a	O
mean	O
absorption	O
of	O
80	O
per	O
cent	O
,	O
in	O
both	O
pregnant	O
and	O
non	O
-	O
pregnant	O
subjects	O
.	O

A	O
diagnosis	O
of	O
MS	O
was	O
made	O
based	O
on	O
subtle	O
neurologic	O
signs	O
,	O
spinal	O
fluid	O
gamma	B
globulin	I
elevations	O
,	O
and	O
abnormalities	O
in	O
neuropsychological	O
testing	O
.	O

The	O
elevated	O
Viso	O
V	O
in	O
the	O
RDS	O
group	O
suggests	O
an	O
increase	O
in	O
small	O
airway	O
resistance	O
secondary	O
to	O
the	O
disease	O
or	O
to	O
its	O
therapy	O
.	O

The	O
psychological	O
tests	O
consisted	O
of	O
a	O
free	O
-	O
recall	O
task	O
,	O
a	O
test	O
for	O
visuomotor	O
coordination	O
and	O
a	O
recognition	O
task	O
.	O

Eleven	O
strains	O
of	O
Fusarium	O
poae	O
and	O
F.	O
sporotrichioides	O
from	O
the	O
U.S.S.R.	O
and	O
7	O
strains	O
of	O
these	O
species	O
and	O
one	O
of	O
F.	O
sporotrichioides	O
var	O
.	O

tricinctum	O
from	O
U.S.A.	O
and	O
France	O
have	O
been	O
compared	O
as	O
to	O
their	O
capacity	O
to	O
yield	O
T-2	B
toxin	I
.	O

Amikacin	O
was	O
used	O
in	O
the	O
treatment	O
of	O
56	O
serious	O
gram	O
-	O
negative	O
infections	O
in	O
54	O
patients	O
of	O
whom	O
47	O
survived	O
.	O

Evaluation	O
of	O
the	O
new	O
Gravigard	O
IUCD	O
inserter	O
.	O

Well	O
-	O
visualised	O
arteriograms	O
of	O
the	O
limbs	O
can	O
be	O
obtained	O
by	O
xeroradiography	O
after	O
rapid	O
manual	O
injection	O
of	O
contrast	O
-	O
medium	O
into	O
an	O
arm	O
vein	O
,	O
as	O
demonstrated	O
in	O
28	O
patients	O
.	O

Possibility	O
of	O
a	O
TSH	B
-	O
Screening	O
method	O
for	O
detection	O
of	O
hypothyroidism	O
in	O
the	O
newborn	O

Thus	O
analysis	O
indicated	O
no	O
reliable	O
evidence	O
that	O
conscious	O
presleep	O
suggestions	O
become	O
incorporated	O
into	O
dream	O
content	O
.	O

Batch	O
cultures	O
of	O
S.	O
mutans	O
serotype	O
a	O
demonstrated	O
no	O
growth	O
on	O
MSB	O
agar	O
.	O

Pregnant	O
women	O
at	O
term	O
had	O
the	O
lowest	O
levels	O
of	O
antithrombin	B
III	I
.	O

The	O
recovered	O
calves	O
were	O
tested	O
for	O
immunity	O
to	O
homologous	O
severe	O
challenge	O
,	O
50	O
or	O
73	O
days	O
after	O
the	O
first	O
infection	O
.	O

Preflight	O
,	O
inflight	O
,	O
and	O
postflight	O
exercise	O
response	O
tests	O
were	O
conducted	O
on	O
the	O
astronauts	O
of	O
the	O
second	O
Skylab	O
mission	O
(	O
Skylab	O
3	O
)	O
as	O
part	O
of	O
an	O
evaluation	O
of	O
physiological	O
adaptation	O
to	O
long	O
-	O
term	O
weightlessness	O
.	O

E	O
50	O
,	O
843	O
(	O
1994	O
)	O
]	O
.	O

With	O
the	O
help	O
of	O
a	O
nomogram	O
one	O
can	O
read	O
off	O
the	O
refraction	O
,	O
when	O
axis	O
length	O
and	O
corneal	O
curvature	O
are	O
known	O
.	O

Potscoital	O
test	O

Since	O
1968	O
,	O
a	O
steep	O
decrease	O
in	O
the	O
number	O
of	O
strains	O
resistant	O
to	O
three	O
or	O
more	O
antibiotics	O
(	O
multiple	O
-	O
resistant	O
)	O
and	O
in	O
strains	O
of	O
the	O
83A	O
complex	O
was	O
noticed	O
.	O

Alpha-1	B
antitrypsin	I
and	O
Indian	O
childhood	O
cirrhosis	O
.	O

Two	O
patients	O
were	O
treated	O
with	O
both	O
regimens	O
.	O

IgG	B
levels	O
of	O
1	O
/	O
100	O
were	O
present	O
in	O
only	O
four	O
out	O
of	O
ten	O
samples	O
obtained	O
150	O
days	O
after	O
the	O
clinical	O
onset	O
.	O

Letter	O
:	O
Perspectives	O
in	O
bone	O
marrow	O
transplantation	O
.	O

A	O
clinically	O
useful	O
diagnostic	O
method	O
has	O
been	O
developed	O
for	O
detecting	O
and	O
quantitating	O
periods	O
of	O
apnea	O
in	O
pediatric	O
patients	O
.	O

Before	O
this	O
date	O
,	O
the	O
drug	O
directly	O
inhibits	O
fetal	O
weight	O
gain	O
,	O
whereas	O
the	O
sensitivity	O
of	O
the	O
placenta	O
is	O
only	O
transient	O
at	O
day	O
16	O
resulting	O
in	O
maximum	O
weight	O
decrease	O
of	O
this	O
organ	O
24	O
h	O
later	O
.	O

The	O
interpretation	O
of	O
antibiotic	O
disc	O
sensitivities	O
.	O

Her	O
serum	O
FT3	O
concentration	O
was	O
,	O
however	O
,	O
much	O
higher	O
than	O
the	O
ranges	O
in	O
normal	O
pregnancy	O
or	O
in	O
GTD	O
patients	O
without	O
clinical	O
hyperthyroidism	O
.	O

Hypertonic	O
glucose	O
administered	O
intrajejunally	O
in	O
Heidenhain	O
pouch	O
dogs	O
resulted	O
in	O
an	O
equal	O
inhibition	O
of	O
pentagastrin	O
-	O
induced	O
acid	O
secretion	O
from	O
the	O
pouch	O
and	O
the	O
main	O
stomach	O
,	O
whereas	O
hypertonic	O
saline	O
had	O
no	O
effect	O
.	O

The	O
study	O
of	O
calcium	O
metabolism	O
in	O
ten	O
thalassaemic	O
children	O
comperatively	O
with	O
controls	O
after	O
oral	O
administration	O
of	O
47Ca	O
has	O
shown	O
diminished	O
intestinal	O
absorption	O
.	O

In	O
contrast	O
,	O
the	O
insulin	B
response	O
had	O
returned	O
to	O
the	O
non	O
-	O
pregnant	O
value	O
by	O
the	O
second	O
day	O
of	O
the	O
puerperium	O
.	O

The	O
apparent	O
Kd	O
of	O
the	O
MetRS	B
/	I
CAU	I
operator	I
complex	I
is	O
one	O
order	O
magnitude	O
higher	O
than	O
that	O
of	O
the	O
ThrRS	B
/	I
CGU	I
operator	I
complex	I
.	O

Characterization	O
of	O
the	O
human	B
gene	I
encoding	I
cytokeratin	I
17	I
and	O
its	O
expression	O
pattern	O
.	O

For	O
the	O
first	O
group	O
,	O
the	O
maximal	O
decrease	O
in	O
plasma	O
potassium	O
elicited	O
by	O
salbutamol	O
was	O
0.80	O
+	O
/-	O

0.19	O
,	O
0.48	O
+	O
/-	O

0.22	O
,	O
and	O
0.78	O
+	O
/-	O

0.46	O
mmol	O
/	O
l	O
,	O
and	O
for	O
the	O
second	O
group	O
,	O
maximal	O
decrement	O
was	O
1.31	O
+	O
/-	O

0.37	O
,	O
0.70	O
+	O
/-	O

0.24	O
,	O
and	O
0.84	O
+	O
/-	O

0.17	O
mmol	O
/	O
l	O
for	O
the	O
iv	O
,	O
po	O
,	O
and	O
it	O
routes	O
,	O
respectively	O
.	O

The	O
two	O
drugs	O
increase	O
the	O
rate	O
of	O
early	O
diastolic	O
filling	O
.	O

100	O
years	O
of	O
dentistry	O
at	O
the	O
Friedrich	O
Schiller	O
University	O
in	O
Jena	O

These	O
studies	O
show	O
that	O
UCRBP	B
binds	O
to	O
various	O
target	O
motifs	O
that	O
are	O
distinct	O
from	O
the	O
UCR	O
motif	O
:	O
the	O
adeno	B
-	I
associated	I
virus	I
P5	I
promoter	I
and	O
elements	O
in	O
the	O
immunoglobulin	B
light-	I
and	I
heavy	I
-	I
chain	I
genes	O
,	O
as	O
well	O
as	O
elements	O
in	O
ribosomal	B
protein	I
genes	I
.	O

The	O
predicted	O
receptor	O
structure	O
includes	O
a	O
cysteine	O
-	O
rich	O
extracellular	O
domain	O
,	O
a	O
single	O
hydrophobic	O
transmembrane	O
domain	O
,	O
and	O
a	O
predicted	O
cytoplasmic	B
serine	I
/	I
threonine	I
kinase	I
domain	I
.	O

In	O
contrast	O
,	O
gel	O
mobility	O
shift	O
experiments	O
have	O
failed	O
to	O
reveal	O
that	O
HAP2	B
or	O
HAP3	B
binds	O
to	O
domain	O
1	O
or	O
that	O
hap3	B
mutations	O
affect	O
the	O
complexes	O
bound	O
to	O
it	O
.	O

Two	O
points	O
are	O
indicated	O
:	O
first	O
,	O
the	O
photosensitized	O
damage	O
of	O
YHPD	O
is	O
interrelated	O
to	O
not	O
only	O
1O2	O
,	O
but	O
also	O
free	O
radicals	O
(	O
O2-	O
.	O

.OH	O
and	O
YHPD-	O
.	O
)	O
;	O
second	O
,	O
although	O
the	O
photosensitized	O
damage	O
of	O
YHPD	O
is	O
stronger	O
than	O
that	O
of	O
BHPD	O
,	O
yet	O
the	O
photosensitized	O
damage	O
is	O
negatively	O
correlated	O
to	O
the	O
yield	O
of	O
1O2	O
but	O
positively	O
correlated	O
to	O
those	O
of	O
O2-	O
.	O

and	O
OH	O
.	O

Fructokinase	B
activity	O
is	O
elevated	O
up	O
to	O
twofold	O
when	O
Z.	O
mobilis	O
was	O
grown	O
on	O
fructose	O
instead	O
of	O
glucose	O
,	O
and	O
there	O
was	O
a	O
parallel	O
increase	O
in	O
frk	B
mRNA	I
levels	O
.	O

METHODS	O
:	O
IgG	B
antibodies	I
vs	O
HHV-6	O
(	O
anti	B
-	I
HHV-6-IgG	I
)	O
were	O
determined	O
by	O
indirect	O
immunofluorescence	O
in	O
100	O
IVDA	O
(	O
29	O
seronegative	O
and	O
71	O
seropositive	O
for	O
HIV-1	O
of	O
which	O
45	O
were	O
in	O
stage	O
II	O
and	O
26	O
in	O
IV	O
-	O
C1	O
of	O
CDC	O
)	O
as	O
well	O
as	O
in	O
100	O
healthy	O
subjects	O
of	O
a	O
similar	O
age	O
(	O
control	O
group	O
)	O
.	O

Possible	O
roles	O
of	O
RAD5	B
putative	O
ATPase	B
/	O
DNA	B
helicase	I
activity	O
in	O
DNA	O
repair	O
and	O
in	O
the	O
maintenance	O
of	O
wild	O
-	O
type	O
rates	O
of	O
instability	O
of	O
simple	O
repetitive	O
sequences	O
are	O
discussed	O
.	O

Replication	O
of	O
bovine	O
papillomavirus-1	O
(	O
BPV-1	O
)	O
DNA	O
requires	O
two	O
viral	O
gene	O
products	O
,	O
the	O
E1	B
protein	I
and	O
the	O
full	B
-	I
length	I
E2	I
protein	I
.	O

Insertional	O
inactivation	O
of	O
sms	B
led	O
to	O
increased	O
sensitivity	O
to	O
the	O
alkylating	O
agent	O
methylmethane	O
sulfonate	O
,	O
but	O
not	O
to	O
a	O
requirement	O
for	O
serine	O
or	O
other	O
metabolites	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
MAP	B
kinase	I
activator	I
/	O
MAP	B
kinase	I
system	O
may	O
be	O
the	O
downstream	O
components	O
of	O
ras	B
signal	O
transduction	O
pathways	O
.	O

T	B
-	I
cell	I
receptor	I
beta	I
(	O
TCR	B
beta	I
)	O
gene	O
rearrangements	O
occur	O
in	O
a	O
third	O
of	O
early	O
B	O
-	O
cell	O
acute	O
lymphoblastic	O
leukemias	O
(	O
ALLs	O
)	O
.	O

The	O
minimal	O
promoter	O
of	O
the	O
RII	B
beta	I
gene	I
was	O
composed	O
of	O
two	O
adjacent	O
functional	O
elements	O
.	O

Here	O
we	O
show	O
that	O
epidermal	B
growth	I
factor	I
or	O
platelet	B
-	I
derived	I
growth	I
factor	I
stimulation	O
of	O
intact	O
human	O
or	O
murine	O
cells	O
leads	O
to	O
phosphorylation	O
of	O
Nck	B
protein	I
on	O
tyrosine	O
,	O
serine	O
,	O
and	O
threonine	O
residues	O
.	O

Structure	O
and	O
expression	O
of	O
a	O
gene	O
from	O
Arabidopsis	O
thaliana	O
encoding	O
a	O
protein	O
related	O
to	O
SNF1	B
protein	O
kinase	O
.	O

Effects	O
of	O
dioxins	O
on	O
thyroid	O
function	O
in	O
newborn	O
babies	O
.	O

cDNA	O
clones	O
encoding	O
Arabidopsis	O
thaliana	O
and	O
Zea	B
mays	I
mitochondrial	I
chaperonin	I
HSP60	B
and	O
gene	O
expression	O
during	O
seed	O
germination	O
and	O
heat	O
shock	O
.	O

Gestational	O
trophoblastic	O
diseases	O
:	O
recent	O
advances	O
in	O
the	O
understanding	O
of	O
cytogenetics	O
,	O
histopathology	O
,	O
and	O
natural	O
history	O
.	O

These	O
sites	O
are	O
also	O
potential	O
keratan	O
sulfate	O
attachment	O
sites	O
.	O

In	O
addition	O
,	O
the	O
hGCSFR	B
gene	I
was	O
chromosomally	O
localized	O
by	O
Southern	O
blot	O
analysis	O
of	O
its	O
segregation	O
pattern	O
in	O
a	O
panel	O
of	O
rodent	O
-	O
human	O
hybrid	O
DNAs	O
using	O
the	O
radiolabeled	O
cDNA	O
probe	O
.	O

Thus	O
,	O
cibenzoline	O
is	O
an	O
effective	O
antiarrhythmic	O
agent	O
with	O
a	O
favourable	O
pharmacokinetic	O
profile	O
that	O
may	O
be	O
considered	O
with	O
other	O
class	O
I	O
drugs	O
in	O
patients	O
requiring	O
therapy	O
for	O
high	O
risk	O
arrhythmias	O
.	O

T	B
antigen	I
contains	O
four	O
H-2Db	O
-	O
restricted	O
cytotoxic	O
T	O
lymphocyte	O
(	O
CTL	O
)	O
recognition	O
epitopes	O
that	O
are	O
targets	O
for	O
CTL	O
clones	O
Y-1	O
,	O
Y-2	O
,	O
Y-3	O
,	O
and	O
Y-5	O
.	O

The	O
treatment	O
group	O
also	O
showed	O
in	O
vivo	O
T	O
-	O
cell	O
activation	O
with	O
an	O
initial	O
lymphopenia	O
followed	O
by	O
a	O
rebound	O
lymphocytosis	O
and	O
upregulation	O
of	O
the	O
subset	O
markers	O
CD25	B
(	O
interleukin	B
2	I
receptor	I
)	O
and	O
CD45RO	B
(	O
T	O
-	O
memory	O
cells	O
)	O
.	O

In	O
contrast	O
,	O
the	O
lumenal	O
domains	O
of	O
Sec12p	B
,	O
Stl1p	B
and	O
Stl2p	B
are	O
very	O
different	O
in	O
size	O
and	O
do	O
not	O
show	O
any	O
appreciable	O
homology	O
.	O

The	O
promoter	O
was	O
stimulated	O
8	O
-	O
20-fold	O
by	O
phorbol	O
esters	O
accounting	O
for	O
the	O
previously	O
observed	O
transcriptional	O
activation	O
of	O
protein	B
kinase	I
C	I
beta	I
.	O

PaO2	O
threshold	O
was	O
determined	O
through	O
an	O
indwelling	O
O2	O
sensor	O
catheter	O
.	O

We	O
found	O
that	O
both	O
the	O
E26	O
virus	O
-	O
encoded	O
v	B
-	I
ets	I
and	O
the	O
myeloid	B
/	I
B	I
-	I
cell	I
-	I
specific	I
factor	I
PU.1	I
bind	O
efficiently	O
to	O
this	O
site	O
in	O
vitro	O
.	O

The	O
IgG	B
subclass	O
profile	O
of	O
untreated	O
coeliac	O
disease	O
was	O
found	O
to	O
be	O
the	O
same	O
as	O
in	O
healthy	O
controls	O
(	O
IgG1	B
approximately	O
IgG2	B
>	O
IgG3	B
>	O
IgG4	B
)	O
,	O
with	O
only	O
the	O
magnitude	O
of	O
the	O
individual	O
subclass	O
responses	O
being	O
increased	O
in	O
coeliac	O
patients	O
.	O

Subcutaneous	O
administration	O
of	O
the	O
somatostatin	B
analogue	O
,	O
octreotide	O
,	O
100	O
micrograms	O
thrice	O
daily	O
,	O
resulted	O
in	O
a	O
sustained	O
improvement	O
in	O
diarrhoea	O
and	O
disappearance	O
of	O
faecal	O
incontinence	O
without	O
reducing	O
calcitonin	B
levels	O
.	O

GAL4-VP16-mediated	B
antirepression	O
required	O
an	O
auxiliary	O
factor	O
,	O
denoted	O
as	O
a	O
co	O
-	O
antirepressor	O
,	O
which	O
was	O
partially	O
purified	O
from	O
Drosophila	O
embryos	O
.	O

One	O
phage	O
clone	O
contains	O
a	O
junction	O
between	O
alpha	O
satellite	O
DNA	O
and	O
a	O
novel	O
low	O
-	O
copy	O
repeated	O
sequence	O
.	O

Dopamine	O
neurons	O
in	O
subjects	O
that	O
received	O
6-OHDA	O
were	O
protected	O
by	O
pre	O
-	O
treatment	O
with	O
GBR-12909	O
.	O

The	O
mean	O
blood	O
flow	O
in	O
the	O
penile	O
foreskin	O
was	O
estimated	O
to	O
be	O
15	O
ml	O
/	O
min	O
/	O
100	O
g	O
and	O
it	O
increased	O
to	O
150	O
-	O
200	O
%	O
after	O
the	O
induction	O
of	O
anesthesia	O
,	O
and	O
then	O
decreased	O
to	O
72	O
%	O
at	O
the	O
tip	O
of	O
the	O
created	O
parameatal	O
foreskin	O
flap	O
.	O

On	O
the	O
other	O
hand	O
,	O
neither	O
phosphate	O
buffered	O
saline	O
injection	O
into	O
the	O
ES	O
nor	O
primary	O
KLH	B
challenges	O
of	O
the	O
ES	O
were	O
capable	O
of	O
elevating	O
the	O
threshold	O
level	O
and	O
changing	O
the	O
latency	O
.	O

Model	O
predictions	O
were	O
in	O
accord	O
with	O
the	O
nine	O
-	O
year	O
survival	O
experience	O
of	O
women	O
in	O
the	O
HIP	O
trial	O
,	O
and	O
,	O
with	O
the	O
exception	O
of	O
women	O
40	O
-	O
44	O
years	O
old	O
,	O
with	O
HIP	O
data	O
on	O
18-year	O
survival	O
.	O

Exon	O
-	O
intron	O
junctions	O
in	O
the	O
human	O
and	O
rat	B
AdoMet	I
decarboxylase	I
genes	I
were	O
in	O
identical	O
positions	O
except	O
that	O
exons	O
6	O
and	O
7	O
of	O
the	O
human	O
gene	O
formed	O
a	O
single	O
exon	O
in	O
the	O
rat	O
gene	O
.	O

The	O
gene	O
encoding	O
TRP-2	B
maps	O
to	O
mouse	O
chromosome	O
14	O
,	O
in	O
the	O
region	O
of	O
the	O
coat	B
colour	I
mutation	I
slaty	I
.	O

Comparison	O
of	O
the	O
genomic	O
DNA	O
sequence	O
with	O
that	O
of	O
the	O
four	O
different	O
mRNAs	O
indicates	O
that	O
these	O
transcripts	O
are	O
produced	O
by	O
alternative	O
splicing	O
of	O
the	O
murine	O
pre	O
-	O
mRNA	O
according	O
to	O
a	O
cassette	O
model	O
.	O

Probable	O
progressive	O
multifocal	O
leukoencephalopathy	O
(	O
PML	O
)	O
was	O
diagnosed	O
on	O
the	O
basis	O
of	O
clinical	O
picture	O
and	O
magnetic	O
resonance	O
imaging	O
in	O
a	O
63-year	O
-	O
old	O
man	O
with	O
a	O
complete	O
remission	O
of	O
a	O
non	O
-	O
Hodgkin	O
's	O
lymphoma	O
.	O

Marker	O
rescue	O
analysis	O
has	O
localized	O
ts8	B
to	O
a	O
910-bp	O
internal	O
segment	O
of	O
rpoB	B
that	O
encodes	O
the	O
Rif	B
domain	I
.	O

Competition	O
analysis	O
by	O
gel	O
mobility	O
shift	O
electrophoresis	O
indicates	O
that	O
this	O
DNA	O
-	O
protein	O
interaction	O
is	O
novel	O
and	O
not	O
related	O
to	O
many	O
transcription	O
factors	O
previously	O
reported	O
.	O

The	O
1.7	O
kb	O
cloned	O
fragment	O
was	O
sequenced	O
and	O
shown	O
to	O
contain	O
the	O
entire	O
fliA	B
gene	I
.	O

The	O
SEN1	B
gene	I
corresponds	O
to	O
a	O
6,336-bp	O
open	O
reading	O
frame	O
coding	O
for	O
a	O
2,112-amino	O
-	O
acid	O
protein	O
(	O
molecular	O
mass	O
,	O
239	O
kDa	O
)	O
.	O

At	O
the	O
C	O
-	O
terminus	O
of	O
the	O
protein	O
is	O
a	O
domain	O
that	O
contains	O
sequences	O
very	O
similar	O
to	O
those	O
found	O
in	O
the	O
breakpoint	O
cluster	O
region	O
gene	O
product	O
,	O
n	B
-	I
chimerin	I
,	O
and	O
rho	B
GAP	I
,	O
all	O
of	O
which	O
have	O
been	O
shown	O
to	O
possess	O
intrinsic	O
GAP	B
activity	O
on	O
small	B
GTPases	I
.	O

Neural	O
-	O
specific	O
expression	O
,	O
genomic	O
structure	O
,	O
and	O
chromosomal	O
localization	O
of	O
the	O
gene	O
encoding	O
the	O
zinc	B
-	I
finger	I
transcription	I
factor	I
NGFI	I
-	I
C.	I

These	O
results	O
support	O
the	O
diagnostic	O
validity	O
of	O
NFPD	O
in	O
CP	O
/	O
NCA	O
patients	O
,	O
because	O
such	O
patients	O
had	O
a	O
family	O
history	O
of	O
panic	O
disorder	O
similar	O
to	O
patients	O
with	O
a	O
more	O
classical	O
panic	O
disorder	O
presentation	O
.	O

Furthermore	O
,	O
no	O
transcripts	O
of	O
the	O
same	O
size	O
and	O
having	O
the	O
same	O
developmental	O
profile	O
as	O
those	O
generated	O
by	O
the	O
wild	B
-	I
type	I
E10	I
fragment	I
were	O
identified	O
by	O
probes	O
covering	O
the	O
remainder	O
of	O
the	O
cloned	O
region	O
.	O

Both	O
parents	O
are	O
clinically	O
normal	O
and	O
unrelated	O
.	O

The	O
sequence	O
-	O
specific	O
interaction	O
of	O
nuclear	B
factor	I
HiNF	I
-	I
D	I
with	O
this	O
key	O
proximal	O
promoter	O
element	O
of	O
the	O
H4-FO108	B
gene	I
is	O
cell	O
cycle	O
regulated	O
in	O
normal	O
diploid	O
cells	O
(	O
J.	O

While	O
blood	O
pressure	O
and	O
noradrenergic	O
activity	O
,	O
assessed	O
as	O
changes	O
in	O
the	O
plasma	O
levels	O
and	O
urinary	O
excretion	O
of	O
norepinephrine	O
,	O
remained	O
unaffected	O
in	O
the	O
Pl	O
group	O
,	O
a	O
significant	O
drop	O
in	O
the	O
supine	O
systolic	O
and	O
diastolic	O
blood	O
pressures	O
,	O
as	O
well	O
as	O
in	O
the	O
resting	O
venous	O
norepinephrine	O
level	O
and	O
in	O
urinary	O
norepinephrine	O
excretion	O
was	O
found	O
after	O
the	O
first	O
month	O
of	O
dF	O
administration	O
.	O

The	O
homologies	O
between	O
RAD16	B
,	O
RAD54	B
and	O
SNF2	B
are	O
also	O
shared	O
by	O
several	O
additional	O
,	O
recently	O
isolated	O
yeast	O
and	O
Drosophila	O
genes	O
.	O

Two	O
cDNAs	O
encoding	O
casein	B
kinase-1	I
have	O
been	O
isolated	O
from	O
a	O
yeast	O
cDNA	O
library	O
and	O
termed	O
CKI1	B
and	O
CKI2	B
.	O

The	O
observed	O
sequence	O
variation	O
disrupts	O
the	O
first	O
ORF	O
in	O
many	O
Y	B
's	O
while	O
most	O
of	O
the	O
second	O
ORF	O
including	O
the	O
putative	O
helicase	B
region	I
is	O
unaffected	O
.	O

The	O
final	O
screening	O
yielded	O
a	O
clone	O
containing	O
a	O
2	O
kilobase	O
(	O
kb	O
)	O
insert	O
.	O

Lesions	O
were	O
made	O
by	O
pressure	O
injection	O
of	O
kainic	O
acid	O
into	O
the	O
SOC	O
through	O
a	O
stereotaxically	O
positioned	O
glass	O
micropipette	O
.	O

Cardiovascular	O
risk	O
factors	O
were	O
measured	O
by	O
standardized	O
techniques	O
.	O

The	O
results	O
indicate	O
that	O
the	O
carbon	O
-	O
perfused	O
areas	O
and	O
MBF	O
in	O
the	O
liver	O
,	O
renal	O
cortex	O
,	O
spleen	O
,	O
and	O
small	O
intestinal	O
serosa	O
(	O
only	O
MBF	O
)	O
increased	O
significantly	O
5	O
h	O
after	O
CLP	O
.	O

Lewis	O
,	O
N.	O

This	O
accurate	O
and	O
rapid	O
method	O
makes	O
the	O
MLPA	O
test	O
logistically	O
feasible	O
for	O
large	O
-	O
scale	O
screening	O
.	O

The	O
modalities	O
for	O
using	O
reference	O
values	O
for	O
individual	O
subjects	O
as	O
well	O
as	O
for	O
groups	O
are	O
then	O
discussed	O
and	O
the	O
main	O
points	O
of	O
research	O
which	O
must	O
be	O
faced	O
in	O
the	O
near	O
future	O
regarding	O
reference	O
values	O
are	O
highlighted	O
.	O

In	O
addition	O
to	O
the	O
previously	O
identified	O
and	O
characterized	O
attenuator	B
1	I
situated	O
93	O
nucleotides	O
downstream	O
from	O
the	O
major	O
late	O
transcription	O
start	O
site	O
,	O
a	O
second	O
attenuator	O
,	O
attenuator	B
2	I
,	O
situated	O
55	O
nucleotides	O
downstream	O
from	O
it	O
,	O
has	O
been	O
identified	O
.	O

These	O
experiments	O
delineate	O
a	O
186-bp	O
,	O
EBNA-2-responsive	B
cell	O
DNA	O
fragment	O
and	O
provide	O
firm	O
evidence	O
that	O
EBNA-2	B
transactivates	O
transcription	O
of	O
cell	O
genes	O
.	O

This	O
repression	O
was	O
mediated	O
through	O
binding	O
to	O
the	O
E2	B
DNA	I
-	I
binding	I
site	I
immediately	O
upstream	O
of	O
the	O
P105	B
promoter	O
TATA	O
box	O
and	O
could	O
be	O
abrogated	O
by	O
preincubation	O
of	O
the	O
HPV-18	B
P105	I
promoter	I
template	O
with	O
the	O
nuclear	O
extract	O
allowing	O
the	O
formation	O
of	O
the	O
preinitiation	O
complex	O
.	O

We	O
have	O
determined	O
that	O
the	O
mutants	O
define	O
two	O
complementation	O
groups	O
,	O
designated	O
cgs1	B
+	I
and	O
cgs2	B
+	I
(	O
continues	O
to	O
grow	O
in	O
stationary	O
)	O
.	O

The	O
strategy	O
has	O
been	O
used	O
to	O
determine	O
2.6	O
kilobases	O
of	O
nucleotide	O
sequence	O
in	O
the	O
Saccharomyces	B
cerevisiae	I
ADE	I
1	I
locus	I
.	O

Its	O
neuromuscular	O
effects	O
are	O
similar	O
to	O
a	O
single	O
ED90	O
dose	O
of	O
vecuronium	O
.	O

Wnt-1	B
(	O
int-1	B
)	O
is	O
a	O
cellular	O
oncogene	O
often	O
activated	O
by	O
insertion	O
of	O
proviral	O
DNA	O
of	O
the	O
mouse	O
mammary	O
tumor	O
virus	O
.	O

We	O
speculate	O
that	O
these	O
tumors	O
may	O
represent	O
congenital	O
hamartomatous	O
growths	O
.	O

Identification	O
and	O
characterization	O
of	O
the	O
promoter	O
for	O
the	O
cytotactin	B
gene	I
.	O

2:121	O
-	O
133	O
,	O
1988	O
)	O
.	O

Although	O
the	O
N13-N20	O
interpeak	O
interval	O
remained	O
stable	O
because	O
of	O
the	O
parallel	O
shift	O
of	O
the	O
2	O
peaks	O
,	O
the	O
central	O
conduction	O
time	O
measured	O
from	O
onset	O
latencies	O
of	O
N11	O
and	O
N20	O
significantly	O
increased	O
.	O

The	O
murine	B
mutation	I
dominant	I
white	I
spotting	I
(	O
W	B
)	O
is	O
in	O
the	O
proto	O
-	O
oncogene	O
,	O
c	B
-	I
kit	I
.	O

A	O
full	B
-	I
length	I
human	I
pim-1	I
cDNA	I
was	O
subcloned	O
into	O
the	O
bacterial	O
vector	O
pGEX-2	O
T	O
and	O
the	O
Pim-1	B
protein	I
expressed	O
as	O
a	O
fusion	O
product	O
with	O
bacterial	B
glutathione	I
S	I
-	I
transferase	I
(	O
GST	B
)	O
.	O

We	O
characterized	O
cDNA	O
clones	O
specific	O
for	O
the	O
extracellular	O
matrix	O
glycoprotein	O
undulin	B
.	O

Regulation	O
of	O
the	O
alpha	B
inhibin	I
gene	I
by	O
cyclic	O
adenosine	O
3',5'-monophosphate	O
after	O
transfection	O
into	O
rat	O
granulosa	O
cells	O
.	O

E.	O
,	O
Hession	O
,	O
C.	O
,	O
Goff	O
,	O
D.	O
,	O
Griffiths	O
,	O
B.	O
,	O
Tizard	O
,	O
R.	O
,	O
Newman	O
,	O
B.	O
,	O
Chi	O
-	O
Rosso	O
,	O
G.	O
,	O
and	O
Lobb	O
,	O
R.	O
,	O
(	O
1990	O
)	O
Cell	O
63	O
,	O
1349	O
-	O
1356	O
)	O
.	O

These	O
results	O
indicate	O
that	O
the	O
sulfhydryl	O
group	O
of	O
certain	O
angiotensin	B
converting	I
enzyme	I
inhibitors	O
can	O
potentiate	O
their	O
effect	O
on	O
the	O
endogenous	O
nitrovasodilator	O
EDRF	B
.	O

They	O
were	O
checked	O
for	O
anti	B
-	I
HCV	I
(	O
anti	B
-	I
C100	I
-	I
3	I
)	O
with	O
HCV	O
EIA	O
kit	O
(	O
Abbott	O
Lab	O
.	O

,	O
North	O
Chicago	O
,	O
IL	O
)	O
.	O

Diltiazem	O
resulted	O
in	O
a	O
significant	O
increase	O
in	O
epicardial	O
diameter	O
(	O
+	O
10	O
%	O
;	O
p	O
=	O
0.001	O
)	O
and	O
in	O
coronary	O
blood	O
flow	O
(	O
CBF	O
)	O
(	O
+	O
30	O
%	O
;	O
p	O
=	O
0.0001	O
)	O
.	O

These	O
risk	O
factors	O
can	O
be	O
divided	O
into	O
2	O
groups	O
:	O
local	O
vessel	O
wall	O
-	O
related	O
factors	O
,	O
and	O
local	O
(	O
focal	O
action	O
)	O
systemic	O
factors	O
.	O

Vaccinia	O
virus	O
(	O
VV	O
)	O
is	O
a	O
potent	O
immunogen	O
,	O
but	O
the	O
nature	O
of	O
VV	O
proteins	O
involved	O
in	O
the	O
activation	O
of	O
the	O
immune	O
response	O
of	O
the	O
host	O
is	O
not	O
yet	O
known	O
.	O

The	O
tissue	O
specificity	O
of	O
gene	O
expression	O
was	O
identical	O
to	O
that	O
described	O
previously	O
for	O
the	O
CaMV	B
35S	I
domain	I
B	I
enhancer	I
element	I
.	O

The	O
size	O
of	O
the	O
mutant	O
molecule	O
corresponds	O
to	O
the	O
unprocessed	O
cytoplasmic	O
precursor	O
(	O
pre	B
-	I
super	I
-	I
pro	I
-	I
PrB	I
)	O
,	O
as	O
detected	O
in	O
sec61	B
mutants	I
,	O
when	O
translocation	O
into	O
the	O
endoplasmic	O
reticulum	O
is	O
blocked	O
.	O

Thus	O
,	O
the	O
active	O
-	O
site	O
mutation	O
prevents	O
the	O
wild	O
-	O
type	O
processing	O
of	O
the	O
N	O
-	O
glycosylated	O
73-kDa	O
precursor	O
of	O
PrB	B
to	O
the	O
41.5	B
kDa	I
pro	I
-	I
PrB	I
in	O
the	O
endoplasmic	O
reticulum	O
.	O

Bone	O
and	O
bones	O
.	O

To	O
overcome	O
this	O
problem	O
,	O
we	O
have	O
overexpressed	O
Kex2p	B
using	O
the	O
baculovirus	O
/	O
insect	O
cell	O
expression	O
system	O
.	O

J.	O

The	O
major	B
49-kDa	I
core	I
protein	I
in	O
the	O
liver	O
HSPG	B
preparation	O
was	O
found	O
to	O
be	O
reactive	O
to	O
an	O
antibody	O
that	O
specifically	O
recognizes	O
the	O
cytoplasmic	O
domain	O
of	O
fibroglycan	B
.	O

We	O
have	O
isolated	O
cDNAs	O
for	O
a	O
gene	O
coding	O
for	O
a	O
G	B
protein	I
alpha	I
subunit	I
from	I
tomato	I
(	O
Lycopersicon	O
esculentum	O
,	O
cv	O
.	O

Substituting	O
a	O
Ser	O
for	O
Gly69	O
or	O
a	O
Glu	O
for	O
Lys	O
71	O
in	O
the	O
conserved	O
TGEK	B
tetrapeptide	I
in	O
finger	O
II	O
of	O
TFIIIA	B
resulted	O
in	O
the	O
loss	O
of	O
DNA	O
binding	O
.	O

The	O
model	O
is	O
able	O
to	O
anticipate	O
why	O
the	O
effect	O
of	O
water	O
fluoridation	O
on	O
caries	O
prevalence	O
is	O
most	O
pronounced	O
when	O
caries	O
is	O
diagnosed	O
at	O
cavity	O
level	O
.	O

Auditory	O
threshold	O
shifts	O
,	O
as	O
measured	O
by	O
the	O
auditory	O
evoked	O
brainstem	O
response	O
,	O
were	O
measured	O
at	O
2,4,8,12,16	O
,	O
20	O
and	O
24	O
kHz	O
.	O

Fundamental	O
and	O
clinical	O
evaluation	O
of	O
equilibrium	O
dialysis	O
--	O
radioimmunoassay	O
system	O
for	O
measurement	O
of	O
serum	O
free	O
thyroxine	O

We	O
conclude	O
that	O
TA	O
caused	O
a	O
specific	O
decrease	O
in	O
AGD	O
on	O
GD	O
20	O
that	O
was	O
largely	O
reversed	O
by	O
PCD	O
23	O
.	O

When	O
examined	O
as	O
adults	O
(	O
8	O
weeks	O
old	O
)	O
,	O
the	O
external	O
genitalia	O
of	O
TA	O
-	O
exposed	O
offspring	O
were	O
normal	O
.	O

A	O
330-kb	O
YAC	O
,	O
A148A7	O
,	O
spanned	O
from	O
the	O
HLA	B
-	O
DQA1	B
locus	O
through	O
the	O
Y3	B
/	O
Ring	B
4	I
locus	O
and	O
extended	O
at	O
least	O
130	O
kb	O
centromeric	O
of	O
YAC	O
B1D12	O
.	O

We	O
examined	O
behavioral	O
alterations	O
in	O
the	O
brown	O
cockroach	O
,	O
Periplaneta	O
brunnea	O
,	O
infected	O
with	O
the	O
acanthocephalan	O
,	O
Moniliformis	O
moniliformis	O
.	O

The	O
existence	O
of	O
threshold	O
concentrations	O
,	O
above	O
which	O
certain	O
phenomena	O
may	O
occur	O
,	O
strengthens	O
the	O
role	O
of	O
sentinels	O
.	O

These	O
changes	O
were	O
n't	O
so	O
significant	O
in	O
the	O
group	O
of	O
obese	O
children	O
who	O
did	O
n't	O
lose	O
weight	O
.	O

Magnetotherapy	O
of	O
hepatitis	O
A	O
and	O
B	O
in	O
children	O

The	O
presence	O
of	O
local	O
abnormalities	O
in	O
both	O
patients	O
can	O
support	O
the	O
hypothesis	O
that	O
the	O
cortex	O
,	O
especially	O
of	O
the	O
temporal	O
anterior	O
lobe	O
,	O
is	O
involved	O
in	O
the	O
origin	O
of	O
the	O
laughing	O
seizures	O
.	O

TPTA	O
produced	O
brain	O
congestion	O
,	O
and	O
hepatic	O
and	O
pulmonary	O
petechial	O
and	O
generalized	O
hemorrhages	O
.	O

Resolution	O
of	O
thermographic	O
asymmetry	O
and/or	O
decrease	O
in	O
Delta	O
T	O
was	O
demonstrated	O
in	O
approximately	O
81	O
%	O
of	O
the	O
post	O
-	O
treatment	O
population	O
.	O

The	O
ED30	O
values	O
were	O
2.4	O
and	O
2.2	O
mg	O
/	O
kg	O
and	O
similar	O
to	O
the	O
respective	O
values	O
of	O
nifedipine	O
(	O
ED	O
30:2.4,2.1	O
mg	O
/	O
kg	O
)	O
.	O

The	O
abundance	O
of	O
transcripts	O
from	O
several	O
unrelated	O
genes	O
is	O
decreased	O
in	O
cdc68	B
-	I
1	I
mutant	I
cells	O
after	O
transfer	O
to	O
the	O
restrictive	O
temperature	O
,	O
while	O
at	O
least	O
one	O
transcript	O
,	O
from	O
the	O
HSP82	B
gene	I
,	O
persists	O
in	O
an	O
aberrant	O
fashion	O
.	O

The	O
spectrum	O
of	O
histologically	O
diagnosed	O
malignant	O
neoplasms	O
in	O
Sabah	O
,	O
1983	O
-	O
1988	O
.	O

When	O
transfected	O
into	O
Drosophila	O
SL-2	O
cells	O
,	O
pCAT	O
plasmid	O
containing	O
2,090	O
bp	O
of	O
5'-flanking	O
region	O
shows	O
a	O
3.0-	O
to	O
3.5-fold	O
increase	O
in	O
chloramphenicol	B
acetyltransferase	I
activity	O
after	O
induction	O
with	O
retinoic	O
acid	O
and/or	O
8-bromo	O
-	O
cAMP	O
.	O

The	O
N	O
-	O
terminus	O
of	O
another	O
open	O
reading	O
frame	O
was	O
found	O
3	O
'	O
from	O
nifA	B
and	O
tentatively	O
identified	O
as	O
nifB	B
by	O
amino	O
acid	O
sequence	O
comparison	O
.	O

A	O
novel	O
cDNA	O
clone	O
termed	O
R2	O
was	O
isolated	O
by	O
subtractive	O
hybridization	O
of	O
a	O
cDNA	O
library	O
of	O
phytohemagglutinin	B
(	O
PHA	B
)	O
/	O
phorbol	O
myristate	O
acetate	O
-	O
stimulated	O
Jurkat	O
cells	O
and	O
by	O
rescreening	O
a	O
cDNA	O
library	O
of	O
PHA	O
-	O
stimulated	O
peripheral	O
blood	O
lymphocytes	O
.	O

Suggestive	O
evidence	O
was	O
obtained	O
that	O
cstA	B
is	O
involved	O
in	O
peptide	O
utilization	O
.	O

Identification	O
and	O
nucleotide	O
sequence	O
of	O
Rhizobium	B
meliloti	I
insertion	I
sequence	I
ISRm3	I
:	O
similarity	O
between	O
the	O
putative	O
transposase	B
encoded	O
by	O
ISRm3	B
and	O
those	O
encoded	O
by	O
Staphylococcus	B
aureus	I
IS256	I
and	O
Thiobacillus	B
ferrooxidans	I
IST2	I
.	O

To	O
determine	O
the	O
relationship	O
of	O
these	O
viruses	O
,	O
the	O
complete	O
DNA	O
sequence	O
of	O
KV	O
consisting	O
of	O
4754	O
bp	O
was	O
determined	O
.	O

Heterodimers	O
of	O
myogenin	B
and	O
E12	B
(	O
or	O
MyoD	B
and	O
E12	B
)	O
specifically	O
bound	O
a	O
restriction	O
fragment	O
extending	O
from	O
-200	O
to	O
-103	O
relative	O
to	O
the	O
start	O
of	O
cardiac	B
alpha	I
-	I
actin	I
transcription	O
.	O

The	O
Italian	O
Lung	O
Cancer	O
Task	O
Force	O
(	O
FONICAP	O
)	O
.	O

The	O
5	O
'	O
region	O
shows	O
strong	O
sequence	O
similarity	O
to	O
Escherichia	O
coli	O
consensus	O
promoters	O
and	O
ribosome	O
-	O
binding	O
sequences	O
and	O
allows	O
high	O
levels	O
of	O
expression	O
in	O
E.	O
coli	O
.	O

Young	O
CD-1	O
mice	O
,	O
4	O
days	O
old	O
,	O
exposed	O
to	O
0.1	O
%	O
nicotine	O
sulfate	O
on	O
gestational	O
days	O
6	O
-	O
20	O
were	O
compared	O
with	O
untreated	O
pups	O
of	O
the	O
same	O
age	O
to	O
determine	O
its	O
effect	O
on	O
the	O
development	O
of	O
mandibular	O
first	O
molars	O
.	O

USF	B
synthesized	O
in	O
an	O
in	O
vitro	O
transcription	O
and	O
translation	O
system	O
also	O
binds	O
to	O
the	O
ADH	B
promoter	I
as	O
well	O
as	O
to	O
the	O
MLP	O
.	O

Arterial	O
radioactivity	O
content	O
after	O
the	O
intravenous	O
administration	O
of	O
HMPAO	O
in	O
seven	O
human	O
subjects	O
was	O
analyzed	O
.	O

Experimentally	O
in	O
green	O
monkeys	O
,	O
Syrian	O
hamsters	O
and	O
white	O
mice	O
the	O
authors	O
studied	O
the	O
pathogenic	O
properties	O
of	O
a	O
new	O
virus	O
Issyk	O
-	O
Kul	O
.	O

Limits	O
of	O
energy	O
turnover	O
in	O
relation	O
to	O
physical	O
performance	O
were	O
addressed	O
in	O
terms	O
of	O
upper	O
and	O
lower	O
limit	O
,	O
changes	O
during	O
a	O
training	O
programme	O
and	O
how	O
to	O
regulate	O
energy	O
balance	O
at	O
a	O
changing	O
energy	O
turnover	O
.	O

The	O
smaller	O
uptake	O
rate	O
and	O
faster	O
clearance	O
rate	O
resulted	O
in	O
the	O
lower	O
BCF	O
for	O
SWA	O
killifish	O
.	O

Determinants	O
of	O
recurrent	O
ischaemia	O
and	O
revascularisation	O
procedures	O
after	O
thrombolysis	O
with	O
recombinant	O
tissue	B
plasminogen	I
activator	I
in	O
primary	O
coronary	O
occlusion	O
.	O

Bronchial	O
mucosa	O
tattooing	O
in	O
persons	O
exposed	O
to	O
different	O
industrial	O
aerosols	O
did	O
not	O
depend	O
on	O
the	O
forms	O
of	O
PC	O
,	O
DB	O
and	O
the	O
diseases	O
'	O
stages	O
.	O

Lipoprotein	B
lipase	I
(	O
LPL	B
)	O
,	O
a	O
key	O
enzyme	O
in	O
normal	O
lipoprotein	O
metabolism	O
,	O
has	O
a	O
complex	O
pattern	O
of	O
regulation	O
and	O
tissue	O
-	O
specific	O
expression	O
.	O

Comparison	O
of	O
the	O
cDNA	O
-	O
predicted	O
avian	B
TnIcardiac	I
amino	I
acid	I
sequences	I
with	O
known	O
TnI	B
sequences	I
indicated	O
1	O
)	O
that	O
the	O
presence	O
of	O
an	O
N	O
-	O
terminal	O
extension	O
sequence	O
carrying	O
a	O
dual	O
protein	B
kinase	I
A	I
phosphorylation	O
target	O
site	O
and	O
an	O
adjacent	O
proline	O
-	O
rich	O
segment	O
is	O
an	O
ancient	O
cardiac	O
-	O
specific	O
feature	O
of	O
TnI	B
which	O
has	O
been	O
conserved	O
since	O
the	O
bird	O
/	O
mammal	O
divergence	O
,	O
2	O
)	O
that	O
features	O
of	O
the	O
near	O
-	O
N	O
-	O
terminal	O
troponin	B
C	I
(	O
TnC	B
)	O
-binding	O
site	O
sequence	O
suggest	O
isoform	O
-	O
specific	O
adaptation	O
of	O
TnI	B
and	O
TnC	B
,	O
and	O
3	O
)	O
that	O
the	O
avian	O
TnIcardiac	B
internal	O
actin	B
/	I
TnC	I
-	I
binding	I
,	I
actomyosin	I
-	I
inhibitory	I
,	I
domain	I
shows	O
significant	O
sequence	O
divergence	O
from	O
mammalian	B
TnIcardiac	I
sequences	I
,	O
including	O
the	O
absence	O
of	O
a	O
protein	B
kinase	I
C	I
target	O
site	O
which	O
is	O
a	O
cardiac	O
-	O
specific	O
feature	O
of	O
TnI	B
in	O
mammals	O
.	O

It	O
was	O
found	O
that	O
the	O
ROSP	O
undergoes	O
a	O
number	O
of	O
fluctuations	O
in	O
the	O
negative	O
and	O
positive	O
directions	O
with	O
a	O
gradually	O
decreasing	O
amplitude	O
in	O
the	O
course	O
of	O
5	O
-	O
25	O
days	O
following	O
the	O
operation	O
,	O
after	O
which	O
relatively	O
stable	O
negative	O
values	O
of	O
the	O
ROSP	O
are	O
established	O
on	O
the	O
average	O
in	O
electrodes	O
implanted	O
to	O
the	O
level	O
of	O
the	O
dura	O
mater	O
,	O
and	O
positive	O
values	O
in	O
electrodes	O
implanted	O
to	O
the	O
level	O
of	O
the	O
pia	O
mater	O
.	O

Blood	O
flow	O
velocity	O
waveforms	O
were	O
recorded	O
by	O
pulsed	O
Doppler	O
examination	O
of	O
the	O
fetal	O
internal	O
carotid	O
and	O
middle	O
cerebral	O
arteries	O
using	O
the	O
established	O
transabdominal	O
route	O
as	O
well	O
as	O
a	O
new	O
transvaginal	O
approach	O
.	O

Twenty	O
-	O
four	O
hours	O
later	O
,	O
the	O
animals	O
were	O
randomized	O
to	O
subretinal	O
treatment	O
with	O
2.5	O
micrograms	O
of	O
tissue	B
plasminogen	I
activator	I
or	O
a	O
similar	O
volume	O
of	O
physiologic	O
saline	O
.	O

Evaluation	O
of	O
antiepileptic	O
drug	O
effect	O
on	O
membrane	O
fluidity	O
.	O

We	O
conclude	O
that	O
solidification	O
could	O
occur	O
in	O
all	O
feeds	O
containing	O
casein	B
and	O
that	O
alternative	O
feeds	O
should	O
be	O
considered	O
in	O
patients	O
with	O
increased	O
gastric	O
acidity	O
.	O

Determination	O
of	O
an	O
RNA	O
structure	O
involved	O
in	O
splicing	O
inhibition	O
of	O
a	O
muscle	O
-	O
specific	O
exon	O
.	O

The	O
antihypertensive	O
effect	O
of	O
Estulic	O
has	O
been	O
examined	O
over	O
a	O
12-month	O
period	O
in	O
101	O
hypertensive	O
patients	O
.	O

Monitoring	O
patients	O
with	O
acute	O
leukemia	O
for	O
IL-1	B
and	O
TNF	B
levels	O
throughout	O
the	O
clinical	O
course	O
of	O
disease	O
may	O
help	O
clarify	O
the	O
causes	O
of	O
febrile	O
episodes	O
.	O

The	O
1489-base	O
pair	O
EFIA	B
cDNA	O
encodes	O
a	O
322-amino	O
acid	O
protein	O
which	O
is	O
nearly	O
identical	O
to	O
two	O
previously	O
described	O
human	O
DNA	O
binding	O
proteins	O
.	O

Translational	O
fusions	O
of	O
the	O
aroF	B
regulatory	I
regions	I
to	O
lacZ	B
were	O
constructed	O
and	O
then	O
introduced	O
in	O
single	O
copy	O
into	O
the	O
E.	O
coli	O
chromosome	O
.	O

beta	B
-	I
Galactosidase	I
assays	O
for	O
tyrR	O
-	O
mediated	O
regulation	O
of	O
aroF	B
-	O
lacZ	B
expression	O
revealed	O
that	O
the	O
E.	B
coli	I
TyrR	I
repressor	I
apparently	O
recognizes	O
the	O
operators	O
of	O
both	O
organisms	O
with	O
about	O
equal	O
efficiency	O
.	O

We	O
reviewed	O
the	O
records	O
of	O
151	O
patients	O
with	O
optic	O
neuritis	O
examined	O
over	O
an	O
eight	O
-	O
year	O
period	O
.	O

The	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
contains	O
three	O
binding	O
sites	O
for	O
the	O
transcriptional	O
factor	O
Sp1	B
.	O

Differences	O
in	O
the	O
clinical	O
presentation	O
and	O
the	O
gross	O
appearance	O
of	O
the	O
two	O
cases	O
are	O
described	O
,	O
and	O
similarities	O
in	O
the	O
microscopic	O
features	O
are	O
discussed	O
.	O

Using	O
an	O
ELISA	O
,	O
we	O
found	O
that	O
surfactant	B
protein	I
A	I
(	O
SP	B
-	I
A	I
)	O
was	O
markedly	O
elevated	O
in	O
the	O
pneumonia	O
patients	O
.	O

The	O
prevalence	O
of	O
opportunistic	O
infection	O
among	O
surviving	O
AIDS	O
patients	O
and	O
the	O
probability	O
of	O
being	O
in	O
tumour	O
response	O
following	O
cancer	O
therapy	O
conditional	O
on	O
being	O
alive	O
are	O
two	O
examples	O
of	O
such	O
functions	O
.	O

To	O
test	O
promotor	O
function	O
,	O
chimeric	O
genes	O
were	O
constructed	O
linking	O
fragments	O
of	O
chicken	O
IGF	B
-	I
I	I
5'-flanking	O
DNA	O
to	O
a	O
promoterless	O
reporter	O
plasmid	O
.	O

The	O
alpha	B
4	I
gene	I
5	O
'	O
flanking	O
region	O
acted	O
as	O
a	O
promoter	O
in	O
transfection	O
assays	O
.	O

Characterization	O
of	O
the	O
alpha	B
4	I
integrin	I
gene	I
promoter	I
.	O

In	O
contrast	O
,	O
similar	O
rates	O
of	O
B.	O
sphaericus	O
products	O
,	O
ABG-6184	O
technical	O
powder	O
and	O
BSP-2	O
flowable	O
concentrate	O
,	O
produced	O
no	O
significant	O
reduction	O
.	O

Some	O
of	O
the	O
PCR	O
products	O
contained	O
mutations	O
in	O
ATG1	B
and/or	O
ATG2	B
.	O

An	O
RME1-independent	B
pathway	O
for	O
sporulation	O
control	O
in	O
Saccharomyces	O
cerevisiae	O
acts	O
through	O
IME1	B
transcript	I
accumulation	O
.	O

Its	O
application	O
in	O
Madagascar	O
:	O
advantages	O
and	O
disadvantages	O

ARPIA	O
has	O
been	O
implemented	O
by	O
using	O
a	O
relational	O
DBMS	O
,	O
very	O
cheap	O
and	O
highly	O
diffused	O
on	O
personal	O
computers	O
.	O

Immuno	O
-	O
cytochemistry	O
,	O
using	O
antisera	O
against	O
Campylobacter	O
jejuni	O
,	O
showed	O
that	O
the	O
positive	O
staining	O
in	O
altered	O
epithelial	O
cells	O
were	O
restricted	O
to	O
intracellular	O
organisms	O
having	O
a	O
structure	O
resembling	O
Campylobacter	O
spp	O
.	O

We	O
also	O
discovered	O
a	O
V	B
lambda	I
pseudogene	I
,	O
called	O
psi	B
V	I
lambda	I
1	I
,	O
3	O
kb	O
upstream	O
of	O
the	O
U266	B
lambda	I
gene	I
.	O

Like	O
other	O
members	O
of	O
this	O
family	O
,	O
the	O
AP-4	B
HLH	O
motif	O
and	O
the	O
adjacent	O
basic	O
domain	O
are	O
necessary	O
and	O
sufficient	O
to	O
confer	O
site	O
-	O
specific	O
DNA	O
binding	O
.	O

A	O
bacteriological	O
relapse	O
requiring	O
treatment	O
occurred	O
by	O
5	O
years	O
in	O
16.8	O
%	O
of	O
113	O
R3	O
,	O
5.2	O
%	O
of	O
97	O
R5	O
,	O
and	O
20.0	O
%	O
of	O
115	O
Z5	O
patients	O
with	O
organisms	O
sensitive	O
to	O
streptomycin	O
and	O
isoniazid	O
initially	O
.	O

Northern	O
blot	O
analysis	O
indicates	O
that	O
AHA2	B
mRNA	I
relative	O
to	O
total	O
cellular	O
RNA	O
is	O
expressed	O
at	O
significantly	O
higher	O
levels	O
in	O
root	O
tissue	O
as	O
compared	O
with	O
shoot	O
tissue	O
.	O

A	O
4.8-kilobase	O
BamHI	B
-	O
HindIII	B
fragment	O
encoding	O
the	O
entire	B
Neurospora	I
crassa	I
CuZn	I
superoxide	I
dismutase	I
gene	I
(	O
herein	O
designated	O
sod-1	B
)	O
was	O
isolated	O
from	O
a	O
genomic	O
library	O
using	O
two	O
60-base	O
deoxyoligonucleotide	O
probes	O
corresponding	O
to	O
the	O
published	O
N.	O
crassa	O
amino	O
acid	O
sequence	O
.	O

The	O
nmr	B
gene	I
is	O
the	O
major	O
negative	O
regulatory	O
gene	O
in	O
the	O
nitrogen	O
control	O
circuit	O
of	O
Neurospora	O
crassa	O
,	O
which	O
,	O
together	O
with	O
positive	O
regulatory	O
genes	O
,	O
governs	O
the	O
expression	O
of	O
multiple	O
unlinked	O
structural	O
genes	O
of	O
the	O
circuit	O
.	O

This	O
result	O
indicates	O
that	O
separate	O
complexes	O
exist	O
containing	O
ankyrin	B
and	O
fodrin	B
with	O
either	O
uvomorulin	B
or	O
Na+,K+-ATPase	B
.	O

It	O
is	O
the	O
human	O
homolog	O
of	O
the	O
mouse	B
Mx	I
protein	I
involved	O
in	O
resistance	O
to	O
influenza	O
virus	O
.	O

Summers	O
,	O
Virology	O
89:517	O
-	O
527	O
,	O
1978	O
)	O
.	O

Various	O
mutant	B
HN	I
genes	I
were	O
constructed	O
to	O
examine	O
the	O
role	O
of	O
residues	O
flanking	O
the	O
signal	O
-	O
anchor	O
domain	O
,	O
including	O
the	O
cytoplasmic	O
tail	O
,	O
on	O
assembly	O
and	O
intracellular	O
transport	O
of	O
the	O
HN	B
glycoprotein	I
.	O

A	O
DNA	O
motif	O
related	O
to	O
the	O
cAMP	O
-	O
responsive	O
element	O
and	O
an	O
exon	B
-	I
located	I
activator	I
protein-2	I
binding	I
site	I
in	O
the	O
human	B
tissue	I
-	I
type	I
plasminogen	I
activator	I
gene	I
promoter	I
cooperate	O
in	O
basal	O
expression	O
and	O
convey	O
activation	O
by	O
phorbol	O
ester	O
and	O
cAMP	O
.	O

The	O
recombinant	O
contains	O
the	O
normal	O
beta	B
A	I
-	I
globin	I
gene	I
,	O
the	O
mutant	O
gene	O
and	O
Ylp	O
vector	O
sequences	O
between	O
the	O
two	O
copies	O
.	O

Some	O
of	O
the	O
mutations	O
obtained	O
do	O
not	O
contain	O
a	O
copy	O
of	O
the	O
Ulysses	B
element	I
at	O
the	O
mutant	O
locus	O
,	O
suggesting	O
that	O
a	O
different	O
transposable	O
element	O
may	O
be	O
responsible	O
for	O
the	O
mutation	O
.	O

Kinetic	O
experiments	O
revealed	O
that	O
within	O
10	O
min	O
this	O
radiolabeled	O
precursor	O
protein	O
was	O
converted	O
in	O
HL-60	O
cells	O
into	O
an	O
Mr	O
approximately	O
150,000	O
chondroitin	O
sulfate	O
proteoglycan	O
intermediate	O
.	O

The	O
Saccharomyces	B
cerevisiae	I
14DM	I
gene	I
,	O
encoding	O
cytochrome	B
P450	I
lanosterol	I
14	I
alpha	I
-	I
demethylase	I
(	O
14DM	B
)	O
,	O
was	O
overexpressed	O
in	O
various	O
S.	O
cerevisiae	O
strains	O
under	O
the	O
control	O
of	O
three	O
strong	O
heterologous	O
yeast	O
transcription	O
promoters	O
(	O
pADC1	B
,	O
pGPD	B
,	O
pPHO5	B
)	O
and	O
under	O
the	O
control	O
of	O
its	O
own	O
promoter	O
.	O

Serum	B
beta	I
2-microglobulin	I
levels	O
(	O
beta-2-M	B
)	O
were	O
studied	O
in	O
150	O
drug	O
addicts	O
,	O
50	O
of	O
them	O
asymptomatic	O
carriers	O
of	O
anti	B
HIV-1	I
antibodies	I
,	O
50	O
symptomatic	O
carriers	O
with	O
persistent	O
generalized	O
lymphadenopathy	O
(	O
P.G.L.	O
)	O
and	O
50	O
serum	O
negative	O
patients	O
who	O
had	O
been	O
living	O
in	O
a	O
closed	O
community	O
for	O
at	O
least	O
2	O
years	O
.	O

This	O
emancipation	O
of	O
the	O
ability	O
to	O
copulate	O
from	O
hormonal	O
influence	O
makes	O
female	O
sexual	O
motivation	O
the	O
primary	O
regulator	O
of	O
mating	O
in	O
primates	O
.	O

Analysis	O
of	O
various	O
deletion	O
mutants	O
indicates	O
that	O
the	O
sequence	O
requirements	O
for	O
binding	O
by	O
QBP	B
in	O
vitro	O
are	O
indistinguishable	O
from	O
those	O
necessary	O
for	O
Q	O
activity	O
in	O
vivo	O
,	O
strongly	O
suggesting	O
that	O
QBP	B
is	O
required	O
for	O
the	O
function	O
of	O
this	O
TATA	O
-	O
independent	O
promoter	O
.	O

The	O
two	O
larger	O
peptides	O
,	O
one	O
containing	O
amino	O
acids	O
1	O
-	O
228	O
and	O
the	O
other	O
containing	O
amino	O
acids	O
85	O
-	O
228	O
,	O
formed	O
dimers	O
in	O
solution	O
and	O
bound	O
DNA	O
specifically	O
as	O
a	O
dimer	O
.	O

In	O
vitro	O
transcription	O
extracts	O
from	O
ret1	B
-	I
1	I
cells	O
terminate	O
less	O
efficiently	O
at	O
weak	O
transcription	O
termination	O
signals	O
than	O
those	O
from	O
RET1	B
cells	O
,	O
using	O
a	O
variety	O
of	O
tRNA	O
templates	O
.	O

These	O
latter	O
results	O
showed	O
that	O
the	O
ABFI	B
protein	I
,	O
like	O
the	O
RAP1	B
protein	I
,	O
bound	O
sequences	O
required	O
for	O
positive	O
as	O
well	O
as	O
negative	O
regulation	O
of	O
gene	O
expression	O
.	O

Homozygous	O
protein	B
C	I
(	O
PC	B
)	O
deficiency	O
is	O
reported	O
in	O
two	O
siblings	O
(	O
girl	O
and	O
boy	O
)	O
who	O
received	O
their	O
proper	O
diagnoses	O
at	O
the	O
ages	O
of	O
7	O
4	O
/	O
12	O
and	O
1	O
3	O
/	O
12	O
years	O
respectively	O
.	O

Horseradish	B
peroxidase	I
as	O
a	O
permeability	O
marker	O
in	O
injured	O
rat	O
caudal	O
and	O
iliac	O
arteries	O
.	O

The	O
effects	O
of	O
coenzyme	O
Q10	O
(	O
CoQ	O
)	O
and	O
captopril	O
on	O
functional	O
capacity	O
,	O
hemodynamics	O
and	O
survival	O
were	O
studied	O
in	O
154	O
rats	O
that	O
recovered	O
after	O
experimental	O
myocardial	O
infarction	O
.	O

Some	O
mutations	O
affected	O
Dhfr	B
in	O
a	O
qualitative	O
manner	O
,	O
such	O
as	O
by	O
changing	O
the	O
startpoint	O
of	O
one	O
of	O
the	O
major	O
Dhfr	B
transcripts	I
or	O
changing	O
the	O
relative	O
abundance	O
of	O
the	O
two	O
major	O
Dhfr	B
transcripts	I
.	O

Modification	O
by	O
this	O
latter	O
compound	O
was	O
so	O
extensive	O
that	O
the	O
amount	O
of	O
membrane	O
-	O
associated	O
N	O
-	O
myristoylated	O
protein	O
was	O
decreased	O
.	O

Expression	O
of	O
the	O
human	O
T	B
cell	I
receptor	I
(	I
TCR	I
)	I
alpha	I
gene	I
is	O
regulated	O
by	O
a	O
T	O
cell	O
-	O
specific	O
transcriptional	O
enhancer	O
that	O
is	O
located	O
4.5	O
kilobases	O
(	O
kb	O
)	O
3	O
'	O
to	O
the	O
C	B
alpha	I
gene	I
segment	I
.	O

Cerebral	O
flow	O
and	O
resistance	O
showed	O
minor	O
reductions	O
with	O
HD	O
.	O

Auditory	O
-	O
visual	O
interaction	O
in	O
the	O
generation	O
of	O
saccades	O
in	O
man	O
.	O

The	O
upstream	O
promoter	O
is	O
located	O
within	O
the	O
coding	O
sequence	O
of	O
a	O
divergent	O
gene	O
expressing	O
a	O
protein	O
of	O
Mr	O
39	O
kDa	O
of	O
unknown	O
function	O
.	O

Coenzyme	O
Q10	O
:	O
blood	O
levels	O
and	O
metabolic	O
demand	O
.	O

Serum	O
Fibrin	B
Degradation	I
Products	I
(	O
FDP	B
)	O
were	O
determined	O
in	O
50	O
oral	O
cancer	O
patients	O
and	O
50	O
normal	O
individuals	O
prior	O
to	O
any	O
kind	O
of	O
treatment	O
.	O

Staining	O
with	O
IF	O
MoAB	O
alone	O
of	O
BAL	O
fluid	O
only	O
seemed	O
to	O
be	O
even	O
more	O
sensitive	O
than	O
silver	O
methenamine	O
staining	O
of	O
BAL	O
,	O
TBB	O
and	O
brushing	O
material	O
.	O

By	O
introducing	O
a	O
series	O
of	O
deletions	O
in	O
the	O
vimentin	B
promoter	O
,	O
we	O
further	O
restrict	O
these	O
sequences	O
to	O
30	O
base	O
pairs	O
,	O
located	O
between	O
241	O
and	O
210	O
base	O
pairs	O
upstream	O
of	O
the	O
mRNA	O
cap	O
site	O
.	O

The	O
beta	O
chain	O
contains	O
five	O
potential	O
N	O
-	O
linked	O
glycosylation	O
sites	O
,	O
and	O
endoglycosidase	B
digestion	O
suggested	O
that	O
the	O
beta	O
chain	O
contained	O
multiple	O
complex	O
carbohydrate	O
side	O
chains	O
.	O

Thyrotropin	B
-	O
induced	O
expression	O
of	O
a	O
gene	O
for	O
a	O
ribosomal	B
protein	I
related	O
to	O
the	O
trk	B
oncogene	I
.	O

The	O
BAL	O
-	O
to	O
-	O
plasma	O
specific	O
activity	O
of	O
urea	O
was	O
about	O
twice	O
that	O
of	O
Na+	O
,	O
indicating	O
that	O
urea	O
diffused	O
into	O
the	O
ELF	O
more	O
rapidly	O
than	O
Na+	O
during	O
the	O
70	O
s	O
that	O
elapsed	O
between	O
the	O
time	O
the	O
radioactive	O
urea	O
and	O
Na+	O
were	O
injected	O
into	O
the	O
circulation	O
and	O
the	O
time	O
when	O
lavage	O
was	O
complete	O
.	O

Intron	O
1	O
is	O
6.5	O
kb	O
long	O
,	O
and	O
the	O
minimal	O
sizes	O
of	O
introns	O
2	O
and	O
3	O
are	O
estimated	O
to	O
be	O
32	O
kb	O
each	O
.	O

Approximately	O
65	O
%	O
of	O
the	O
total	O
cAMP	B
-	I
dependent	I
phosphotransferase	I
activity	O
is	O
recovered	O
in	O
particulate	O
fractions	O
of	O
homogenates	O
prepared	O
from	O
asynchronous	O
populations	O
of	O
C.	O
elegans	O
.	O

High	O
levels	O
of	O
C	B
subunits	I
are	O
observed	O
in	O
several	O
subsequent	O
larval	O
and	O
adult	O
stages	O
of	O
development	O
.	O

French	O
,	O
M.	O

There	O
was	O
a	O
gradual	O
increase	O
in	O
the	O
myocyte	O
diameter	O
according	O
to	O
age	O
in	O
the	O
biopsy	O
and	O
autopsy	O
specimens	O
.	O

Despite	O
the	O
absence	O
of	O
exercise	O
-	O
induced	O
asthma	O
(	O
EIA	O
)	O
while	O
breathing	O
WH	O
air	O
,	O
asthmatic	O
patients	O
still	O
had	O
significantly	O
higher	O
mean	O
GH	O
increments	O
than	O
normal	O
subjects	O
(	O
9.2	O
vs	O
2.3	O
ng	O
/	O
ml	O
,	O
P	O
less	O
than	O
0.05	O
)	O
.	O

Sequence	O
analysis	O
of	O
these	O
genes	O
and	O
their	O
surrounding	O
sequences	O
are	O
presented	O
and	O
compared	O
with	O
other	O
known	O
tRNA	O
genes	O
from	O
plant	O
mitochondria	O
.	O

Basing	O
on	O
experimental	O
toxicity	O
research	O
it	O
was	O
established	O
that	O
,	O
out	O
of	O
50	O
atmosphere	O
metal	O
corrosion	O
inhibitors	O
,	O
some	O
14	O
per	O
cent	O
were	O
found	O
extremely	O
hazardous	O
,	O
42	O
per	O
cent	O
--	O
of	O
high	O
level	O
hazardous	O
,	O
33	O
percent	O
--	O
of	O
moderate	O
and	O
11	O
per	O
cent	O
--	O
of	O
low	O
hazardous	O
.	O

Changes	O
in	O
prognosis	O
of	O
twin	O
births	O
over	O
20	O
years	O
.	O

In	O
contrast	O
,	O
2,397	O
(	O
74	O
%	O
)	O
had	O
one	O
or	O
more	O
risk	O
factors	O
(	O
not	O
low	O
risk	O
)	O
;	O
of	O
these	O
,	O
5.3	O
%	O
died	O
in	O
6	O
weeks	O
(	O
p	O
less	O
than	O
0.001	O
)	O
.	O

In	O
6	O
of	O
24	O
infants	O
studied	O
(	O
27th-40th	O
weeks	O
of	O
gestation	O
)	O
,	O
acquired	O
and	O
congenital	O
structural	O
anomalies	O
of	O
the	O
airways	O
were	O
detected	O
with	O
an	O
ultrathin	O
flexible	O
fiberscope	O
(	O
Olympus	O
PF18	O
S	O
,	O
1.8	O
mm	O
)	O
.	O

Sprague	O
-	O
Dawley	O
newborn	O
rats	O
(	O
n	O
=	O
85	O
)	O
breathed	O
100	O
%	O
oxygen	O
(	O
O2	O
)	O
or	O
room	O
air	O
(	O
RA	O
)	O
during	O
the	O
first	O
8	O
days	O
of	O
life	O
,	O
and	O
then	O
RA	O
.	O

The	O
Lm	O
increased	O
and	O
the	O
alveoli	O
/	O
mm2	O
and	O
elastic	O
recoil	O
pressure	O
decreased	O
.	O

Thus	O
,	O
this	O
reading	O
frame	O
was	O
concluded	O
to	O
encode	O
the	O
precursor	O
of	O
mitochondrial	B
fumarase	I
.	O

Role	O
of	O
superoxide	B
dismutase	I
in	O
cellular	O
oxidative	O
processes	O
and	O
method	O
of	O
its	O
determination	O
in	O
biological	O
materials	O

A.	O

The	O
levels	O
of	O
both	O
MAP1-specific	B
and	I
MAP2-specific	I
mRNAs	I
decline	O
in	O
the	O
postnatal	O
developing	O
brain	O
;	O
the	O
level	O
of	O
MAP1-specific	B
mRNA	I
also	O
increases	O
slightly	O
in	O
rat	O
PC12	O
cells	O
upon	O
exposure	O
to	O
nerve	B
growth	I
factor	I
.	O

Prognosis	O
of	O
asymptomatic	O
multiple	O
myeloma	O
.	O

The	O
size	O
discrepancy	O
is	O
not	O
due	O
to	O
glycosylation	O
or	O
phosphorylation	O
of	O
Ag35	B
but	O
may	O
result	O
from	O
a	O
proline	O
-	O
rich	O
sequence	O
which	O
occurs	O
in	O
this	O
polypeptide	O
.	O

Serum	O
prostatic	B
acid	I
phosphatase	I
levels	O
showed	O
a	O
significantly	O
weaker	O
correlation	O
with	O
cancer	O
volume	O
(	O
r	O
equals	O
0.51	O
)	O
and	O
every	O
other	O
pathological	O
parameter	O
.	O

Their	O
studies	O
have	O
revealed	O
a	O
considerable	O
increase	O
of	O
CSF	B
AP	I
activity	O
in	O
purulent	O
meningitides	O
whereas	O
in	O
serous	O
meningitides	O
it	O
grows	O
negligibly	O
.	O

Dopamine	O
caused	O
a	O
prominent	O
potassium	O
efflux	O
measured	O
as	O
86Rb+	O
efflux	O
from	O
control	O
glands	O
,	O
but	O
was	O
without	O
effect	O
in	O
denervated	O
glands	O
.	O

The	O
ratio	O
of	O
radioactivity	O
in	O
tumour	O
compared	O
with	O
normal	O
tissue	O
(	O
T	O
:	O
N	O
ratio	O
)	O
was	O
determined	O
after	O
simultaneously	O
injecting	O
microspheres	O
into	O
the	O
portal	O
and	O
arterial	O
circulation	O
of	O
each	O
animal	O
.	O

The	O
mRNA	O
was	O
converted	O
to	O
cDNA	O
and	O
amplified	O
by	O
the	O
polymerase	O
chain	O
reaction	O
technique	O
.	O

Cotransfection	O
of	O
either	O
construct	O
with	O
plasmids	O
encoding	O
PKI	B
(	I
1	I
-	I
31	I
)	I
inhibits	O
cAMP	O
-	O
stimulated	O
but	O
not	O
basal-	O
or	O
phorbol	O
ester	O
-	O
stimulated	O
expression	O
.	O

Structural	O
organization	O
and	O
expression	O
of	O
the	O
mouse	B
estrogen	I
receptor	I
.	O

Muscle	O
action	O
potential	O
and	O
masticatory	O
rhythm	O
of	O
anterior	O
temporal	O
and	O
masseter	O
muscles	O
in	O
children	O
and	O
adults	O

Growth	O
of	O
tracheal	O
anastomoses	O
in	O
growing	O
animals	O

The	O
other	O
patients	O
continued	O
the	O
trial	O
with	O
single	O
daily	O
doses	O
of	O
monotherapy	O
.	O

Using	O
mutated	B
IL2R	I
alpha	I
promoter	I
constructs	I
in	O
transient	O
transfection	O
and	O
DNA	O
binding	O
assays	O
,	O
we	O
now	O
demonstrate	O
that	O
sequences	O
located	O
immediately	O
upstream	O
and	O
downstream	O
of	O
the	O
kappa	B
B	I
enhancer	I
also	O
contribute	O
to	O
the	O
regulation	O
of	O
IL2R	B
alpha	I
gene	I
expression	O
.	O

The	O
overall	O
prevalence	O
of	O
HBV	O
markers	O
was	O
higher	O
among	O
staff	O
members	O
than	O
in	O
the	O
blood	O
donors	O
of	O
our	O
area	O
.	O

Plasma	O
concentrations	O
of	O
ANF	B
(	O
pANF	B
)	O
,	O
aldosterone	O
(	O
PAC	O
)	O
and	O
renin	B
(	O
PRC	B
)	O
were	O
measured	O
daily	O
,	O
as	O
were	O
hemodynamic	O
parameters	O
.	O

Administration	O
of	O
dexamethasone	O
was	O
associated	O
with	O
progressive	O
rises	O
in	O
plasma	O
17	O
alpha	O
OH	O
progesterone	O
,	O
11	O
beta	O
-	O
desoxycortisol	O
,	O
DHEA	O
sulphate	O
,	O
androstenedione	O
and	O
testosterone	O
,	O
together	O
with	O
increased	O
urinary	O
excretion	O
of	O
androsterone	O
,	O
11	O
beta	O
OH	O
androsterone	O
,	O
etiocholanolone	O
,	O
DHEA	O
,	O
and	O
16	O
alpha	O
OH	O
DHEA	O
.	O

In	O
HeLa	O
cells	O
,	O
it	O
activated	O
transcription	O
from	O
the	O
herpes	B
simplex	I
virus	I
type	I
1	I
thymidine	I
kinase	I
promoter	I
linked	O
to	O
the	O
chloramphenicol	B
acetyltransferase	I
gene	I
when	O
located	O
in	O
inverted	O
orientation	O
upstream	O
of	O
the	O
thymidine	B
kinase	I
promoter	I
or	O
downstream	O
of	O
the	O
chloramphenicol	B
acetyltransferase	I
gene	I
coding	I
sequence	I
.	O

The	O
mustard	B
chloroplast	I
gene	I
rps16	I
is	O
split	O
by	O
an	O
887	O
bp	O
group	O
II	O
(	O
or	O
III	O
)	O
intron	O
.	O

A	O
brief	O
account	O
of	O
the	O
1988	O
seminar	O
in	O
Shanghai	O
on	O
viral	O
hepatitis	O
A	O

Restriction	O
maps	O
of	O
the	O
cloned	O
plasmids	O
revealed	O
that	O
their	O
chromosomal	O
inserts	O
consisted	O
of	O
overlapping	O
fragments	O
.	O

Insert2	O
contains	O
repetitive	O
non	O
-	O
Ig	B
-	O
related	O
sequences	O
and	O
a	O
small	B
Ig	I
-	I
related	I
sequence	I
.	O

In	O
patients	O
resistant	O
to	O
VAD	O
,	O
high	O
-	O
dose	O
therapies	O
with	O
intravenous	O
melphalan	O
,	O
a	O
CBV	O
combination	O
(	O
cyclophosphamide	O
-	O
BCNU	O
-	O
VP-16	O
)	O
or	O
an	O
EDAP	O
regimen	O
(	O
VP-16	O
-platinum	O
)	O
produced	O
responses	O
in	O
about	O
40	O
%	O
of	O
patients	O
.	O

Most	O
of	O
them	O
were	O
situated	O
at	O
Sylvius	O
fissure	O
(	O
13	O
cases	O
)	O
.	O

Specifically	O
,	O
they	O
were	O
performed	O
to	O
determine	O
whether	O
detection	O
of	O
envelope	O
phase	O
disparity	O
was	O
consistent	O
with	O
processing	O
within	O
a	O
single	O
channel	O
in	O
which	O
the	O
AM	O
tones	O
were	O
simply	O
added	O
.	O

Gel	O
retardation	O
assays	O
combined	O
with	O
DNase	B
I	I
footprinting	O
and	O
diethyl	O
pyrocarbonate	O
interference	O
showed	O
that	O
a	O
nuclear	O
factor	O
from	O
differentiated	O
C2	O
myotubes	O
and	O
BC3H1	O
myocytes	O
recognized	O
a	O
conserved	O
A	O
+	O
T	O
-	O
rich	O
sequence	O
within	O
the	O
peripheral	O
activating	O
region	O
.	O

No	O
changes	O
were	O
evident	O
in	O
the	O
FR	O
-	O
task	O
performance	O
of	O
controls	O
that	O
received	O
daily	O
saline	O
injections	O
.	O

Collaborative	O
study	O
of	O
Japanese	O
Pharmacopoeia	O
Heparin	O
Sodium	O
Reference	O
Standard	O

In	O
Rat-1a	O
cells	O
the	O
expression	O
of	O
human	B
c	I
-	I
jun	I
mRNA	I
was	O
associated	O
with	O
the	O
ability	O
to	O
clone	O
in	O
soft	O
agarose	O
and	O
form	O
tumors	O
in	O
nude	O
mice	O
.	O

Furthermore	O
,	O
formation	O
of	O
foci	O
of	O
transformed	O
RECs	O
by	O
the	O
c	B
-	I
jun	I
/	O
ras	B
combination	O
was	O
augmented	O
3-fold	O
by	O
the	O
tumor	O
promoter	O
phorbol	O
12-tetradecanoate	O
13-acetate	O
.	O

US	O
-	O
Doppler	O
has	O
recently	O
gained	O
attention	O
as	O
a	O
noninvasive	O
method	O
for	O
the	O
functional	O
evaluation	O
of	O
arteriovenous	O
fistulas	O
(	O
FAV	O
)	O
.	O

Doppler	O
echo	O
in	O
evaluating	O
arteriovenous	O
fistulae	O
for	O
dialysis	O

Improved	O
cosmesis	O
,	O
extension	O
of	O
the	O
scope	O
of	O
the	O
problems	O
that	O
can	O
be	O
addressed	O
with	O
this	O
repair	O
(	O
including	O
treatment	O
of	O
a	O
distal	O
urethrocutaneous	O
fistula	O
)	O
and	O
the	O
ease	O
with	O
which	O
the	O
Arap	O
procedure	O
can	O
be	O
performed	O
are	O
the	O
advantages	O
that	O
this	O
operation	O
has	O
over	O
other	O
1-stage	O
distal	O
hypospadias	O
repairs	O
.	O

Following	O
the	O
patients	O
during	O
a	O
course	O
of	O
therapy	O
with	O
a	O
selective	O
vasodilator	O
calcium	O
antagonist	O
,	O
the	O
beta	O
-	O
adrenergic	O
reflex	O
vasodilation	O
became	O
substantially	O
attenuated	O
but	O
was	O
preserved	O
during	O
a	O
placebo	O
course	O
of	O
therapy	O
.	O

Psychiatry	O
and	O
the	O
skin	O
.	O

The	O
present	O
data	O
also	O
suggest	O
that	O
when	O
compared	O
to	O
the	O
systemic	O
vascular	O
bed	O
,	O
the	O
pulmonary	O
vascular	O
bed	O
is	O
less	O
responsive	O
to	O
bolus	O
administration	O
of	O
ET-1	B
.	O

A	O
significant	O
relationship	O
existed	O
during	O
the	O
evolution	O
of	O
the	O
disease	O
between	O
CRS	O
/	O
BW	O
and	O
gas	O
exchange	O
parameters	O
(	O
FIO2	O
and	O
a	O
/	O
AO2	O
ratio	O
)	O
(	O
P	O
less	O
than	O
0.01	O
)	O
,	O
but	O
gas	O
exchange	O
improved	O
earlier	O
than	O
lung	O
mechanics	O
.	O

The	O
predicted	O
molecular	O
weight	O
of	O
the	O
polyprotein	O
encoded	O
by	O
ORF1	O
is	O
33	O
kilodaltons	O
(	O
kDa	O
)	O
.	O

Allelic	O
variation	O
in	O
HLA	B
-	I
B	I
and	O
HLA	B
-	I
C	I
sequences	I
and	O
the	O
evolution	O
of	O
the	O
HLA	B
-	I
B	I
alleles	I
.	O

Similarly	O
,	O
the	O
sequence	O
of	O
the	O
U2	B
RNA	I
region	I
shown	O
to	O
be	O
involved	O
in	O
pre	O
-	O
mRNA	O
branchpoint	O
recognition	O
in	O
yeast	O
,	O
and	O
exactly	O
conserved	O
in	O
metazoan	B
U2	I
RNAs	I
,	O
was	O
totally	O
divergent	O
in	O
trypanosomes	O
.	O

A	O
raised	O
amplitude	O
of	O
the	O
aggregation	O
of	O
plates	O
and	O
a	O
decrease	O
in	O
the	O
threshold	O
of	O
their	O
sensitivity	O
to	O
ADP	O
were	O
established	O
in	O
the	O
persons	O
with	O
types	O
IIa	O
and	O
IIb	O
HLP	O
and	O
in	O
CHD	O
without	O
HLP	O
.	O

Significant	O
intergroup	O
differences	O
are	O
highlighted	O
for	O
both	O
selected	O
dentoskeletal	O
and	O
soft	O
tissue	O
profile	O
variables	O
.	O

Molecular	O
cloning	O
and	O
characterisation	O
of	O
the	O
two	O
homologous	O
genes	O
coding	O
for	O
nitrate	B
reductase	I
in	I
tobacco	I
.	O

COUP	B
transcription	I
factor	I
is	O
a	O
member	O
of	O
the	O
steroid	B
receptor	I
superfamily	I
.	O

Qualitatively	O
,	O
the	O
results	O
are	O
similar	O
for	O
the	O
two	O
species	O
:	O
Both	O
rhesus	O
monkey	O
and	O
man	O
have	O
photopic	O
and	O
scotopic	O
branches	O
,	O
which	O
cross	O
at	O
approximately	O
the	O
same	O
time	O
in	O
the	O
dark	O
and	O
at	O
approximately	O
the	O
same	O
background	O
luminance	O
.	O

Endometrial	O
biopsies	O
and	O
plasma	O
oestradiol	O
(	O
E2	O
)	O
and	O
progesterone	O
(	O
P4	O
)	O
levels	O
in	O
23	O
patients	O
were	O
evaluated	O
during	O
26	O
replacement	O
therapy	O
cycles	O
for	O
premature	O
ovarian	O
failure	O
.	O

Behaviorally	O
,	O
a	O
pain	O
-	O
tolerant	O
group	O
(	O
PT	O
=	O
29	O
Ss	O
)	O
tolerated	O
the	O
entire	O
3-min	O
test	O
(	O
means	O
=	O
180	O
+	O
/-	O

0	O
sec	O
)	O
,	O
while	O
a	O
pain	O
-	O
sensitive	O
group	O
(	O
PS	O
=	O
13	O
Ss	O
)	O
averaged	O
only	O
50.31	O
+	O
/-	O

20.81	O
sec	O
of	O
the	O
cold	O
-	O
pressor	O
test	O
(	O
t	O
=	O
16.75	O
,	O
P	O
less	O
than	O
0.0001	O
)	O
,	O
replicating	O
our	O
earlier	O
studies	O
.	O

Initial	O
experience	O
with	O
a	O
microprocessor	O
controlled	O
current	O
based	O
defibrillator	O
.	O

The	O
values	O
were	O
consistently	O
lower	O
(	O
P	O
less	O
than	O
0.01	O
)	O
during	O
summer	O
(	O
3.79	O
+	O
/-	O

0.13	O
micrograms	O
/	O
100	O
ml	O
)	O
,	O
as	O
compared	O
to	O
winter	O
(	O
5.06	O
+	O
/-	O
0.27	O
)	O
.	O

Changes	O
in	O
xanthine	B
oxidase	I
activity	O
in	O
patients	O
with	O
circulatory	O
failure	O

The	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
preferentially	O
infects	O
CD4	B
+	I
T	O
lymphocytes	O
and	O
may	O
exist	O
as	O
a	O
latent	O
provirus	O
within	O
these	O
cells	O
for	O
extended	O
periods	O
.	O

The	O
subepicardial	O
lymphatic	O
capillaries	O
were	O
ramified	O
and	O
anastomosed	O
with	O
each	O
other	O
to	O
form	O
a	O
relatively	O
dense	O
network	O
which	O
extended	O
over	O
the	O
entire	O
surface	O
of	O
both	O
ventricles	O
.	O

During	O
sub	O
-	O
maximal	O
exercise	O
,	O
DCR	O
in	O
the	O
UT	O
dogs	O
decreased	O
from	O
a	O
resting	O
value	O
of	O
4.08	O
+	O
/-	O

0.18	O
mm	O
Hg	O
X	O
ml-1	O
X	O
min-1	O
to	O
1.91	O
+	O
/-	O

0.17	O
mm	O
Hg	O
X	O
ml-1	O
X	O
min-1	O
at	O
a	O
workload	O
of	O
6.4	O
kph	O
(	O
speed	O
)	O
/	O
16	O
%	O
(	O
grade	O
)	O
.	O

An	O
analysis	O
of	O
the	O
steady	O
state	O
RNA	O
levels	O
in	O
T	O
-	O
lymphoid	O
cell	O
lines	O
showed	O
that	O
at	O
least	O
three	O
different	O
incomplete	O
proviral	O
transcripts	O
and	O
their	O
spliced	O
products	O
made	O
up	O
the	O
majority	O
of	O
expressed	O
RD-114	B
mRNA	I
,	O
and	O
further	O
demonstrated	O
that	O
partially	O
deleted	O
proviral	O
loci	O
have	O
the	O
potential	O
to	O
be	O
transcriptionally	O
vigorous	O
in	O
certain	O
feline	O
cell	O
types	O
.	O

Sodium	O
dodecyl	O
sulphate	O
-	O
induced	O
cleavage	O
by	O
eukaryotic	B
topoisomerase	I
I	I
is	O
known	O
to	O
yield	O
enzyme	O
covalently	O
attached	O
to	O
the	O
3	O
'	O
cut	O
end	O
of	O
the	O
DNA	O
.	O

RVEF	O
and	O
LVEF	O
both	O
increased	O
by	O
about	O
14	O
%	O
(	O
p	O
less	O
than	O
0.05	O
and	O
p	O
less	O
than	O
0.01	O
)	O
.	O

Quantitative	O
assays	O
in	O
which	O
the	O
activity	O
of	O
the	O
synthetic	B
alpha	I
s-1	I
was	O
compared	O
to	O
that	O
of	O
native	O
purified	O
human	B
erythrocyte	I
type-1	I
Gs	I
,	O
indicated	O
that	O
the	O
two	O
products	O
are	O
equipotent	O
within	O
a	O
2-fold	O
margin	O
of	O
error	O
.	O

Most	O
patients	O
with	O
high	O
blood	O
pressure	O
(	O
BP	O
)	O
can	O
be	O
managed	O
by	O
using	O
one	O
of	O
4	O
classes	O
of	O
compounds	O
:	O
a	O
diuretic	O
,	O
beta	O
blocker	O
,	O
converting	O
enzyme	O
inhibitor	O
or	O
calcium	O
antagonist	O
.	O

Seventy	O
-	O
one	O
supplementary	O
doses	O
of	O
vecuronium	O
were	O
used	O
for	O
muscle	O
relaxation	O
during	O
a	O
22-h	O
-	O
long	O
NLA	O
II	O
anaesthesia	O
.	O

The	O
East	O
African	O
dik	O
-	O
dik	O
antelope	O
represents	O
a	O
miniature	O
model	O
ruminant	O
for	O
comparative	O
studies	O
.	O

2	O
cases	O
of	O
type	O
II	O
tyrosinosis	O
(	O
Richner	O
-	O
Hanhart	O
syndrome	O
)	O

Effects	O
of	O
aging	O
and	O
beta	O
-	O
adrenergic	O
-	O
blockade	O
on	O
standing	O
-	O
induced	O
QT	O
/	O
QS2	O
changes	O
.	O

Hemodynamic	O
assessment	O
was	O
obtained	O
before	O
and	O
following	O
administration	O
of	O
digoxin	O
10	O
micrograms	O
/	O
kg	O
IV	O
or	O
dopamine	O
,	O
5	O
to	O
12	O
micrograms	O
/	O
kg	O
/	O
min	O
IV	O
.	O

For	O
the	O
present	O
work	O
we	O
used	O
water	O
saturated	O
with	O
a	O
50	O
/	O
50	O
mixture	O
of	O
H2	O
and	O
O2	O
gases	O
,	O
for	O
which	O
the	O
heat	O
defect	O
is	O
calculated	O
to	O
be	O
-2.1	O
%	O
.	O

During	O
flexion	O
whiplash	O
,	O
the	O
torque	O
at	O
the	O
occipital	O
condyle	O
reverses	O
its	O
direction	O
at	O
about	O
25	O
ms	O
after	O
impact	O
.	O

Functional	O
flow	O
was	O
evaluated	O
using	O
laser	O
Doppler	O
flowmetry	O
(	O
LDF	O
)	O
,	O
for	O
which	O
the	O
output	O
signal	O
,	O
blood	O
cell	O
flux	O
(	O
BCF	O
)	O
,	O
is	O
expressed	O
in	O
terms	O
of	O
volts	O
.	O

The	O
clinical	O
picture	O
and	O
laboratory	O
parameters	O
were	O
consistent	O
with	O
a	O
serum	O
sickness	O
reaction	O
.	O

The	O
seco	O
-	O
steroid	O
hormone	O
1,25-dihydroxyvitamin	O
D3	O
is	O
known	O
to	O
induce	O
the	O
expression	O
of	O
a	O
calcium	O
binding	O
protein	O
termed	O
calbindin	B
-	I
D28	I
K	I
in	O
a	O
variety	O
of	O
target	O
tissues	O
.	O

In	O
addition	O
,	O
the	O
calbindin	B
-	I
D28	I
K	I
promoter	I
is	O
composed	O
of	O
a	O
variety	O
of	O
simple	O
repeated	O
sequences	O
,	O
some	O
of	O
which	O
are	O
components	O
of	O
putative	O
regulatory	O
signals	O
.	O

Organ	O
transplantation	O
in	O
Denmark	O
.	O

Those	O
dosages	O
that	O
inhibited	O
mean	O
NTE	B
activity	O
in	O
spinal	O
cord	O
greater	O
than	O
or	O
equal	O
to	O
72	O
%	O
and	O
brain	O
greater	O
than	O
or	O
equal	O
to	O
66	O
%	O
of	O
control	O
values	O
within	O
44	O
hr	O
postexposure	O
produced	O
marked	O
spinal	O
cord	O
pathology	O
14	O
days	O
postexposure	O
in	O
greater	O
than	O
or	O
equal	O
to	O
90	O
%	O
of	O
similarly	O
dosed	O
animals	O
.	O

Thirty	O
of	O
the	O
clones	O
contained	O
a	O
complete	O
340	O
base	O
-	O
pair	O
dimer	O
unit	O
of	O
the	O
repeat	O
.	O

Cattaneo	O
,	O
and	O
J.	O

Next	O
,	O
with	O
carcinoma	O
presenting	O
a	O
leather	O
bottle	O
(	O
linitis	O
plastica	O
type	O
)	O
of	O
the	O
stomach	O
itself	O
,	O
the	O
II	O
c	O
portion	O
of	O
the	O
stomach	O
consisted	O
of	O
fundic	O
glands	O
(	O
undifferentiated	O
carcinoma	O
)	O
shall	O
become	O
the	O
primary	O
focus	O
supporting	O
Nakamura	O
's	O
theory	O
.	O

In	O
the	O
DNAs	O
of	O
all	O
Ph1-positive	O
chronic	O
myelocytic	O
leukemia	O
patients	O
studied	O
to	O
date	O
,	O
a	O
breakpoint	O
on	O
chromosome	O
22	O
(	O
the	O
Ph1	O
chromosome	O
)	O
can	O
be	O
demonstrated	O
with	O
a	O
probe	O
from	O
the	O
bcr	B
(	O
breakpoint	B
cluster	I
region	I
)	O
.	O

The	O
5'-nontranslated	O
sequences	O
and	O
parts	O
of	O
the	O
coding	O
sequences	O
of	O
various	O
yeast	O
genes	O
have	O
been	O
cloned	O
into	O
representative	O
lacZ	B
fusion	O
vectors	O
.	O

It	O
is	O
concluded	O
that	O
suppression	O
of	O
elevated	O
prolactin	B
levels	O
in	O
progressive	O
metastatic	O
breast	O
cancer	O
patients	O
is	O
not	O
effective	O
in	O
restoring	O
tumor	O
sensitivity	O
to	O
chemotherapy	O
.	O

We	O
also	O
found	O
an	O
eIF-4A	B
intronless	O
retroposon	O
which	O
,	O
when	O
compared	O
to	O
the	O
cDNA	O
,	O
contains	O
a	O
single	O
nucleotide	O
difference	O
.	O

In	O
view	O
of	O
these	O
results	O
,	O
simultaneous	O
pancreas	O
-	O
kidney	O
transplantation	O
appears	O
to	O
be	O
the	O
treatment	O
of	O
choice	O
for	O
Type	O
I	O
diabetic	O
patients	O
.	O

Factors	O
influencing	O
the	O
bond	O
strength	O
between	O
glass	O
polyalkenoate	O
(	O
ionomer	O
)	O
cements	O
and	O
dentine	O
.	O

Research	O
on	O
ethylene	O
glycol	O
and	O
diethylene	O
glycol	O
for	O
carcinogenic	O
effects	O

Isolation	O
and	O
characterization	O
of	O
a	O
vinculin	B
cDNA	I
from	I
chick	I
-	I
embryo	I
fibroblasts	I
.	O

A	O
complementary	O
study	O
,	O
showing	O
a	O
good	O
agreement	O
between	O
surface	O
and	O
oesophageal	O
EMGd	O
seems	O
to	O
confirm	O
that	O
surface	O
EMGd	O
is	O
a	O
useful	O
and	O
promising	O
tool	O
for	O
clinical	O
investigation	O
.	O

No	O
differences	O
in	O
fixation	O
quality	O
were	O
observed	O
between	O
cochleas	O
fixed	O
by	O
intravascular	O
perfusion	O
and	O
cochleas	O
fixed	O
by	O
intralabyrinthine	O
perfusion	O
.	O

The	O
requirement	O
of	O
different	O
essential	O
fatty	O
acids	O
in	O
patients	O
with	O
total	O
parenteral	O
nutrition	O
after	O
heavy	O
injury	O
is	O
of	O
special	O
interest	O
with	O
respect	O
to	O
the	O
development	O
and	O
prognosis	O
of	O
shock	O
,	O
sepsis	O
or	O
adult	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
protein	O
mixtures	O
of	O
sesame	O
flour	O
and	O
soybean	O
flour	O
were	O
well	O
accepted	O
.	O

The	O
5	O
'	O
end	O
of	O
the	O
coding	O
region	O
was	O
located	O
precisely	O
by	O
comparing	O
the	O
deduced	O
amino	O
acid	O
sequence	O
to	O
the	O
actual	O
N	O
-	O
terminal	O
amino	O
acid	O
sequence	O
of	O
IHF	B
.	O

Conservative	O
treatment	O
of	O
bladder	O
carcinoma	O
by	O
partial	O
cystectomy	O
and	O
interstitial	O
iridium	O
192	O
.	O

Existence	O
and	O
uniqueness	O
of	O
solutions	O
of	O
the	O
appropriate	O
boundary	O
value	O
problems	O
are	O
established	O
,	O
in	O
the	O
case	O
of	O
small	O
permeability	O
coefficients	O
and	O
transport	O
rates	O
,	O
or	O
large	O
diffusion	O
coefficients	O
and	O
small	O
resistance	O
to	O
flow	O
constants	O
.	O

Neuromyelitis	O
optica	O
(	O
Devic	O
's	O
syndrome	O
)	O
:	O
not	O
always	O
multiple	O
sclerosis	O
.	O

None	O
had	O
a	O
past	O
history	O
of	O
opportunistic	O
infections	O
;	O
neither	O
did	O
any	O
have	O
lymphopenia	O
.	O

Post	O
-	O
transcriptional	O
regulation	O
of	O
ribosomal	B
protein	I
gene	I
expression	O
during	O
development	O
in	O
Dictyostelium	O
discoideum	O
.	O

The	O
temporal	O
and	O
static	O
plasma	O
concentration	O
-	O
effect	O
relationships	O
were	O
evaluated	O
by	O
pharmacodynamic	O
modeling	O
and	O
linear	O
regression	O
.	O

Many	O
children	O
with	O
BGC	O
are	O
delayed	O
in	O
their	O
development	O
,	O
but	O
calcifications	O
are	O
not	O
directly	O
related	O
to	O
specific	O
forms	O
of	O
neurologic	O
dysfunction	O
.	O

R	O
-	O
wave	O
voltage	O
in	O
the	O
right	O
precordial	O
leads	O
in	O
anthracycline	O
cardiomyopathy	O
:	O
a	O
clinical	O
study	O
.	O

Secretory	O
function	O
of	O
the	O
prostate	O
gland	O
.	O

Minor	O
differences	O
were	O
noted	O
with	O
latamoxef	O
producing	O
mild	O
persistant	O
elevation	O
of	O
prothrombin	B
time	O
(	O
0.7	O
second	O
)	O
associated	O
with	O
depression	O
of	O
factor	B
II	I
and	O
factor	B
VII	I
.	O

The	O
size	O
of	O
the	O
group	O
allocated	O
to	O
the	O
good	O
compliance	O
category	O
by	O
the	O
use	O
of	O
the	O
digoxin	O
marker	O
was	O
equivalent	O
in	O
size	O
to	O
a	O
group	O
of	O
patients	O
who	O
had	O
returned	O
less	O
than	O
15	O
%	O
of	O
their	O
prescribed	O
dose	O
or	O
reported	O
a	O
deviation	O
of	O
less	O
than	O
6	O
%	O
from	O
their	O
prescription	O
.	O

Bullous	O
keratopathy	O
was	O
usually	O
aphakic	O
in	O
origin	O
in	O
1982	O
,	O
but	O
after	O
1983	O
pseudophakic	O
bullous	O
keratopathy	O
(	O
PBK	O
)	O
was	O
the	O
most	O
common	O
cause	O
of	O
bullous	O
keratopathy	O
.	O

The	O
epidermal	B
growth	I
factor	I
(	I
EGF	I
)	I
receptor	I
,	O
which	O
exhibits	O
intrinsic	O
protein	B
tyrosine	I
kinase	I
activity	O
,	O
undergoes	O
a	O
rapid	O
,	O
intramolecular	O
self	O
-	O
phosphorylation	O
reaction	O
following	O
EGF	B
activation	O
.	O

The	O
glomerular	O
filtration	O
rate	O
and	O
effective	O
renal	O
plasma	O
flow	O
were	O
determined	O
by	O
a	O
standard	O
clearance	O
method	O
,	O
employing	O
continuous	O
infusion	O
of	O
inulin	O
and	O
para	O
-	O
aminohippuric	O
acid	O
.	O

In	O
contrast	O
,	O
the	O
MAN	O
showed	O
a	O
unimodal	O
,	O
skewed	O
distribution	O
,	O
with	O
a	O
range	O
from	O
approximately	O
1	O
to	O
14	O
micron	O
and	O
a	O
maximum	O
at	O
3	O
-	O
4	O
micron	O
.	O

Abnormal	O
technetium	O
Tc	O
99	O
m	O
medronate	O
scans	O
in	O
patients	O
with	O
previously	O
undiagnosed	O
polyarthralgias	O
suggested	O
inflammatory	O
arthropathy	O
and	O
influenced	O
management	O
decisions	O
with	O
favorable	O
therapeutic	O
outcomes	O
.	O

The	O
state	O
of	O
the	O
liver	O
in	O
generalized	O
forms	O
of	O
meningococcal	O
infection	O

The	O
actuarial	O
local	O
control	O
rates	O
at	O
10	O
years	O
for	O
the	O
three	O
treatment	O
groups	O
were	O
as	O
follows	O
:	O
subtotal	O
excision	O
alone	O
,	O
18	O
%	O
;	O
subtotal	O
excision	O
plus	O
postoperative	O
radiation	O
therapy	O
,	O
82	O
%	O
;	O
and	O
total	O
excision	O
alone	O
,	O
77	O
%	O
.	O

Ischemic	O
heart	O
disease	O
,	O
age	O
of	O
more	O
than	O
75	O
years	O
,	O
and	O
the	O
fact	O
that	O
the	O
patient	O
was	O
a	O
woman	O
were	O
independent	O
predictors	O
of	O
poor	O
cardiac	O
function	O
.	O

These	O
findings	O
indicate	O
that	O
autophosphorylation	O
of	O
Thr286	O
(	O
alpha	O
subunit	O
)	O
and	O
Thr287	O
(	O
beta	O
subunit	O
)	O
is	O
responsible	O
for	O
transition	O
of	O
CaM	B
-	I
kinase	I
II	I
to	O
the	O
Ca2	O
+	O
-independent	O
form	O
.	O

This	O
rapid	O
and	O
extensive	O
penetration	O
of	O
intrathecally	O
administered	O
chemotherapy	O
may	O
offer	O
insight	O
into	O
the	O
myelopathy	O
observed	O
with	O
these	O
treatments	O
.	O

Moreover	O
,	O
unlike	O
control	O
rats	O
operated	O
animals	O
did	O
not	O
show	O
aversion	O
to	O
the	O
highest	O
concentrations	O
of	O
saccharin	O
solutions	O
.	O

Two	O
scintigraphic	O
methods	O
,	O
resting	O
dipyridamole	O
and	O
exercise	O
thallium-201	O
myocardial	O
perfusion	O
imaging	O
,	O
to	O
detect	O
and	O
localize	O
coronary	O
artery	O
stenosis	O
were	O
compared	O
in	O
32	O
patients	O
suffering	O
from	O
coronary	O
artery	O
disease	O
.	O

X2	O
test	O
,	O
with	O
Yates	O
correction	O
if	O
need	O
,	O
was	O
used	O
as	O
statistical	O
.	O

method	O
.	O

Mean	O
fluorosis	O
scores	O
,	O
however	O
,	O
were	O
similar	O
.	O

Pharmacologic	O
properties	O
of	O
serotonergic	O
agents	O
and	O
antidepressant	O
drugs	O
.	O

The	O
incidence	O
of	O
second	O
malignant	O
neoplasms	O
was	O
lower	O
(	O
1.3	O
%	O
)	O
in	O
the	O
group	O
treated	O
with	O
5-fluorouracil	O
,	O
doxorubicin	O
,	O
and	O
cyclophosphamide	O
than	O
in	O
the	O
historical	O
control	O
group	O
(	O
4.8	O
%	O
)	O
.	O

Based	O
on	O
our	O
observations	O
,	O
we	O
propose	O
a	O
model	O
whereby	O
inactive	O
precursor	O
molecules	O
produced	O
from	O
the	O
PEP4	B
gene	I
self	O
-	O
activate	O
within	O
the	O
yeast	O
vacuole	O
and	O
subsequently	O
activate	O
other	O
vacuolar	B
hydrolases	I
.	O

Several	O
new	O
techniques	O
are	O
available	O
for	O
monitoring	O
control	O
of	O
diabetes	O
.	O

Postglucose	O
serum	B
insulin	I
levels	O
showed	O
no	O
significant	O
correlations	O
with	O
systolic	O
or	O
diastolic	O
blood	O
pressure	O
levels	O
in	O
men	O
,	O
but	O
in	O
female	O
diabetic	O
and	O
non	O
-	O
diabetic	O
subjects	O
significant	O
correlations	O
were	O
found	O
in	O
particular	O
with	O
systolic	O
blood	O
pressure	O
level	O
.	O

We	O
used	O
oligonucleotide	O
-	O
directed	O
mutagenesis	O
to	O
alter	O
a	O
site	O
in	O
MucA	B
homologous	O
to	O
the	O
Ala	O
-	O
Gly	O
cleavage	O
site	O
of	O
LexA.	B

The	O
latter	O
was	O
determined	O
as	O
follows	O
:	O
Type	O
I	O
-	O
solid	O
tumor	O
tissue	O
without	O
significant	O
peripheral	O
isolated	O
tumor	O
cells	O
;	O
Type	O
II	O
-	O
solid	O
tumor	O
tissue	O
associated	O
with	O
peripheral	O
isolated	O
tumor	O
cells	O
;	O
Type	O
III	O
-	O
isolated	O
tumor	O
cells	O
only	O
.	O

Rabbits	O
developed	O
profound	O
hypocalcemia	O
,	O
with	O
levels	O
falling	O
from	O
15.5	O
+	O
/-	O

0.2	O
to	O
7.6	O
+	O
/-	O

0.4	O
mg	O
/	O
dl	O
under	O
the	O
influence	O
of	O
TSST-1	B
.	O

Dorsal	O
foot	O
TcpO2	O
was	O
measured	O
by	O
using	O
oxygen	O
-	O
sensing	O
electrodes	O
with	O
surface	O
temperatures	O
of	O
42	O
degrees	O
C	O
and	O
45	O
degrees	O
C	O
;	O
in	O
theory	O
,	O
changes	O
in	O
sympathetic	O
activity	O
should	O
affect	O
vasomotor	O
tone	O
and	O
TcpO2	O
in	O
skin	O
beneath	O
an	O
electrode	O
at	O
42	O
degrees	O
C	O
(	O
submaximal	O
vasodilation	O
)	O
,	O
but	O
not	O
at	O
45	O
degrees	O
C	O
(	O
maximal	O
vasodilation	O
)	O
.	O

The	O
nucleotide	O
sequences	O
of	O
the	O
human	B
and	I
murine	I
ornithine	I
decarboxylase	I
mRNAs	I
share	O
an	O
85	O
%	O
homology	O
,	O
even	O
in	O
their	O
3'-noncoding	O
regions	O
.	O

In	O
cases	O
of	O
1	O
degrees	O
HPT	O
,	O
the	O
plasma	O
1,25-	O
(	O
OH	O
)	O
2D	O
level	O
rose	O
significantly	O
in	O
all	O
cases	O
(	O
P	O
less	O
than	O
0.05	O
)	O
,	O
although	O
the	O
pattern	O
of	O
the	O
increase	O
was	O
not	O
uniform	O
.	O

Data	O
from	O
119	O
men	O
and	O
40	O
women	O
undergoing	O
coronary	O
angiography	O
provide	O
an	O
opportunity	O
to	O
compare	O
these	O
associations	O
in	O
relation	O
to	O
a	O
direct	O
and	O
continuous	O
measure	O
of	O
atherosclerosis	O
while	O
controlling	O
for	O
age	O
,	O
sex	O
,	O
income	O
,	O
hypertension	O
,	O
serum	O
cholesterol	O
,	O
smoking	O
,	O
angina	O
,	O
diabetes	O
,	O
family	O
history	O
of	O
heart	O
disease	O
,	O
Type	O
A	O
behavior	O
pattern	O
,	O
and	O
hostility	O
.	O

Immobilization	O
of	O
the	O
fracture	O
in	O
a	O
collar	O
and	O
cuff	O
sling	O
was	O
as	O
effective	O
as	O
more	O
elaborate	O
methods	O
.	O

Comparison	O
of	O
patients	O
receiving	O
phenytoin	O
and	O
those	O
who	O
were	O
not	O
showed	O
significantly	O
lower	O
serum	O
folate	O
in	O
the	O
sub	O
-	O
group	O
receiving	O
phenytoin	O
,	O
but	O
there	O
was	O
no	O
significant	O
difference	O
between	O
the	O
sub	O
-	O
groups	O
with	O
respect	O
to	O
vitamin	O
B12	O
or	O
behaviour	O
problem	O
rating	O
.	O

Effects	O
of	O
a	O
low	O
-	O
energy	O
laser	O
beam	O
on	O
the	O
cells	O
of	O
the	O
newt	O
embryo	O

Separate	O
experiments	O
measured	O
AIB	O
and	O
86RbCl	O
uptake	O
in	O
36B-10	O
cells	O
in	O
vitro	O
1	O
and	O
2	O
days	O
following	O
20	O
Gy	O
irradiation	O
to	O
assess	O
whether	O
this	O
radiation	O
dose	O
reduced	O
the	O
capacity	O
of	O
tumor	O
cells	O
to	O
trap	O
AIB	O
or	O
Rb+	O
.	O

Hyperthyroidism	O

These	O
changes	O
at	O
the	O
site	O
of	O
injection	O
consist	O
of	O
a	O
focal	O
abnormality	O
characterized	O
by	O
a	O
slight	O
increase	O
in	O
signal	O
intensity	O
on	O
T1	O
weighted	O
images	O
and	O
markedly	O
increased	O
signal	O
intensity	O
on	O
T2	O
weighted	O
images	O
.	O

References	O
for	O
occupational	O
fitness	O
of	O
adolescents	O
with	O
diseases	O
of	O
the	O
respiratory	O
tract	O
and	O
lungs	O

Salzburg	O
,	O
9	O
-	O
12	O
September	O
1987	O
.	O

The	O
selenium	O
level	O
and	O
glutathione	B
peroxidase	I
activity	O
in	O
the	O
blood	O
,	O
liver	O
,	O
and	O
stomach	O
mucosa	O
were	O
significantly	O
higher	O
in	O
the	O
high	O
-	O
selenium	O
diet	O
group	O
than	O
in	O
the	O
low	O
-	O
selenium	O
diet	O
group	O
.	O

Oxygen	O
delivery	O
and	O
consumption	O
and	O
P50	O
in	O
patients	O
with	O
acute	O
myocardial	O
infarction	O
.	O

It	O
was	O
found	O
that	O
the	O
primary	O
visual	O
cortex	O
of	O
the	O
rat	O
is	O
asymmetrical	O
in	O
volume	O
,	O
and	O
that	O
the	O
asymmetry	O
reflects	O
side	O
differences	O
in	O
the	O
number	O
of	O
neurons	O
.	O

Estimated	O
nucleic	O
acid	O
N	O
absorption	O
is	O
7	O
-	O
8	O
%	O
of	O
N	O
intake	O
.	O

However	O
,	O
further	O
analyses	O
of	O
the	O
data	O
indicate	O
that	O
increasing	O
VO2	O
AT	O
(	O
r	O
=	O
-0.63	O
,	O
P	O
less	O
than	O
0.05	O
)	O
rather	O
than	O
VO2max	O
(	O
r	O
=	O
-0.15	O
)	O
could	O
result	O
in	O
improving	O
the	O
10,000	O
m	O
race	O
performance	O
to	O
a	O
larger	O
extent	O
,	O
and	O
that	O
the	O
absolute	O
amount	O
of	O
change	O
(	O
delta	O
)	O
in	O
the	O
10,000	O
m	O
run	O
time	O
is	O
best	O
accounted	O
for	O
by	O
a	O
combination	O
of	O
delta	O
VO2	O
AT	O
and	O
delta	O
5,000	O
m	O
run	O
time	O
.	O

Liver	O
TG	O
and	O
serum	O
NEFA	O
concentrations	O
were	O
positively	O
correlated	O
.	O

Pharmacological	O
action	O
of	O
eptazocine	O
(	O
l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz	O
azonine	O
)	O
.	O

Failures	O
of	O
colorimetric	O
additivity	O
under	O
these	O
experimental	O
conditions	O
are	O
discussed	O
.	O

Further	O
investigations	O
are	O
necessary	O
to	O
elucidate	O
the	O
biochemical	O
and	O
physiological	O
properties	O
of	O
DLIS	O
.	O

Renal	O
clearance	O
fell	O
from	O
19.0	O
+	O
/-	O

4.9	O
ml	O
/	O
min	O
/	O
1.73	O
m2	O
(	O
group	O
I	O
)	O
to	O
1.0	O
+	O
/-	O

0.4	O
ml	O
/	O
min	O
/	O
1.73	O
m2	O
(	O
group	O
IV	O
)	O
.	O

The	O
mechanism	O
of	O
action	O
is	O
explored	O
in	O
some	O
detail	O
,	O
specifically	O
as	O
it	O
relates	O
to	O
reticuloendothelial	O
system	O
(	O
RES	O
)	O
Fc	B
receptor	I
blockade	O
and	O
suppression	O
of	O
antiplatelet	O
antibody	O
synthesis	O
.	O

We	O
analyzed	O
data	O
from	O
56	O
patients	O
with	O
Systemic	O
Lupus	O
Erythematosus	O
(	O
SLE	O
)	O
in	O
whom	O
renal	O
biopsies	O
were	O
done	O
systematically	O
.	O

The	O
possibility	O
of	O
a	O
hereditary	O
disorder	O
leading	O
to	O
a	O
minor	O
defect	O
in	O
elastic	O
fibre	O
structure	O
which	O
could	O
be	O
responsible	O
for	O
the	O
spontaneous	O
lesions	O
is	O
discussed	O
.	O

Seventeen	O
of	O
them	O
were	O
on	O
treatment	O
with	O
systemic	O
steroids	O
.	O

This	O
lack	O
of	O
correlation	O
may	O
be	O
due	O
to	O
variations	O
in	O
the	O
metabolic	O
activity	O
of	O
the	O
endometriotic	O
implants	O
present	O
at	O
different	O
stages	O
of	O
the	O
disease	O
.	O

Human	O
and	O
Chinese	B
hamster	I
S14	I
protein	I
sequences	I
deduced	O
from	O
the	O
cDNAs	O
are	O
identical	O
.	O

These	O
fusion	O
proteins	O
also	O
allowed	O
the	O
localization	O
of	O
the	O
transcriptional	O
activation	O
and	O
DNA	O
binding	O
domains	O
of	O
the	O
ToxR	B
protein	I
to	O
its	O
cytoplasmically	O
located	O
N	O
-	O
terminal	O
portion	O
.	O

The	O
risk	O
for	O
these	O
complications	O
is	O
increased	O
by	O
the	O
following	O
factors	O
:	O
multiple	O
gestation	O
,	O
the	O
combination	O
of	O
magnesium	O
sulfate	O
and	O
beta	O
-	O
adrenergic	O
agonist	O
,	O
and	O
the	O
use	O
of	O
adrenocortico	O
-	O
steroids	O
to	O
hasten	O
fetal	O
pulmonary	O
maturity	O
.	O

II	O
.	O

In	O
19	O
patients	O
vagotomy	O
not	O
only	O
curbed	O
the	O
bleeding	O
but	O
provided	O
definitive	O
therapy	O
(	O
Visick	O
I	O
-	O
II	O
)	O
;	O
4	O
patients	O
died	O
(	O
mortality	O
rate	O
16	O
%	O
)	O
.	O

A	O
retrospective	O
study	O
of	O
banked	O
sera	O
from	O
19	O
cats	O
with	O
the	O
eosinophilic	O
granuloma	O
complex	O
revealed	O
that	O
68	O
%	O
of	O
affected	O
cats	O
had	O
circulating	O
antibodies	O
to	O
components	O
of	O
normal	O
cat	O
epithelium	O
.	O

In	O
memory	O
of	O
Magdelaine	O
Comtesse	O

All	O
patients	O
had	O
elevated	O
levels	O
of	O
serum	B
IgE	I
antibodies	I
to	O
the	O
crude	O
soybean	O
extract	O
;	O
binding	O
values	O
ranged	O
from	O
2.3	O
to	O
28.1	O
times	O
that	O
of	O
a	O
negative	O
control	O
serum	O
.	O

Dual	O
radionuclide	O
subtraction	O
imaging	O
of	O
the	O
spleen	O
using	O
67Ga	O
citrate	O
and	O
99mTc	O
is	O
useful	O
in	O
further	O
delineating	O
lesions	O
that	O
are	O
identified	O
on	O
either	O
a	O
routine	O
radiogallium	O
survey	O
or	O
on	O
a	O
conventional	O
sulfur	O
colloid	O
liver	O
-	O
spleen	O
image	O
.	O

The	O
volume	O
of	O
blood	O
to	O
the	O
flap	O
ranges	O
from	O
1	O
to	O
2	O
ml	O
/	O
min	O
,	O
collateral	O
circulation	O
to	O
the	O
flap	O
exists	O
,	O
but	O
is	O
negligible	O
,	O
and	O
there	O
is	O
little	O
change	O
in	O
the	O
capillary	O
blood	O
flow	O
as	O
the	O
flap	O
ages	O
.	O

Laboratory	O
pyrolyses	O
have	O
indeed	O
shown	O
that	O
PCBs	O
give	O
significant	O
yields	O
of	O
PCDFs	O
,	O
and	O
chlorobenzenes	O
give	O
both	O
PCDFs	O
and	O
PCDDs	O
.	O

No	O
consistent	O
correlation	O
between	O
blood	O
pressure	O
change	O
and	O
SCR	O
-	O
change	O
was	O
seen	O
.	O

Piroxicam	O
produced	O
a	O
lower	O
incidence	O
of	O
gastric	O
ulcers	O
than	O
equivalent	O
doses	O
of	O
indomethacin	O
.	O

Since	O
1970	O
the	O
frequency	O
of	O
potassium	O
-	O
induced	O
ulceration	O
has	O
been	O
low--3	O
cases	O
per	O
100	O
000	O
patient	O
-	O
years	O
of	O
slow	O
-	O
release	O
tablet	O
use	O
.	O

Ultrastructure	O
of	O
the	O
heart	O
muscle	O
in	O
experimental	O
myocardial	O
infarct	O
following	O
physical	O
training	O

Pharmacological	O
desympathization	O
leads	O
to	O
the	O
development	O
of	O
hyper	O
-	O
reactivity	O
of	O
the	O
true	O
pacemakers	O
to	O
noradrenaline	O
and	O
dopamine	O
and	O
triggers	O
off	O
changes	O
in	O
the	O
regulation	O
of	O
the	O
electric	O
activity	O
of	O
these	O
cells	O
by	O
catecholamines	O
.	O

Vitiligo	O
in	O
diabetes	O
mellitus	O
.	O

The	O
pharmacokinetics	O
of	O
each	O
tetracycline	O
in	O
serum	O
and	O
dermal	O
,	O
suction	O
blister	O
fluid	O
were	O
determined	O
after	O
oral	O
doses	O
of	O
300	O
mg	O
lymecycline	O
or	O
100	O
mg	O
doxycycline	O
on	O
the	O
3rd	O
day	O
.	O

Either	O
a	O
UV	O
detector	O
set	O
at	O
268	O
nm	O
or	O
an	O
electrochemical	O
(	O
EC	O
)	O
detector	O
set	O
at	O
a	O
potential	O
of	O
+	O
0.9	O
V	O
(	O
versus	O
Ag	O
/	O
AgCl	O
/	O
3	O
M	O
NaCl	O
)	O
was	O
used	O
to	O
monitor	O
the	O
drug	O
.	O

The	O
mean	O
transfer	O
ratios	O
of	O
the	O
drug	O
into	O
the	O
genital	O
tissues	O
to	O
the	O
concentration	O
in	O
the	O
uterine	O
arterial	O
blood	O
were	O
such	O
that	O
the	O
transfer	O
ratio	O
into	O
the	O
portio	O
vaginalis	O
was	O
the	O
highest	O
,	O
followed	O
by	O
the	O
uterine	O
cervix	O
and	O
the	O
myometrium	O
,	O
and	O
that	O
into	O
the	O
oviduct	O
was	O
the	O
lowest	O
with	O
about	O
1	O
/	O
2	O
that	O
into	O
the	O
portio	O
vaginalis	O
.	O

Lower	O
extremity	O
weight	O
bearing	O
under	O
various	O
standing	O
conditions	O
in	O
independently	O
ambulatory	O
patients	O
with	O
hemiparesis	O
.	O

On	O
d	O
112	O
,	O
progesterone	O
was	O
higher	O
(	O
P	O
less	O
than	O
.05	O
)	O
in	O
hysterectomized	O
heifers	O
than	O
in	O
other	O
treatment	O
groups	O
.	O

Supraventricular	O
arrhythmias	O
--	O
digoxin	O
and	O
quinidine	O
revisited	O
.	O

Visidex	O
I	O
is	O
unsuitable	O
for	O
storage	O
and	O
re	O
-	O
reading	O
.	O

The	O
transit	O
time	O
was	O
significantly	O
shortened	O
.	O

Relations	O
between	O
cellular	O
electrical	O
activity	O
and	O
cardiac	O
mechanical	O
activity	O
in	O
man	O
,	O
the	O
dog	O
and	O
the	O
rabbit	O

Ultraviolet	O
light	O
-	O
induced	O
kinin	B
formation	O
in	O
human	O
skin	O
.	O

Prevention	O
of	O
maternal	O
Rh	O
sensitization	O
:	O
anti	B
-	I
Rh	I
immune	I
globulin	I
.	O

Enzyme	O
histochemical	O
findings	O
in	O
the	O
ultimobranchial	O
body	O
of	O
the	O
horse	O

Pre	B
-	I
beta-1	I
lipoprotein	I
and	O
early	O
detection	O
of	O
risk	O
factors	O
for	O
coronary	O
heart	O
disease	O
.	O

Absence	O
of	O
action	O
potentials	O
in	O
frog	O
slow	O
muscle	O
fibres	O
paralysed	O
by	O
botulinum	B
toxin	I
.	O

I.	O

Particles	O
resembling	O
microbodies	O
in	O
normal	O
and	O
neoplastic	O
perianal	O
glands	O
of	O
dogs	O
.	O

Problems	O
common	O
to	O
pediatrics	O
and	O
anesthesiology	O

Junctions	O
between	O
cells	O
of	O
the	O
human	O
enamel	O
organ	O
.	O

Taxonomically	O
significant	O
colour	O
changes	O
in	O
Brevibacterium	O
linens	O
probably	O
associated	O
with	O
a	O
carotenoid	O
-	O
like	O
pigment	O
.	O

A	O
short	O
history	O
of	O
dermatology	O
in	O
Lagos	O
,	O
Nigeria	O
.	O

Glucose	O
disappearance	O
rate	O
and	O
changes	O
in	O
plasma	O
nutrients	O
after	O
intravenouly	O
injected	O
glucose	O
in	O
normoglycaemic	O
and	O
hypoglycaemic	O
underweight	O
newborns	O
.	O

Normal	O
values	O
for	O
the	O
peripheral	O
blood	O
and	O
bone	O
marrow	O
of	O
the	O
grey	O
(	O
Armenian	O
)	O
hamster	O

Methyl	O
mercury	O
intoxication	O
in	O
rat	O
kidneys	O
.	O

Suppression	O
of	O
food	O
intake	O
in	O
the	O
rat	O
by	O
tung	O
oil	O
.	O

Change	O
in	O
the	O
makeup	O
of	O
the	O
blood	O
following	O
a	O
short	O
-	O
term	O
local	O
action	O
of	O
a	O
permanent	O
magnetic	O
field	O
on	O
the	O
human	O
body	O

Observations	O
on	O
saccules	O
of	O
rats	O
exposed	O
to	O
long	O
-	O
term	O
hypergravity	O
.	O

The	O
levels	O
of	O
galactosyltransferase	B
activity	O
in	O
sera	O
from	O
normal	O
children	O
and	O
patients	O
with	O
cystic	O
fibrosis	O
.	O

Effects	O
of	O
ionizing	O
radiation	O
in	O
the	O
human	O
oral	O
cavity	O
and	O
oropharynx	O
:	O
results	O
of	O
a	O
survey	O
.	O

Isolation	O
of	O
Proteus	O
vulgaris	O
MC-63	O
from	O
carcinoma	O
63	O
and	O
its	O
antitumor	O
effect	O
on	O
Crocker	O
sarcoma	O
180	O
and	O
Ehrlich	O
carcinoma	O
.	O

Heterogeneity	O
of	O
human	B
serum	I
albumin	I
.	O

Reactivities	O
to	O
horse	B
anti	I
-	I
lymphocyte	I
globulin	I
.	O

Relation	O
between	O
mixing	O
ratio	O
of	O
raw	O
materials	O
and	O
composition	O
of	O
products	O
in	O
the	O
synthesis	O
of	O
aluminosilicates	O

Sinusoidal	O
oscillations	O
of	O
a	O
gas	O
dilution	O
indicator	O

Studies	O
on	O
the	O
hereditary	O
nature	O
of	O
sole	O
prints	O
--	O
with	O
special	O
reference	O
to	O
interdigital	O
and	O
triradii	O

Successive	O
abdominal	O
scintillation	O
with	O
131-I	O
-	O
tagged	O
BSP	O
--	O
description	O
of	O
the	O
thyroid	O
gland	O
,	O
kidney	O
and	O
spleen	O
(	O
comparison	O
with	O
131-I	O
-	O
RB	O
)	O

Osteosarcoma	O
caused	O
by	O
3,4-benzopyrene	O

The	O
content	O
of	O
glucosamine	O
and	O
galactosamine	O
in	O
tartar	O

Relapse	O
of	O
leukemia	O
after	O
prolonged	O
remission	O
.	O

Influence	O
of	O
cigarette	O
smoking	O
on	O
some	O
blood	O
coagulation	O
tests	O
.	O

SAM	O
-	O
TR-68	O
-	O
54	O
.	O

Spinal	O
cord	O
representation	O
of	O
the	O
micturition	O
reflex	O
.	O

Pitfalls	O
in	O
the	O
use	O
of	O
chromosome	O
aberration	O
analysis	O
for	O
biological	O
radiation	O
dosimetry	O
.	O

Midge	O
control	O
in	O
flood	O
channels	O
.	O

The	O
effects	O
of	O
taloximine	O
and	O
aminophylline	O
on	O
isolated	O
human	O
smooth	O
muscle	O
.	O

The	O
exploratory	O
behaviour	O
in	O
normal	O
and	O
aggressive	O
mice	O
.	O

18F	O
and	O
85Sr	O
scintimetry	O
in	O
the	O
study	O
of	O
primary	O
arthropathies	O
.	O

Endocardial	O
fibro	O
-	O
elastosis	O
,	O
mitral	O
incompetence	O
,	O
and	O
coarctation	O
of	O
abdominal	O
aorta	O
.	O

The	O
significance	O
of	O
structural	O
integrity	O
of	O
lymphoid	O
tissue	O
for	O
antibody	O
production	O
in	O
culture	O
in	O
vivo	O

Hemodynamics	O
changes	O
in	O
man	O
during	O
flight	O

Automatic	O
view	O
box	O
.	O

I.	O

Experience	O
with	O
the	O
restoration	O
of	O
agglutination	O
properties	O
of	O
non	O
-	O
agglutinating	O
dysenterial	O
cultures	O
with	O
the	O
use	O
of	O
Rzhaninov	O
's	O
method	O

Study	O
on	O
the	O
evagination	O
of	O
Cysticercus	O
pisiformis	O
.	O

Compensatory	O
renal	O
hypertrophy	O
in	O
parabiotic	O
rats	O
.	O

In	O
vitro	O
evaluation	O
of	O
the	O
mucolytic	O
action	O
of	O
urea	O
.	O

Histogenetic	O
aspects	O
of	O
mesoblastic	O
nephroma	O
.	O

Upstream	O
activation	O
sites	O
of	O
the	O
CYC1	B
gene	I
of	O
Saccharomyces	O
cerevisiae	O
are	O
active	O
when	O
inverted	O
but	O
not	O
when	O
placed	O
downstream	O
of	O
the	O
""""	O
TATA	O
box	O
""""	O
.	O

Cardiac	O
taurine	O
levels	O
and	O
sarcolemmal	O
calcium	O
binding	O
activity	O
in	O
furazolidone	O
-	O
induced	O
cardiomyopathy	O
.	O

Separation	O
of	O
malaria	O
-	O
infected	O
erythrocytes	O
from	O
whole	O
blood	O
:	O
use	O
of	O
a	O
selective	O
high	O
-	O
gradient	O
magnetic	O
separation	O
technique	O
.	O

Brief	O
report	O
.	O

In	O
several	O
cases	O
of	O
definite	O
SjS	O
,	O
labial	O
salivary	O
gland	O
examinations	O
after	O
more	O
than	O
a	O
one	O
year	O
interval	O
were	O
performed	O
on	O
two	O
occasions	O
,	O
and	O
the	O
clinical	O
and	O
histopathological	O
changes	O
were	O
investigated	O
.	O

In	O
most	O
cases	O
of	O
acute	O
transmural	O
infarction	O
,	O
the	O
reciprocal	O
ST	O
segment	O
depressions	O
observed	O
in	O
contralateral	O
leads	O
are	O
less	O
marked	O
than	O
the	O
primary	O
ST	O
segment	O
elevations	O
.	O

No	O
direct	O
repeats	O
flank	O
the	O
pseudogene	O
in	O
the	O
U2	B
/	I
4	I
locus	I
.	O

Radioimmunoassay	O
of	O
serum	O
creatine	B
kinase	I
B	I
isoenzyme	I
in	O
the	O
diagnosis	O
of	O
acute	O
myocardial	O
infarction	O
.	O

Selective	O
macrophage	O
inhibition	O
abolishes	O
warfarin	O
-	O
induced	O
reduction	O
of	O
metastasis	O
.	O

A	O
haemolytic	O
enterotoxigenic	O
strain	O
of	O
E.	O
coli	O
(	O
O149	O
:	O
K88	O
:	O
H10	O
)	O
was	O
regularly	O
recovered	O
from	O
piglets	O
with	O
PWD	O
while	O
rotavirus	O
was	O
demonstrated	O
on	O
a	O
number	O
of	O
occasions	O
.	O

Restoration	O
of	O
impaired	O
immune	O
functions	O
in	O
aging	O
animals	O
.	O

Another	O
sequence	O
,	O
GGGXGGAG	O
,	O
which	O
is	O
repeated	O
several	O
times	O
in	O
many	O
polyomaviruses	O
and	O
adenoviruses	O
,	O
and	O
which	O
is	O
thought	O
to	O
play	O
a	O
role	O
in	O
DNA	O
replication	O
and/or	O
transcription	O
,	O
is	O
not	O
found	O
in	O
the	O
JCV	O
sequence	O
presented	O
.	O

I.	O

USA	O
80	O
,	O
802	O
-	O
806	O
]	O
was	O
used	O
to	O
isolate	O
a	O
genomic	O
clone	O
lambda	O
PGK-1	B
containing	O
a	O
portion	O
of	O
an	O
autosomal	O
locus	O
for	O
phosphoglycerate	B
kinase	I
(	O
PGK	B
)	O
.	O

A.	O

Frog	O
type	O
I	O
(	O
Ft	O
I	O
)	O
and	O
frog	O
type	O
II	O
(	O
Ft	O
II	O
)	O
slowly	O
adapting	O
(	O
SA	O
)	O
units	O
produced	O
spikes	O
only	O
at	O
the	O
indentation	O
phase	O
,	O
and	O
the	O
threshold	O
response	O
phase	O
(	O
TRP	O
)	O
,	O
i.e	O
..	O
the	O
phase	O
of	O
the	O
first	O
spike	O
was	O
for	O
ca	O
.	O

The	O
clinical	O
efficacy	O
rates	O
evaluated	O
in	O
151	O
cases	O
(	O
KS	O
-	O
R1	O
group	O
in	O
77	O
cases	O
,	O
oral	O
group	O
in	O
74	O
cases	O
)	O
on	O
standard	O
criteria	O
of	O
committee	O
members	O
were	O
88.3	O
%	O
for	O
the	O
KS	O
-	O
R1	O
group	O
and	O
86.5	O
%	O
for	O
the	O
oral	O
group	O
,	O
respectively	O
.	O

Martin	O
Luther	O
and	O
his	O
physicians	O
.	O

Renal	O
response	O
to	O
captopril	O
in	O
severe	O
heart	O
failure	O
:	O
role	O
of	O
furosemide	O
in	O
natriuresis	O
and	O
reversal	O
of	O
hyponatremia	O
.	O

EGV	O
had	O
no	O
detectable	O
effect	O
on	O
PP	B
secretion	O
under	O
basal	O
or	O
stimulated	O
conditions	O
.	O

Lung	O
prostacyclin	O
production	O
may	O
be	O
related	O
to	O
flow	O
.	O

For	O
the	O
first	O
30	O
min	O
following	O
insulin	B
administration	O
,	O
the	O
rate	O
of	O
change	O
in	O
glucose	O
levels	O
was	O
significantly	O
less	O
among	O
the	O
patients	O
with	O
major	O
depressive	O
disorder	O
than	O
among	O
either	O
the	O
patients	O
with	O
dysthymic	O
disorder	O
or	O
the	O
normal	O
control	O
subjects	O
.	O

Urease	B
activity	O
of	O
97	O
%	O
of	O
these	O
organisms	O
became	O
evident	O
within	O
30	O
min	O
.	O

Regional	O
CBF	O
was	O
determined	O
by	O
clearance	O
of	O
xenon	O
133	O
in	O
67	O
patients	O
undergoing	O
coronary	O
bypass	O
grafting	O
procedures	O
.	O

Cardiovascular	O
and	O
adrenal	O
medullo	O
-	O
sympathetic	O
reactions	O
to	O
acute	O
tobacco	O
poisoning	O

Exposure	O
of	O
endothelium	O
to	O
pulsatile	O
shear	O
stresses	O
that	O
followed	O
a	O
tape	O
recording	O
of	O
physiological	O
flow	O
waveforms	O
(	O
electromagnetic	O
flowmeter	O
)	O
did	O
not	O
cause	O
gross	O
injury	O
or	O
denudation	O
even	O
when	O
peak	O
shear	O
exceeded	O
1500	O
dyne	O
/	O
cm2	O
.	O

Hydrocortisone	O
seems	O
to	O
be	O
unable	O
to	O
hinder	O
the	O
postdenervation	O
changes	O
in	O
the	O
muscle	O
membrane	O
whereas	O
high	O
doses	O
of	O
the	O
hormone	O
are	O
able	O
to	O
induce	O
changes	O
in	O
the	O
muscle	O
membrane	O
.	O

Salivary	O
estradiol	O
17	O
beta	O
(	O
E2	O
-	O
17	O
beta	O
)	O
and	O
progesterone	O
(	O
P	O
)	O
were	O
determined	O
by	O
using	O
radioimmunoassay	O
techniques	O
in	O
30	O
pregnant	O
females	O
in	O
the	O
first	O
,	O
second	O
and	O
third	O
trimesters	O
as	O
well	O
as	O
in	O
10	O
non	O
-	O
pregnant	O
controls	O
during	O
the	O
luteal	O
phase	O
of	O
the	O
menstrual	O
cycle	O
.	O

Variable	O
FHR	O
decelerations	O
or	O
bradycardias	O
were	O
encountered	O
on	O
95	O
nonstress	O
tests	O
(	O
18.8	O
%	O
)	O
in	O
80	O
(	O
33.5	O
%	O
)	O
postdate	O
patients	O
.	O

The	O
response	O
chain	O
in	O
each	O
component	O
was	O
maintained	O
by	O
food	O
presentation	O
under	O
a	O
fixed	O
-	O
ratio	O
schedule	O
.	O

This	O
machine	O
drift	O
,	O
which	O
was	O
not	O
associated	O
with	O
a	O
rise	O
in	O
water	O
phantom	O
temperature	O
and	O
did	O
not	O
consistently	O
correlate	O
with	O
estimated	O
x	O
-	O
ray	O
tube	O
heat	O
,	O
could	O
result	O
in	O
a	O
significant	O
overestimation	O
of	O
regional	O
cerebral	O
blood	O
flow	O
(	O
rCBF	O
)	O
for	O
a	O
xenon	O
/	O
CT	O
rCBF	O
protocol	O
involving	O
5	O
-	O
7	O
sequential	O
scans	O
obtained	O
at	O
1-min	O
interscan	O
intervals	O
.	O

Reaction	O
of	O
human	O
organism	O
to	O
exercise	O
.	O

HA	O
resulted	O
in	O
decreased	O
(	O
p	O
less	O
than	O
0.05	O
)	O
Tre	O
(	O
0.4	O
degrees	O
C	O
)	O
and	O
HR	O
(	O
17	O
b	O
X	O
min-1	O
)	O
,	O
and	O
increased	O
(	O
p	O
less	O
than	O
0.05	O
)	O
Msw	O
(	O
16	O
g	O
X	O
m-2	O
X	O
h-1	O
)	O
during	O
the	O
saline	O
experiments	O
.	O

We	O
conclude	O
that	O
administration	O
of	O
the	O
calcium	O
antagonist	O
Verapamil	O
is	O
of	O
no	O
additional	O
value	O
in	O
tocolytic	O
treatment	O
with	O
beta	O
-	O
mimetics	O
.	O

During	O
a	O
single	O
LAD	O
occlusion	O
lasting	O
35	O
minutes	O
(	O
series	O
I	O
,	O
n	O
=	O
10	O
)	O
9	O
microns	O
TMs	O
were	O
infused	O
immediately	O
and	O
30	O
minutes	O
after	O
ligation	O
,	O
15	O
microns	O
TMs	O
being	O
infused	O
after	O
15	O
-	O
20	O
minutes	O
.	O

Brain	O
pH	O
following	O
3	O
h	O
of	O
cerebral	O
focal	O
ischemia	O
changed	O
from	O
a	O
normal	O
value	O
of	O
7.0	O
to	O
6.5	O
and	O
6.2	O
in	O
animals	O
studied	O
under	O
barbiturate	O
and	O
halothane	O
anesthesia	O
,	O
respectively	O
.	O

After	O
clofelin	O
administration	O
the	O
autoregulation	O
borders	O
shifted	O
to	O
the	O
right	O
i.	O
e.	O
towards	O
higher	O
AP	O
levels	O
.	O

Angionephroscintigraphy	O
in	O
the	O
diagnosis	O
of	O
diseases	O
of	O
the	O
kidney	O

Serum	O
lipids	O
and	O
lipoproteins	O
of	O
29	O
insulin	B
dependent	O
diabetic	O
children	O
have	O
been	O
determined	O
and	O
related	O
to	O
the	O
metabolic	O
status	O
of	O
the	O
patients	O
.	O

Out	O
of	O
these	O
families	O
74,3	O
%	O
planned	O
next	O
pregnancy	O
(	O
table	O
IX	O
)	O
,	O
57,6	O
%	O
wanted	O
to	O
have	O
prenatal	O
diagnosis	O
(	O
table	O
VI	O
)	O
.	O

Dipetalonema	O
(	O
Alafilaria	O
)	O
hydrochoerus	O
subgen	O
.	O

et	O
sp.	O
n.	O

Despite	O
total	O
tumor	O
resection	O
,	O
multiple	O
intraperitoneal	O
tumor	O
nodules	O
of	O
varying	O
sizes	O
were	O
found	O
and	O
resected	O
six	O
months	O
and	O
one	O
year	O
later	O
.	O

Additionally	O
,	O
observations	O
that	O
patients	O
with	O
mitral	O
versus	O
aortic	O
regurgitation	O
respond	O
differently	O
to	O
valve	O
replacement	O
suggest	O
that	O
differences	O
exist	O
preoperatively	O
between	O
these	O
two	O
types	O
of	O
volume	O
overload	O
.	O

Is	O
nisoldipine	O
capable	O
of	O
reducing	O
left	O
ventricular	O
preload	O
?	O

In	O
ten	O
anesthetized	O
pigs	O
,	O
nisoldipine	O
(	O
2	O
-	O
4	O
micrograms	O
X	O
kg-1	O
X	O
min-1	O
)	O
,	O
a	O
calcium	O
channel	O
blocker	O
structurally	O
related	O
to	O
nifedipine	O
,	O
reduced	O
left	O
ventricular	O
systolic	O
pressure	O
(	O
40	O
%	O
)	O
and	O
systemic	O
vascular	O
resistance	O
(	O
35	O
%	O
)	O
,	O
whereas	O
maxLVdP	O
/	O
dt	O
decreased	O
by	O
20	O
%	O
and	O
cardiac	O
output	O
was	O
unchanged	O
.	O

The	O
importance	O
of	O
selective	O
renal	O
vein	O
phlebography	O
in	O
the	O
evaluation	O
of	O
unexplained	O
hematuria	O
and	O
filing	O
defects	O
in	O
the	O
excretory	O
urogram	O
is	O
illustrated	O
.	O

The	O
pyramidal	O
tract	O
and	O
Mesencephalic	O
Reticular	O
Formation	O
(	O
MRF	O
)	O
were	O
stimulated	O
before	O
and	O
after	O
the	O
transection	O
.	O

There	O
is	O
now	O
a	O
significative	O
difference	O
between	O
age	O
group	O
1	O
-	O
5	O
and	O
the	O
others	O
(	O
p	O
Less	O
Than	O
0,02	O
)	O
.	O

The	O
sympathetic	O
neuroeffector	O
influence	O
on	O
the	O
myocardium	O
with	O
ATCI	O
depends	O
to	O
a	O
large	O
measure	O
on	O
the	O
intensity	O
of	O
the	O
neurotransmitter	O
biosynthesis	O
and	O
function	O
of	O
cardiomyocyte	O
adrenoreceptors	O
.	O

In	O
silicosis	O
,	O
significant	O
relationships	O
between	O
patients	O
and	O
sons	O
were	O
not	O
seen	O
with	O
respect	O
to	O
arterial	O
blood	O
gas	O
determinations	O
and	O
ventilatory	O
responses	O
except	O
for	O
Paco2	O
of	O
patients	O
and	O
hypercapnic	O
ventilatory	O
responses	O
of	O
sons	O
.	O

This	O
study	O
was	O
designed	O
to	O
assess	O
and	O
compare	O
the	O
ability	O
of	O
three	O
different	O
forms	O
of	O
DSG	O
to	O
block	O
EIB	O
.	O

Many	O
of	O
these	O
landfill	O
operations	O
were	O
undertaken	O
in	O
the	O
early	O
1950s	O
and	O
1960s	O
,	O
when	O
knowledge	O
regarding	O
the	O
safe	O
and	O
prolonged	O
containment	O
of	O
the	O
waste	O
buried	O
was	O
nonexistent	O
or	O
minimal	O
at	O
best	O
.	O

Acute	O
type	O
A	O
hepatitis	O
in	O
three	O
patients	O
with	O
chronic	O
HBV	O
infection	O
.	O

Echosismography	O
enables	O
to	O
improve	O
the	O
diagnosis	O
when	O
compared	O
with	O
classical	O
sonography	O
in	O
about	O
20	O
%	O
of	O
cases	O
.	O

A	O
reassessment	O
of	O
the	O
prevalence	O
data	O
was	O
carried	O
out	O
in	O
the	O
southern	O
province	O
of	O
Uusimaa	O
and	O
in	O
the	O
western	O
province	O
of	O
Vaasa	O
,	O
the	O
prevalence	O
day	O
being	O
January	O
1	O
,	O
1979	O
.	O

In	O
visible	O
tumours	O
the	O
best	O
results	O
were	O
obtained	O
with	O
FB	O
(	O
85	O
%	O
)	O
while	O
TBN	O
was	O
positive	O
in	O
65	O
%	O
.	O

Alveolar	O
growth	O
,	O
contemporary	O
with	O
dental	O
eruption	O
,	O
is	O
sufficient	O
to	O
compensate	O
possible	O
hypotrophy	O
of	O
maxillary	O
bone	O
bases	O
.	O

Correlation	O
between	O
intraocular	O
involvement	O
and	O
systemic	O
outcome	O
was	O
poor	O
.	O

At	O
necropsy	O
28	O
days	O
post	O
-	O
inoculation	O
,	O
F344	O
rats	O
had	O
no	O
gross	O
lung	O
lesions	O
,	O
even	O
those	O
given	O
the	O
maximum	O
dose	O
of	O
1.4	O
X	O
10	O
(	O
9	O
)	O
colony	O
-	O
forming	O
units	O
of	O
M.	O
pulmonis	O
.	O

Aneurysmectomy	O
and	O
the	O
performance	O
of	O
CABG	O
were	O
not	O
significantly	O
associated	O
with	O
postoperative	O
ECG	O
changes	O
,	O
but	O
more	O
bypass	O
grafts	O
per	O
patient	O
grafted	O
appeared	O
in	O
the	O
group	O
with	O
postoperative	O
ECG	O
changes	O
,	O
suggesting	O
that	O
coronary	O
artery	O
disease	O
may	O
be	O
more	O
severe	O
in	O
that	O
group	O
.	O

Contractile	O
responses	O
to	O
norepinephrine	O
,	O
serotonin	O
and	O
potassium	O
(	O
K+	O
)	O
and	O
relaxant	O
responses	O
to	O
isoproterenol	O
and	O
papaverine	O
were	O
studied	O
in	O
vitro	O
with	O
spirally	O
cut	O
thoracic	O
aortic	O
strips	O
from	O
aortic	O
coarcted	O
hypertensive	O
rats	O
(	O
AHR	O
)	O
2	O
,	O
6	O
,	O
14	O
and	O
28	O
days	O
postoperatively	O
and	O
compared	O
to	O
time	O
-	O
matched	O
,	O
sham	O
-	O
operated	O
normotensive	O
controls	O
.	O

In	O
the	O
diabetics	O
,	O
Ca2	O
+	O
infusions	O
induced	O
a	O
rise	O
of	O
plasma	O
Ca2	O
+	O
up	O
to	O
3.2	O
+	O
/-	O

0.1	O
mmol	O
/	O
1	O
and	O
a	O
fall	O
of	O
circulating	O
glucagon	B
(	O
-26.4	O
+	O
/-	O

5.7	O
%	O
;	O
p	O
less	O
than	O
0.001	O
)	O
and	O
glucose	O
(	O
-23.3	O
+	O
/-	O

3.6	O
%	O
;	O
p	O
less	O
than	O
0.05	O
)	O
.	O

Rats	O
underwent	O
either	O
a	O
90	O
-	O
95	O
%	O
JIB	O
or	O
a	O
sham	O
operation	O
.	O

Large	O
and	O
small	O
medullary	O
lesions	O
inhibited	O
the	O
occurrence	O
of	O
target	O
fibres	O
in	O
the	O
tenotomized	O
muscles	O
,	O
the	O
smallest	O
one	O
being	O
neurolysis	O
of	O
the	O
dorsal	O
roots	O
.	O

Selenium	O
status	O
of	O
thoroughbreds	O
in	O
the	O
United	O
Kingdom	O
.	O

These	O
results	O
suggested	O
the	O
possibility	O
that	O
the	O
fetus	O
played	O
some	O
role	O
in	O
the	O
production	O
of	O
E3	O
-	O
16-G	O
in	O
early	O
pregnancy	O
.	O

This	O
study	O
demonstrates	O
secretion	O
of	O
bicarbonate	O
by	O
the	O
human	O
stomach	O
in	O
vivo	O
at	O
a	O
rate	O
equivalent	O
to	O
10	O
-	O
-20	O
%	O
of	O
basal	O
acid	O
secretion	O
.	O

The	O
tetraphasic	O
action	O
of	O
lidocaine	O
on	O
CNS	O
electrical	O
activity	O
and	O
behavior	O
in	O
cats	O
.	O

The	O
favourable	O
effect	O
of	O
thymic	O
shielding	O
was	O
also	O
reflected	O
in	O
a	O
significant	O
increase	O
of	O
LD50	O
/	O
30	O
,	O
and	O
the	O
dose	O
reduction	O
factor	O
was	O
equal	O
to	O
2	O
.	O

Mastocytosis	O
.	O

TCZ	O
provides	O
quick	O
,	O
inexpensive	O
,	O
noninvasive	O
indication	O
of	O
tissue	O
necrosis	O
,	O
moderate	O
-	O
to	O
-	O
severe	O
intracranial	O
hemorrhage	O
,	O
and	O
delayed	O
brain	O
maturation	O
.	O

Adverse	O
reaction	O
of	O
the	O
apparently	O
healthy	O
partner	O
in	O
response	O
to	O
improvement	O
in	O
the	O
overtly	O
dysfunctional	O
partner	O
.	O

Since	O
only	O
58	O
%	O
of	O
our	O
sample	O
could	O
be	O
adequately	O
classified	O
with	O
one	O
diagnosis	O
,	O
we	O
expect	O
that	O
the	O
ASDC	O
nosology	O
will	O
need	O
to	O
evolve	O
further	O
.	O

Static	O
lung	O
function	O
in	O
puppies	O
after	O
pneumonectomy	O
.	O

Current	O
status	O
of	O
chemotherapy	O
for	O
Hodgkin	O
's	O
disease	O

In	O
Group	O
V	O
,	O
the	O
salvaged	O
tissue	O
was	O
primarily	O
subepicardial	O
with	O
virtually	O
no	O
lateral	O
zone	O
of	O
salvaged	O
tissue	O
(	O
ratio	O
of	O
salvaged	O
subepicardium	O
to	O
salvaged	O
subendocardium	O
14.8	O
+	O
/-	O

1.9	O
to	O
1	O
)	O
.	O

Responses	O
to	O
brainstem	O
of	O
nuclei	O
medialis	O
dorsalis	O
,	O
lateralis	O
posterior	O
were	O
of	O
considerably	O
longer	O
latency	O
.	O

A	O
simplified	O
thin	O
-	O
layer	O
chromatographic	O
determination	O
of	O
hippuric	O
acid	O
and	O
methylhippuric	O
acids	O
.	O

MSMS	O
Council	O
hears	O
new	O
public	O
health	O
director	O
.	O

Twenty	O
patients	O
aged	O
45	O
or	O
older	O
with	O
the	O
diagnosis	O
of	O
endogenous	O
depression	O
were	O
evaluated	O
in	O
terms	O
of	O
safety	O
and	O
efficacy	O
in	O
their	O
response	O
to	O
multiple	O
monitored	O
electroconvulsive	O
therapy	O
(	O
MMECT	O
)	O
versus	O
single	O
electroconvulsive	O
therapy	O
(	O
SECT	O
)	O
.	O

Tests	O
of	O
the	O
method	O
indicate	O
(	O
1	O
)	O
the	O
Mossbauer	O
source	O
can	O
be	O
placed	O
on	O
the	O
basilar	O
membrane	O
without	O
altering	O
the	O
signal	O
-	O
transmission	O
properties	O
of	O
the	O
cochlea	O
,	O
and	O
(	O
2	O
)	O
the	O
source	O
adheres	O
to	O
the	O
basilar	O
membrane	O
.	O

Importance	O
of	O
determining	O
the	O
blood	O
sulfhydryl	O
groups	O
in	O
fractures	O
of	O
the	O
long	O
tubular	O
bones	O
complicated	O
by	O
infection	O

The	O
ability	O
of	O
sodium	O
phenobarbital	O
(	O
60	O
mg	O
/	O
kg	O
)	O
and	O
sodium	O
barbital	O
(	O
80	O
mg	O
/	O
kg	O
)	O
to	O
produce	O
a	O
taste	O
aversion	O
in	O
23	O
hr	O
fluid	O
deprived	O
rats	O
was	O
examined	O
using	O
a	O
discrimination	O
or	O
two	O
bottle	O
taste	O
aversion	O
task	O
(	O
0.125	O
%	O
sodium	O
saccharin	O
solution	O
or	O
water	O
)	O
.	O

In	O
spite	O
of	O
this	O
and	O
other	O
complications	O
of	O
corticosteroids	O
,	O
she	O
made	O
a	O
full	O
recovery	O
from	O
the	O
fungal	O
infection	O
following	O
treatment	O
with	O
amphotericin	O
B	O
and	O
surgical	O
excision	O
of	O
the	O
lung	O
abscess	O
.	O

Marked	O
sedative	O
activity	O
was	O
observed	O
with	O
9-methoxy-5-phenylpyrrolo	O
[	O
2,1-d	O
]	O
[	O
1,5	O
]	O
benzothiazepin-6,6-dioxide	O
(	O
NF19	O
)	O
and	O
9-chloro-5-p	O
-	O
nitrophenylpyrrolo	O
[	O
2,1-d	O
]	O
[	O
1,5	O
]	O
benzothiazepin-6,6-dioxide	O
(	O
NF20	O
)	O
.	O

The	O
potentially	O
SLE	O
-	O
inducing	O
drugs	O
are	O
reviewed	O
.	O

EUK-8	O
is	O
a	O
novel	O
,	O
synthetic	O
,	O
low	O
-	O
molecular	O
-	O
weight	O
salen	O
-	O
manganese	O
complex	O
that	O
exhibits	O
both	O
superoxide	B
dismutase	I
and	O
catalase	B
activities	O
in	O
vitro	O
.	O

Patients	O
with	O
psychotropic	O
drugs	O
showed	O
significantly	O
higher	O
PRL	B
levels	O
.	O

BSE	O
and	O
farmworkers	O
.	O

Considerably	O
high	O
levels	O
of	O
IgE	B
antibodies	I
was	O
also	O
established	O
while	O
other	O
pollens	O
did	O
not	O
show	O
such	O
correspondence	O
.	O

This	O
is	O
particularly	O
intriguing	O
because	O
SKUT-1B-20	O
cells	O
lack	O
the	O
transcription	O
factor	O
Pit-1	B
.	O

The	O
number	O
of	O
lactotropes	O
,	O
somatotropes	O
,	O
thyrotropes	O
,	O
and	O
gonadotropes	O
was	O
not	O
altered	O
compared	O
with	O
controls	O
,	O
indicating	O
that	O
in	O
the	O
adult	O
pituitary	O
,	O
POMC	B
products	I
are	O
not	O
required	O
to	O
maintain	O
the	O
distribution	O
of	O
cell	O
types	O
.	O

Correlation	O
coefficients	O
between	O
the	O
reference	O
methods	O
and	O
NIT	O
were	O
>	O
or	O
=	O
0.95	O
for	O
water	O
,	O
fat	O
,	O
crude	O
protein	O
and	O
connective	O
-	O
tissue	O
-	O
protein	O
frei	O
meat	O
protein	O
,	O
and	O
>	O
or	O
=	O
0.86	O
for	O
connective	O
-	O
tissue	O
-	O
protein	O
.	O

Histopathologic	O
observations	O
showed	O
that	O
both	O
somatostatin	B
and	O
triamcinolone	O
acetonide	O
reduced	O
the	O
inflammatory	O
signs	O
in	O
the	O
joint	O
structures	O
,	O
although	O
triamcinolone	O
acetonide	O
appeared	O
to	O
be	O
more	O
effective	O
.	O

Preferential	O
heterodimeric	O
parallel	O
coiled	O
-	O
coil	O
formation	O
by	O
synthetic	B
Max	I
and	O
c	B
-	I
Myc	I
leucine	I
zippers	I
:	O
a	O
description	O
of	O
putative	O
electrostatic	O
interactions	O
responsible	O
for	O
the	O
specificity	O
of	O
heterodimerization	O
.	O

These	O
results	O
demonstrate	O
that	O
tip	B
acts	O
at	O
an	O
early	O
stage	O
of	O
the	O
T	O
-	O
cell	O
signal	O
transduction	O
cascade	O
by	O
associating	O
with	O
Lck	B
and	O
downregulating	O
Lck	O
-	O
mediated	O
activation	O
.	O

As	O
hGM	B
-	I
CSF	I
receptor	I
(	O
hGMR	B
)	O
does	O
not	O
contain	O
a	O
consensus	O
sequence	O
for	O
binding	O
of	O
PI	B
3-kinase	I
,	O
hGMR	B
must	O
use	O
a	O
distinct	O
mechanism	O
for	O
its	O
association	O
with	O
and	O
activation	O
of	O
PI	B
3-kinase	I
.	O

Therefore	O
,	O
we	O
studied	O
ninety	O
coagulopathic	O
patients	O
with	O
the	O
aim	O
of	O
determining	O
the	O
prevalence	O
of	O
hepatitis	B
C	I
virus	I
(	I
HCV	I
)	I
antibodies	I
using	O
the	O
ELISA	O
and	O
RIBA	O
methods	O
.	O

Hepatitis	B
B	I
surface	I
antigen	I
was	O
detected	O
in	O
2	O
patients	O
,	O
with	O
negative	O
hepatitis	B
C	I
virus	I
antibody	I
.	O

Liver	O
transplantation	O
in	O
one	O
patient	O
resolved	O
metabolic	O
complications	O
but	O
did	O
not	O
improve	O
PMN	O
count	O
or	O
the	O
infectious	O
status	O
,	O
while	O
neutropenia	O
was	O
corrected	O
by	O
G	B
-	I
CSF	I
.	O

Activation	O
of	O
the	O
SH2-containing	B
protein	I
tyrosine	I
phosphatase	I
,	O
SH	B
-	I
PTP2	I
,	O
by	O
phosphotyrosine	O
-	O
containing	O
peptides	O
derived	O
from	O
insulin	B
receptor	I
substrate-1	I
.	O

Tyrosine	O
phosphorylation	O
of	O
cellular	O
proteins	O
is	O
the	O
earliest	O
identifiable	O
event	O
following	O
T	B
-	I
cell	I
antigen	I
receptor	I
(	O
TCR	B
)	O
stimulation	O
and	O
is	O
essential	O
for	O
activating	O
downstream	O
signaling	O
machinery	O
.	O

Microvessels	O
were	O
counted	O
in	O
a	O
x200	O
field	O
(	O
0.754	O
mm2	O
)	O
in	O
the	O
area	O
of	O
maximal	O
angiogenesis	O
.	O

Pharmacological	O
and	O
pharmacokinetic	O
characteristics	O
of	O
the	O
non	O
-	O
ionic	O
monomeric	O
X	O
-	O
ray	O
contrast	O
agent	O
iopromide	O
(	O
Ultravist	O
,	O
CAS	O
73334	O
-	O
07	O
-	O
3	O
)	O
were	O
evaluated	O
in	O
preclinical	O
studies	O
.	O

In	O
this	O
paper	O
we	O
report	O
that	O
ligand	O
binding	O
induced	O
tyrosine	O
phosphorylation	O
in	O
BaF3	O
cells	O
engineered	O
to	O
express	O
the	O
murine	B
Mpl	I
receptor	I
(	O
BaF3	O
/	O
mMpl	B
)	O
.	O

To	O
identify	O
critical	O
regions	O
mediating	O
growth	O
signal	O
transduction	O
by	O
hG	B
-	I
CSFR	I
,	O
deletions	O
or	O
site	O
-	O
directed	O
amino	O
acid	O
substitutions	O
were	O
introduced	O
into	O
the	O
cytoplasmic	O
domain	O
of	O
hG	B
-	I
CSFR	I
,	O
and	O
the	O
mutant	O
cDNAs	O
were	O
transfected	O
into	O
the	O
murine	B
interleukin-3	I
(	O
IL-3	B
)	O
-dependent	O
Ba	O
/	O
F3	O
and	O
FDCP	O
cell	O
lines	O
.	O

The	O
fusion	O
proteins	O
were	O
tested	O
by	O
ELISA	O
for	O
reactivity	O
with	O
a	O
panel	O
of	O
human	B
anti	I
-	I
La	I
sera	I
in	O
order	O
to	O
define	O
the	O
nature	O
of	O
the	O
epitopes	O
.	O

Our	O
results	O
suggest	O
that	O
protein	O
binding	O
to	O
the	O
E2F	B
-	I
like	I
sequences	I
may	O
act	O
to	O
reduce	O
expression	O
.	O

The	O
optimal	O
care	O
of	O
CHF	O
patient	O
includes	O
the	O
recognition	O
and	O
management	O
of	O
these	O
electrolyte	O
disturbances	O
.	O

METHODS	O
:	O
rHb1.1	B
or	O
human	B
serum	I
albumin	I
was	O
administered	O
intravenously	O
to	O
fasting	O
male	O
volunteers	O
.	O

Several	O
different	O
oncogenes	O
and	O
growth	O
factors	O
promote	O
G1	O
phase	O
progression	O
.	O

The	O
chloramphenicol	B
-	I
resistance	I
transposon	I
Tn4451	B
undergoes	O
precise	O
conjugative	O
deletion	O
from	O
its	O
parent	O
plasmid	O
plP401	O
in	O
Clostridium	O
perfringens	O
and	O
precise	O
spontaneous	O
excision	O
from	O
multicopy	O
plasmids	O
in	O
Escherichia	O
coli	O
.	O

Deletions	O
were	O
examined	O
in	O
the	O
LYS2	B
gene	I
,	O
using	O
a	O
set	O
of	O
31-	O
to	O
156-bp	O
inserts	O
that	O
included	O
inserts	O
with	O
no	O
apparent	O
potential	O
for	O
secondary	O
structure	O
as	O
well	O
as	O
two	O
quasipalindromes	O
.	O

The	O
hydropathy	O
plot	O
revealed	O
a	O
rather	O
hydrophilic	O
N	O
-	O
terminal	O
region	O
and	O
the	O
absence	O
of	O
a	O
hydrophobic	O
signal	O
peptide	O
.	O

All	O
carcasses	O
resulted	O
in	O
contamination	O
with	O
aerobic	O
mesophilic	O
bacteria	O
in	O
the	O
range	O
from	O
6	O
x	O
10	O
(	O
3	O
)	O
to	O
1.2	O
x	O
10	O
(	O
6	O
)	O
CFU	O
/	O
ml	O
liquid	O
washed	O
,	O
and	O
94	O
%	O
them	O
with	O
sporulate	O
bacteria	O
,	O
the	O
threshold	O
being	O
under	O
100	O
CFU	O
/	O
ml	O
(	O
Figure	O
1	O
)	O
.	O

The	O
debate	O
over	O
electives--1899	O
.	O

The	O
effects	O
of	O
Codonopsis	O
pilosula	O
oral	O
liquor	O
(	O
CPOL	O
)	O
on	O
tissue	B
-	I
type	I
plasminogen	I
activator	I
(	O
t	B
-	I
PA	I
)	O
and	O
plasminogen	B
activator	I
inhibitor	I
(	O
PAI	B
)	O
in	O
the	O
plasma	O
of	O
25	O
patients	O
of	O
coronary	O
heart	O
disease	O
with	O
blood	O
stasis	O
were	O
studied	O
.	O

We	O
also	O
isolated	O
two	O
alternatively	O
spliced	O
forms	O
of	O
human	B
CD6	I
cDNA	I
lacking	O
sequences	O
encoding	O
membrane	O
-	O
proximal	O
regions	O
of	O
the	O
cytoplasmic	O
domain	O
which	O
maintain	O
the	O
same	O
reading	O
frame	O
as	O
CD6-PB1	B
.	O

The	O
average	O
values	O
were	O
199	O
and	O
424	O
revertants	O
/	O
g	O
for	O
the	O
hamburgers	O
and	O
hot	O
dogs	O
,	O
respectively	O
.	O

Another	O
common	O
mutation	O
involved	O
amino	O
acids	O
that	O
are	O
thought	O
to	O
make	O
specific	O
contacts	O
with	O
DNA	O
.	O

Altogether	O
our	O
data	O
indicate	O
that	O
PEDF	B
belongs	O
to	O
the	O
subgroup	O
of	O
noninhibitory	O
serpins	B
and	O
that	O
its	O
N	O
-	O
terminal	O
region	O
confers	O
a	O
neurite	O
-	O
promoting	O
activity	O
to	O
the	O
protein	O
.	O

We	O
conclude	O
that	O
this	O
new	O
measurement	O
technique	O
provides	O
an	O
easy	O
and	O
accurate	O
P0.1	O
measurement	O
using	O
standard	O
respiratory	O
equipment	O
when	O
tested	O
in	O
a	O
lung	O
model	O
.	O

After	O
cells	O
were	O
stably	O
transfected	O
with	O
CIITA	B
,	O
endogenous	O
MHC	B
class	I
II	I
genes	I
were	O
constitutively	O
expressed	O
,	O
and	O
MHC	B
class	I
II	I
promoters	I
,	O
delivered	O
by	O
transfection	O
,	O
were	O
actively	O
transcribed	O
in	O
CIITA	B
-	O
expressing	O
cells	O
.	O

Mean	O
growth	O
changes	O
in	O
this	O
Class	O
II	O
sample	O
were	O
comparable	O
to	O
those	O
previously	O
reported	O
for	O
male	O
subjects	O
with	O
Class	O
I	O
malocclusions	O
over	O
the	O
same	O
age	O
period	O
,	O
suggesting	O
a	O
similarity	O
in	O
postpubertal	O
development	O
between	O
these	O
two	O
groups	O
.	O

In	O
this	O
report	O
,	O
we	O
describe	O
the	O
characterization	O
of	O
two	O
early	O
class	B
II	I
flagellar	I
genes	I
contained	O
in	O
the	O
orfX	O
-	O
fliP	B
locus	O
.	O

To	O
discern	O
whether	O
these	O
disorders	O
of	O
GnRH	B
deficiency	O
are	O
associated	O
with	O
altered	O
melatonin	O
secretion	O
profiles	O
,	O
we	O
compared	O
untreated	O
young	O
males	O
IGD	O
(	O
n	O
=	O
7	O
)	O
and	O
DP	O
(	O
n	O
=	O
7	O
)	O
to	O
normal	O
pubertal	O
male	O
controls	O
(	O
n	O
=	O
6	O
)	O
.	O

Oncological	O
,	O
clinical	O
and	O
psychological	O
aspects	O
are	O
evaluated	O
according	O
to	O
experience	O
accumulated	O
in	O
recent	O
years	O
,	O
with	O
immediate	O
and	O
delayed	O
reconstruction	O
,	O
carried	O
out	O
in	O
the	O
most	O
diverse	O
specialized	O
centers	O
.	O

Basal	O
promoter	O
activity	O
is	O
enhanced	O
by	O
a	O
functional	O
M1	O
domain	O
in	O
LHR	B
-	O
expressing	O
mouse	O
Leydig	O
tumor	O
cells	O
(	O
MLTC	O
)	O
but	O
not	O
in	O
non	O
-	O
expressing	O
CHO	O
cells	O
.	O

CCAAT	B
/	I
enhancer	I
-	I
binding	I
protein	I
isoforms	I
beta	I
and	I
delta	I
are	O
expressed	O
in	O
mammary	O
epithelial	O
cells	O
and	O
bind	O
to	O
multiple	O
sites	O
in	O
the	O
beta	B
-	I
casein	I
gene	I
promoter	I
.	O

To	O
explore	O
the	O
mechanism	O
of	O
RSK	B
activation	O
,	O
a	O
cloned	O
human	O
RSK	B
cDNA	O
(	O
RSK3	B
)	O
was	O
used	O
to	O
generate	O
and	O
characterize	O
several	O
site	O
-	O
directed	O
RSK	B
mutants	I
;	O
K91A	O
(	O
N	O
-	O
Lys	O
,	O
NH2-terminal	O
ATP	O
-	O
binding	O
mutant	O
)	O
,	O
K444A	O
(	O
C	O
-	O
Lys	O
,	O
COOH	O
-	O
terminal	O
ATP	O
-	O
binding	O
mutant	O
)	O
,	O
N	O
/	O
C	O
-	O
Lys	O
(	O
double	O
ATP	O
-	O
binding	O
mutant	O
)	O
T570A	O
(	O
C	O
-	O
Thr	O
,	O
mutant	O
of	O
the	O
putative	O
MAPK	B
phosphorylation	O
site	O
in	O
subdomain	O
VIII	O
of	O
the	O
C	O
-	O
domain	O
)	O
,	O
S218A	O
(	O
N	O
-	O
Ser	O
,	O
mutant	O
of	O
the	O
corresponding	O
NH2-terminal	O
residue	O
)	O
.	O

Furthermore	O
,	O
microinjection	O
of	O
dominant	O
negative	O
forms	O
of	O
Rac	B
and	O
Cdc42	B
or	O
of	O
the	O
Rho	B
inhibitor	O
C3	B
transferase	I
blocked	O
serum	O
-	O
induced	O
DNA	O
synthesis	O
.	O

The	O
yeast	O
enzyme	O
was	O
6-fold	O
slower	O
than	O
the	O
mammalian	O
enzymes	O
,	O
which	O
made	O
it	O
amenable	O
to	O
pre	O
-	O
steady	O
-	O
state	O
stopped	O
-	O
flow	O
spectroscopic	O
kinetic	O
analysis	O
at	O
30	O
degrees	O
C	O
and	O
pH	O
6.0	O
.	O

The	O
CVA16.4	B
proteolipid	I
transcript	I
is	O
the	O
most	O
prevalent	O
of	O
the	O
two	O
proteolipid	O
messages	O
in	O
expanding	O
ovules	O
harvested	O
10	O
d	O
post	O
-	O
anthesis	O
.	O

IgE	B
levels	O
showed	O
higher	O
values	O
compared	O
to	O
normal	O
individuals	O
and	O
IgE	B
levels	O
were	O
higher	O
in	O
children	O
groups	O
than	O
in	O
adults	O
regardless	O
of	O
the	O
intensity	O
of	O
infection	O
.	O

In	O
one	O
glioblastoma	O
cell	O
line	O
,	O
a	O
Shc	B
-	O
associated	O
p190	B
was	O
identified	O
as	O
the	O
activated	O
PDGFR	B
.	O

Using	O
the	O
polymerase	O
chain	O
reaction	O
,	O
Whipple	O
-	O
specific	O
DNA	O
fragments	O
of	O
284	O
base	O
pairs	O
from	O
the	O
genome	O
of	O
the	O
Whipple	O
bacterium	O
(	O
Tropheryma	O
whippelii	O
)	O
were	O
demonstrated	O
.	O

The	O
immunosuppressant	O
FK506	O
inhibits	O
amino	O
acid	O
import	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

This	O
300	O
bp	O
5'-upstream	O
sequence	O
of	O
K3	B
keratin	I
gene	I
,	O
which	O
can	O
function	O
in	O
vitro	O
as	O
a	O
keratinocyte	O
-	O
specific	O
promoter	O
,	O
contains	O
two	O
clusters	O
of	O
partially	O
overlapping	O
motifs	O
,	O
one	O
with	O
an	O
NFkB	B
consensus	O
sequence	O
and	O
another	O
with	O
a	O
GC	O
box	O
.	O

Here	O
the	O
cloning	O
and	O
molecular	O
analysis	O
of	O
the	O
Zm	B
-	I
ERabp1	I
,	O
Zm	B
-	I
ERabp4	I
,	O
and	O
Zm	B
-	I
ERabp5	I
genes	I
is	O
presented	O
.	O

The	O
presence	O
of	O
the	O
RV	O
5'	O
(	O
+	O
)	O
SL	O
sequence	O
had	O
the	O
primary	O
enhancing	O
effect	O
on	O
translation	O
.	O

Solitary	O
thyroid	O
nodule	O
.	O

The	O
amino	O
acid	O
sequence	O
of	O
the	O
protein	O
in	O
the	O
region	O
of	O
the	O
specificity	O
pocket	O
is	O
similar	O
to	O
that	O
of	O
S.	B
griseus	I
proteases	I
A	I
,	I
B	I
,	I
and	I
C.	I

Binding	O
of	O
meAda	B
is	O
necessary	O
to	O
activate	O
transcription	O
of	O
the	O
adaptive	O
response	O
genes	O
;	O
accordingly	O
,	O
in	O
vitro	O
transcription	O
of	O
aidB	B
is	O
dependent	O
on	O
the	O
presence	O
of	O
meAda	B
.	O

Vascular	O
endothelial	O
cells	O
undergo	O
profound	O
changes	O
upon	O
cellular	O
activation	O
including	O
expression	O
of	O
a	O
spectrum	O
of	O
cell	O
activation	O
-	O
associated	O
genes	O
.	O

The	O
MPS1	B
open	I
reading	I
frame	I
has	O
been	O
fused	O
to	O
those	O
that	O
encode	O
the	O
LexA	B
protein	I
or	O
the	O
GST	B
protein	I
and	O
both	O
of	O
these	O
constructs	O
function	O
in	O
yeast	O
.	O

Restriction	O
mapping	O
analysis	O
localized	O
this	O
cDNA	O
to	O
the	O
HHV-6A	B
(	I
U1102	I
)	I
genomic	I
BamHI	I
G	I
fragment	I
,	O
at	O
the	O
right	O
end	O
of	O
the	O
unique	O
long	O
segment	O
of	O
the	O
genome	O
and	O
to	O
the	O
SalI	B
L	I
and	O
SalI	B
O	I
fragments	I
within	O
the	O
left	O
and	O
right	O
terminal	O
direct	O
repeat	O
regions	O
,	O
respectively	O
.	O

Sequence	O
comparisons	O
of	O
prokaryotic	B
RCR	I
initiators	I
has	O
revealed	O
a	O
set	O
of	O
three	O
common	O
motifs	O
,	O
two	O
of	O
which	O
,	O
a	O
putative	O
metal	O
coordination	O
site	O
and	O
a	O
downstream	O
active	O
-	O
site	O
tyrosine	O
motif	O
,	O
could	O
be	O
tentatively	O
identified	O
in	O
parvoviral	B
replicator	I
proteins	I
.	O

The	O
2	O
kb	O
of	O
5'-flanking	O
region	O
and	O
the	O
1.1	O
kb	O
of	O
the	O
entire	O
sGTH	B
alpha	I
subunit	I
coding	O
region	O
were	O
sequenced	O
from	O
the	O
genomic	O
clone	O
,	O
sGTH	B
alpha	I
-	I
G1	I
.	O

His	O
carnitine	B
palmitoyltransferase	I
(	I
CPT	I
)	I
I	I
and	I
II	I
activities	O
were	O
0.06	O
and	O
0.12	O
nmol	O
/	O
min	O
/	O
mg	O
protein	O
,	O
as	O
compared	O
with	O
a	O
mean	O
value	O
of	O
0.22	O
+	O
/-	O

0.14	O
and	O
0.27	O
+	O
/-	O

0.07	O
nmol	O
/	O
min	O
/	O
mg	O
protein	O
,	O
respectively	O
,	O
in	O
control	O
subjects	O
.	O

We	O
used	O
two	O
approaches	O
to	O
ascertain	O
whether	O
CDP	B
/	O
cut	B
serves	O
as	O
a	O
repressor	O
of	O
gp91-phox	B
gene	O
expression	O
.	O

Despite	O
the	O
activation	O
of	O
these	O
intracellular	O
signaling	O
molecules	O
,	O
PDGF	B
beta	I
receptor	I
activation	O
elicited	O
no	O
detectable	O
effect	O
on	O
cell	O
proliferation	O
or	O
differentiation	O
.	O

Furthermore	O
,	O
45Ca	O
-	O
binding	O
assays	O
revealed	O
that	O
CCaMK	B
directly	O
binds	O
Ca2	O
+	O
.	O

Primer	O
extension	O
experiments	O
revealed	O
a	O
strong	O
transcription	O
initiation	O
site	O
102	O
bp	O
upstream	O
of	O
the	O
translational	O
start	O
site	O
.	O

The	O
bHLH	B
proteins	I
function	O
as	O
potent	O
transcriptional	O
activators	O
of	O
tissue	O
-	O
specific	O
genes	O
by	O
forming	O
heterodimers	O
between	O
ubiquitous	O
and	O
cell	O
-	O
restricted	O
family	O
members	O
.	O

The	O
other	O
two	O
clones	O
,	O
Ash	B
-	I
m	I
and	I
-s	I
,	O
had	O
nucleotide	O
sequences	O
identical	O
with	O
Ash	B
-	I
l	I
cDNA	O
in	O
the	O
amino	O
-	O
terminal	O
region	O
.	O

We	O
demonstrate	O
here	O
that	O
the	O
-DEDDDL	O
sequence	O
stabilizes	O
GDP	O
binding	O
to	O
Ran	B
,	O
and	O
that	O
the	O
domain	O
is	O
required	O
for	O
high	O
affinity	O
interaction	O
with	O
a	O
Ran	B
-	I
binding	I
protein	I
,	O
HTF9A	B
/	O
RanBP1	B
.	O

OBJECTIVE	O
:	O
To	O
investigate	O
the	O
incidence	O
and	O
presentation	O
of	O
acute	O
pernicious	O
or	O
fulminating	O
beriberi	O
in	O
a	O
general	O
district	O
hospital	O
.	O

CPT-11	O
was	O
administered	O
as	O
a	O
30-minute	O
i.v	O
.	O

infusion	O
at	O
a	O
dose	O
of	O
350	O
mg	O
/	O
m2	O
diluted	O
in	O
250	O
ml	O
normal	O
saline	O
every	O
3	O
weeks	O
.	O

Moreover	O
,	O
Western	O
blots	O
demonstrated	O
at	O
least	O
six	O
types	O
of	O
Ypt	B
in	O
both	O
Cr	O
and	O
Vc	O
,	O
suggesting	O
that	O
these	O
Ypt	B
are	O
used	O
for	O
household	O
functions	O
responsible	O
for	O
vesicle	O
transport	O
rather	O
than	O
for	O
cellular	O
differentiation	O
.	O

There	O
is	O
a	O
national	O
effort	O
to	O
begin	O
to	O
ask	O
all	O
female	O
patients	O
about	O
family	O
violence	O
.	O

SRY	B
-	I
related	I
cDNA	I
encoding	O
a	O
protein	O
with	O
a	O
high	B
-	I
mobility	I
-	I
group	I
(	O
HMG	B
)	O
box	O
and	O
a	O
leucine	O
zipper	O
motif	O
,	O
which	O
was	O
designated	O
SOX	B
-	I
LZ	I
,	O
was	O
isolated	O
from	O
a	O
rainbow	O
trout	O
testis	O
cDNA	O
library	O
.	O

We	O
compared	O
the	O
inhibitory	O
effect	O
of	O
naturally	O
occurring	O
mutant	B
hTR	I
beta	I
1	I
,	O
artificially	O
created	O
hTR	B
alpha	I
1	I
mutants	I
,	O
c	B
-	I
erbA	I
alpha	I
2	I
and	O
the	O
human	B
peroxisome	I
proliferator	I
-	I
activated	I
receptor	I
(	O
hPPAR	B
)	O
on	O
three	O
prototypic	O
T3-response	O
elements	O
(	O
TREs	O
)	O
,	O
TRE	O
-	O
PAL	O
,	O
DR	O
+	O
4	O
and	O
TRE	O
-	O
LAP	O
.	O

The	O
27-base	O
element	O
interacts	O
with	O
a	O
PDGF	B
-	O
activated	O
serine	O
/	O
threonine	O
phosphoprotein	O
that	O
is	O
detected	O
only	O
within	O
the	O
nucleus	O
of	O
PDGF	O
-	O
treated	O
3T3	O
cells	O
.	O

Characterization	O
of	O
the	O
promoter	O
for	O
the	O
human	B
85	I
kDa	I
cytosolic	I
phospholipase	I
A2	I
gene	I
.	O

Characterization	O
of	O
FIII	B
/	O
YY1	B
,	O
a	O
Xenopus	B
laevis	I
conserved	I
zinc	I
-	I
finger	I
protein	I
binding	O
to	O
the	O
first	O
exon	O
of	O
L1	B
and	O
L14	B
ribosomal	I
protein	I
genes	I
.	O

This	O
structure	O
of	O
cucumisin	B
suggests	O
that	O
it	O
is	O
probably	O
synthesized	O
as	O
an	O
inactive	O
precursor	O
.	O

A	O
unique	O
leucine	O
-	O
proline	O
repeat	O
element	O
found	O
N	O
-	O
terminal	O
to	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
EmBP-1	B
does	O
not	O
appear	O
to	O
play	O
a	O
role	O
in	O
DNA	O
-	O
binding	O
or	O
dimerization	O
.	O

Deletion	O
of	O
both	O
prfA	B
and	O
ponA	B
resulted	O
in	O
extremely	O
slow	O
growth	O
and	O
a	O
reduction	O
in	O
sporulation	O
efficiency	O
.	O

In	O
broken	O
L	O
-	O
cell	O
membranes	O
expressing	O
wild	O
type	O
or	O
mutant	B
M6P	I
/	I
IGF	I
II	I
receptors	I
,	O
30	O
nM	O
IGF	B
II	I
also	O
failed	O
to	O
affect	O
the	O
pertussis	B
toxin	I
substrate	O
activity	O
.	O

For	O
the	O
first	O
time	O
we	O
describe	O
deletion	O
and	O
point	O
mutations	O
within	O
the	O
plasma	B
membrane	I
family	I
of	I
guanylyl	I
cyclase	I
receptors	I
that	O
result	O
in	O
the	O
formation	O
of	O
effective	O
dominant	O
negative	O
proteins	O
.	O

Similarly	O
approximately	O
300	O
bp	O
of	O
sequence	O
downstream	O
of	O
the	O
translation	O
terminator	O
TGA	O
of	O
the	O
beta	B
-	I
tubulin	I
2	I
(	O
BTU2	B
)	O
gene	O
could	O
substitute	O
for	O
the	O
3	O
'	O
region	O
of	O
the	O
H4-I	B
gene	I
.	O

The	O
introduction	O
of	O
an	O
acidic	O
residue	O
at	O
the	O
second	O
site	O
was	O
essential	O
for	O
suppression	O
of	O
the	O
Asn-285	O
mutation	O
because	O
Lys-220	O
and	O
Gln-220	O
second	O
-	O
site	O
mutants	O
of	O
the	O
Asn-285	O
mutant	O
showed	O
very	O
low	O
tetracycline	O
resistance.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

One	O
complex	O
appears	O
to	O
be	O
ubiquitous	O
but	O
enriched	O
in	O
lymphoid	O
cells	O
and	O
represents	O
the	O
binding	O
of	O
a	O
potentially	O
novel	O
factor	O
with	O
an	O
apparent	O
molecular	O
mass	O
of	O
approximately	O
50	O
kDa	O
.	O

Each	O
type	O
was	O
divided	O
into	O
two	O
subgroups	O
on	O
the	O
basis	O
of	O
whether	O
the	O
body	O
and	O
tail	O
of	O
the	O
pancreas	O
showed	O
intense	O
fatty	O
replacement	O
(	O
type	O
a	O
=	O
negative	O
for	O
intense	O
fatty	O
replacement	O
,	O
type	O
b	O
=	O
positive	O
for	O
intense	O
fatty	O
replacement	O
)	O
.	O

Between	O
the	O
subgroups	O
of	O
dementia	O
disorders	O
there	O
were	O
no	O
significant	O
differences	O
in	O
basal	O
cortisol	O
levels	O
.	O

The	O
region	O
between	O
DXS52	B
and	O
Factor	B
VIII	I
gene	I
in	O
the	O
human	O
Xq28	O
chromosomal	O
band	O
contains	O
a	O
G+C	O
-	O
rich	O
isochore	O
to	O
which	O
many	O
genes	O
have	O
been	O
mapped	O
.	O

Nucleotide	O
sequence	O
and	O
transcriptional	O
analysis	O
of	O
the	O
DNA	B
polymerase	I
gene	I
of	I
Bombyx	I
mori	I
nuclear	I
polyhedrosis	I
virus	I
.	O

A	O
comparison	O
of	O
the	O
Flavobacterium	O
glycosylasparaginase	B
with	O
a	O
mammalian	O
glycosylasparaginase	B
revealed	O
30	O
%	O
structural	O
identity	O
and	O
60	O
%	O
overall	O
similarity	O
between	O
the	O
prokaryotic	O
and	O
eukaryotic	O
forms	O
of	O
the	O
enzyme	O
.	O

To	O
understand	O
the	O
function	O
of	O
receptor	B
-	I
linked	I
tyrosine	I
phosphatases	I
in	O
neural	O
development	O
,	O
we	O
sought	O
to	O
identify	O
LAR	B
isoforms	I
preferentially	O
expressed	O
in	O
the	O
nervous	O
system	O
and	O
cellular	O
processes	O
regulating	O
LAR	B
alternative	O
splicing	O
.	O

135	O
students	O
had	O
a	O
count	O
of	O
less	O
than	O
50	O
eggs	O
/	O
10	O
ml	O
.	O

urine	O
and	O
56	O
had	O
more	O
than	O
50	O
eggs	O
/	O
10ml	O
.	O

Physical	O
analysis	O
maps	O
SAL6	B
to	O
chromosome	O
XVI	O
between	O
TPK2	B
and	O
spt14	B
.	O

Rho	B
GDP	I
/	I
GTP	I
exchange	I
inhibitor	I
,	O
Rho	B
GDI	I
,	O
comigrated	O
with	O
Rac2	B
and	O
RhoA	B
,	O
but	O
not	O
Rac1	B
.	O

Schnell	O
,	O
J.	O

The	O
expression	O
of	O
this	O
clone	O
in	O
a	O
wee1	B
/	O
mik1-deficient	B
mutant	O
causes	O
an	O
elongated	O
cell	O
phenotype	O
under	O
non	O
-	O
permissive	O
growth	O
conditions	O
.	O

The	O
mean	O
jitter	O
and	O
the	O
fiber	O
density	O
did	O
not	O
change	O
significantly	O
from	O
day	O
0	O
(	O
30.1	O
+	O
/-	O

3.6	O
microseconds	O
;	O
1.4	O
+	O
/-	O

0.07	O
)	O
to	O
day	O
30	O
(	O
34.5	O
+	O
/-	O

2.7	O
microseconds	O
;	O
1.6	O
+	O
/-	O

0.13	O
)	O
.	O

One	O
member	O
of	O
this	O
family	O
,	O
RFX1	B
,	O
is	O
a	O
transcription	O
factor	O
for	O
a	O
variety	O
of	O
viral	O
and	O
cellular	O
genes	O
.	O

During	O
ISO+AT	O
infusion	O
,	O
abdominal	O
fat	O
blood	O
flow	O
was	O
still	O
significantly	O
increased	O
as	O
compared	O
with	O
control	O
values	O
in	O
lean	O
and	O
obese	O
subjects	O
.	O

The	O
first	O
open	O
reading	O
frame	O
of	O
the	O
blueberry	O
scorch	O
carlavirus	O
(	O
BBScV	O
)	O
genome	O
encodes	O
a	O
putative	O
replication	O
-	O
associated	O
protein	O
of	O
223	O
kDa	O
(	O
p223	B
)	O
.	O

From	O
sequence	O
alignments	O
with	O
phylogenetically	O
related	O
viruses	O
,	O
including	O
tymoviruses	O
,	O
we	O
predicted	O
that	O
p223	B
contained	O
a	O
papain	B
-	I
like	I
proteinase	I
domain	I
with	O
a	O
putative	O
catalytic	O
cysteine994	O
and	O
histidine1075	O
.	O

The	O
regions	O
of	O
the	O
tooth	O
fracture	O
are	O
determined	O
.	O

Like	O
humans	O
,	O
the	O
PITSLRE	B
PK	I
genes	I
in	I
chickens	I
must	O
be	O
closely	O
linked	O
,	O
based	O
on	O
fluorescent	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
localization	O
of	O
these	O
genes	O
to	O
a	O
single	O
chicken	O
microchromosome	O
.	O

Mutation	O
of	O
the	O
P450BM-3	B
Barbie	I
box	I
significantly	O
increased	O
the	O
expression	O
of	O
both	O
P450BM-3	B
and	O
Bm3P1	B
(	O
another	O
small	O
gene	O
located	O
upstream	O
of	O
the	O
P450BM-3	B
gene	I
that	O
encodes	O
a	O
second	O
putative	O
regulatory	O
protein	O
)	O
in	O
response	O
to	O
pentobarbital	O
induction	O
but	O
left	O
the	O
basal	O
levels	O
unaffected	O
.	O

When	O
combined	O
with	O
serum	O
ferritin	B
and	O
hemoglobin	B
determinations	O
,	O
the	O
serum	O
transferrin	B
receptor	I
assay	O
is	O
a	O
valuable	O
addition	O
in	O
epidemiologic	O
surveys	O
because	O
it	O
provides	O
a	O
quantitative	O
measure	O
of	O
functional	O
iron	O
deficiency	O
and	O
it	O
distinguishes	O
true	O
IDA	O
from	O
the	O
anemia	O
of	O
chronic	O
disease	O
.	O

We	O
have	O
screened	O
the	O
mouse	O
cDNA	O
library	O
of	O
an	O
MIN6	O
cell	O
line	O
,	O
derived	O
from	O
pancreatic	O
beta	O
cells	O
,	O
for	O
its	O
novel	O
isoform	O
and	O
have	O
identified	O
a	O
cDNA	O
encoding	O
a	O
593-amino	O
acid	O
protein	O
having	O
63	O
,	O
53	O
,	O
and	O
30	O
%	O
identity	O
with	O
munc-18	B
/	I
n	I
-	I
Sec1	I
/	I
rbSec1	I
,	O
Caenorhabditis	B
elegans	I
unc18	I
,	O
and	O
Saccharomyces	B
cerevisiae	I
Sec1p	I
,	O
respectively	O
.	O

Moreover	O
,	O
the	O
hypoxia	O
-	O
induced	O
expression	O
of	O
the	O
endogenous	O
Epo	B
gene	I
was	O
significantly	O
inhibited	O
in	O
Hep3B	O
cells	O
stably	O
transfected	O
with	O
HNF-4	B
delta	I
C.	I

Small	B
Maf	I
proteins	I
heterodimerize	O
with	O
Fos	B
and	O
may	O
act	O
as	O
competitive	O
repressors	O
of	O
the	O
NF	B
-	I
E2	I
transcription	I
factor	I
.	O

Glomerular	O
hemodynamics	O
during	O
abortion	O
induced	O
by	O
RU	O
486	O
and	O
sepsis	O
in	O
rats	O
.	O

Alternatively	O
processed	O
isoforms	O
of	O
cellular	B
nucleic	I
acid	I
-	I
binding	I
protein	I
interact	O
with	O
a	O
suppressor	O
region	O
of	O
the	O
human	B
beta	I
-	I
myosin	I
heavy	I
chain	I
gene	I
.	O

Erythrocyte	B
delta	I
-	I
aminolevulinic	I
acid	I
dehydratase	I
(	O
ALAD	B
)	O
activity	O
,	O
erythrocyte	O
zinc	O
protoporphyrin	O
(	O
ZPP	O
)	O
/	O
heme	O
ratio	O
,	O
and	O
urinary	O
coproporphyrin	O
(	O
UC	O
)	O
concentration	O
have	O
been	O
employed	O
as	O
biological	O
indicators	O
of	O
moderate	O
-	O
to	O
high	O
-	O
level	O
lead	O
exposure	O
,	O
corresponding	O
to	O
blood	O
levels	O
in	O
excess	O
of	O
50	O
micrograms	O
/	O
dl	O
,	O
in	O
human	O
subjects	O
.	O

Analysis	O
of	O
disassociation	O
rates	O
indicates	O
that	O
the	O
Grf10-Swi5-DNA	B
complex	O
has	O
a	O
longer	O
half	O
-	O
life	O
than	O
protein	O
-	O
DNA	O
complexes	O
that	O
contain	O
only	O
Swi5	B
or	O
Grf10	B
.	O

Results	O
from	O
in	O
vitro	O
transcription	O
-	O
translation	O
analysis	O
and	O
maxicell	O
experiments	O
suggested	O
that	O
the	O
447-bp	O
ORF	O
was	O
the	O
one	O
being	O
actively	O
expressed	O
.	O

The	O
use	O
of	O
specific	O
antibodies	O
allowed	O
the	O
identification	O
of	O
at	O
least	O
RAR	B
beta	I
in	O
some	O
of	O
the	O
DNA	O
-	O
protein	O
complexes	O
,	O
although	O
the	O
four	O
sequences	O
bind	O
single	O
RARs	B
transfected	O
in	O
COS	O
cells	O
much	O
less	O
efficiently	O
,	O
or	O
not	O
at	O
all	O
,	O
when	O
compared	O
to	O
a	O
canonical	O
RAR	B
responsive	I
element	I
.	O

A	O
decanucleotide	O
promoter	O
sequence	O
homologous	O
to	O
those	O
found	O
in	O
humans	O
and	O
mice	O
was	O
located	O
in	O
the	O
5	O
'	O
untranslated	O
region	O
of	O
one	O
horse	O
gene	O
.	O

BACKGROUND	O
:	O
We	O
conducted	O
a	O
phase	O
I	O
study	O
with	O
MDL	O
73,147EF	O
,	O
a	O
new	O
5	B
hydroxytryptamine	I
3	I
(	I
5-HT3	I
)	I
receptor	I
antagonist	O
,	O
in	O
25	O
patients	O
requiring	O
emetogenic	O
chemotherapy	O
.	O

The	O
DNA	O
sequence	O
adjacent	O
to	O
the	O
lacZ	B
gene	I
has	O
been	O
determined	O
for	O
91	O
vegetative	O
fusion	O
genes	O
whose	O
products	O
have	O
been	O
localized	O
and	O
for	O
43	O
meiotically	O
induced	O
fusions	O
.	O

PATIENTS	O
AND	O
METHODS	O
:	O
One	O
hundred	O
eighty	O
-	O
four	O
chemotherapy	O
-	O
naive	O
patients	O
receiving	O
high	O
-	O
dose	O
cisplatin	O
(	O
81	O
to	O
120	O
mg	O
/	O
m2	O
)	O
were	O
randomized	O
to	O
receive	O
one	O
of	O
four	O
granisetron	O
doses	O
(	O
5	O
,	O
10	O
,	O
20	O
,	O
or	O
40	O
micrograms	O
/	O
kg	O
)	O
administered	O
before	O
chemotherapy	O
.	O

We	O
previously	O
showed	O
that	O
v	B
-	I
Rel	I
,	O
the	O
oncoprotein	O
of	O
the	O
avian	O
retrovirus	O
Rev	O
-	O
T	O
,	O
can	O
increase	O
expression	O
from	O
promoters	O
containing	O
binding	O
sites	O
for	O
the	O
cellular	O
transcription	O
factor	O
Sp1	B
in	O
chicken	O
embryo	O
fibroblasts	O
(	O
S.	O

Treatment	O
with	O
amphotericin	O
B	O
and	O
flucytosine	O
led	O
to	O
improvement	O
of	O
the	O
symptoms	O
but	O
did	O
not	O
eradicate	O
the	O
micro	O
-	O
organisms	O
from	O
the	O
cerebrospinal	O
fluid	O
(	O
CSF	O
)	O
.	O

Consequently	O
functional	O
mRNAs	O
can	O
be	O
produced	O
by	O
endogenous	B
RNA	I
polymerase	I
I.	O

Univariate	O
statistical	O
analysis	O
based	O
on	O
Kaplan	O
-	O
Meier	O
-	O
estimates	O
and	O
Log	O
-	O
Rank	O
-	O
Test	O
showed	O
the	O
following	O
prognostically	O
beneficial	O
factors	O
:	O
Limited	O
disease	O
stage	O
(	O
p	O
=	O
0.009	O
)	O
,	O
NSE	B
serum	O
level	O
less	O
than	O
25	O
micrograms	O
/	O
l	O
(	O
p	O
=	O
0.016	O
)	O
,	O
serum	O
alkaline	B
phosphatase	I
less	O
than	O
200	O
U	O
/	O
l	O
(	O
p	O
=	O
0.035	O
)	O
,	O
normal	O
serum	O
albumin	B
(	O
p	O
=	O
0.003	O
)	O
and	O
activity	O
index	O
of	O
minimum	O
of	O
70	O
(	O
p	O
<	O
0.001	O
)	O
.	O

Of	O
419	O
persons	O
surveyed	O
,	O
207	O
(	O
49.4	O
%	O
)	O
were	O
antigen	O
-	O
positive	O
with	O
the	O
Og4C3	B
assay	O
.	O

Ten	O
volunteers	O
were	O
tested	O
at	O
18,000	O
ft	O
(	O
5,486	O
m	O
)	O
,	O
and	O
through	O
12,000	O
,	O
8,000	O
,	O
and	O
5,000	O
ft	O
(	O
3,657	O
,	O
2,438	O
,	O
and	O
1,524	O
m	O
)	O
with	O
directional	O
sounds	O
recorded	O
via	O
a	O
dummy	O
head	O
microphone	O
and	O
presented	O
binaurally	O
.	O

Upon	O
differentiation	O
with	O
retinoic	O
acid	O
(	O
RA	O
)	O
,	O
transcription	O
of	O
the	O
Rex-1	B
gene	I
decreases	O
rapidly	O
.	O

Rat	B
kidney	I
carboxylesterase	I
.	O

Infect	O
.	O

The	O
Nur77	B
protein	I
can	O
act	O
as	O
a	O
potent	O
transcription	O
activator	O
and	O
may	O
function	O
to	O
regulate	O
the	O
expression	O
of	O
downstream	O
genes	O
in	O
response	O
to	O
extracellular	O
stimuli	O
.	O

KRN2391	O
and	O
cromakalim	O
produced	O
a	O
dose	O
-	O
dependent	O
increase	O
in	O
aortic	O
and	O
coronary	O
blood	O
flow	O
.	O

Basal	O
plasma	O
AVP	B
levels	O
and	O
AVP	B
release	O
after	O
postural	O
change	O
were	O
assessed	O
,	O
and	O
plasma	O
NPY	B
levels	O
were	O
measured	O
in	O
the	O
same	O
samples	O
.	O

Surprisingly	O
,	O
nuclear	O
forms	O
of	O
IE110	B
were	O
found	O
to	O
move	O
a	O
cytoplasmic	O
form	O
of	O
IE175	B
into	O
nuclear	O
punctate	O
structures	O
,	O
and	O
a	O
cytoplasmic	O
form	O
of	O
IE110	B
was	O
able	O
to	O
retain	O
nuclear	O
forms	O
of	O
IE175	B
in	O
cytoplasmic	O
punctate	O
structures	O
.	O

The	O
inflation	O
hub	O
of	O
the	O
probe	O
is	O
recreated	O
by	O
modifying	O
a	O
standard	O
USCI	O
Tuohy	O
-	O
Borst	O
Y	O
adaptor	O
and	O
attaching	O
this	O
to	O
the	O
transected	O
probe	O
hypotube	O
.	O

Mutational	O
analysis	O
of	O
yeast	B
CEG1	I
demonstrated	O
that	O
four	O
of	O
the	O
five	O
conserved	O
motifs	O
are	O
essential	O
for	O
capping	B
enzyme	I
function	O
in	O
vivo	O
.	O

A	O
sequence	O
representing	O
about	O
50	O
%	O
of	O
the	O
expected	O
complete	O
sequence	O
was	O
obtained	O
by	O
translation	O
of	O
the	O
two	O
open	O
reading	O
frames	O
present	O
on	O
a	O
1.6	O
kb	O
DNA	O
genomic	O
fragment	O
.	O

METHODS--16	O
volunteered	O
for	O
spirometry	O
with	O
methacholine	O
provocation	O
test	O
including	O
a	O
test	O
for	O
small	O
airways	O
function	O
by	O
volume	O
of	O
trapped	O
gas	O
(	O
VTG	O
)	O
.	O

Relationship	O
of	O
CDK	B
-	I
activating	I
kinase	I
and	O
RNA	B
polymerase	I
II	I
CTD	O
kinase	O
TFIIH	B
/	O
TFIIK	B
.	O

The	O
effects	O
of	O
social	O
isolation	O
on	O
morphine	O
-	O
induced	O
locomotor	O
activity	O
were	O
compared	O
in	O
:	O
(	O
i	O
)	O
animals	O
with	O
an	O
intact	O
hypothalamo	O
-	O
pituitary	O
-	O
adrenal	O
(	O
HPA	O
)	O
axis	O
;	O
(	O
ii	O
)	O
animals	O
in	O
which	O
stress	O
-	O
induced	O
corticosterone	O
secretion	O
was	O
blocked	O
by	O
adrenalectomy	O
.	O

Standard	O
curve	O
correlation	O
coefficients	O
of	O
0.995	O
or	O
greater	O
were	O
obtained	O
during	O
validation	O
experiments	O
and	O
analysis	O
of	O
study	O
samples	O
.	O

There	O
was	O
no	O
difference	O
in	O
plasma	O
concentrations	O
of	O
PGI2	O
(	O
figure	O
4	O
)	O
and	O
TxA2	O
in	O
patients	O
with	O
normal	O
blood	O
pressure	O
,	O
mild	O
preeclampsia	O
and	O
hypotension	O
,	O
whereas	O
in	O
severe	O
preeclampsia	O
,	O
the	O
plasma	O
concentration	O
of	O
PGI2	O
was	O
significantly	O
lower	O
(	O
p	O
<	O
0.001	O
)	O
and	O
of	O
TxA2	O
significantly	O
higher	O
(	O
p	O
<	O
0.001	O
)	O
.	O

Under	O
resting	O
conditions	O
,	O
activity	O
levels	O
of	O
cardiac	O
vagal	O
and	O
sympathetic	O
outflows	O
are	O
not	O
related	O
across	O
young	O
,	O
healthy	O
human	O
subjects	O
and	O
peripheral	O
interaction	O
is	O
not	O
manifest	O
between	O
the	O
autonomic	O
divisions	O
.	O

Both	O
proprioceptive	O
and	O
electroreceptive	O
units	O
showed	O
a	O
progression	O
of	O
receptive	O
fields	O
from	O
anterior	O
to	O
posterior	O
body	O
in	O
the	O
rostral	O
to	O
caudal	O
direction	O
along	O
the	O
length	O
of	O
DGR	O
.	O

Granisetron	O
,	O
but	O
not	O
saline	O
,	O
abolished	O
vomiting	O
and	O
nausea	O
when	O
given	O
as	O
intervention	O
after	O
this	O
combined	O
emetic	O
regimen	O
.	O

This	O
was	O
obtained	O
with	O
the	O
thermal	O
neutron	O
fluency	O
2.0	O
x	O
10	O
(	O
10	O
)	O
n	O
/	O
cm2	O
.	O

Endotoxemia	O
induced	O
by	O
gram	O
-	O
negative	O
bacteria	O
leads	O
to	O
endotoxic	O
shock	O
pathogenetically	O
stemming	O
from	O
the	O
integral	O
component	O
of	O
the	O
bacterial	O
wall	O
--	O
lipid	O
A.	O

The	O
study	O
made	O
to	O
define	O
the	O
ability	O
of	O
lipid	B
A	I
monoclonal	I
antibodies	I
to	O
correct	O
hemodynamic	O
disturbances	O
due	O
to	O
endotoxemia	O
in	O
dog	O
experiments	O
showed	O
the	O
efficacy	O
of	O
the	O
antibodies	O
administration	O
.	O

This	O
sequenced	O
region	O
of	O
the	O
V	O
beta	O
locus	O
contains	O
an	O
average	O
number	O
of	O
repetitive	O
DNA	O
elements	O
(	O
21	O
Alu	B
,	O
three	O
L1	B
,	O
three	O
MER	O
,	O
and	O
three	O
retrovirus	O
-	O
related	O
elements	O
.	O

In	O
an	O
in	O
vitro	O
study	O
,	O
10	O
/	O
0	O
nylon	O
was	O
found	O
to	O
require	O
a	O
significantly	O
lower	O
laser	O
energy	O
density	O
to	O
produce	O
suture	O
lysis	O
following	O
a	O
single	O
shot	O
than	O
either	O
10	O
/	O
0	O
Dacron	O
or	O
10	O
/	O
0	O
prolene	O
.	O

We	O
report	O
here	O
that	O
microinjection	O
of	O
an	O
anti	B
-	I
CBP	I
antiserum	I
into	O
fibroblasts	O
can	O
inhibit	O
transcription	O
from	O
a	O
cAMP	O
responsive	O
promoter	O
.	O

Ketamine	O
in	O
the	O
treatment	O
of	O
bronchospasm	O
during	O
mechanical	O
ventilation	O
.	O

In	O
conclusion	O
,	O
the	O
disposition	O
of	O
venlafaxine	O
and	O
O	O
-	O
desmethylvenlafaxine	O
is	O
markedly	O
altered	O
in	O
renal	O
disease	O
;	O
therefore	O
dosage	O
adjustment	O
is	O
warranted	O
for	O
patients	O
with	O
creatinine	O
clearance	O
values	O
below	O
30	O
ml	O
/	O
min	O
.	O

M.	O
,	O
and	O
D.	O

At	O
least	O
some	O
of	O
the	O
difference	O
in	O
stability	O
of	O
the	O
two	O
kinds	O
of	O
complexes	O
was	O
due	O
to	O
the	O
fact	O
that	O
the	O
dissociation	O
rate	O
of	O
the	O
A	O
stem	O
substrate	O
from	O
the	O
protein	O
-	O
DNA	O
complexes	O
was	O
approximately	O
fourfold	O
faster	O
than	O
that	O
of	O
the	O
complete	O
TR	B
.	O

Number	O
and	O
size	O
of	O
silver	O
-	O
stained	O
nucleoli	O
(	O
Ag	O
-	O
NOR	O
clusters	O
)	O
in	O
canine	O
seminomas	O
:	O
correlation	O
with	O
histological	O
features	O
and	O
tumour	O
behaviour	O
.	O

The	O
tumor	O
suppressor	O
and	O
transcriptional	O
factor	O
p53	B
is	O
a	O
phosphorylated	O
protein	O
.	O

The	O
acfD	B
gene	I
encompasses	O
254	O
nt	O
that	O
are	O
predicted	O
to	O
encode	O
an	O
88-amino	O
-	O
acid	O
(	O
aa	O
)	O
protein	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
KRAB	B
domain	I
present	O
in	O
the	O
non	O
-	O
finger	O
region	O
of	O
many	O
ZFP	B
genes	I
quenches	O
transcription	O
possibly	O
due	O
to	O
specific	O
protein	O
-	O
protein	O
interactions	O
between	O
the	O
KRAB	B
-	I
A	I
domain	I
and	O
components	O
of	O
the	O
proximal	O
transcriptional	O
apparatus	O
.	O

The	O
newly	O
recognised	O
skeletogenital	O
syndrome	O
.	O

The	O
immune	O
response	O
of	O
past	O
-	O
infection	O
of	O
cytomegalovirus	O
in	O
the	O
patients	O
of	O
RTID	O
is	O
rather	O
remarkable	O
.	O

Reduced	O
NK	O
activity	O
correlates	O
with	O
active	O
disease	O
in	O
HIV-	O
patients	O
with	O
multidrug	O
-	O
resistant	O
pulmonary	O
tuberculosis	O
.	O

These	O
results	O
suggest	O
that	O
leader	O
-	O
mRNA	O
fusion	O
in	O
coronavirus	O
transcription	O
does	O
not	O
require	O
direct	O
RNA	O
-	O
RNA	O
interaction	O
between	O
complementary	O
sequences	O
.	O

Comparison	O
with	O
the	O
bovine	O
gene	O
showed	O
that	O
the	O
5'-flanking	O
region	O
of	O
the	O
hATP1	B
gene	I
has	O
an	O
unconserved	O
guanine	O
-	O
cytosine	O
(	O
GC	O
)	O
rich	O
region	O
,	O
including	O
several	O
binding	O
motifs	O
of	O
transcriptional	O
factors	O
,	O
such	O
as	O
Sp1	B
,	O
AP-2	B
,	O
and	O
GCF	B
.	O

Here	O
,	O
we	O
present	O
genetic	O
evidence	O
in	O
Saccharomyces	O
cerevisiae	O
for	O
a	O
functional	O
interaction	O
between	O
the	O
DEAH	B
protein	I
Prp16	B
,	O
and	O
the	O
U6	B
and	O
U2	B
spliceosomal	I
snRNAs	I
.	O

These	O
mutants	O
had	O
deletions	O
of	O
the	O
extreme	O
amino	O
-	O
terminal	O
residues	O
as	O
far	O
as	O
amino	O
acid	O
residue	O
30	O
.	O

Through	O
a	O
stretch	O
of	O
56	O
amino	O
acids	O
,	O
constituting	O
the	O
MADS	B
domain	I
,	O
the	O
two	O
proteins	O
are	O
identical	O
except	O
for	O
two	O
conservative	O
amino	O
acid	O
substitutions	O
.	O

Clinical	O
aspects	O
of	O
early	O
increase	O
in	O
serum	O
gamma	B
-	I
glutamyl	I
transferase	I
in	O
cerebral	O
infarction	O
.	O

The	O
indoor	O
radon	O
concentration	O
in	O
the	O
summer	O
(	O
1990	O
)	O
period	O
ranged	O
between	O
8	O
and	O
81	O
Bq	O
m-3	O
,	O
while	O
in	O
the	O
winter	O
(	O
1989	O
-	O
1990	O
)	O
it	O
ranged	O
between	O
20	O
and	O
143	O
Bq	O
m-3	O
for	O
the	O
first	O
year	O
of	O
measurements	O
or	O
between	O
8	O
and	O
92	O
Bq	O
m-3	O
in	O
the	O
summer	O
(	O
1991	O
)	O
period	O
and	O
between	O
12	O
and	O
119	O
Bq	O
m-3	O
in	O
the	O
winter	O
(	O
1990	O
-	O
1991	O
)	O
for	O
the	O
second	O
year	O
of	O
measurements	O
.	O

The	O
results	O
indicate	O
that	O
hrpRS	B
and	O
hrpL	B
are	O
part	O
of	O
a	O
regulatory	O
cascade	O
in	O
which	O
HrpR	B
and	O
HrpS	B
activate	O
expression	O
of	O
hrpL	B
and	O
HrpL	B
,	O
a	O
putative	O
sigma	B
factor	I
,	O
induces	O
expression	O
of	O
HrpL	B
-	I
responsive	I
genes	I
.	O

DtxR	B
is	O
an	O
iron	O
-	O
dependent	O
sequence	O
-	O
specific	O
DNA	O
-	O
binding	O
protein	O
that	O
binds	O
to	O
the	O
tox	B
operator	I
,	O
an	O
inverted	O
-	O
repeat	O
nucleotide	O
sequence	O
located	O
upstream	O
from	O
the	O
diphtheria	B
toxin	I
gene	I
.	O

We	O
have	O
previously	O
shown	O
that	O
LBP-1	B
represses	O
HIV-1	O
transcription	O
by	O
inhibiting	O
the	O
binding	O
of	O
TFIID	B
to	O
the	O
TATA	O
box	O
.	O

Sodium	O
-	O
taurocholate	O
-	O
induced	O
acute	O
necrotizing	O
pancreatitis	O
does	O
not	O
affect	O
jejunal	O
oxygenation	O
in	O
pigs	O
.	O

The	O
epidemic	O
occurred	O
in	O
a	O
group	O
of	O
26	O
community	O
members	O
(	O
23	O
men	O
and	O
3	O
women	O
,	O
mean	O
age	O
,	O
28.9	O
-	O
-3	O
years	O
)	O
living	O
and	O
working	O
together	O
,	O
who	O
underwent	O
acute	O
and	O
convalescent	O
serologic	O
tests	O
for	O
Mycoplasma	O
pneumoniae	O
,	O
Legionella	O
pneumophila	O
,	O
cytomegalovirus	O
,	O
adenovirus	O
,	O
Coxiella	O
burnetii	O
,	O
and	O
Chlamydia	O
pneumoniae	O
.	O

Genomic	O
DNA	O
clones	O
containing	O
the	O
T	B
-	I
cell	I
-	I
specific	I
human	I
MAL	I
gene	I
were	O
isolated	O
.	O

Expression	O
of	O
the	O
dibasic	O
proprotein	O
processing	O
enzyme	O
furin	B
is	O
directed	O
by	O
multiple	O
promoters	O
.	O

Genetic	O
and	O
phenotypic	O
analysis	O
indicates	O
that	O
NHP6A	B
and	O
NHP6B	B
function	O
downstream	O
of	O
SLT2	B
.	O

Rather	O
,	O
complete	O
skipping	O
of	O
exon	O
V	O
and	O
subsequent	O
joining	O
of	O
exon	O
IV	O
to	O
exon	O
VI	O
caused	O
a	O
shift	O
in	O
the	O
open	O
reading	O
frame	O
,	O
which	O
remodeled	O
GPHe	B
(	I
P2	I
)	I
with	O
an	O
elongated	O
new	O
hydrophobic	O
sequence	O
for	O
membrane	O
anchoring	O
.	O

The	O
presence	O
of	O
the	O
foreign	O
gene	O
was	O
confirmed	O
by	O
Southern	O
analysis	O
.	O

Functional	O
postnatal	O
development	O
of	O
the	O
rat	O
primary	O
visual	O
cortex	O
and	O
the	O
role	O
of	O
visual	O
experience	O
:	O
dark	O
rearing	O
and	O
monocular	O
deprivation	O
.	O

Altogether	O
,	O
these	O
data	O
suggest	O
that	O
Ypt51p	B
,	O
Ypt52p	B
,	O
and	O
Ypt53p	B
are	O
required	O
for	O
transport	O
in	O
the	O
endocytic	O
pathway	O
and	O
for	O
correct	O
sorting	O
of	O
vacuolar	B
hydrolases	I
suggesting	O
a	O
possible	O
intersection	O
of	O
the	O
endocytic	O
with	O
the	O
vacuolar	O
sorting	O
pathway	O
.	O

The	O
variable	O
regions	O
of	O
vertebrate	O
striated	O
TnT	B
isoforms	I
reflect	O
the	O
subsequent	O
addition	O
and	O
modification	O
of	O
genomic	O
sequences	O
to	O
give	O
rise	O
to	O
members	O
of	O
the	O
TnT	B
multigene	I
family	I
.	O

These	O
viruses	O
depend	O
on	O
the	O
host	O
cell	O
machinery	O
for	O
their	O
existence	O
,	O
and	O
interference	O
with	O
these	O
processes	O
typically	O
interferes	O
with	O
other	O
important	O
host	O
physiology	O
.	O

The	O
experiment	O
included	O
6	O
male	O
and	O
4	O
female	O
healthy	O
subjects	O
who	O
,	O
during	O
a	O
24-hour	O
stay	O
in	O
the	O
respiration	O
chambers	O
,	O
performed	O
,	O
in	O
the	O
morning	O
and	O
afternoon	O
,	O
15	O
min	O
cycling	O
with	O
the	O
total	O
work	O
of	O
6,750	O
kg	O
m.	O

Using	O
the	O
sequence	O
data	O
obtained	O
from	O
the	O
human	O
TCRAC	B
/	O
TCRDC	B
region	O
,	O
we	O
have	O
extended	O
a	O
polymerase	O
chain	O
reaction	O
-	O
based	O
assay	O
to	O
test	O
for	O
the	O
expression	O
of	O
the	O
individual	O
TCRAJ	B
gene	I
segments	I
.	O

The	O
baroreflex	O
latency	O
(	O
from	O
the	O
ECG	O
R	O
-	O
wave	O
to	O
the	O
integrated	O
MSNA	O
burst	O
peak	O
)	O
was	O
constant	O
at	O
approximately	O
1.20	O
s	O
during	O
sleep	O
,	O
suggesting	O
that	O
pulse	O
-	O
synchronicity	O
was	O
maintained	O
.	O

Furthermore	O
,	O
unlike	O
the	O
case	O
for	O
HIS3	B
where	O
only	O
a	O
limited	O
subset	O
of	O
TATA	O
-	O
like	O
sequences	O
can	O
activate	O
transcription	O
in	O
conjunction	O
with	O
GCN4p	B
,	O
many	O
divergent	O
TATA	O
-	O
like	O
sequences	O
allowed	O
GCN4p	B
activation	O
of	O
TRP3	B
.	O

This	O
strategy	O
was	O
used	O
to	O
place	O
both	O
the	O
Tn903	B
neo	I
gene	I
and	O
the	O
Rhodosporidium	B
toruloides	I
phenylalanine	I
ammonia	I
lyase	I
(	O
PAL	B
)	O
-encoding	O
gene	O
under	O
the	O
transcriptional	O
control	O
of	O
pPGK::REP2	B
.	O

A-69-year	O
-	O
old	O
patient	O
with	O
postoperative	O
small	O
-	O
bowel	O
obstruction	O
underwent	O
laparotomy	O
three	O
times	O
.	O

VP-16	O
,	O
ifosfamide	O
and	O
cisplatin	O
(	O
VIP	O
)	O
for	O
extensive	O
small	O
cell	O
lung	O
cancer	O
.	O

To	O
identify	O
the	O
precise	O
location	O
of	O
the	O
phosphorylation	O
site	O
on	O
the	O
64-kDa	O
protein	O
,	O
a	O
step	O
-	O
by	O
-	O
step	O
mutagenesis	O
procedures	O
was	O
followed	O
.	O

Measurement	O
of	O
SaO2	O
at	O
moderate	O
altitude	O
can	O
be	O
helpful	O
in	O
the	O
care	O
of	O
both	O
healthy	O
and	O
ill	O
newborns	O
or	O
infants	O
.	O

TATA	O
and	O
CCAAT	O
boxes	O
are	O
located	O
34-bp	O
and	O
68-bp	O
,	O
respectively	O
,	O
upstream	O
of	O
the	O
transcription	O
start	O
site	O
,	O
the	O
5'-untranslated	O
leader	O
is	O
78	O
nucleotides	O
long	O
,	O
and	O
the	O
intronless	O
gene	O
has	O
at	O
least	O
two	O
different	O
polyadenylation	O
sites	O
.	O

GGS1	B
is	O
the	O
same	O
gene	O
as	O
TPS1	B
which	O
was	O
identified	O
as	O
encoding	O
a	O
subunit	O
of	O
the	O
trehalose-6-phosphate	B
synthase	I
/	I
phosphatase	I
complex	I
and	O
it	O
is	O
allelic	O
to	O
the	O
fdp1	B
,	O
byp1	B
,	O
glc6	B
and	O
cif1	O
mutations	O
.	O

CONCLUSION	O
:	O
The	O
study	O
demonstrates	O
that	O
transvaginal	O
ultrasonography	O
has	O
an	O
efficiency	O
of	O
88	O
%	O
in	O
differentiating	O
endometriomas	O
from	O
other	O
ovarian	O
masses	O
with	O
a	O
specificity	O
of	O
90	O
%	O
.	O

A	O
series	O
of	O
5'-deletions	O
revealed	O
that	O
the	O
fragment	O
-218	O
to	O
+	O
4	O
from	O
the	O
TSS	O
had	O
the	O
highest	O
promoter	O
activity	O
,	O
nearly	O
1000-fold	O
greater	O
than	O
the	O
promoterless	O
chloramphenicol	B
acetyltransferase	I
construct	I
.	O

The	O
bioavailability	O
of	O
etodolac	O
from	O
capsules	O
exposed	O
to	O
stressed	O
conditions	O
was	O
compared	O
in	O
both	O
dogs	O
and	O
humans	O
to	O
capsules	O
stored	O
at	O
RT	O
conditions	O
.	O

Four	O
forms	O
of	O
salmonellosis	O
were	O
recognised	O
in	O
feedlots	O
and	O
during	O
transport	O
by	O
sea	O
:	O
septicaemic	O
,	O
and	O
acute	O
,	O
subacute	O
and	O
chronic	O
enteric	O
.	O

In	O
addition	O
to	O
the	O
protein	B
-	I
tyrosine	I
kinase	I
domain	I
,	O
p56lck	B
possesses	O
Src	B
homology	I
2	I
and	I
3	I
(	O
SH2	B
and	O
SH3	B
)	O
domains	O
as	O
well	O
as	O
a	O
unique	O
N	O
-	O
terminal	O
region	O
.	O

The	O
fourth	O
dose	O
produced	O
favorable	O
results	O
(	O
66.7	O
%	O
)	O
in	O
individuals	O
with	O
HB	B
antibodies	I
between	O
10	O
and	O
100	O
IU	O
/	O
ml	O
and	O
unfavorable	O
ones	O
(	O
3.8	O
%	O
)	O
where	O
the	O
HB	B
antibodies	I
were	O
below	O
10	O
IU	O
/	O
ml	O
.	O

Similarly	O
,	O
the	O
N	O
-	O
terminal	O
cytoplasmic	O
domain	O
of	O
the	O
latent	B
membrane	I
protein	I
2A	I
(	O
LMP2A	B
)	O
of	O
the	O
Epstein	O
-	O
Barr	O
virus	O
(	O
EBV	O
)	O
contains	O
a	O
single	O
copy	O
of	O
the	O
Tyr	O
-	O
X	O
-	O
X	O
-	O
Leu	O
/	O
Ile	O
-	O
containing	O
motif	O
which	O
could	O
play	O
a	O
critical	O
role	O
in	O
B	O
cell	O
transformation	O
.	O

The	O
cloning	O
of	O
PTR2	B
represents	O
the	O
first	O
example	O
of	O
the	O
molecular	O
genetic	O
characterization	O
of	O
a	O
eucaryotic	O
peptide	O
transport	O
gene	O
.	O

TGF	B
beta	I
1	I
expression	O
is	O
largely	O
governed	O
by	O
three	O
AP-1	B
binding	I
sites	I
located	O
in	O
two	O
different	O
promoters	O
of	O
this	O
gene	O
.	O

Strategic	O
change	O
in	O
the	O
NHS	O
.	O

A	O
favourable	O
response	O
was	O
achieved	O
with	O
a	O
combination	O
of	O
amphotericin	O
B	O
and	O
cotrimoxazole	O
.	O

RESULTS	O
:	O
At	O
the	O
beginning	O
of	O
the	O
QA	O
/	O
QI	O
process	O
,	O
monitoring	O
of	O
blood	O
administration	O
practices	O
revealed	O
that	O
a	O
variance	O
from	O
institutional	O
blood	O
administration	O
policy	O
occurred	O
during	O
50	O
percent	O
of	O
blood	O
and	O
component	O
transfusions	O
.	O

The	O
predicted	O
Pay4p	B
sequence	I
contains	O
two	O
putative	O
ATP	O
-	O
binding	O
domains	O
and	O
shows	O
structural	O
relationships	O
to	O
other	O
potential	O
ATP	B
-	I
binding	I
proteins	I
involved	O
in	O
biological	O
processes	O
as	O
diverse	O
as	O
peroxisome	O
biogenesis	O
,	O
vesicle	O
-	O
mediated	O
protein	O
transport	O
,	O
cell	O
cycle	O
control	O
,	O
and	O
transcriptional	O
regulation	O
.	O

Peripheral	O
vitreochorioretinal	O
dystrophies	O
in	O
myopia	O
patients	O

Thomas	O
'	O
Hospital	O
solution	O
(	O
with	O
95	O
%	O
O2:5	O
%	O
CO2	O
)	O
can	O
meet	O
the	O
metabolic	O
demand	O
of	O
the	O
ischaemic	O
myocardium	O
and	O
thus	O
increase	O
the	O
safe	O
duration	O
of	O
cardiac	O
arrest	O
.	O

Animal	O
age	O
and	O
sex	O
had	O
no	O
significant	O
effects	O
on	O
CSF	O
composition	O
,	O
but	O
serum	O
IgG	B
concentration	O
increased	O
with	O
age	O
.	O

A	O
randomized	O
,	O
multicenter	O
study	O
comparing	O
the	O
efficacy	O
and	O
tolerability	O
of	O
tropisetron	O
,	O
a	O
new	O
5-HT3	B
receptor	I
antagonist	O
,	O
with	O
a	O
metoclopramide	O
-	O
containing	O
antiemetic	O
cocktail	O
in	O
the	O
prevention	O
of	O
cisplatin	O
-	O
induced	O
emesis	O
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
of	O
the	O
SAP-1	B
cDNA	I
showed	O
that	O
mature	B
SAP-1	I
consisted	O
of	O
1093	O
amino	O
acids	O
and	O
a	O
transmembrane	B
-	I
type	I
PTP	I
,	O
which	O
possessed	O
a	O
single	O
PTP	B
-	I
conserved	I
domain	I
in	O
the	O
cytoplasmic	O
region	O
.	O

Several	O
features	O
of	O
10.24.6	O
cells	O
suggest	O
that	O
the	O
mutation	O
disrupts	O
normal	O
intracellular	O
formation	O
of	O
peptide	B
/	I
DR	I
complexes	I
.	O

One	O
of	O
these	O
elements	O
,	O
the	O
homeodomain	B
-	I
binding	I
element	I
,	O
was	O
identified	O
to	O
mediate	O
negative	O
regulation	O
.	O

Twenty	O
-	O
three	O
sequence	O
-	O
tagged	O
sites	O
(	O
STSs	O
)	O
were	O
mapped	O
within	O
the	O
contig	O
,	O
a	O
density	O
of	O
approximately	O
1	O
per	O
200	O
kb	O
.	O

These	O
results	O
demonstrate	O
that	O
dopamine	B
receptor	I
stimulation	O
by	O
different	O
dopamine	O
agonists	O
produces	O
a	O
different	O
pattern	O
of	O
effects	O
on	O
the	O
characteristics	O
of	O
the	O
reaction	O
time	O
response	O
.	O

The	O
first	O
group	O
of	O
sequential	O
BMB	O
showed	O
a	O
significant	O
progress	O
to	O
myelofibrosis	O
in	O
so	O
-	O
called	O
""""	O
Chronic	O
Megakaryocytic	O
-	O
Granulocytic	O
Myelosis	O
"""--"	O
CMGM-	O
,	O
which	O
corresponds	O
to	O
Agnogenic	O
Myeloid	O
Metaplasia	O
-	O
AMM	O
-	O
in	O
72.4	O
%	O
(	O
21	O
/	O
29	O
patients	O
)	O
,	O
as	O
well	O
as	O
in	O
CML	O
with	O
megakaryocytic	O
increase	O
-	O
CML.MI	O
-	O
in	O
39.2	O
%	O
(	O
20	O
/	O
51	O
)	O
.	O

Chicken	O
sterol	B
carrier	I
protein	I
2	I
/	O
sterol	B
carrier	I
protein	I
x	I
:	O
cDNA	O
cloning	O
reveals	O
evolutionary	O
conservation	O
of	O
structure	O
and	O
regulated	O
expression	O
.	O

A	O
single	O
five	O
minute	O
period	O
of	O
rapid	O
atrial	O
pacing	O
fails	O
to	O
limit	O
infarct	O
size	O
in	O
the	O
in	O
situ	O
rabbit	O
heart	O
.	O

Previous	O
studies	O
indicated	O
that	O
the	O
20S	B
proteasome	I
is	O
a	O
catalytic	O
core	O
of	O
the	O
26S	B
proteolytic	I
complex	I
that	O
possesses	O
a	O
latent	O
multicatalytic	O
proteinase	O
activity	O
and	O
catalyzes	O
an	O
ATP	O
-	O
dependent	O
,	O
selective	O
breakdown	O
of	O
proteins	O
ligated	O
to	O
ubiquitin	B
.	O

The	O
phosphorylation	O
efficiency	O
is	O
improved	O
by	O
increasing	O
the	O
number	O
of	O
N	O
-	O
terminal	O
arginine	O
residues	O
and	O
by	O
moving	O
the	O
arginyl	O
cluster	O
one	O
residue	O
further	O
away	O
from	O
the	O
serine	O
,	O
the	O
nonapeptide	O
(	O
Arg	O
)	O
4-Ala	O
-	O
Ala	O
-	O
Ser	O
-	O
Val	O
-	O
Ala	O
being	O
the	O
best	O
substrate	O
among	O
all	O
the	O
short	O
peptides	O
tested	O
(	O
Km	O
=	O
15	O
microM	O
)	O
.	O

The	O
UV	O
induction	O
of	O
c	B
-	I
jun	I
is	O
mediated	O
by	O
two	O
UV	O
response	O
elements	O
consisting	O
of	O
AP-1-like	B
sequences	I
within	O
its	O
5	O
'	O
control	O
region	O
.	O

When	O
comparing	O
the	O
barley	B
PSI	I
-	I
K	I
and	O
PSI	B
-	I
G	I
with	O
the	O
reported	O
PSI	B
-	I
K	I
sequence	I
from	I
Synechococcus	I
vulcanus	I
,	O
the	O
degree	O
of	O
similarity	O
is	O
equal	O
,	O
suggesting	O
that	O
an	O
ancestral	O
gene	O
has	O
been	O
duplicated	O
in	O
a	O
chloroplast	O
progenitor	O
but	O
not	O
in	O
a	O
cyanobacterial	O
.	O

The	O
simultaneous	O
recording	O
of	O
electrical	O
activity	O
from	O
the	O
surface	O
electrocardiogram	O
,	O
right	O
ventricular	O
apex	O
,	O
His	O
bundle	O
,	O
high	O
right	O
atrium	O
,	O
coronary	O
sinus	O
,	O
with	O
or	O
without	O
a	O
roving	O
mapping	O
catheter	O
,	O
enables	O
us	O
to	O
precisely	O
map	O
the	O
electrical	O
activation	O
sequence	O
in	O
the	O
heart	O
.	O

Differences	O
in	O
profiles	O
of	O
viscosity	O
variables	O
between	O
subgroups	O
of	O
EAD	O
in	O
RA	O
patients	O
were	O
observed	O
.	O

Since	O
the	O
-172	O
/	O
-148	O
element	O
also	O
conferred	O
estrogen	O
and	O
thyroid	O
hormone	O
responsiveness	O
,	O
it	O
can	O
be	O
considered	O
a	O
composite	O
hormone	O
response	O
element	O
.	O

Together	O
with	O
a	O
considerably	O
shortened	O
and	O
interrupted	O
aromatic	O
aa	O
stretch	O
in	O
this	O
region	O
,	O
these	O
differences	O
are	O
discussed	O
in	O
terms	O
of	O
the	O
peculiar	O
affinity	O
of	O
cyanobacterial	B
cytochrome	I
oxidases	I
for	O
acidic	O
c	B
-	I
type	I
cytochromes	I
.	O

Mutation	O
of	O
the	O
presumptive	O
phosphorylated	O
tyrosine	O
and	O
threonine	O
residues	O
of	O
Mpk1p	B
individually	O
to	O
phenylalanine	O
and	O
alanine	O
,	O
respectively	O
,	O
severely	O
impaired	O
Mpk1p	B
function	O
.	O

16	O
,	O
99	O
-	O
104	O
)	O
.	O

In	O
this	O
report	O
,	O
we	O
focus	O
on	O
the	O
genetics	O
of	O
the	O
region	O
of	O
the	O
17	B
hep	I
syn	I
gB	I
gene	I
that	O
conferred	O
both	O
the	O
syncytial	O
and	O
pathogenic	O
phenotypes	O
to	O
17	B
syn+	I
.	O

Drugs	O
suppressed	O
>	O
or	O
=	O
75	O
%	O
of	O
the	O
total	O
premature	O
ventricular	O
contractions	O
in	O
all	O
patients	O
who	O
had	O
both	O
use	O
-	O
dependent	O
QRS	O
prolongation	O
and	O
reverse	O
use	O
-	O
dependent	O
QT	O
prolongation	O
,	O
in	O
79	O
%	O
of	O
patients	O
with	O
use	O
-	O
dependent	O
QRS	O
prolongation	O
alone	O
,	O
in	O
70	O
%	O
with	O
reverse	O
use	O
-	O
dependent	O
QT	O
prolongation	O
alone	O
,	O
and	O
in	O
11	O
%	O
with	O
neither	O
use	O
-	O
dependent	O
QRS	O
prolongation	O
nor	O
reverse	O
use	O
-	O
dependent	O
QT	O
prolongation	O
.	O

Genetic	O
interactions	O
between	O
BCK2	B
and	O
other	O
pathway	O
components	O
suggested	O
that	O
BCK2	B
functions	O
on	O
a	O
common	O
pathway	O
branch	O
with	O
PPZ1	B
and	O
PPZ2	B
.	O

These	O
experiments	O
confirm	O
that	O
the	O
6-S	O
liganded	O
form	O
of	O
the	O
receptor	O
identified	O
in	O
nuclear	O
extracts	O
of	O
cells	O
treated	O
with	O
2,3,7,8-tetrachlorodibenzo	O
-	O
p	O
-	O
dioxin	O
(	O
TCDD	O
)	O
contains	O
the	O
Ah	B
receptor	I
protein	I
and	O
ARNT	B
but	O
not	O
the	O
90-kDa	B
heat	I
shock	I
protein	I
.	O

Regulated	O
activity	O
of	O
the	O
distal	O
promoter	O
-	O
like	O
element	O
of	O
the	O
human	B
corticotropin	I
-	I
releasing	I
hormone	I
gene	I
and	O
secondary	O
structural	O
features	O
of	O
its	O
corresponding	O
transcripts	O
.	O

We	O
linked	O
hypersensitivity	O
site	O
2	O
(	O
HS2	O
)	O
from	O
the	O
locus	O
control	O
region	O
(	O
LCR	O
)	O
to	O
a	O
A	B
gamma	I
-	I
globin	I
gene	O
(	O
A	B
gamma	I
*	I
)	O
mutationally	O
marked	O
to	O
allow	O
its	O
transcript	O
to	O
be	O
distinguished	O
from	O
endogenous	O
gamma	B
-	I
globin	I
mRNA	O
.	O

Skin	O
and	O
bowel	O
TPO2	O
varied	O
with	O
DO2	O
and	O
each	O
other	O
(	O
P	O
<	O
0.05	O
)	O
.	O

Transgenic	O
mice	O
harboring	O
the	O
rat	O
TnI	B
-	O
CAT	B
fusion	O
gene	O
expressed	O
the	O
reporter	O
specifically	O
in	O
the	O
skeletal	O
muscle	O
.	O

METHODS	O
:	O
Fifty	O
-	O
one	O
healthy	O
eyes	O
,	O
169	O
ocular	O
hypertensive	O
eyes	O
with	O
normal	O
visual	O
fields	O
,	O
and	O
132	O
glaucomatous	O
eyes	O
with	O
early	O
visual	O
field	O
defects	O
were	O
evaluated	O
with	O
qualitative	O
and	O
quantitative	O
measures	O
of	O
structural	O
damage	O
to	O
the	O
optic	O
nerve	O
and	O
nerve	O
fiber	O
layer	O
.	O

To	O
identify	O
factors	O
that	O
may	O
modify	O
the	O
heterosexual	O
transmission	O
of	O
human	O
T	O
cell	O
leukemia	O
/	O
lymphoma	O
virus	O
type	O
I	O
(	O
HTLV	O
-	O
I	O
)	O
,	O
534	O
married	O
couples	O
enrolled	O
in	O
the	O
Miyazaki	O
Cohort	O
Study	O
between	O
November	O
1984	O
and	O
April	O
1989	O
were	O
studied	O
:	O
95	O
husband	O
HTLV	O
-	O
I	O
-	O
seropositive	O
(	O
H+	O
)	O
/	O
wife	O
seropositive	O
(	O
W+	O
)	O
,	O
33	O
H+	O
/	O
W-	O
,	O
64	O
H-	O
/	O
W+	O
,	O
and	O
342	O
H-	O
/	O
W-	O
.	O

The	O
nucleotide	O
sequence	O
of	O
the	O
gene	O
predicts	O
a	O
polypeptide	O
of	O
215	O
amino	O
acids	O
(	O
25.2	O
kDa	O
)	O
with	O
two	O
putative	O
membrane	O
-	O
spanning	O
domains	O
.	O

An	O
extensive	O
inverted	O
repeat	O
is	O
present	O
3	O
'	O
of	O
rpeA	B
;	O
inverted	O
repeats	O
are	O
found	O
downstream	O
of	O
all	O
PE	B
operons	I
sequenced	O
to	O
date	O
,	O
although	O
the	O
sequence	O
is	O
not	O
conserved	O
.	O

Localization	O
of	O
the	O
intronless	O
gene	O
coding	O
for	O
calmodulin	B
-	I
like	I
protein	I
CLP	B
to	O
human	O
chromosome	O
10p13-ter	O
.	O

In	O
wandering	O
stage	O
larvae	O
,	O
the	O
OBP	B
transcript	I
appeared	O
to	O
be	O
at	O
least	O
250-fold	O
less	O
abundant	O
than	O
ribosomal	O
RNA	O
.	O

However	O
,	O
L	B
-	I
plastin	I
has	O
been	O
found	O
in	O
many	O
types	O
of	O
malignant	O
human	O
cells	O
of	O
non	O
-	O
hemopoietic	O
origin	O
suggesting	O
that	O
its	O
expression	O
is	O
induced	O
accompanying	O
tumorigenesis	O
in	O
solid	O
tissues	O
.	O

The	O
DNase	B
I	I
footprint	O
extended	O
5	O
'	O
in	O
the	O
silencer	O
region	O
to	O
include	O
an	O
inverted	O
repeat	O
of	O
a	O
six	O
-	O
nucleotide	O
motif	O
(	O
epsilon	O
-267	O
to	O
-278	O
bp	O
)	O
which	O
shares	O
5	O
of	O
6	O
bases	O
with	O
the	O
GATA-1	B
consensus	I
sequence	I
.	O

This	O
report	O
describes	O
the	O
identification	O
of	O
a	O
gene	O
of	O
related	O
function	O
,	O
SMD1	B
,	O
located	O
immediately	O
3	O
'	O
to	O
PRP38	B
.	O

This	O
short	O
communication	O
compares	O
a	O
novel	O
fluorimetric	O
microplate	O
enzyme	O
immunoassay	O
(	O
FEIA	O
)	O
with	O
a	O
commercial	O
time	O
-	O
resolved	O
fluoroimmunoassay	O
for	O
the	O
determination	O
of	O
thyrotropin	B
in	O
dried	O
blood	O
spots	O
.	O

Constructs	O
containing	O
the	O
full	B
-	I
length	I
PfCPK	I
cDNA	I
have	O
been	O
expressed	O
in	O
Escherichia	O
coli	O
at	O
a	O
high	O
level	O
to	O
generate	O
a	O
60-kDa	O
recombinant	O
protein	O
.	O

Endosonography	O
accurately	O
assessed	O
tumor	O
extension	O
in	O
two	O
T2	O
tumors	O
,	O
14	O
T3	O
tumors	O
,	O
and	O
seven	O
T4	O
tumors	O
.	O

Analysis	O
of	O
cell	O
cycle	O
regulation	O
in	O
the	O
budding	O
yeast	O
Saccharomyces	O
cerevisiae	O
has	O
shown	O
that	O
a	O
central	O
regulatory	O
protein	O
kinase	O
,	O
Cdc28	B
,	O
undergoes	O
changes	O
in	O
activity	O
through	O
the	O
cell	O
cycle	O
by	O
associating	O
with	O
distinct	O
groups	O
of	O
cyclins	B
that	O
accumulate	O
at	O
different	O
times	O
.	O

Ig	B
-	I
alpha	I
and	O
Ig	B
-	I
beta	I
contain	O
extended	O
cytoplasmic	O
structure	O
(	O
61	O
and	O
48	O
amino	O
acids	O
,	O
respectively	O
)	O
and	O
associate	O
with	O
cytoplasmic	O
effectors	O
indicating	O
that	O
they	O
are	O
directly	O
involved	O
in	O
signal	O
transduction	O
.	O

Internal	O
amino	O
acid	O
sequence	O
has	O
now	O
been	O
obtained	O
from	O
this	O
protein	O
which	O
shares	O
50	O
-	O
100	O
%	O
sequence	O
identity	O
with	O
sequences	O
encoded	O
by	O
mammalian	B
G	I
alpha	I
11	I
and	O
G	B
alpha	I
q	I
cDNAs	I
.	O

Nitric	O
oxide	O
inhalation	O
selectively	O
reduces	O
pulmonary	O
hypertension	O
in	O
porcine	O
endotoxin	O
shock	O
and	O
improves	O
arterial	O
oxygenation	O
and	O
pH	O
with	O
a	O
marked	O
attenuation	O
of	O
sympathetic	O
activation	O
.	O

The	O
fission	B
yeast	I
dsk1	I
+	I
gene	I
,	O
a	O
multicopy	O
suppressor	O
for	O
cold	O
-	O
sensitive	O
dis1	B
mutants	I
,	O
encodes	O
a	O
novel	O
61-kd	O
protein	O
kinase	O
.	O

The	O
strategies	O
by	O
which	O
hepatitis	O
B	O
and	O
hepatitis	O
D	O
can	O
be	O
diminished	O
and	O
eventually	O
eliminated	O
are	O
:	O
immunization	O
,	O
measures	O
to	O
prevent	O
exposure	O
to	O
infective	O
blood	O
or	O
blood	O
derivatives	O
and	O
education	O
(	O
in	O
particular	O
awareness	O
that	O
hepatitis	O
B	O
is	O
a	O
sexually	O
transmitted	O
disease	O
)	O
.	O

The	O
gene	O
encoding	O
the	O
receptor	O
for	O
macrophage	B
colony	I
-	I
stimulating	I
factor	I
1	I
(	O
CSF-1	B
)	O
,	O
the	O
c	B
-	I
fms	I
protooncogene	I
,	O
is	O
selectively	O
expressed	O
in	O
immature	O
and	O
mature	O
mononuclear	O
phagocytes	O
and	O
trophoblasts	O
.	O

This	O
sequence	O
similarity	O
raises	O
the	O
possibility	O
that	O
GCN1	B
interacts	O
with	O
ribosomes	O
or	O
tRNA	O
molecules	O
and	O
functions	O
in	O
conjunction	O
with	O
GCN2	B
in	O
monitoring	O
uncharged	O
tRNA	O
levels	O
during	O
the	O
process	O
of	O
translation	O
elongation	O
.	O

However	O
,	O
study	O
of	O
the	O
productive	O
gamma	O
gene	O
showed	O
that	O
the	O
skipped	O
variable	O
exon	O
was	O
bounded	O
by	O
normal	O
splicing	O
signals	O
and	O
that	O
the	O
adjacent	O
intron	O
organization	O
was	O
not	O
altered	O
.	O

Patient	O
characteristics	O
associated	O
with	O
deep	O
wounds	O
as	O
well	O
as	O
patient	O
and	O
wound	O
characteristics	O
predictive	O
of	O
the	O
extent	O
of	O
healing	O
and	O
time	O
required	O
for	O
healing	O
were	O
identified	O
.	O

The	O
remaining	O
RAD+	B
cells	O
progressed	O
to	O
form	O
microcolonies	O
(	O
<	O
30	O
cells	O
)	O
containing	O
aberrantly	O
shaped	O
inviable	O
cells	O
.	O

The	O
human	B
gp39	I
promoter	I
.	O

There	O
is	O
no	O
TATA	O
box	O
around	O
the	O
transcriptional	O
start	O
points	O
(	O
tsp	O
)	O
,	O
as	O
determined	O
by	O
primer	O
extension	O
analysis	O
.	O

In	O
summary	O
,	O
the	O
efficacies	O
of	O
adjuvant	O
carboplatin	O
and	O
of	O
abdominal	O
radiotherapy	O
seem	O
to	O
be	O
identical	O
.	O

Thus	O
,	O
SPECT	O
was	O
not	O
as	O
sensitive	O
as	O
PET	O
in	O
this	O
activation	O
task	O
.	O

Transcriptional	O
activation	O
of	O
the	O
chicken	B
lysozyme	I
gene	I
by	O
NF	B
-	I
kappa	I
Bp65	I
(	O
RelA	B
)	O
and	O
c	B
-	I
Rel	I
,	O
but	O
not	O
by	O
NF	B
-	I
kappa	I
Bp50	I
.	O

Consistent	O
with	O
a	O
possible	O
role	O
in	O
transcription	O
,	O
Paf1p	B
is	O
localized	O
to	O
the	O
nucleus	O
.	O

Hb	B
levels	O
remained	O
adequate	O
(	O
Hb	B
=	O
10.68	O
+	O
/-	O

0.77	O
g	O
/	O
dl	O
)	O
after	O
14.6	O
+	O
/-	O

7.64	O
months	O
.	O

SBF	B
binds	O
to	O
the	O
promoter	O
prior	O
to	O
the	O
activation	O
of	O
transcription	O
in	O
late	O
G1	O
,	O
suggesting	O
that	O
Cln	B
/	O
Cdc28	B
kinase	O
regulates	O
the	O
ability	O
of	O
previously	O
bound	O
SBF	B
to	O
activate	O
transcription	O
.	O

This	O
analysis	O
revealed	O
that	O
SAP	B
145	I
,	O
together	O
with	O
four	O
other	O
SF3a	B
/	O
SF3b	B
subunits	O
,	O
UV	O
cross	O
-	O
links	O
to	O
pre	O
-	O
mRNA	O
in	O
a	O
20-nucleotide	O
region	O
upstream	O
of	O
the	O
BPS	O
.	O

Molecular	O
cloning	O
,	O
expression	O
pattern	O
,	O
and	O
chromosomal	O
localization	O
of	O
human	O
CDKN2D	B
/	O
INK4d	B
,	O
an	O
inhibitor	O
of	O
cyclin	B
D	I
-	I
dependent	I
kinases	I
.	O

The	O
IL-8	B
receptor	I
is	O
a	O
seven	O
-	O
transmembrane	O
spanning	O
receptor	O
coupled	O
to	O
specific	O
heterotrimeric	B
G	I
proteins	I
including	O
Gi	B
and	O
G16	B
.	O

During	O
the	O
following	O
pregnancy	O
ultrasonographic	O
studies	O
of	O
the	O
male	O
fetus	O
in	O
the	O
16th	O
week	O
of	O
gestation	O
revealed	O
severe	O
micrognathia	O
,	O
short	O
and	O
wide	O
thumbs	O
,	O
and	O
big	O
toes	O
,	O
and	O
bowed	O
tibiae	O
.	O

The	O
mean	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
was	O
31.8	O
+	O
/-	O

6.3	O
kg	O
/	O
m2	O
and	O
28.5	O
+	O
/-	O

6.3	O
kg	O
/	O
m2	O
in	O
women	O
and	O
men	O
,	O
respectively	O
.	O

These	O
data	O
suggest	O
that	O
RPF-1	B
is	O
likely	O
to	O
be	O
involved	O
in	O
early	O
steps	O
in	O
the	O
differentiation	O
of	O
amacrine	O
and	O
ganglion	O
cells	O
.	O

In	O
the	O
point	O
mutant	O
we	O
observed	O
normal	O
repair	O
of	O
endonuclease	B
III	I
site	I
(	O
i.e.	O
as	O
wild	O
type	O
)	O
,	O
but	O
no	O
removal	O
of	O
CPDs	O
at	O
the	O
MAT	B
alpha	I
and	O
HML	B
alpha	I
loci	I
.	O

Carboxy	O
-	O
terminal	O
Spc110p	B
truncations	O
lacking	O
the	O
calmodulin	B
binding	O
site	O
can	O
support	O
growth	O
and	O
are	O
also	O
phosphorylated	O
in	O
a	O
cell	O
cycle	O
-	O
specific	O
manner	O
.	O

Ongoing	O
and	O
future	O
investigations	O
may	O
better	O
define	O
the	O
optimal	O
approach	O
for	O
local	O
control	O
,	O
the	O
optimal	O
duration	O
of	O
maintenance	O
chemotherapy	O
,	O
and	O
the	O
possible	O
role	O
of	O
biologic	O
response	O
modifiers	O
and	O
growth	O
factors	O
in	O
further	O
improving	O
the	O
outcome	O
for	O
patients	O
with	O
this	O
disease	O
.	O

SUMMARY	O
OF	O
REVIEW	O
:	O
We	O
discuss	O
the	O
criteria	O
that	O
make	O
such	O
studies	O
comparable	O
,	O
drawing	O
on	O
the	O
experiences	O
of	O
recent	O
studies	O
performed	O
around	O
the	O
world	O
.	O

Left	O
atrial	O
volumes	O
were	O
greater	O
in	O
old	O
compared	O
with	O
young	O
subjects	O
(	O
maximal	O
:	O
31	O
+	O
/-	O

10	O
cm3	O
/	O
m2	O
vs	O
24	O
+	O
/-	O

8	O
cm3	O
/	O
m2	O
,	O
p	O
=	O
0.02	O
;	O
at	O
onset	O
of	O
atrial	O
systole	O
:	O
23	O
+	O
/-	O

8	O
cm3	O
/	O
m2	O
vs	O
15	O
+	O
/-	O

5	O
cm3	O
/	O
m2	O
,	O
p	O
=	O
0.0002	O
;	O
minimal	O
:	O
13	O
+	O
/-	O

5	O
cm3	O
/	O
m2	O
vs	O
9	O
+	O
/-	O

4	O
cm3	O
/	O
m2	O
,	O
p	O
=	O
0.001	O
)	O
.	O

We	O
observed	O
abundant	O
levels	O
of	O
Rev	B
-	O
erbA	B
alpha	I
mRNA	O
in	O
dividing	O
C2C12	O
myoblasts	O
,	O
which	O
were	O
suppressed	O
when	O
the	O
cells	O
differentiated	O
into	O
postmitotic	O
multinucleated	O
myotubes	O
.	O

As	O
expected	O
,	O
glycosylation	O
of	O
Env	B
produced	O
from	O
mutants	O
was	O
affected	O
but	O
,	O
irrespective	O
of	O
the	O
glycosylation	O
phenotype	O
,	O
(	O
i	O
)	O
similar	O
quantities	O
of	O
Env	B
were	O
synthesized	O
,	O
(	O
ii	O
)	O
the	O
immunoreactivity	O
of	O
V3	B
was	O
similar	O
,	O
(	O
iii	O
)	O
gp160	B
was	O
efficiently	O
cleaved	O
into	O
gp120	B
and	O
gp41	B
,	O
(	O
vi	O
)	O
Env	B
was	O
exposed	O
at	O
the	O
cell	O
membrane	O
,	O
(	O
v	O
)	O
secreted	O
gp120	B
bound	O
CD4	B
,	O
and	O
(	O
vi	O
)	O
membrane	O
gp41	B
was	O
able	O
to	O
induce	O
membrane	O
fusion	O
with	O
CD4	B
+	I
cells	O
.	O

On	O
the	O
trail	O
of	O
Dr.	O

Analysis	O
of	O
RAR	B
alpha	I
mutants	I
in	O
transfection	O
studies	O
reveals	O
that	O
the	O
DNA	O
binding	O
domain	O
is	O
sufficient	O
for	O
inhibition	O
of	O
BZLF1	B
activity	O
.	O

We	O
measured	O
serum	B
hepatocyte	I
growth	I
factor	I
(	O
HGF	B
)	O
in	O
patients	O
with	O
acute	O
myocardial	O
infarction	O
,	O
angina	O
pectoris	O
,	O
and	O
other	O
heart	O
diseases	O
.	O

No	O
significant	O
differences	O
existed	O
between	O
the	O
two	O
age	O
groups	O
in	O
baseline	O
characteristics	O
,	O
including	O
treatment	O
protocol	O
,	O
performance	O
status	O
,	O
and	O
serum	B
lactate	I
dehydrogenase	I
(	O
LDH	B
)	O
level	O
.	O

In	O
agreement	O
with	O
previous	O
in	O
vitro	O
data	O
,	O
we	O
have	O
shown	O
that	O
UmuD	B
and	O
UmuD	B
'	I
are	O
able	O
to	O
form	O
both	O
homodimers	O
(	O
UmuD	B
-	O
UmuD	B
and	O
UmuD'-UmuD	B
'	B
)	O
and	O
a	O
heterodimer	O
(	O
UmuD	B
-	O
UmuD	B
'	I
)	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
using	O
crude	O
extracts	O
from	O
FREJ4	O
cells	O
revealed	O
the	O
binding	O
of	O
a	O
member	O
(	O
s	O
)	O
of	O
the	O
Ets	B
family	I
of	I
transcription	I
factors	I
to	O
the	O
P4	B
EBS	I
,	O
as	O
well	O
as	O
the	O
interaction	O
of	O
two	O
members	O
of	O
the	O
Sp1	B
family	I
,	O
Sp1	B
and	O
Sp3	B
,	O
with	O
the	O
adjacent	O
GC	O
box	O
.	O

Taken	O
together	O
,	O
our	O
results	O
indicate	O
that	O
thrombin	B
-	O
stimulated	O
vascular	O
smooth	O
muscle	O
proliferation	O
is	O
delayed	O
and	O
requires	O
the	O
de	O
novo	O
expression	O
of	O
one	O
or	O
more	O
autocrine	O
mitogens	O
.	O

Adduction	O
of	O
the	O
human	B
N	I
-	I
ras	I
codon	I
61	I
sequence	I
with	O
(	O
-	O
)	O
-	O
(	O
7S,8R,9R,10S	O
)	O
-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo	O
[	O
a	O
]	O
pyrene	O
:	O
structural	O
refinement	O
of	O
the	O
intercalated	O
SRSR	O
(	O
61,2	O
)	O
(	O
-	O
)	O
-	O
(	O
7S,8R,9S,10R	O
)	O
-N6-	O
[	O
10-	O
(	O
7,8,9,10-	O
tetrahydrobenzo	O
[	O
a	O
]	O
pyrenyl	O
)	O
]	O
-2'-deoxyadenosyl	O
adduct	O
from	O
1H	O
NMR	O
.	O

Menstrual	O
-	O
cycle	O
phase	O
did	O
not	O
significantly	O
affect	O
personality	O
variables	O
in	O
either	O
group	O
.	O

Ca2	O
+	O
decreased	O
Zn2	O
+	O
binding	O
in	O
S100	B
beta	I
but	O
it	O
did	O
not	O
influence	O
binding	O
to	O
MRP14	B
,	O
suggesting	O
that	O
the	O
Zn2	O
+	O
binding	O
site	O
was	O
distinct	O
from	O
and	O
independent	O
of	O
the	O
two	O
Ca2	O
+	O
binding	O
domains	O
.	O

A	O
direct	O
role	O
for	O
sterol	B
regulatory	I
element	I
binding	I
protein	I
in	O
activation	O
of	O
3-hydroxy-3-methylglutaryl	B
coenzyme	I
A	I
reductase	I
gene	I
.	O

An	O
inactive	O
analog	O
of	O
wortmannin	O
,	O
WM12	O
,	O
did	O
not	O
affect	O
TCR	B
/	O
CD3-induced	B
Erk2	B
activation	O
,	O
and	O
wortmannin	O
had	O
no	O
effect	O
on	O
the	O
activity	O
of	O
Erk2	B
when	O
added	O
directly	O
to	O
the	O
in	O
vitro	O
assays	O
.	O

The	O
transcription	O
start	O
point	O
of	O
the	O
proximal	O
promoter	O
aligns	O
to	O
that	O
of	O
mouse	O
promoter	O
P3	O
and	O
lies	O
within	O
a	O
conserved	O
region	O
of	O
sequence	O
.	O

To	O
determine	O
the	O
signal	B
recognition	I
particle	I
(	O
SRP	B
)	O
-SRP	O
receptor	B
(	O
Srb	B
)	O
system	O
in	O
Bacillus	O
subtilis	O
(	O
Bs	O
)	O
,	O
we	O
cloned	O
the	O
Bs	B
srb	I
gene	I
,	O
which	O
encodes	O
a	O
homologue	O
of	O
the	O
mammalian	B
SRP	I
receptor	I
alpha	I
-	I
subunit	I
[	O
Oguro	O
et	O
al.	O
,	O
DNA	O
Res	O
.	O

An	O
apparent	O
ufo	B
mRNA	I
overexpression	O
was	O
not	O
found	O
in	O
any	O
of	O
the	O
positive	O
leukemia	O
cell	O
lines	O
,	O
but	O
was	O
identified	O
in	O
the	O
drug	O
-	O
resistant	O
subclones	O
of	O
the	O
cervix	O
carcinoma	O
cell	O
line	O
HeLa	O
.	O

Reproducing	O
populations	O
of	O
this	O
aphid	O
were	O
first	O
detected	O
in	O
Puerto	O
Rico	O
in	O
April	O
1992	O
.	O

At	O
cuticular	O
positions	O
exhibiting	O
the	O
Brd	B
bristle	I
loss	I
phenotype	I
,	O
we	O
have	O
found	O
that	O
the	O
progeny	O
of	O
the	O
multiplied	O
SOPs	O
develop	O
aberrantly	O
,	O
in	O
that	O
neurons	O
and	O
thecogen	O
(	O
sheath	O
)	O
cells	O
appear	O
but	O
not	O
trichogen	O
(	O
shaft	O
)	O
and	O
tormogen	O
(	O
socket	O
)	O
cells	O
.	O

Transcriptional	O
blockade	O
was	O
reversed	O
by	O
co	O
-	O
transfections	O
of	O
a	O
wild	B
-	I
type	I
SRF	I
expression	O
vector	O
,	O
but	O
was	O
not	O
rescued	O
by	O
the	O
expression	O
of	O
other	O
myogenic	O
factors	O
,	O
such	O
as	O
MyoD	B
and	O
Mef-2C	B
.	O

The	O
mMIWC1	B
promoter	I
was	O
identified	O
and	O
contained	O
TATA	O
,	O
CAAT	O
,	O
GATA	O
,	O
and	O
AP-2	B
elements	I
;	O
primer	O
extension	O
revealed	O
mMIWC	B
transcription	O
initiation	O
at	O
621	O
bp	O
upstream	O
from	O
the	O
mMIWC1	B
translational	O
initiation	O
site	O
.	O

We	O
have	O
obtained	O
the	O
human	B
EP4	I
receptor	I
gene	I
sequence	I
and	O
determined	O
its	O
structure	O
relative	O
to	O
EP4R	B
cDNA	I
synthesized	O
from	O
peripheral	O
blood	O
lymphocytes	O
.	O

Specifically	O
,	O
the	O
deduced	O
FR-19	B
amino	I
acid	I
sequence	I
has	O
approximately89	O
,	O
77	O
,	O
and	O
68	O
%	O
overall	O
identity	O
to	O
chicken	B
TEF-1A	I
,	O
mouse	B
TEF-1	I
,	O
and	O
mouse	B
embryonic	I
TEA	I
domain	I
-	I
containing	I
factor	I
,	O
respectively	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
cloned	O
the	O
human	B
DSG3	I
gene	I
and	O
examined	O
the	O
transcriptional	O
regulation	O
of	O
its	O
expression	O
.	O

ZIOS	O
was	O
significantly	O
more	O
sensitive	O
than	O
all	O
subsequent	O
methods	O
,	O
and	O
Ptc	O
,	O
O2	O
was	O
significantly	O
more	O
sensitive	O
than	O
FEV1	O
.	O

Vacuolar	O
membrane	O
vesicles	O
from	O
hum1	B
mutants	I
lack	O
all	O
Ca2+	O
/	O
H+	O
antiport	O
activity	O
,	O
demonstrating	O
that	O
Hum1p	B
catalyzes	O
the	O
exchange	O
of	O
Ca2	O
+	O
for	O
H+	O
across	O
the	O
yeast	O
vacuolar	O
membrane	O
.	O

However	O
,	O
one	O
3	O
'	O
splice	O
site	O
,	O
located	O
at	O
nucleotide	O
(	O
nt	O
)	O
3225	O
,	O
is	O
used	O
for	O
the	O
processing	O
of	O
most	O
BPV-1	O
pre	O
-	O
mRNAs	O
in	O
BPV-1-transformed	O
C127	O
cells	O
and	O
at	O
early	O
to	O
intermediate	O
times	O
in	O
productively	O
infected	O
warts	O
.	O

HS	O
inducibility	O
required	O
the	O
HSE	O
which	O
was	O
bound	O
by	O
HS	B
transcription	I
factor-1	I
(	O
HSF-1	B
)	O
present	O
in	O
extracts	O
prepared	O
from	O
cells	O
exposed	O
to	O
HS	O
.	O

The	O
logistic	O
regression	O
analysis	O
of	O
the	O
manual	O
method	O
(	O
percentage	O
normal	O
morphology	O
)	O
and	O
IVOS	O
indicated	O
that	O
both	O
were	O
predictors	O
of	O
fertilization	O
.	O

There	O
was	O
a	O
general	O
broadening	O
of	O
proton	O
resonances	O
for	O
a	O
three	O
-	O
nucleotide	O
segment	O
centered	O
about	O
the	O
lesion	O
site	O
which	O
resulted	O
in	O
a	O
tentative	O
assignment	O
for	O
the	O
sugar	O
protons	O
of	O
the	O
C7	O
residue	O
in	O
the	O
spectrum	O
of	O
the	O
adduct	O
duplex	O
.	O

Cbl	B
constitutively	O
interacts	O
with	O
the	O
SH3	B
domains	I
of	O
Grb2	B
,	O
with	O
a	O
preference	O
for	O
the	O
amino	O
-	O
terminal	O
domain	O
,	O
and	O
is	O
in	O
this	O
way	O
recruited	O
to	O
Shc	B
upon	O
BCR	B
stimulation	O
.	O

Activation	O
mediated	O
by	O
Cat8p	B
was	O
no	O
longer	O
detectable	O
in	O
a	O
cat1	B
mutant	I
.	O

METHODS	O
:	O
DSF	O
was	O
instilled	O
in	O
one	O
eye	O
chosen	O
at	O
random	O
and	O
CF	O
in	O
the	O
fellow	O
eye	O
of	O
13	O
normal	O
subjects	O
and	O
in	O
13	O
patients	O
with	O
KCS	O
.	O

In	O
addition	O
,	O
they	O
display	O
common	O
features	O
that	O
make	O
them	O
strikingly	O
related	O
to	O
snoRNA	B
U14	I
.	O

The	O
relative	O
tumor	O
FDG	O
-	O
uptake	O
(	O
Q	O
-	O
MRGlu	O
)	O
(	O
tumor	O
/	O
contralateral	O
cortex	O
)	O
of	O
all	O
meningiomas	O
was	O
calculated	O
with	O
0.73	O
+	O
/-	O

0.37	O
(	O
0.24	O
-	O
1.79	O
)	O
.	O

The	O
most	O
frequent	O
causes	O
of	O
the	O
meningitis	O
was	O
the	O
external	O
ventricular	O
drainage	O
(	O
14.8	O
%	O
)	O
,	O
post	O
-	O
neurosurgical	O
(	O
0.8	O
%	O
)	O
and	O
head	O
injury	O
(	O
0.0007	O
%	O
)	O
.	O

Fifty	O
-	O
one	O
patients	O
with	O
primary	O
refractory	O
or	O
relapsed	O
malignant	O
lymphoma	O
(	O
47	O
non	O
-	O
Hodgkin	O
's	O
lymphoma	O
and	O
four	O
Hodgkin	O
's	O
disease	O
)	O
were	O
treated	O
with	O
a	O
new	O
chemotherapeutic	O
regimen	O
(	O
cisplatinum	O
,	O
methyl	O
GAG	O
,	O
bleomocyin	O
,	O
methyl	O
prednisolon	O
)	O
.	O

In	O
3	O
treatments	O
the	O
diet	O
was	O
supplemented	O
with	O
0	O
,	O
100	O
and	O
150	O
mg	O
probiotic	O
/	O
kg	O
food	O
.	O

This	O
caused	O
severe	O
cortical	O
damage	O
and	O
neuronal	O
loss	O
in	O
hippocampus	O
subfields	O
CA1	O
,	O
CA3	O
,	O
and	O
hilus	O
.	O

Thus	O
,	O
the	O
characterization	O
of	O
the	O
promoter	O
region	O
should	O
help	O
to	O
define	O
regulatory	O
elements	O
that	O
control	O
neuron	O
-	O
specific	O
and	O
developmental	O
expression	O
of	O
the	O
MAP1B	B
gene	I
.	O

Mutants	O
lacking	O
the	O
3	O
'	O
stem	O
-	O
loop	O
exhibited	O
a	O
75	O
%	O
reduction	O
in	O
the	O
level	O
of	O
psaB	B
mRNA	O
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
was	O
highly	O
conserved	O
across	O
the	O
wide	O
range	O
of	O
eukaryotes	O
(	O
vertebrates	O
,	O
invertebrates	O
,	O
fungi	O
,	O
plants	O
and	O
protozoa	O
)	O
in	O
which	O
this	O
gene	O
has	O
now	O
been	O
identified	O
.	O

Semidominant	O
mutations	O
in	O
the	O
yeast	B
Rad51	I
protein	I
and	O
their	O
relationships	O
with	O
the	O
Srs2	B
helicase	I
.	O

The	O
cDNA	O
clone	O
was	O
used	O
as	O
a	O
homologous	O
probe	O
to	O
isolate	O
a	O
truncated	O
genomic	O
clone	O
encoding	O
H2A1	B
.	O

Subsequent	O
to	O
their	O
secretion	O
,	O
the	O
IGF	B
-	I
II	I
in	O
xz97	O
and	O
G11	O
cells	O
accumulated	O
in	O
the	O
conditioned	O
medium	O
mostly	O
as	O
two	O
partially	O
processed	O
species	O
with	O
appMr	O
,	O
of	O
17	O
K	O
and	O
14	O
K	O
,	O
respectively	O
.	O

Stably	O
transfected	O
human	O
kidney	O
293	O
cells	O
expressing	O
the	O
wild	B
type	I
rat	I
LH	I
/	I
CG	I
receptor	I
(	O
rLHR	B
)	O
or	O
receptors	O
with	O
C	O
-	O
terminal	O
tails	O
truncated	O
at	O
residues	O
653	O
,	O
631	O
,	O
or	O
628	O
(	O
designated	O
rLHR	B
-	I
t653	I
,	O
rLHR	B
-	I
t631	I
,	O
and	O
rLHR	B
-	I
t628	I
)	O
were	O
used	O
to	O
probe	O
the	O
importance	O
of	O
this	O
region	O
on	O
the	O
regulation	O
of	O
hormonal	O
responsiveness	O
.	O

Sleep	O
was	O
determined	O
again	O
for	O
an	O
additional	O
3	O
days	O
and	O
6	O
hours	O
.	O

A	O
neuropsychological	O
test	O
battery	O
was	O
used	O
that	O
contained	O
the	O
Wisconsin	O
card	O
sorting	O
test	O
,	O
Street	O
completion	O
test	O
,	O
Stroop	O
test	O
,	O
a	O
dichotic	O
memory	O
listening	O
test	O
,	O
and	O
a	O
facial	O
recognition	O
test	O
.	O

We	O
conclude	O
that	O
CPET	O
is	O
a	O
useful	O
investigation	O
in	O
the	O
management	O
of	O
patients	O
with	O
cardiopulmonary	O
disease	O
and	O
complements	O
the	O
various	O
other	O
investigations	O
offered	O
by	O
a	O
pulmonary	O
function	O
laboratory	O
.	O

Update	O
:	O
diphtheria	O
epidemic	O
in	O
the	O
newly	O
independent	O
states	O
of	O
the	O
former	O
USSR	O
,	O
January	O
1995-March	O
1996	O
.	O

A	O
novel	O
phosphotyrosine	O
-	O
binding	O
domain	O
in	O
the	O
N	O
-	O
terminal	O
transforming	O
region	O
of	O
Cbl	B
interacts	O
directly	O
and	O
selectively	O
with	O
ZAP-70	B
in	O
T	O
cells	O
.	O

Myelomatous	O
pleural	O
effusion	O
as	O
presentation	O
form	O
of	O
multiple	O
myeloma	O

METHODS	O
AND	O
RESULTS	O
:	O
A	O
64-year	O
-	O
old	O
woman	O
with	O
confirmed	O
AV	O
nodal	O
reentrant	O
tachycardia	O
underwent	O
a	O
successful	O
""""	O
slow	O
pathway	O
""""	O
AV	O
modification	O
with	O
a	O
single	O
radiofrequency	O
application	O
.	O

Mutations	O
in	O
three	O
loci	O
(	O
SIC1	B
,	O
SWI5	B
,	O
and	O
RIC3	B
)	O
were	O
identified	O
.	O

Almost	O
complete	O
sequence	O
identity	O
was	O
found	O
between	O
the	O
3	O
'	O
end	O
of	O
the	O
DXS6673E	B
gene	I
and	O
two	O
expressed	O
sequence	O
tags	O
(	O
ESTs	O
)	O
and	O
between	O
the	O
5	O
'	O
end	O
of	O
the	O
DXS6673E	B
gene	I
and	O
a	O
third	O
EST	O
.	O

Sequencing	O
of	O
the	O
16p	O
11.1	O
/	O
Xq28	O
duplication	O
breakpoints	O
has	O
revealed	O
the	O
presence	O
of	O
repetitive	O
immunoglobulin	B
-	I
like	I
CAGGG	I
pentamer	I
sequences	I
at	O
or	O
near	O
the	O
paralogy	O
boundaries	O
.	O

Chernoff	O
,	O
submitted	O
for	O
publication	O
)	O
.	O

Neither	O
CES1	B
nor	O
CES4	B
is	O
essential	O
for	O
cell	O
growth	O
,	O
and	O
a	O
double	O
deletion	O
mutant	O
is	O
viable	O
.	O

Constitutive	O
phosphorylation	O
of	O
the	O
CD30v	B
protein	I
was	O
demonstrated	O
by	O
in	O
vitro	O
labeling	O
with	O
[	O
32P	O
]	O
.	O

A	O
system	O
is	O
described	O
in	O
which	O
the	O
volume	O
flow	O
rate	O
of	O
blood	O
in	O
a	O
vessel	O
is	O
determined	O
using	O
transverse	O
colour	O
Doppler	O
ultrasound	O
imaging	O
.	O

This	O
paper	O
gives	O
an	O
overview	O
of	O
the	O
global	O
pattern	O
of	O
casualties	O
in	O
earthquakes	O
which	O
occurred	O
during	O
the	O
30-month	O
period	O
from	O
1	O
September	O
1993	O
to	O
29	O
February	O
1996	O
.	O

Transcription	O
factor	O
recognition	O
surface	O
on	O
the	O
RNA	B
polymerase	I
alpha	I
subunit	I
is	O
involved	O
in	O
contact	O
with	O
the	O
DNA	O
enhancer	O
element	O
.	O

Moreover	O
,	O
it	O
also	O
discusses	O
the	O
effects	O
of	O
antihypertensive	O
drugs	O
currently	O
regarded	O
as	O
first	O
-	O
choice	O
agents	O
,	O
i.e.	O
calcium	O
antagonists	O
and	O
the	O
angiotensin	B
converting	I
enzyme	I
inhibitors	O
,	O
on	O
intrarenal	O
hemodynamics	O
.	O

B	B
cell	I
antigen	I
receptor	I
(	O
BCR	B
)	O
-induced	O
apoptosis	O
in	O
the	O
WEHI-231	O
B	O
lymphoma	O
cell	O
line	O
can	O
be	O
prevented	O
by	O
engaging	O
CD40	B
.	O

An	O
InlC	B
deletion	I
mutant	I
shows	O
reduced	O
virulence	O
when	O
tested	O
in	O
an	O
intravenous	O
mouse	O
model	O
,	O
but	O
intracellular	O
replication	O
of	O
the	O
mutant	O
in	O
Caco-2	O
and	O
J774	O
cells	O
appears	O
to	O
be	O
comparable	O
with	O
that	O
of	O
the	O
wild	O
-	O
type	O
strain	O
.	O

Mutations	O
at	O
two	O
neighboring	O
sites	O
,	O
serine	O
242	O
and	O
threonine	O
255	O
,	O
exacerbated	O
the	O
effect	O
.	O

In	O
both	O
settings	O
,	O
it	O
can	O
be	O
phosphorylated	O
by	O
cyclin	B
D	I
-	I
dependent	I
kinases	I
,	O
suggesting	O
that	O
its	O
transcriptional	O
activity	O
may	O
normally	O
be	O
regulated	O
through	O
such	O
mechanisms	O
.	O

Individuals	O
attending	O
the	O
GUM	O
Department	O
in	O
the	O
Royal	O
Infirmary	O
of	O
Edinburgh	O
between	O
1990	O
and	O
1994	O
with	O
the	O
diagnosis	O
of	O
HIV	O
infection	O
,	O
genital	O
warts	O
,	O
genital	O
herpes	O
,	O
non	O
-	O
specific	O
genital	O
infection	O
(	O
NSGI	O
)	O
,	O
gonorrhoea	O
and	O
syphilis	O
were	O
included	O
in	O
the	O
study	O
.	O

Rss1p	B
encodes	O
a	O
novel	O
essential	O
protein	O
of	O
538	O
amino	O
acids	O
,	O
which	O
contains	O
an	O
extended	O
predicted	O
coiled	O
-	O
coil	O
domain	O
and	O
is	O
located	O
both	O
at	O
nuclear	O
pore	O
complexes	O
(	O
NPCs	O
)	O
and	O
in	O
the	O
cytoplasm	O
.	O

In	O
spite	O
of	O
much	O
effort	O
,	O
no	O
one	O
has	O
succeeded	O
in	O
isolating	O
and	O
characterizing	O
the	O
enzyme	O
(	O
s	O
)	O
responsible	O
for	O
synthesis	O
of	O
cellulose	O
,	O
the	O
major	O
cell	O
wall	O
polymer	O
of	O
plants	O
.	O

Factor	O
V	O
Leiden	O
is	O
a	O
genetic	O
disorder	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
venous	O
thrombosis	O
.	O

In	O
vitro	O
DNase	B
I	I
footprinting	O
showed	O
that	O
OxyR	B
-	I
C199S	I
protected	O
Pmom	B
from	O
-104	O
to	O
-46	O
on	O
the	O
top	O
strand	O
and	O
produced	O
a	O
protection	O
pattern	O
characteristic	O
of	O
reduced	B
wild	I
-	I
type	I
OxyR.	I

These	O
data	O
provide	O
strong	O
evidence	O
that	O
E2F	B
or	O
an	O
E2F	B
-	I
related	I
transcription	I
factor	I
is	O
involved	O
in	O
the	O
regulation	O
of	O
nonmuscle	B
myosin	I
expression	O
.	O

The	O
nucleotide	O
sequence	O
alignment	O
between	O
mouse	O
and	O
human	B
CA	I
IV	I
shows	O
69	O
%	O
identity	O
in	O
the	O
coding	O
region	O
and	O
all	O
of	O
the	O
exon	O
-	O
intron	O
boundaries	O
are	O
conserved	O
,	O
as	O
are	O
the	O
sizes	O
of	O
the	O
introns	O
.	O

These	O
findings	O
suggest	O
that	O
fodrin	B
proteolysis	O
in	O
vivo	O
may	O
reflect	O
the	O
activity	O
of	O
multiple	O
ICE	B
/	O
Ced-3	B
proteases	O
whose	O
partial	O
sensitivity	O
to	O
DEVD	O
-	O
CHO	O
reflects	O
a	O
limited	O
contribution	O
from	O
CPP32	B
,	O
or	O
an	O
ICE	B
/	O
Ced-3	B
protease	O
less	O
sensitive	O
than	O
CPP32	B
to	O
DEVD	O
-	O
CHO	O
inhibition	O
.	O

Recurrent	O
G	O
-	O
to	O
-	O
A	O
substitution	O
in	O
a	O
single	O
codon	O
of	O
SREBP	B
cleavage	I
-	I
activating	I
protein	I
causes	O
sterol	O
resistance	O
in	O
three	O
mutant	O
Chinese	O
hamster	O
ovary	O
cell	O
lines	O
.	O

The	O
Escherichia	B
coli	I
tet	I
-	I
repressor	I
(	O
TetR	B
)	O
operator	O
system	O
was	O
used	O
to	O
develop	O
a	O
variation	O
of	O
the	O
yeast	O
two	O
-	O
hybrid	O
assay	O
in	O
which	O
disruptions	O
of	O
protein	O
-	O
protein	O
interactions	O
can	O
be	O
identified	O
by	O
a	O
positive	O
selection	O
.	O

FK506	O
is	O
10-	O
to	O
100-fold	O
more	O
potent	O
than	O
cyclosporin	O
A	O
in	O
preventing	O
organ	O
rejection	O
and	O
in	O
toxicity	O
.	O

Our	O
results	O
demonstrate	O
that	O
the	O
promoter	O
and	O
enhancer	O
regions	O
identified	O
here	O
are	O
essential	O
for	O
maintaining	O
the	O
efficient	O
promoter	O
activity	O
of	O
the	O
human	B
activin	I
betaA	I
subunit	I
gene	I
.	O

Northern	O
(	O
RNA	O
)	O
blot	O
analyses	O
indicated	O
that	O
the	O
cdh	B
genes	I
encoding	O
the	O
five	O
subunits	O
and	O
an	O
open	O
reading	O
frame	O
(	O
ORF1	O
)	O
with	O
unknown	O
function	O
are	O
cotranscribed	O
during	O
growth	O
on	O
acetate	O
.	O

Damage	O
to	O
the	O
BBB	O
was	O
judged	O
by	O
extravasation	O
of	O
Evans	O
Blue	O
(	O
EB	O
)	O
dye	O
,	O
which	O
was	O
administered	O
either	O
2	O
,	O
3	O
,	O
24	O
or	O
48	O
h	O
after	O
onset	O
of	O
MCAo	O
.	O

The	O
determination	O
of	O
immunoglobulin	B
E	I
(	O
IgE	B
)	O
antibodies	O
by	O
one	O
of	O
several	O
laboratory	O
tests	O
,	O
by	O
skin	O
-	O
prick	O
tests	O
or	O
by	O
appropriate	O
challenge	O
procedures	O
is	O
useful	O
either	O
to	O
identify	O
atopic	O
individuals	O
or	O
as	O
outcome	O
predictors	O
in	O
wheezy	O
children	O
.	O

In	O
contrast	O
,	O
extracts	O
of	O
the	O
mutant	O
virions	O
catalyze	O
the	O
wild	O
-	O
type	O
level	O
of	O
transcription	O
from	O
an	O
exogenous	O
template	O
containing	O
an	O
early	O
promoter	O
.	O

In	O
Group	O
IV	O
dogs	O
that	O
received	O
alpha	B
-	I
MSH	I
only	O
during	O
reperfusion	O
,	O
BAEPs	O
were	O
increased	O
approximately	O
10	O
to	O
14	O
%	O
more	O
than	O
in	O
Group	O
II	O
during	O
the	O
late	O
reperfusion	O
period	O
.	O

Complementary	O
DNAs	O
encompassing	O
the	O
coat	B
protein	I
coding	O
and	O
adjacent	O
regions	O
of	O
Agropyron	O
mosaic	O
virus	O
(	O
AgMV	O
)	O
and	O
Hordeum	O
mosaic	O
virus	O
(	O
HoMV	O
)	O
were	O
cloned	O
and	O
sequenced	O
.	O

In	O
some	O
cases	O
,	O
factor	O
-	O
induced	O
Rac	B
activation	O
results	O
in	O
Rho	B
activation	O
,	O
and	O
factor	O
-	O
induced	O
Cdc42	B
activation	O
leads	O
to	O
Rac	B
activation	O
,	O
as	O
determined	O
by	O
specific	O
morphological	O
changes	O
.	O

However	O
,	O
we	O
did	O
not	O
observe	O
a	O
correlation	O
between	O
serum	O
and	O
seminal	B
plasma	I
PSA	I
levels	O
.	O

This	O
establishes	O
Rad3	B
/	O
Mec1	B
as	O
the	O
only	O
conserved	O
protein	O
which	O
is	O
required	O
for	O
all	O
the	O
DNA	O
structure	O
checkpoints	O
in	O
both	O
yeast	O
model	O
systems	O
.	O

The	O
P13	O
and	O
N22	O
of	O
ppSEPs	O
had	O
phase	O
reversal	O
relationship	O
with	O
the	O
P2	O
and	O
N2	O
recorded	O
from	O
the	O
PES	O
,	O
respectively	O
.	O

The	O
promoter	O
region	O
(	O
P1	O
)	O
corresponding	O
to	O
the	O
main	O
group	O
of	O
transcription	O
initiation	O
sites	O
is	O
devoid	O
of	O
TATA	O
and	O
CAAT	O
boxes	O
but	O
has	O
putative	O
binding	O
sites	O
for	O
the	O
transcription	B
factor	I
SP1	I
and	O
is	O
embedded	O
in	O
a	O
large	O
G	O
+	O
C	O
-	O
rich	O
domain	O
of	O
a	O
CpG	O
island	O
,	O
features	O
shared	O
by	O
the	O
promoters	O
of	O
constitutively	O
expressed	O
housekeeping	O
genes	O
.	O

Children	O
born	O
from	O
chronic	O
alcoholic	O
mothers	O
have	O
shown	O
behavioral	O
teratogenic	O
effects	O
more	O
frequently	O
than	O
morphological	O
malformations	O
.	O

Here	O
we	O
report	O
that	O
expression	O
of	O
the	O
I	B
-	I
POU	I
/	O
tI	B
-	I
POU	I
message	O
is	O
maximal	O
late	O
in	O
the	O
embryonic	O
phase	O
of	O
Drosophila	O
development	O
,	O
and	O
I	B
-	I
POU	I
is	O
the	O
preferred	O
splice	O
variant	O
.	O

Although	O
p48	B
gene	I
induction	O
is	O
dependent	O
on	O
STAT1	B
and	O
JAK1	B
,	O
activated	O
STAT1	B
does	O
not	O
bind	O
to	O
GATE	B
.	O

Differential	O
signaling	O
and	O
immediate	B
-	I
early	I
gene	I
activation	O
by	O
four	O
splice	O
variants	O
of	O
the	O
human	B
pituitary	I
adenylate	I
cyclase	I
-	I
activating	I
polypeptide	I
receptor	I
(	O
hPACAP	B
-	I
R	I
)	O
.	O

Fourth	O
,	O
the	O
3'-region	O
splice	O
junctions	O
of	O
the	O
MSRs	B
during	O
latent	O
and	O
productive	O
infection	O
were	O
determined	O
by	O
sequencing	O
RNA	O
-	O
PCR	O
products	O
generated	O
with	O
primers	O
that	O
flank	O
the	O
3	O
'	O
splice	O
region	O
.	O

In	O
all	O
cases	O
the	O
antigenemia	O
was	O
transient	O
and	O
cleared	O
by	O
28th	O
day	O
post	O
-	O
vaccination	O
.	O

However	O
,	O
five	O
new	O
mutation	O
sites	O
(	O
S61	B
,	O
SL1	B
,	O
S29	B
,	O
SL11	B
,	O
SL196	B
and	O
SL126	B
)	O
are	O
unique	O
to	O
the	O
nrdB	B
intron	O
and	O
disrupt	O
self	O
-	O
splicing	O
.	O

Serotonin	O
concentration	O
in	O
the	O
blood	O
of	O
patients	O
with	O
hemorrhagic	O
fever	O
with	O
renal	O
syndrome	O

CONCLUSION	O
:	O
Some	O
Gulf	O
War	O
veterans	O
may	O
have	O
delayed	O
,	O
chronic	O
neurotoxic	O
syndromes	O
from	O
wartime	O
exposure	O
to	O
combinations	O
of	O
chemicals	O
that	O
inhibit	O
butyrylcholinesterase	B
and	O
neuropathy	B
target	I
esterase	I
.	O

No	O
correlation	O
between	O
the	O
age	O
of	O
the	O
horses	O
and	O
the	O
antibody	O
level	O
could	O
be	O
found	O
.	O

The	O
Y	O
-	O
type	O
structural	O
motif	O
is	O
also	O
conserved	O
among	O
a	O
number	O
of	O
divergent	O
BiP	B
mRNAs	I
.	O

SIM1	B
and	O
SIM2	B
do	O
not	O
form	O
homodimers	O
,	O
and	O
they	O
do	O
not	O
interact	O
with	O
AHR	B
.	O

A	O
heterologous	O
promoter	O
construct	O
containing	O
three	O
repeats	O
of	O
a	O
consensus	O
Sp1	B
site	I
,	O
cloned	O
upstream	O
of	O
a	O
single	O
copy	O
of	O
the	O
ZII	B
(	O
CREB	B
/	I
AP1	I
)	O
element	O
from	O
the	O
BZLF1	B
promoter	I
linked	O
to	O
the	O
beta	B
-	I
globin	I
TATA	O
box	O
,	O
exhibited	O
phorbol	O
ester	O
inducibility	O
.	O

Together	O
,	O
the	O
data	O
suggest	O
that	O
cAMP	O
-	O
dependent	O
control	O
of	O
the	O
amounts	O
of	O
the	O
activator	O
SF-1	B
vs.	O
the	O
repressor	O
COUP	B
-	I
TF	I
could	O
influence	O
CRS2-dependent	O
transcription	O
.	O

Interaction	O
of	O
Ets-1	B
and	O
the	O
POU	B
-	I
homeodomain	I
protein	I
GHF-1	B
/	O
Pit-1	B
reconstitutes	O
pituitary	O
-	O
specific	O
gene	O
expression	O
.	O

Enhanced	O
period	O
-	O
peak	O
analysis	O
of	O
electro	O
-	O
encephalograms	O
using	O
a	O
fast	O
sinc	O
function	O
.	O

We	O
have	O
measured	O
the	O
MBF	O
on	O
incisors	O
and	O
its	O
direction	O
in	O
three	O
dimensions	O
for	O
different	O
jaw	O
openings	O
in	O
ten	O
subjects	O
.	O

The	O
neuroprotective	O
efficacy	O
of	O
the	O
selective	O
N	O
-	O
type	O
voltage	O
-	O
sensitive	O
calcium	O
channel	O
blocker	O
,	O
SNX-111	O
,	O
was	O
evaluated	O
in	O
spontaneously	O
hypertensive	O
rats	O
subjected	O
to	O
60	O
min	O
of	O
focal	O
cerebral	O
ischemia	O
by	O
permanent	O
ligation	O
of	O
the	O
right	O
common	O
carotid	O
artery	O
and	O
temporary	O
occlusion	O
of	O
the	O
right	O
middle	O
cerebral	O
artery	O
.	O

The	O
HBP	B
gene	I
is	O
composed	O
of	O
eight	O
exons	O
covering	O
19.5	O
kb	O
on	O
the	O
short	O
arm	O
of	O
chromosome	O
4	O
.	O

The	O
intensity	O
of	O
the	O
SSTEs	O
is	O
an	O
order	O
of	O
magnitude	O
larger	O
than	O
that	O
of	O
the	O
MSEs	O
and	O
determines	O
the	O
signal	O
contrast	O
if	O
both	O
effects	O
are	O
selected	O
simultaneously	O
.	O

In	O
eukaryotic	O
cells	O
,	O
premature	O
termination	O
of	O
translation	O
at	O
nonsense	O
codons	O
has	O
been	O
implicated	O
as	O
the	O
cause	O
of	O
a	O
variety	O
of	O
posttranscriptional	O
events	O
,	O
including	O
rapid	O
mRNA	O
decay	O
in	O
the	O
cytoplasm	O
or	O
the	O
nucleus	O
,	O
altered	O
splice	O
site	O
selection	O
,	O
and	O
exon	O
skipping	O
.	O

A	O
miracle	O
cure	O
and	O
its	O
solution	O

Ume6p	B
,	O
which	O
also	O
controls	O
the	O
expression	O
of	O
early	O
meiotic	O
genes	O
,	O
represses	O
CAR1	B
expression	O
through	O
a	O
sequence	O
called	O
URS	O
,	O
as	O
a	O
function	O
of	O
nitrogen	O
availability	O
.	O

None	O
of	O
these	O
organic	O
manifestations	O
was	O
discovered	O
by	O
scintigraphic	O
means	O
.	O

Recent	O
studies	O
have	O
demonstrated	O
that	O
the	O
U1	B
snRNP	I
is	O
recruited	O
to	O
the	O
5	O
'	O
splice	O
site	O
by	O
protein	O
/	O
protein	O
interactions	O
involving	O
the	O
SR	B
domains	O
of	O
the	O
U1	B
-	I
70	I
K	I
protein	I
and	O
SF2	B
/	O
ASF	B
.	O

An	O
aromatic	O
stacking	O
interaction	O
between	O
subunits	O
helps	O
mediate	O
DNA	O
sequence	O
specificity	O
:	O
operator	O
site	O
discrimination	O
by	O
phage	B
lambda	I
cI	I
repressor	I
.	O

Here	O
we	O
report	O
the	O
purification	O
of	O
this	O
larger	O
form	O
as	O
an	O
approximately	O
320-kDa	O
particle	O
that	O
contains	O
mRNP3	B
+	I
4	I
and	O
nine	O
additional	O
polypeptides	O
,	O
including	O
mRNA	O
-	O
binding	O
polypeptides	O
of	O
34	O
and	O
36	O
kDa	O
and	O
a	O
doublet	O
of	O
110	O
/	O
105	O
kDa	O
that	O
proved	O
to	O
be	O
nucleolin	B
.	O

The	O
perioperative	O
mortality	O
of	O
all	O
patients	O
was	O
1.9	O
%	O
,	O
the	O
mortality	O
of	O
patients	O
older	O
than	O
70	O
years	O
was	O
4.3	O
%	O
.	O

Having	O
an	O
LRR	B
domain	I
and	O
an	O
SH3-binding	B
domain	I
,	O
Acan125	B
and	O
the	O
C.	O
elegans	O
homologue	O
define	O
a	O
novel	O
family	O
of	O
bifunctional	O
binding	O
proteins	O
.	O

The	O
capacity	O
to	O
repair	O
8-OxoG	O
has	O
been	O
measured	O
in	O
cell	O
-	O
free	O
extracts	O
of	O
wild	O
-	O
type	O
and	O
ogg1	B
strains	O
using	O
a	O
34mer	O
DNA	O
fragment	O
containing	O
a	O
single	O
8-OxoG	O
residue	O
paired	O
with	O
a	O
cytosine	O
(	O
8-OxoG	O
/	O
C	O
)	O
as	O
a	O
substrate	O
.	O

The	O
likelihood	O
that	O
a	O
common	O
region	O
of	O
deletions	O
would	O
contain	O
a	O
tumor	O
suppressor	O
is	O
strongly	O
enhanced	O
by	O
coincidence	O
of	O
that	O
region	O
with	O
a	O
chromosome	O
fragment	O
suppressing	O
tumorigenicity	O
upon	O
introduction	O
in	O
tumor	O
cells	O
.	O

However	O
,	O
in	O
some	O
of	O
them	O
either	O
pattern	O
may	O
predominate	O
or	O
be	O
exclusively	O
present	O
.	O

The	O
carboxyl	O
-	O
terminal	O
CCCC	O
module	O
is	O
structurally	O
related	O
to	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
the	O
erythroid	B
transcription	I
factor	I
GATA-1	I
.	O

A	O
polypeptide	O
encoded	O
by	O
the	O
NTS	O
16	O
open	O
reading	O
frame	O
has	O
sequence	O
similarity	O
to	O
the	O
catalytic	O
domain	O
of	O
several	O
receptor	B
protein	I
kinases	I
from	I
plants	I
including	O
the	O
S	B
-	I
receptor	I
kinases	I
implicated	O
in	O
the	O
rejection	O
of	O
self	O
-	O
pollen	O
in	O
Brassica	O
species	O
and	O
the	O
Pto	B
gene	I
product	I
of	I
tomato	I
which	O
confers	O
resistance	O
to	O
a	O
bacterial	O
pathogen	O
.	O

In	O
gel	O
mobility	O
shift	O
assays	O
,	O
factors	O
present	O
in	O
nuclear	O
extracts	O
derived	O
from	O
differentiated	O
osteoblast	O
bound	O
to	O
oligonucleotide	O
probes	O
containing	O
the	O
E	O
-	O
box	O
1	O
and	O
E	O
-	O
box	O
2	O
elements	O
.	O

RESULTS	O
:	O
Surprisingly	O
,	O
PAF	B
blockade	O
increased	O
mortality	O
after	O
trauma	O
(	O
5	O
of	O
11	O
WEB-2086	O
animals	O
versus	O
1	O
of	O
9	O
vehicle	O
animals	O
;	O
p	O
=	O
0.15	O
)	O
and	O
depressed	O
cardiac	O
index	O
and	O
O2	O
delivery	O
at	O
72	O
hours	O
(	O
p	O
<	O
0.05	O
)	O
.	O

We	O
thus	O
conclude	O
that	O
the	O
NFAT	B
RIR	I
plays	O
an	O
essential	O
dual	O
role	O
in	O
DNA	O
recognition	O
and	O
cooperative	O
binding	O
to	O
AP-1	B
family	I
transcription	I
factors	I
.	O

Thus	O
,	O
the	O
association	O
of	O
PS1	B
fragments	I
may	O
be	O
maintained	O
during	O
cycles	O
of	O
phosphorylation	O
/	O
dephosphorylation	O
of	O
the	O
PS1	B
CTF	I
.	O

A	O
patient	O
of	O
Group	O
B	O
had	O
severe	O
athetoid	O
CP	O
with	O
spasticity	O
,	O
being	O
unable	O
to	O
right	O
his	O
trunk	O
and	O
neck	O
.	O

Thus	O
,	O
our	O
studies	O
suggest	O
that	O
pV	O
-	O
mediated	O
activation	O
of	O
HIV-1	B
LTR	I
activity	O
is	O
controlled	O
by	O
the	O
nuclear	O
translocation	O
of	O
the	O
NF	B
-	I
kappaB	I
transcription	I
factor	I
,	O
which	O
is	O
mediated	O
by	O
IkappaBalpha	B
serine	O
phosphorylation	O
and	O
degradation	O
,	O
but	O
also	O
by	O
a	O
still	O
undefined	O
NF	B
-	I
kappaB	I
-	O
independent	O
pathway	O
.	O

We	O
also	O
review	O
the	O
role	O
of	O
grains	O
in	O
the	O
formation	O
of	O
complex	O
molecules	O
in	O
interstellar	O
molecular	O
clouds	O
.	O

Like	O
the	O
elicitors	O
of	O
the	O
hypersensitive	O
reaction	O
(	O
HR	O
)	O
produced	O
by	O
E.	O
chrysanthemi	O
(	O
HarpinEch	O
)	O
and	O
E.	O
amylovora	O
(	O
HarpinEa	O
)	O
,	O
the	O
deduced	O
36-kDa	O
protein	O
does	O
not	O
possess	O
a	O
typical	O
signal	O
sequence	O
,	O
but	O
it	O
contains	O
a	O
putative	O
membrane	O
-	O
spanning	O
domain	O
.	O

Rep	B
-	O
Rep	B
protein	O
interaction	O
was	O
confirmed	O
in	O
vitro	O
through	O
coimmunoprecipitation	O
experiments	O
with	O
a	O
bacterially	O
expressed	O
maltose	B
-	I
binding	I
protein	I
-	O
Rep78	B
fusion	O
protein	O
in	O
combination	O
with	O
[	O
35S	O
]	O
methionine	O
-	O
labeled	O
Rep78	B
synthesized	O
in	O
a	O
coupled	O
in	O
vitro	O
transcription	O
-	O
translation	O
system	O
.	O

Fourteen	O
patients	O
with	O
New	O
York	O
Heart	O
Association	O
class	O
II	O
congestive	O
heart	O
failure	O
were	O
enrolled	O
in	O
a	O
double	O
-	O
blind	O
,	O
cross	O
-	O
over	O
study	O
.	O

The	O
main	O
advantages	O
of	O
Multi	O
-	O
MUP	O
analysis	O
are	O
:	O
(	O
1	O
)	O
quick	O
acquisition	O
of	O
many	O
MUPs	O
;	O
(	O
2	O
)	O
simultaneous	O
collection	O
of	O
several	O
MUPs	O
at	O
one	O
recording	O
site	O
;	O
(	O
3	O
)	O
possibility	O
to	O
analyze	O
not	O
only	O
low	O
threshold	O
MUPs	O
;	O
(	O
4	O
)	O
less	O
bias	O
in	O
the	O
selection	O
of	O
MUPs	O
and	O
(	O
5	O
)	O
the	O
reproducibility	O
of	O
the	O
results	O
that	O
allow	O
the	O
same	O
reference	O
values	O
to	O
be	O
used	O
in	O
different	O
laboratories	O
.	O

Previous	O
studies	O
have	O
indicated	O
that	O
a	O
hamster	O
cell	O
line	O
(	O
ts13	O
)	O
with	O
a	O
point	O
mutation	O
in	O
the	O
TAF	B
(	I
II	I
)	I
250	I
/	O
CCG1	B
(	O
TAF	B
(	I
II	I
)	I
250	I
)	O
gene	O
shows	O
temperature	O
-	O
sensitive	O
expression	O
of	O
a	O
subset	O
of	O
genes	O
and	O
arrests	O
in	O
late	O
G1	O
at	O
39.5	O
degrees	O
C.	O

METHODS	O
:	O
The	O
responses	O
of	O
a	O
31-year	O
-	O
old	O
woman	O
with	O
complex	O
regional	O
pain	O
syndrome	O
type	O
I	O
(	O
reflex	O
sympathetic	O
dystrophy	O
)	O
to	O
a	O
thermal	O
grill	O
were	O
evaluated	O
before	O
and	O
after	O
stellate	O
ganglion	O
block	O
.	O

More	O
recently	O
,	O
however	O
,	O
a	O
number	O
of	O
developments	O
such	O
as	O
the	O
successful	O
use	O
of	O
the	O
inhaled	O
steroid	O
budesonide	O
and	O
oral	O
dexamethasone	O
have	O
reinforced	O
the	O
argument	O
for	O
using	O
steroids	O
.	O

In	O
ciliates	O
,	O
both	O
mechanisms	O
are	O
readily	O
observed	O
.	O

Based	O
on	O
the	O
occurrence	O
of	O
several	O
transcription	O
signals	O
in	O
the	O
Thermus	B
pyr	I
promoter	I
region	I
and	O
strong	O
amino	O
acid	O
sequence	O
identities	O
(	O
about	O
60	O
%	O
)	O
between	O
Thermus	B
PyrR	I
and	O
the	O
PyrR	B
attenuation	I
proteins	I
of	O
two	O
Bacillus	O
sp.	O
,	O
we	O
propose	O
a	O
regulatory	O
mechanism	O
involving	O
transcriptional	O
attenuation	O
to	O
control	O
pyr	B
gene	I
expression	O
in	O
Thermus	O
.	O

Thus	O
,	O
the	O
B	O
-	O
S	O
mutant	O
does	O
not	O
mimic	O
efficiently	O
the	O
chloroplastic	B
GAPDHs	I
,	O
and	O
long	O
-	O
range	O
and/or	O
second	O
-	O
layer	O
effects	O
,	O
not	O
easily	O
predictable	O
from	O
visual	O
inspection	O
of	O
three	O
-	O
dimensional	O
structures	O
,	O
need	O
to	O
be	O
taken	O
into	O
account	O
for	O
designing	O
a	O
true	O
""""	O
chloroplastic	O
-	O
like	O
""""	O
mutant	O
of	O
cytosolic	B
GAPDH	I
.	O

Evaluation	O
of	O
myocardial	O
perfusion	O
by	O
99mTc	O
-	O
tetrofosmin	O
SPECT	O
before	O
and	O
after	O
emergent	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
for	O
acute	O
myocardial	O
infarction	O

The	O
1.1-	O
and	O
1.3-kb	O
mRNA	O
species	O
were	O
found	O
only	O
in	O
the	O
heart	O
,	O
and	O
the	O
2.6-kb	O
species	O
was	O
found	O
in	O
the	O
heart	O
,	O
kidney	O
and	O
brain	O
,	O
but	O
not	O
in	O
skeletal	O
muscle	O
or	O
liver	O
.	O

This	O
investigation	O
was	O
undertaken	O
to	O
determine	O
whether	O
consuming	O
several	O
small	O
feedings	O
of	O
preexercise	O
carbohydrate	O
(	O
CHO	O
)	O
,	O
rather	O
than	O
a	O
single	O
bolus	O
,	O
would	O
affect	O
blood	O
glucose	O
and	O
insulin	B
responses	O
during	O
rest	O
and	O
exercise	O
.	O

Whereas	O
the	O
mutant	O
enzymes	O
terminate	O
normally	O
at	O
the	O
late	O
terminator	O
in	O
T7	O
DNA	O
(	O
T	O
(	O
phi	O
)	O
)	O
and	O
rrnB	B
T2	O
,	O
they	O
fail	O
to	O
terminate	O
at	O
one	O
of	O
the	O
termination	O
sites	O
of	O
rrnB	B
T1	O
,	O
and	O
also	O
fail	O
to	O
recognize	O
the	O
PTH	B
and	O
CJ	O
signals	O
.	O

Cytological	O
data	O
suggest	O
that	O
the	O
transgenes	O
associate	O
with	O
a	O
nucleolus	O
.	O

Strikingly	O
,	O
stoichiometric	O
association	O
of	O
p107	B
or	O
p130	B
with	O
either	O
cyclin	B
E	I
-	O
cdk2	B
or	O
cyclin	B
A	I
-	O
cdk2	B
negated	O
the	O
activities	O
of	O
these	O
kinases	O
.	O

Clinical	O
and	O
haematological	O
signs	O
are	O
not	O
specific	O
in	O
this	O
setting	O
,	O
and	O
the	O
diagnosis	O
relies	O
on	O
histological	O
features	O
,	O
mainly	O
bone	O
marrow	O
examination	O
.	O

A	O
striking	O
feature	O
of	O
the	O
recombinant	B
H19	I
allele	I
is	O
the	O
occurrence	O
of	O
a	O
parental	O
imprint	O
set	O
on	O
the	O
neo	B
replacement	I
cassette	I
.	O

Identification	O
of	O
five	O
new	O
genes	O
,	O
closely	O
related	O
to	O
the	O
interleukin-1beta	B
converting	I
enzyme	I
gene	I
,	O
that	O
do	O
not	O
encode	O
functional	O
proteases	O
.	O

However	O
,	O
we	O
could	O
not	O
find	O
the	O
homologous	O
regions	O
with	O
guanine	B
nucleotide	I
exchange	I
factors	I
or	O
GTPase	B
-	I
activating	I
proteins	I
in	O
the	O
c	B
-	I
cbl	I
gene	I
.	O

Serum	B
response	I
factor	I
(	O
SRF	B
)	O
,	O
a	O
member	O
of	O
an	O
ancient	O
family	O
of	O
DNA	O
-	O
binding	O
proteins	O
,	O
is	O
generally	O
assumed	O
to	O
be	O
a	O
ubiquitous	O
transcription	O
factor	O
involved	O
in	O
regulating	O
growth	O
factor	O
-	O
responsive	O
genes	O
.	O

Activity	O
of	O
palgD	B
in	O
the	O
cysB	B
mutant	I
,	O
in	O
CHA	O
and	O
in	O
the	O
non	O
-	O
mucoid	O
strain	O
PAO	O
was	O
assessed	O
by	O
the	O
use	O
of	O
a	O
transcriptional	O
algD	B
-	O
xylE	B
fusion	O
.	O

The	O
Man9-mannosidase	B
specificity	O
of	O
the	O
cDNA	O
construct	O
was	O
verified	O
by	O
the	O
observation	O
that	O
all	O
peptide	O
sequences	O
derived	O
from	O
a	O
previously	O
purified	O
,	O
catalytically	O
active	O
49-kDa	O
fragment	O
were	O
found	O
within	O
the	O
coding	O
region	O
.	O

ORF	O
M1	O
has	O
striking	O
homology	O
to	O
poxvirus	O
serpins	B
,	O
while	O
ORF	O
M11	O
encodes	O
a	O
potential	O
homolog	O
of	O
Bcl-2-like	B
molecules	I
encoded	O
by	O
other	O
gammaherpesviruses	O
(	O
gene	B
16	I
of	O
HVS	O
and	O
KSHV	O
and	O
the	O
BHRF1	B
gene	I
of	O
EBV	O
)	O
.	O

Stereotactic	O
radiofrequency	O
lesioning	O
of	O
the	O
hamartoma	O
resulted	O
in	O
seizure	O
remission	O
without	O
complications	O
20	O
months	O
after	O
surgery	O
.	O

However	O
,	O
mean	O
food	O
intake	O
in	O
the	O
40	O
%	O
group	O
was	O
half	O
that	O
of	O
the	O
ACT	O
group	O
(	O
p	O
<	O
0.001	O
)	O
and	O
significantly	O
less	O
(	O
p	O
<	O
0.01	O
)	O
than	O
the	O
SEP	O
group	O
,	O
which	O
consumed	O
amounts	O
equivalent	O
to	O
65	O
%	O
of	O
daily	O
requirement	O
.	O

The	O
following	O
technique	O
describes	O
a	O
modification	O
to	O
a	O
bar	O
superstructure	O
that	O
provided	O
the	O
advantages	O
of	O
convenience	O
,	O
security	O
,	O
and	O
consistent	O
positioning	O
even	O
though	O
one	O
implant	O
was	O
lost	O
and	O
the	O
angulation	O
of	O
implants	O
limited	O
accuracy	O
.	O

Its	O
potential	O
as	O
a	O
diagnostic	O
tool	O
for	O
epidemiological	O
surveillance	O
was	O
assessed	O
in	O
comparison	O
with	O
three	O
other	O
diagnostic	O
tests	O
:	O
stool	O
examination	O
,	O
ELISA	O
with	O
soluble	B
egg	I
antigen	I
(	O
SEA	B
)	O
and	O
the	O
circumoval	O
precipitin	B
test	O
(	O
COPT	O
)	O
.	O

Human	B
thymine	I
-	I
DNA	I
glycosylase	I
maps	O
at	O
chromosome	O
12q22-q24.1	O
:	O
a	O
region	O
of	O
high	O
loss	O
of	O
heterozygosity	O
in	O
gastric	O
cancer	O
.	O

FOG	B
is	O
coexpressed	O
with	O
GATA-1	B
during	O
embryonic	O
development	O
and	O
in	O
erythroid	O
and	O
megakaryocytic	O
cells	O
.	O

Autoimmune	O
neutropenia	O
(	O
AIN	O
)	O
is	O
a	O
frequent	O
cause	O
of	O
chronic	O
neutropenia	O
especially	O
in	O
youngest	O
children	O
.	O

Here	O
we	O
have	O
tested	O
the	O
hypothesis	O
that	O
the	O
short	O
transcripts	O
,	O
or	O
proteins	O
translated	O
from	O
the	O
short	O
transcripts	O
,	O
are	O
also	O
required	O
for	O
respiration	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
this	O
notion	O
by	O
using	O
ligation	O
-	O
mediated	O
PCR	O
to	O
assess	O
the	O
formation	O
of	O
recombination	B
-	I
activating	I
gene	I
(	O
RAG	B
)	O
-dependent	O
double	O
-	O
strand	O
breaks	O
(	O
DSBs	O
)	O
at	O
RSSs	O
3	O
'	O
of	O
Ddelta3	B
and	O
5	O
'	O
of	O
Jdelta1	B
.	O

Recent	O
studies	O
have	O
demonstrated	O
that	O
Cbl	B
,	O
the	O
120-kDa	O
protein	O
product	O
of	O
the	O
c	B
-	I
cbl	I
proto	I
-	I
oncogene	I
,	O
serves	O
as	O
a	O
substrate	O
of	O
a	O
number	O
of	O
receptor	B
-	I
coupled	I
tyrosine	I
kinases	I
and	O
forms	O
complexes	O
with	O
SH3	B
and	O
SH2	B
domain	O
-	O
containing	O
proteins	O
,	O
pointing	O
to	O
its	O
role	O
in	O
signal	O
transduction	O
.	O

Volunteers	O
were	O
irradiated	O
on	O
their	O
backs	O
with	O
suberythemal	O
UV	O
daily	O
for	O
5	O
d	O
after	O
application	O
of	O
the	O
sunscreens	O
and	O
their	O
base	O
lotion	O
to	O
different	O
sites	O
.	O

It	O
is	O
thus	O
one	O
of	O
the	O
key	O
enzymes	O
involved	O
in	O
the	O
triiodothyronine	O
-	O
mediated	O
control	O
of	O
growth	O
,	O
differentiation	O
and	O
basal	O
metabolism	O
in	O
vertebrates	O
.	O

Patients	O
received	O
either	O
diltiazem	O
CD	O
180	O
mg	O
or	O
placebo	O
once	O
/	O
day	O
in	O
combination	O
with	O
existing	O
antianginal	O
therapy	O
.	O

Induction	O
of	O
B	O
cell	O
apoptosis	O
by	O
co	O
-	O
cross	O
-	O
linking	O
CD23	B
and	O
sIg	B
involves	O
aberrant	O
regulation	O
of	O
c	B
-	I
myc	I
and	O
is	O
inhibited	O
by	O
bcl-2	B
.	O

Because	O
the	O
biosynthetic	O
pathway	O
to	O
the	O
vacuole	O
intersects	O
with	O
the	O
endocytic	O
pathway	O
,	O
internalization	O
of	O
a	O
bulk	O
membrane	O
endocytic	O
marker	O
FM	O
4	O
-	O
64	O
was	O
assayed	O
in	O
the	O
sop	B
mutants	I
.	O

Genes	O
belonging	O
to	O
the	O
ras	B
superfamily	I
encode	O
low	B
-	I
molecular	I
-	I
weight	I
GTP	I
/	I
GDP	I
-	I
binding	I
proteins	I
that	O
are	O
highly	O
conserved	O
in	O
wide	O
variety	O
of	O
organisms	O
.	O

In	O
this	O
report	O
,	O
we	O
identify	O
and	O
characterize	O
two	O
overlapping	O
ELL	B
functional	I
domains	I
that	O
govern	O
its	O
interaction	O
with	O
RNA	B
polymerase	I
II	I
and	O
the	O
ternary	O
elongation	O
complex	O
.	O

The	O
position	O
,	O
transcription	O
orientation	O
,	O
and	O
imprinted	O
status	O
of	O
the	O
genes	O
immediately	O
flanking	O
Igf2r	B
have	O
been	O
assessed	O
.	O

The	O
MCAD	B
nuclear	I
receptor	I
response	I
element	I
1	I
(	O
NRRE-1	B
)	O
interacts	O
in	O
vitro	O
with	O
ERR	B
alpha	I
expressed	O
in	O
COS-7	O
cells	O
.	O

Analysis	O
of	O
the	O
5	O
'	O
flanking	O
region	O
of	O
the	O
gene	O
also	O
revealed	O
the	O
presence	O
of	O
multiple	O
TATA	O
and	O
CAAT	O
sequences	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
and	O
competition	O
experiments	O
showed	O
that	O
site	O
A	O
is	O
recognized	O
by	O
an	O
NF1	B
protein	I
.	O

A	O
specific	O
distal	O
promoter	O
controls	O
gamma	B
-	I
glutamyl	I
transpeptidase	I
gene	I
expression	O
in	O
undifferentiated	O
rat	O
transformed	O
liver	O
cells	O
.	O

Proteasomes	O
are	O
the	O
multisubunit	O
protease	O
involved	O
in	O
the	O
generation	O
of	O
peptides	O
presented	O
by	O
MHC	B
class	I
I	I
molecules	I
.	O

These	O
discoloration	O
's	O
can	O
be	O
treated	O
in	O
several	O
ways	O
but	O
up	O
to	O
lately	O
tooth	O
structure	O
had	O
to	O
be	O
removed	O
in	O
an	O
irreversible	O
manner	O
in	O
order	O
to	O
provide	O
sufficient	O
bulk	O
for	O
the	O
new	O
restorative	O
material	O
.	O

We	O
report	O
the	O
preliminary	O
biochemical	O
characterization	O
of	O
the	O
T	B
antigens	I
encoded	O
by	O
three	O
SV40	O
mutants	O
,	O
5030	O
,	O
5031	O
,	O
and	O
5061	O
,	O
each	O
of	O
which	O
have	O
altered	O
residues	O
within	O
or	O
near	O
the	O
ATP	O
binding	O
pocket	O
.	O

Interestingly	O
,	O
the	O
RXRalphaF318A	B
constitutive	O
activity	O
generated	O
within	O
heterodimers	O
in	O
the	O
presence	O
of	O
BMS614	O
requires	O
the	O
integrity	O
of	O
both	O
RXR	B
and	O
RAR	B
AF-2	O
domains	O
.	O

Recent	O
studies	O
have	O
shown	O
that	O
the	O
Src	B
homology-2	I
(	O
SH2	B
)	O
domain	O
-	O
containing	O
protein	B
-	I
tyrosine	I
phosphatase	I
,	O
SHP-2	B
,	O
associates	O
with	O
the	O
cytoplasmic	O
domain	O
of	O
PECAM-1	B
as	O
it	O
becomes	O
tyrosine	O
-	O
phosphorylated	O
during	O
platelet	O
aggregation	O
:	O
a	O
process	O
that	O
can	O
be	O
mimicked	O
in	O
part	O
by	O
small	O
synthetic	O
phosphopeptides	O
corresponding	O
to	O
the	O
cytoplasmic	O
domain	O
of	O
PECAM-1	B
encompassing	O
tyrosine	O
residues	O
Tyr-663	O
or	O
Tyr-686	O
.	O

We	O
found	O
that	O
multiple	O
tumor	O
suppressor	O
genes	O
(	O
e.g.	O
,	O
p53	B
,	O
DCC	B
,	O
APC	B
,	O
MCC	B
,	O
BRCA1	B
,	O
and	O
WAF1	B
/	O
CIP1	B
)	O
were	O
inactivated	O
at	O
different	O
frequencies	O
via	O
various	O
mechanisms	O
[	O
e.g.	O
,	O
loss	O
of	O
heterozygosity	O
(	O
LOH	O
)	O
,	O
loss	O
of	O
expression	O
(	O
LOE	O
)	O
,	O
mutation	O
,	O
and	O
inactivation	O
by	O
cellular	O
binding	O
protein	O
]	O
.	O

Because	O
the	O
deletion	O
included	O
the	O
TK	B
gene	I
,	O
selection	O
with	O
gancyclovir	O
against	O
cells	O
not	O
having	O
undergone	O
recombination	O
was	O
possible	O
.	O

Fermentation	O
process	O
after	O
supplementation	O
of	O
nitrate	O
,	O
nitrite	O
,	O
lactic	O
acid	O
bacteria	O
and	O
formic	O
acid	O

The	O
Trx	B
-	O
CT	B
fusion	O
protein	O
was	O
produced	O
less	O
efficiently	O
(	O
20	O
%	O
of	O
total	O
soluble	O
cellular	O
protein	O
)	O
.	O

U4	B
/	O
U6	B
snRNP	O
is	O
one	O
of	O
four	O
essential	O
small	O
nuclear	O
ribonucleoprotein	O
(	O
snRNP	O
)	O
particles	O
(	O
U1	B
,	O
U2	B
,	O
U5	B
and	O
U4	B
/	O
U6	B
)	O
present	O
in	O
the	O
spliceosome	O
.	O

We	O
cloned	O
a	O
complete	O
cDNA	O
(	O
2.9	O
kb	O
)	O
for	O
HET	B
from	O
an	O
MCF-7	O
cDNA	O
library	O
.	O

Thus	O
,	O
ZNF74	B
sublocalization	O
in	O
nuclear	O
domains	O
enriched	O
in	O
pre	O
-	O
mRNA	O
maturating	O
factors	O
,	O
its	O
RNA	O
binding	O
activity	O
,	O
and	O
its	O
direct	O
phosphodependent	O
interaction	O
with	O
the	O
pol	B
IIo	I
,	O
a	O
form	O
of	O
the	O
RNA	B
polymerase	I
functionally	O
associated	O
with	O
pre-	O
mRNA	O
processing	O
,	O
suggest	O
a	O
role	O
for	O
this	O
member	O
of	O
the	O
KRAB	B
multifinger	I
protein	I
family	I
in	O
RNA	O
processing	O
.	O

Modulation	O
of	O
AUUUA	O
response	O
element	O
binding	O
by	O
heterogeneous	B
nuclear	I
ribonucleoprotein	I
A1	I
in	O
human	O
T	O
lymphocytes	O
.	O

In	O
addition	O
,	O
mutation	O
of	O
the	O
Sp1	B
site	I
also	O
significantly	O
reduced	O
promoter	O
activity	O
.	O

These	O
residues	O
,	O
Ile244	O
at	O
the	O
extracellular	O
end	O
of	O
transmembrane	O
helix	O
3	O
,	O
and	O
Tyr318	O
at	O
the	O
COOH	O
-	O
terminal	O
portion	O
of	O
extracellular	O
loop	O
2	O
,	O
are	O
replaced	O
by	O
Leu	O
and	O
Ile	O
in	O
the	O
PTH-1	B
receptor	I
,	O
respectively	O
.	O

Together	O
,	O
our	O
results	O
show	O
that	O
tinman	B
is	O
controlled	O
by	O
an	O
array	O
of	O
discrete	O
enhancer	O
elements	O
that	O
are	O
activated	O
successively	O
by	O
differential	O
genetic	O
inputs	O
,	O
as	O
well	O
as	O
by	O
closely	O
linked	O
activator	O
and	O
repressor	O
binding	O
sites	O
within	O
an	O
early	O
-	O
acting	O
enhancer	O
,	O
which	O
restrict	O
twist	B
activity	O
to	O
specific	O
areas	O
within	O
the	O
twist	B
expression	I
domain	I
.	O

The	O
Fis	B
protein	I
regulates	O
site	O
-	O
specific	O
DNA	O
inversion	O
catalyzed	O
by	O
a	O
family	O
of	O
DNA	B
invertases	I
when	O
bound	O
to	O
a	O
cis	O
-	O
acting	O
recombinational	O
enhancer	O
.	O

These	O
studies	O
serve	O
as	O
the	O
basis	O
for	O
the	O
further	O
characterization	O
of	O
the	O
regulatory	O
mechanism	O
of	O
aromatase	B
expression	O
in	O
human	O
breast	O
cancer	O
and	O
ASCs	O
.	O

A	O
second	O
aim	O
was	O
to	O
determine	O
whether	O
the	O
decrease	O
in	O
muscle	O
-	O
tendon	O
unit	O
rest	O
length	O
produced	O
by	O
prolonged	O
immobilisation	O
in	O
a	O
shortened	O
position	O
is	O
mediated	O
primarily	O
by	O
adaptations	O
of	O
the	O
muscle	O
or	O
tendon	O
.	O

The	O
lysozyme	B
FEF	B
site	O
is	O
immediately	O
5	O
'	O
to	O
a	O
PU	B
.	O

Expression	O
of	O
thiamin	O
biosynthetic	O
genes	O
(	O
thiCOGE	B
)	O
and	O
production	O
of	O
symbiotic	B
terminal	I
oxidase	I
cbb3	I
in	O
Rhizobium	O
etli	O
.	O

Chimeras	O
containing	O
IE1	B
peptides	I
dramatically	O
activated	O
transcription	O
of	O
the	O
basal	O
promoter	O
only	O
when	O
lac	B
operator	I
sequences	I
were	O
present	O
.	O

Transfection	O
of	O
HepG2	O
and	O
SK	O
-	O
N	O
-	O
MC	O
cells	O
with	O
constructs	O
deleted	O
of	O
additional	O
5'-flanking	O
fragments	O
permitted	O
the	O
definition	O
of	O
a	O
minimal	O
200	O
bp	O
promoter	O
fragment	O
containing	O
the	O
pseudo	O
-	O
TATA	O
box	O
and	O
two	O
putative	O
SP1-binding	B
sites	I
.	O

Epitopes	O
of	O
adhesion	O
-	O
perturbing	O
monoclonal	O
antibodies	O
map	O
within	O
a	O
predicted	O
alpha	O
-	O
helical	O
domain	O
of	O
the	O
integrin	B
beta	I
1	I
subunit	I
.	O

Radiation	O
decreased	O
the	O
levels	O
of	O
T4	O
and	O
T3	O
6	O
h	O
and	O
72	O
h	O
in	O
group	O
C	O
,	O
in	O
group	O
A	O
at	O
72	O
h	O
,	O
in	O
group	O
B	O
at	O
24	O
h	O
postexposure	O
.	O

Furthermore	O
,	O
DNA	O
-	O
bound	O
LAZ3	B
/	O
BCL6	B
recruits	O
SMRT	B
in	O
vivo	O
,	O
and	O
both	O
overexpressed	O
proteins	O
completely	O
colocalize	O
in	O
nuclear	O
dots	O
.	O

All	O
pigs	O
had	O
significant	O
regional	O
LV	O
dysfunction	O
and	O
reduced	O
LV	O
ejection	O
fraction	O
(	O
41+	O
/	O
-11	O
%	O
)	O
.	O

4	O
)	O
PU	B
and	O
PD	B
lacked	O
the	O
canonical	O
TATA	O
or	O
CAAT	O
motifs	O
,	O
and	O
are	O
AT	O
-	O
rich	O
.	O

The	O
prescription	O
for	O
apoplexy	O
includes	O
C1	O
-	O
7	O
,	O
T1	O
-	O
9	O
and	O
L2	O
-	O
4	O
.	O

Interleukin-1	B
levels	O
remained	O
low	O
throughout	O
the	O
course	O
.	O

Sequences	O
required	O
for	O
interaction	O
of	O
mu2	B
and	O
CTLA-4	B
were	O
localized	O
to	O
residues	O
,	O
161TTGVY	O
in	O
CTLA-4	B
;	O
this	O
sequence	O
is	O
N	O
-	O
terminal	O
to	O
,	O
but	O
overlaps	O
with	O
,	O
a	O
previously	O
identified	O
SH2	B
binding	I
motif	I
,	O
165YVKM	O
,	O
involved	O
in	O
CTLA-4	B
signaling	O
.	O

During	O
the	O
conditioning	O
procedure	O
,	O
the	O
C	O
-	O
fiber	O
reflex	O
was	O
facilitated	O
(	O
wind	O
-	O
up	O
)	O
in	O
a	O
stimulus	O
-	O
dependent	O
fashion	O
in	O
intact	O
,	O
anesthetized	O
animals	O
during	O
the	O
application	O
of	O
the	O
first	O
seven	O
conditioning	O
stimuli	O
;	O
thereafter	O
,	O
the	O
magnitude	O
of	O
the	O
responses	O
reached	O
a	O
plateau	O
and	O
then	O
decreased	O
.	O

Multiple	O
regression	O
analyses	O
revealed	O
that	O
WAIS	O
-	O
R	O
factor	O
scores	O
Verbal	O
Comprehension	O
and	O
Freedom	O
from	O
Distractibility	O
accounted	O
for	O
up	O
to	O
42	O
%	O
of	O
the	O
variance	O
in	O
WMS	O
-	O
R	O
and	O
CVLT	O
indices	O
.	O

In	O
ICU	O
patients	O
,	O
the	O
LIS	O
related	O
to	O
the	O
postoperative	O
rise	O
in	O
IL-6	B
level	O
only	O
,	O
even	O
though	O
the	O
rise	O
in	O
plasma	O
concentrations	O
of	O
cytokines	O
interrelated	O
.	O

The	O
SR	B
protein	I
family	I
is	O
involved	O
in	O
constitutive	O
and	O
regulated	O
pre	O
-	O
mRNA	O
splicing	O
and	O
has	O
been	O
found	O
to	O
be	O
evolutionarily	O
conserved	O
in	O
metazoan	O
organisms	O
.	O

Holliday	B
junction	I
resolvase	I
in	O
Schizosaccharomyces	O
pombe	O
has	O
identical	O
endonuclease	O
activity	O
to	O
the	O
CCE1	B
homologue	O
YDC2	B
.	O

In	O
Xenopus	O
embryos	O
,	O
the	O
engineered	B
PDGF	I
receptor	I
protein	I
induced	O
the	O
formation	O
of	O
mesoderm	O
from	O
animal	O
-	O
pole	O
explants	O
in	O
an	O
FK1012-dependent	O
manner	O
.	O

A	O
genomic	O
clone	O
was	O
isolated	O
that	O
contained	O
12.5	O
kb	O
of	O
the	O
5'-flanking	O
region	O
and	O
the	O
first	O
exon	O
of	O
the	O
p69	B
/	I
71	I
2	I
-	I
5A	I
synthetase	I
gene	I
.	O

In	O
the	O
clinical	O
study	O
,	O
the	O
defect	O
size	O
shown	O
by	O
BMIPP	O
imaging	O
was	O
greater	O
in	O
anterior	O
than	O
in	O
inferior	O
infarcts	O
(	O
p	O
<	O
0.001	O
)	O
and	O
correlated	O
well	O
with	O
the	O
risk	O
area	O
revealed	O
by	O
contrast	O
ventriculography	O
(	O
r	O
=	O
0.80	O
,	O
p	O
<	O
0.0001	O
)	O
CONCLUSION	O
:	O
The	O
above	O
preliminary	O
data	O
,	O
admittedly	O
from	O
a	O
small	O
group	O
of	O
patients	O
,	O
suggest	O
that	O
tomographic	O
BMIPP	O
imaging	O
provides	O
an	O
accurate	O
quantification	O
of	O
defect	O
size	O
by	O
means	O
of	O
a	O
simple	O
threshold	O
technique	O
and	O
,	O
in	O
the	O
subacute	O
phase	O
,	O
permits	O
determination	O
of	O
the	O
amount	O
of	O
myocardium	O
at	O
risk	O
after	O
acute	O
myocardial	O
infarction	O
.	O

This	O
information	O
,	O
together	O
with	O
estimation	O
of	O
the	O
size	O
of	O
the	O
deglycosylated	O
A	O
subunit	O
relative	O
to	O
a	O
series	O
of	O
C	B
-	I
terminal	I
truncated	I
TSHR	I
ectodomain	I
variants	I
,	O
places	O
cleavage	O
Site	O
1	O
in	O
the	O
vicinity	O
of	O
,	O
or	O
closely	O
upstream	O
to	O
,	O
residue	O
317	O
.	O

Here	O
we	O
report	O
that	O
in	O
cultured	O
cells	O
from	O
Drosophila	O
melanogaster	O
human	B
Sp1	I
efficiently	O
activates	O
transcription	O
from	O
synthetic	O
promoters	O
containing	O
TATA	O
boxes	O
,	O
but	O
not	O
from	O
promoters	O
that	O
contain	O
an	O
initiator	O
instead	O
of	O
a	O
TATA	O
box	O
.	O

No	O
apparent	O
clinical	O
signs	O
indicative	O
of	O
systemic	O
toxicity	O
were	O
observed	O
in	O
the	O
F0	O
and	O
F1	O
animals	O
of	O
either	O
sex	O
.	O

Such	O
mutations	O
are	O
thought	O
to	O
exert	O
their	O
dominant	O
phenotype	O
by	O
sequestration	O
of	O
the	O
guanine	B
nucleotide	I
exchange	I
factor	I
(	O
GNEF	B
)	O
.	O

Upon	O
analysis	O
of	O
various	O
deletion	O
and	O
point	O
-	O
mutated	O
variants	O
of	O
the	O
human	B
IL-6	I
gene	I
promoter	I
coupled	O
to	O
a	O
reporter	O
gene	O
,	O
we	O
screened	O
for	O
possible	O
cooperating	O
transcription	O
factors	O
.	O

Our	O
purpose	O
was	O
to	O
determine	O
if	O
intact	O
perianal	O
(	O
S4	O
-	O
5	O
)	O
pin	O
sensation	O
(	O
PPS	O
)	O
and	O
bulbocavernosus	O
(	O
S2	O
-	O
4	O
)	O
reflex	O
(	O
BCR	O
)	O
shortly	O
after	O
spinal	O
cord	O
injury	O
(	O
SCI	O
)	O
are	O
predictive	O
of	O
bladder	O
function	O
recovery	O
.	O

Platelet	O
aggregation	O
in	O
response	O
to	O
10	O
micrograms	O
collagen	B
/	O
ml	O
was	O
decreased	O
in	O
parallel	O
after	O
treatment	O
with	O
ASA	O
.	O

The	O
inhibition	O
of	O
focus	O
formation	O
observed	O
in	O
the	O
presence	O
of	O
C3	B
G	I
was	O
not	O
due	O
to	O
toxic	O
effects	O
on	O
cell	O
viability	O
,	O
since	O
transfected	O
C3	B
G	I
cells	O
exhibited	O
the	O
same	O
survival	O
and	O
growth	O
rates	O
as	O
untransfected	O
NIH3T3	O
cells	O
or	O
cells	O
transfected	O
with	O
plasmid	O
vector	O
alone	O
.	O

Furthermore	O
,	O
direct	O
association	O
with	O
D3	O
phosphatidylinositides	O
seems	O
to	O
be	O
essential	O
for	O
activation	O
of	O
PKB	B
/	O
Akt	B
.	O

The	O
FMN	O
moiety	O
but	O
not	O
the	O
[	O
3Fe-4S	O
]	O
cluster	O
of	O
the	O
subunit	O
appears	O
to	O
participate	O
in	O
this	O
reaction	O
.	O

However	O
,	O
laparoscopy	O
failed	O
to	O
establish	O
inoperability	O
in	O
any	O
cases	O
of	O
carcinoma	O
spread	O
to	O
areas	O
not	O
accessible	O
to	O
laparoscopic	O
visualization	O
.	O

Molecular	O
characterization	O
of	O
the	O
50-	O
and	O
57-kDa	O
subunits	O
of	O
the	O
bovine	B
vacuolar	I
proton	I
pump	I
.	O

In	O
C.	O
albicans	O
,	O
HST6	B
is	O
expressed	O
constitutively	O
at	O
high	O
levels	O
in	O
the	O
different	O
cell	O
types	O
analysed	O
(	O
yeast	O
,	O
hyphae	O
,	O
white	O
and	O
opaque	O
)	O
,	O
demonstrating	O
that	O
HST6	B
transcription	O
is	O
not	O
repressed	O
in	O
this	O
diploid	O
yeast	O
,	O
unlike	O
in	O
diploid	O
S.	O
cerevisiae	O
,	O
and	O
suggesting	O
a	O
basic	O
biological	O
function	O
for	O
the	O
Hst6p	B
transporter	O
in	O
C.	O
albicans	O
.	O

No	O
TATA	O
box	O
was	O
found	O
in	O
the	O
putative	O
promoter	O
region	O
,	O
but	O
multiple	O
GC	O
boxes	O
were	O
found	O
around	O
the	O
cap	O
sites	O
,	O
supporting	O
the	O
previously	O
inferred	O
housekeeping	O
nature	O
of	O
CYP51	B
gene	I
and	O
the	O
existence	O
of	O
the	O
multiple	O
transcription	O
initiation	O
sites	O
.	O

Cis	O
-	O
regulation	O
downstream	O
of	O
cell	O
type	O
specification	O
:	O
a	O
single	O
compact	O
element	O
controls	O
the	O
complex	O
expression	O
of	O
the	O
CyIIa	B
gene	I
in	O
sea	O
urchin	O
embryos	O
.	O

Randomised	O
comparison	O
of	O
addition	O
of	O
autologous	O
bone	O
-	O
marrow	O
transplantation	O
to	O
intensive	O
chemotherapy	O
for	O
acute	O
myeloid	O
leukaemia	O
in	O
first	O
remission	O
:	O
results	O
of	O
MRC	O
AML	O
10	O
trial	O
.	O

In	O
ferrets	O
naturally	O
infected	O
with	O
H.	O
mustelae	O
,	O
a	O
single	O
dose	O
(	O
50	O
mg	O
/	O
kg	O
,	O
per	O
os	O
)	O
of	O
fluorofamide	O
completely	O
inhibited	O
bacterial	B
urease	I
.	O

The	O
risk	O
factors	O
for	O
hematuria	O
in	O
patients	O
with	O
renal	O
hypouricemia	O
are	O
the	O
elevation	O
of	O
urinary	O
urate	O
concentration	O
and	O
the	O
subtypes	O
of	O
Post	O
and	O
Secretion	O
.	O

RESULTS	O
:	O
Using	O
information	O
in	O
the	O
dbEST	O
database	O
of	O
expressed	O
sequence	O
tags	O
,	O
we	O
isolated	O
an	O
Arabidopsis	O
thaliana	O
gene	O
(	O
GCR1	B
)	O
that	O
encodes	O
a	O
protein	O
with	O
seven	O
predicted	O
membrane	O
-	O
spanning	O
domains	O
and	O
other	O
features	O
characteristic	O
of	O
7TM	B
receptors	I
.	O

Purification	O
of	O
MvaT	B
enriched	O
for	O
two	O
polypeptides	O
of	O
approximate	O
molecular	O
mass	O
15	O
kDa	O
and	O
16	O
kDa	O
,	O
designated	O
P15	B
and	O
P16	B
.	O

BACKGROUND	O
:	O
Defensins	B
,	O
also	O
known	O
as	O
human	B
neutrophil	I
peptides	I
,	O
are	O
antimicrobial	O
peptides	O
present	O
in	O
the	O
azurophil	O
granules	O
of	O
neutrophils	O
.	O

The	O
PDH	B
complex	I
-	I
encoding	I
genes	I
were	O
identified	O
by	O
hybridization	O
experiments	O
and	O
sequence	O
analysis	O
in	O
two	O
separate	O
gene	O
regions	O
in	O
the	O
genome	O
of	O
Z.	O
mobilis	O
.	O

Cervicovaginal	O
foetal	B
fibronectin	I
in	O
the	O
prediction	O
of	O
preterm	O
labour	O
in	O
a	O
low	O
-	O
risk	O
population	O
.	O

The	O
RAS	B
-	O
cyclic	B
AMP	I
-	I
dependent	I
protein	I
kinase	I
cAPK	B
pathway	O
prevents	O
the	O
UAS	O
activity	O
of	O
IREu	B
in	O
the	O
presence	O
of	O
glucose	O
as	O
the	O
sole	O
carbon	O
source	O
,	O
while	O
the	O
transcriptional	O
activators	O
Msn2p	B
and	O
Msn4p	B
promote	O
the	O
UAS	O
activity	O
of	O
this	O
repeat	O
in	O
the	O
presence	O
of	O
acetate	O
.	O

Cytochrome	B
b	I
in	O
human	B
complex	I
II	I
(	O
succinate	B
-	I
ubiquinone	I
oxidoreductase	I
)	O
:	O
cDNA	O
cloning	O
of	O
the	O
components	O
in	O
liver	O
mitochondria	O
and	O
chromosome	O
assignment	O
of	O
the	O
genes	O
for	O
the	O
large	O
(	O
SDHC	B
)	O
and	O
small	O
(	O
SDHD	B
)	O
subunits	O
to	O
1q21	O
and	O
11q23	O
.	O

Analysis	O
of	O
promoter	O
and	O
androgen	O
regulatory	O
sequences	O
required	O
for	O
optimal	O
transcription	O
of	O
the	O
rat	O
androgen	B
-	I
binding	I
protein	I
gene	O
.	O

Thus	O
,	O
Sir	B
proteins	I
from	O
K.	O
lactis	O
have	O
roles	O
in	O
both	O
silencing	O
and	O
telomere	O
length	O
maintenance	O
,	O
reflecting	O
conserved	O
functional	O
themes	O
.	O

We	O
recently	O
characterized	O
a	O
single	O
yeast	B
hnRNP	I
methyltransferase	I
(	O
HMT1	B
)	O
.	O

Serum	O
levels	O
of	O
testosterone	O
also	O
showed	O
no	O
significant	O
changes	O
by	O
exposure	O
to	O
p	O
,	O
p'-DDE	O
under	O
the	O
conditions	O
of	O
this	O
study	O
.	O

Based	O
on	O
the	O
current	O
literature	O
,	O
the	O
mechanisms	O
involved	O
in	O
the	O
toxicity	O
of	O
OA	B
indicate	O
three	O
major	O
effects	O
:	O
(	O
1	O
)	O
inhibition	O
of	O
mitochondrial	O
respiration	O
correlated	O
with	O
a	O
depletion	O
of	O
ATP	O
;	O
(	O
2	O
)	O
inhibition	O
of	O
tRNA	B
-	I
synthetase	I
accompanied	O
by	O
a	O
reduced	O
protein	O
synthesis	O
;	O
and	O
(	O
3	O
)	O
enhanced	O
lipid	O
peroxidation	O
.	O

In	O
addition	O
to	O
restoring	O
checkpoint	O
control	O
,	O
overexpression	O
of	O
sum1	B
+	I
inhibits	O
the	O
normal	O
cell	O
cycle	O
response	O
to	O
osmotic	O
stress	O
.	O

Decreased	O
levels	O
of	O
alpha2-antiplasmin	B
were	O
also	O
observed	O
in	O
the	O
mediastinum	O
(	O
0.50	O
versus	O
0.61	O
U	O
/	O
mL	O
;	O
p	O
<	O
0.05	O
)	O
.	O

In	O
this	O
study	O
,	O
the	O
effect	O
of	O
acute	O
administration	O
of	O
various	O
doses	O
of	O
malathion	O
via	O
oral	O
and	O
dermal	O
routes	O
to	O
mice	O
and	O
rats	O
on	O
serum	O
levels	O
of	O
histamine	O
was	O
evaluated	O
.	O

Using	O
Southern	O
blot	O
analysis	O
and	O
restriction	O
mapping	O
of	O
genomic	O
YAC	O
(	O
yeast	O
artificial	O
chromosome	O
)	O
and	O
cosmid	O
clones	O
,	O
we	O
located	O
the	O
human	B
RIL	I
gene	I
240	O
-	O
260	O
kb	O
telomeric	O
to	O
the	O
IRF1	B
gene	I
and	O
characterized	O
its	O
genomic	O
structure	O
.	O

However	O
,	O
mandibular	O
position	O
(	O
S	O
-	O
N	O
-	O
B	O
and	O
S	O
-	O
N	O
-	O
Pog	O
)	O
was	O
found	O
to	O
be	O
significantly	O
more	O
retrusive	O
in	O
Class	O
II	O
when	O
compared	O
with	O
Class	O
I	O
subjects	O
.	O

Echinostomiasis	O
is	O
aggravated	O
by	O
socioeconomic	O
factors	O
such	O
as	O
poverty	O
,	O
malnutrition	O
,	O
an	O
explosively	O
growing	O
free	O
-	O
food	O
market	O
,	O
a	O
lack	O
of	O
supervised	O
food	O
inspection	O
,	O
poor	O
or	O
insufficient	O
sanitation	O
,	O
other	O
helminthiases	O
,	O
and	O
declining	O
economic	O
conditions	O
.	O

To	O
clarify	O
whether	O
seizure	O
-	O
offset	O
patterns	O
are	O
reliable	O
in	O
predicting	O
seizure	O
outcome	O
,	O
we	O
studied	O
SEEG	O
/	O
ECoG	O
in	O
a	O
similar	O
group	O
of	O
patients	O
with	O
temporal	O
lobe	O
epilepsy	O
(	O
TLE	O
)	O
.	O

These	O
modifications	O
may	O
improve	O
the	O
interlaboratory	O
reproducibility	O
of	O
CD34	B
determinations	O
due	O
to	O
the	O
reduction	O
in	O
sample	O
handling	O
and	O
calculation	O
of	O
results	O
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
is	O
78.0	O
%	O
identical	O
to	O
the	O
cytoplasmic	B
dynein	I
heavy	I
chain	I
of	I
Neurospora	I
crassa	I
,	O
70.2	O
%	O
identical	O
to	O
that	O
of	O
Aspergillus	O
nidulans	O
and	O
24.8	O
%	O
identical	O
to	O
that	O
of	O
Saccharomyces	O
cerevisiae	O
.	O

The	O
5'-flanking	O
region	O
,	O
from	O
nucleotide	O
-837	O
to	O
-336	O
,	O
contains	O
TATA	O
and	O
inverted	O
CAAT	O
boxes	O
as	O
well	O
as	O
GATA-1	B
/	O
SP1	B
erythroid	O
-	O
specific	O
cis	O
-	O
acting	O
regulatory	O
elements	O
.	O

RESULTS	O
:	O
Horses	O
with	O
colic	O
had	O
significantly	O
higher	O
fibrinogen	B
concentration	O
,	O
greater	O
alpha	B
2AP	I
and	O
protein	B
C	I
activities	O
,	O
and	O
longer	O
PT	O
and	O
APTT	O
than	O
did	O
healthy	O
horses	O
.	O

The	O
same	O
IL-4-inducible	B
reporter	O
gene	O
is	O
also	O
synergistically	O
activated	O
by	O
the	O
endogenous	B
Stat6	I
and	O
NF	B
-	I
kappaB	I
proteins	I
in	O
IL-4-stimulated	B
I.29mu	O
B	O
lymphoma	O
cells	O
.	O

Convulsive	O
seizure	O
during	O
a	O
treatment	O
with	O
interferon	B
alpha	I
for	O
chronic	O
viral	O
hepatitis	O
C	O

A	O
stratified	O
random	O
sample	O
of	O
20	O
active	O
employees	O
from	O
a	O
cohort	O
of	O
phenoxy	O
herbicide	O
workers	O
was	O
selected	O
in	O
1995	O
for	O
determining	O
PCDD	O
and	O
PCDF	O
congeners	O
in	O
blood	O
lipids	O
to	O
assess	O
the	O
extent	O
of	O
past	O
PCDD	O
and	O
PCDF	O
exposure	O
in	O
this	O
cohort	O
and	O
whether	O
that	O
exposure	O
might	O
explain	O
site	O
-	O
specific	O
cancer	O
findings	O
in	O
the	O
total	O
cohort	O
.	O

We	O
specially	O
devised	O
3	O
types	O
of	O
turbo	O
pumps	O
,	O
a	O
centrifugal	O
pump	O
(	O
CFP	O
)	O
,	O
a	O
mixed	O
flow	O
pump	O
(	O
MFP	O
)	O
,	O
and	O
an	O
axial	O
flow	O
pump	O
(	O
AFP	O
)	O
,	O
and	O
analyzed	O
their	O
in	O
vitro	O
performance	O
.	O

Two	O
members	O
of	O
the	O
Cbl	B
family	I
have	O
since	O
been	O
defined	O
in	O
mammals	O
(	O
c	B
-	I
Cbl	I
and	O
Cbl	B
-	I
b	I
)	O
,	O
one	O
in	O
C.	O
elegans	O
(	O
Sli-1	B
)	O
and	O
one	O
in	O
Drosophila	O
(	O
D	B
-	I
Cbl	I
)	O
.	O

The	O
therapeutic	O
use	O
of	O
botulinum	B
toxin	I
(	O
Botox	B
)	O
is	O
increasing	O
in	O
popularity	O
.	O

The	O
viral	B
oncoprotein	I
E1A	I
inhibits	O
NFAT	B
-	O
dependent	O
transactivation	O
in	O
a	O
p300-dependent	B
manner	O
.	O

The	O
pre	O
-	O
mRNA	O
splicing	O
factor	O
U2AF	B
(	O
U2	B
small	I
nuclear	I
ribonucleoprotein	I
particle	I
[	I
snRNP	I
]	I
auxiliary	I
factor	I
)	O
plays	O
a	O
critical	O
role	O
in	O
3	O
'	O
splice	O
site	O
selection	O
.	O

The	O
second	O
patient	O
had	O
received	O
pituitary	B
-	I
derived	I
growth	I
hormone	I
for	O
treatment	O
of	O
growth	B
hormone	I
deficiency	O
,	O
secondary	O
to	O
a	O
third	O
ventricle	O
teratoma	O
,	O
exised	O
13	O
yr	O
earlier	O
.	O

Osteoadherin	B
is	O
a	O
recently	O
described	O
bone	O
proteoglycan	O
containing	O
keratan	O
sulfate	O
.	O

Intron	O
8	O
harbored	O
a	O
strong	O
erythroid	O
-	O
specific	O
enhancer	O
activity	O
which	O
was	O
orientation	O
-	O
dependent	O
.	O

The	O
intron	O
8	O
enhancer	O
region	O
was	O
not	O
activated	O
by	O
GATA-1	B
together	O
with	O
Sp1	B
in	O
transactivation	O
experiments	O
in	O
COS-1	O
cells	O
indicating	O
the	O
involvement	O
of	O
a	O
related	O
Sp1	B
protein	I
or	O
of	O
another	O
unidentified	O
erythroid	O
factor	O
.	O

Moreover	O
,	O
the	O
mass	O
estimated	O
with	O
the	O
QCM	O
response	O
through	O
the	O
Sauerbrey	O
equation	O
and	O
the	O
mass	O
which	O
can	O
be	O
measured	O
thanks	O
to	O
other	O
analytical	O
techniques	O
,	O
in	O
our	O
case	O
an	O
enzymatic	O
assay	O
,	O
are	O
different	O
:	O
the	O
deposited	O
mass	O
is	O
generally	O
overestimated	O
by	O
the	O
QCM	O
.	O

Human	O
isoforms	O
,	O
designated	O
1	O
to	O
4	O
,	O
differ	O
from	O
each	O
other	O
by	O
the	O
start	O
codon	O
used	O
.	O

He	O
was	O
administered	O
recombinant	B
IFN	I
alpha-2b	I
under	O
the	O
diagnosis	O
of	O
chronic	O
hepatitis	O
C.	O

We	O
then	O
studied	O
four	O
unrelated	O
Japanese	O
families	O
with	O
GSD	O
-	O
Ib	O
,	O
and	O
found	O
three	O
novel	O
mutations	O
:	O
a	O
four	O
-	O
base	O
deletion	O
/	O
two	O
-	O
base	O
insertion	O
,	O
a	O
point	O
mutation	O
within	O
a	O
consensus	O
splicing	O
donor	O
site	O
,	O
and	O
a	O
missense	O
mutation	O
(	O
W118R	O
)	O
.	O

Downregulation	O
of	O
FUS	B
expression	O
in	O
BCR	B
/	O
ABL	B
-	O
expressing	O
32Dcl3	O
cells	O
was	O
associated	O
with	O
suppression	O
of	O
growth	O
factor	O
-	O
independent	O
colony	O
formation	O
,	O
restoration	O
of	O
G	B
-	I
CSF	I
-	O
induced	O
granulocytic	O
differentiation	O
and	O
reduced	O
tumorigenic	O
potential	O
in	O
vivo	O
.	O

These	O
results	O
with	O
clozapine	O
illustrate	O
that	O
LI	O
is	O
sensitive	O
to	O
antipsychotics	O
which	O
differ	O
in	O
their	O
mode	O
of	O
action	O
and	O
furthermore	O
emphasize	O
the	O
value	O
of	O
LI	O
as	O
a	O
test	O
model	O
for	O
detecting	O
the	O
antipsychotic	O
potential	O
of	O
novel	O
drugs	O
.	O

The	O
complement	B
C3a	I
anaphylatoxin	I
receptor	I
(	O
C3aR	B
)	O
is	O
a	O
seven	B
-	I
transmembrane	I
G	I
-	I
protein	I
coupled	I
chemoattractant	I
receptor	I
that	O
on	O
binding	O
the	O
C3a	B
peptide	I
ligand	I
mediates	O
numerous	O
cellular	O
responses	O
,	O
including	O
histamine	O
release	O
from	O
mast	O
cells	O
.	O

smooth	O
muscle	O
contraction	O
,	O
and	O
the	O
directed	O
migration	O
of	O
eosinophils	O
.	O

The	O
heterogeneous	O
nuclear	B
ribonucleoprotein	I
C	I
protein	I
tetramer	I
binds	O
U1	B
,	O
U2	B
,	O
and	O
U6	B
snRNAs	I
through	O
its	O
high	O
affinity	O
RNA	O
binding	O
domain	O
(	O
the	O
bZIP	O
-	O
like	O
motif	O
)	O
.	O

Acute	O
idiopathic	O
thrombocytopenic	O
purpura	O
presenting	O
a	O
high	O
serum	O
level	O
of	O
immunoglobulin	B
E	I
and	O
eosinophilia	O
in	O
an	O
elderly	O
patient	O
.	O

Anesthesia	O
with	O
M	O
/	O
K	O
was	O
reversed	O
after	O
41.6	O
min	O
of	O
immobilization	O
with	O
atipamezole	O
.	O

MK-801	O
administration	O
resulted	O
in	O
a	O
biphasic	O
response	O
in	O
seizure	O
latency	O
.	O

The	O
binding	O
of	O
NF	B
-	I
ATp	I
,	O
although	O
not	O
NF	B
-	I
AT4	I
,	O
to	O
this	O
enhancer	O
also	O
occurs	O
along	O
with	O
HTLV	O
-	O
I	O
-	O
mediated	O
infection	O
of	O
human	O
peripheral	O
blood	O
T	O
-	O
cells	O
.	O

Peroxisome	B
proliferator	I
-	I
activated	I
receptors	I
(	O
PPAR	B
)	O
modulate	O
transcription	O
by	O
binding	O
to	O
specific	O
peroxisome	O
proliferator	O
-	O
response	O
elements	O
(	O
PPRE	O
)	O
through	O
heterodimerization	O
with	O
the	O
9-cis	B
retinoic	I
acid	I
receptor	I
(	O
RXR	B
)	O
.	O

Co	O
-	O
transfection	O
of	O
the	O
Sp1	B
expression	O
plasmid	O
and	O
the	O
-58	O
promoter	O
construct	O
into	O
Drosophila	O
Schneider	O
cells	O
revealed	O
that	O
Sp1	B
contributed	O
to	O
the	O
kinase	O
basal	O
promoter	O
activity	O
by	O
binding	O
to	O
the	O
non	O
-	O
consensus	O
site	O
in	O
the	O
-58	O
region	O
.	O

Likewise	O
,	O
at	O
150	O
degrees	O
C	O
with	O
2	O
%	O
APS	O
the	O
surface	O
density	O
of	O
NH2	O
groups	O
reached	O
a	O
maximum	O
at	O
24	O
hr	O
and	O
remained	O
relatively	O
constant	O
up	O
to	O
96	O
hr	O
.	O

Studies	O
using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
also	O
did	O
not	O
provide	O
evidence	O
for	O
the	O
formation	O
of	O
a	O
VDR	B
-	O
TR	B
protein	O
-	O
protein	O
interaction	O
.	O

Mutation	O
of	O
either	O
the	O
AP-1	B
or	O
the	O
ets	B
component	O
of	O
this	O
site	O
also	O
prevented	O
promoter	O
activity	O
in	O
SMCs	O
.	O

Surprisingly	O
,	O
double	O
mutants	O
of	O
the	O
shy2	B
-	I
1D	I
mutant	I
with	O
the	O
phytochrome	B
-	O
deficient	O
mutants	O
hy2	B
,	O
hy3	B
(	O
phyB-1	B
)	O
and	O
fre1	B
-	I
1	I
(	O
phyA-201	B
)	O
showed	O
reduced	O
photomorphogenic	O
response	O
in	O
darkness	O
with	O
a	O
longer	O
hypocotyl	O
,	O
a	O
longer	O
inflorescence	O
stem	O
,	O
and	O
a	O
lower	O
level	O
expression	O
of	O
the	O
CAB	B
gene	I
than	O
the	O
shy2	B
-	I
1D	I
single	I
mutant	I
.	O

Wild	O
-	O
type	O
and	O
mutant	O
MyoD	B
were	O
introduced	O
into	O
cells	O
using	O
an	O
E1	B
,	O
E3-deleted	B
adenoviral	O
vector	O
.	O

Endoscopic	O
examinations	O
,	O
peripheral	O
white	O
blood	O
cell	O
(	O
WBC	O
)	O
counts	O
,	O
and	O
assays	O
of	O
myeloperoxidase	B
activity	O
(	O
MPO	B
)	O
in	O
homogenates	O
of	O
colon	O
mucosa	O
were	O
performed	O
after	O
one	O
week	O
(	O
4	O
%	O
DSS	O
model	O
)	O
and	O
eight	O
weeks	O
(	O
1	O
%	O
DSS	O
model	O
)	O
.	O

The	O
human	O
T	O
cell	O
lymphotropic	O
retrovirus	O
type	O
I	O
(	O
HTLV	O
-	O
I	O
)	O
trans	O
-	O
activator	O
,	O
Tax	B
,	O
interacts	O
specifically	O
with	O
the	O
basic	B
-	I
domain	I
/	I
leucine	I
-	I
zipper	I
(	I
bZip	I
)	I
protein	I
,	O
cAMP	B
response	I
element	I
binding	I
protein	I
(	O
CREB	B
)	O
,	O
bound	O
to	O
the	O
viral	B
Tax	I
-	I
responsive	I
element	I
consisting	O
of	O
three	O
imperfect	O
21-base	O
pair	O
repeats	O
,	O
each	O
with	O
a	O
cAMP	O
response	O
element	O
core	O
flanked	O
by	O
G	O
/	O
C	O
-	O
rich	O
sequences	O
.	O

However	O
,	O
changing	O
the	O
half	O
-	O
site	O
to	O
the	O
consensus	O
sequence	O
AGGTCA	O
(	O
IRper-1	O
)	O
increased	O
binding	O
of	O
AaEcR.AaUSP	B
10-fold	O
over	O
IRhsp-1	O
and	O
,	O
at	O
the	O
same	O
time	O
,	O
reduced	O
the	O
stringency	O
of	O
the	O
spacer	O
length	O
requirement	O
,	O
with	O
IRper-0	O
to	O
IRper-5	O
showing	O
detectable	O
binding	O
.	O

Sequence	O
comparisons	O
strongly	O
suggest	O
that	O
the	O
S27a	B
and	O
the	O
ubiquitin	B
coding	O
sequences	O
found	O
in	O
the	O
genome	O
of	O
CP	O
Rit	O
were	O
both	O
derived	O
from	O
a	O
bovine	O
mRNA	O
encoding	O
a	O
hybrid	O
protein	O
with	O
the	O
structure	O
NH2-ubiquitin	O
-	O
S27a	B
-	O
COOH	O
.	O

J.	O

EGFR	B
levels	O
were	O
found	O
to	O
be	O
elevated	O
5-	O
,	O
3	O
.	O

T.	O
,	O
Mahasneh	O
,	O
A.	O
,	O
and	O
Cote	O
,	O
G.	O

A	O
simple	O
analytical	O
method	O
for	O
l	O
-	O
menthol	O
by	O
high	O
-	O
performance	O
liquid	O
chromatography	O
with	O
a	O
polarized	O
photometric	O
detector	O
was	O
established	O
.	O

Although	O
E2FBP1	B
lacks	O
the	O
transactivation	O
domain	O
,	O
it	O
stimulates	O
E2F	B
site	O
-	O
dependent	O
transcription	O
in	O
cooperation	O
with	O
E2F-1	B
.	O

Analysis	O
of	O
chromosomal	O
DNA	O
sequence	O
immediately	O
downstream	O
of	O
the	O
transposon	O
insertion	O
identified	O
two	O
open	O
reading	O
frames	O
,	O
designated	O
csrR	B
and	O
csrS	B
,	O
which	O
exhibited	O
sequence	O
similarity	O
to	O
bacterial	O
two	O
-	O
component	O
regulatory	O
systems	O
.	O

We	O
previously	O
delineated	O
a	O
region	O
in	O
the	O
fatty	B
-	I
acid	I
synthase	I
promoter	I
,	O
which	O
was	O
responsible	O
for	O
obesity	O
-	O
related	O
overexpression	O
of	O
the	O
fatty	B
-	I
acid	I
synthase	I
(	O
FAS	B
)	O
gene	O
,	O
by	O
negatively	O
regulating	O
the	O
activity	O
of	O
the	O
downstream	O
promoter	O
in	O
lean	O
but	O
not	O
obese	O
rat	O
fat	O
cells	O
.	O

J.	O

RESULTS	O
:	O
We	O
identified	O
a	O
full	O
-	O
length	O
cDNA	O
with	O
an	O
open	O
reading	O
frame	O
of	O
2883	O
bp	O
corresponding	O
to	O
a	O
predicted	O
protein	O
of	O
961	O
amino	O
acids	O
that	O
shares	O
greater	O
than	O
95	O
%	O
homology	O
with	O
the	O
rat	B
gamma	I
-	I
aminobutyric	I
acid	I
B	I
(	I
GABAB	I
)	I
receptor	I
.	O

Another	O
tentative	O
hotspot	O
mutation	O
in	O
the	O
third	O
patient	O
,	O
a	O
frame	O
shift	O
caused	O
by	O
a	O
G	O
nucleotide	O
insertion	O
in	O
a	O
monotonous	O
repeat	O
of	O
six	O
Gs	O
in	O
HPRT	B
exon	I
3	I
,	O
has	O
been	O
reported	O
previously	O
in	O
three	O
other	O
LN	O
patients	O
.	O

One	O
of	O
these	O
fragments	O
shows	O
the	O
highest	O
amino	O
acid	O
sequence	O
homology	O
to	O
the	O
insect	O
ecdysone	O
inducible	O
gene	B
E75	I
.	O

Based	O
on	O
sequence	O
homology	O
,	O
the	O
genes	O
were	O
identified	O
as	O
TEF	B
,	O
encoding	O
translation	B
elongation	I
factor-1	I
alpha	I
and	O
RPS7	B
,	O
encoding	O
ribosomal	O
protein	O
S7	B
.	O

Fatal	O
apneusis	O
was	O
observed	O
under	O
following	O
conditions	O
:	O
(	O
1	O
)	O
Persistent	O
apnea	O
was	O
produced	O
after	O
a	O
single	O
KA	O
microinjection	O
in	O
one	O
side	O
of	O
the	O
VRG	O
-	O
Apa	O
(	O
5	O
animals	O
)	O
.	O

Competition	O
EMSA	O
established	O
that	O
constitutively	O
expressed	O
nuclear	O
proteins	O
bound	O
the	O
KCS	B
element	I
selectively	O
;	O
KCS	B
protein	I
binding	O
activity	O
correlated	O
with	O
promoter	O
activity	O
in	O
the	O
transient	O
transfection	O
reporter	O
assay	O
.	O

Paralemmin	B
is	O
also	O
phosphorylated	O
,	O
and	O
its	O
mRNA	O
is	O
differentially	O
spliced	O
in	O
a	O
tissue	O
-	O
specific	O
and	O
developmentally	O
regulated	O
manner	O
.	O

Here	O
we	O
demonstrate	O
that	O
the	O
mechanism	O
of	O
activation	O
of	O
HIF-1alpha	B
is	O
a	O
multi	O
-	O
step	O
process	O
which	O
includes	O
hypoxia	O
-	O
dependent	O
nuclear	O
import	O
and	O
activation	O
(	O
derepression	O
)	O
of	O
the	O
transactivation	O
domain	O
,	O
resulting	O
in	O
recruitment	O
of	O
the	O
CREB	B
-	I
binding	I
protein	I
(	O
CBP	B
)	O
/	O
p300	B
coactivator	I
.	O

It	O
is	O
now	O
well	O
established	O
that	O
progression	O
through	O
the	O
eukaryotic	O
cell	O
cycle	O
is	O
controlled	O
by	O
oscillations	O
in	O
the	O
activity	O
of	O
cyclin-	B
dependent	I
kinases	I
(	O
CDKs	B
)	O
.	O

The	O
hematopoietic	B
colony	I
-	I
stimulating	I
factors	I
(	O
CSF	B
)	O
have	O
been	O
introduced	O
into	O
clinical	O
practice	O
as	O
additional	O
supportive	O
measures	O
that	O
can	O
reduce	O
the	O
incidence	O
of	O
infectious	O
complications	O
in	O
patients	O
with	O
cancer	O
and	O
neutropenia	O
.	O

This	O
model	O
is	O
supported	O
by	O
experiments	O
showing	O
that	O
Cdr2	B
associates	O
with	O
the	O
N	B
-	I
terminal	I
regulatory	I
domain	I
of	I
Wee1	I
in	O
cell	O
lysates	O
and	O
phosphorylates	O
Wee1	B
in	O
vitro	O
.	O

Mean	O
intake	O
of	O
vitamin	O
A	O
amounted	O
to	O
1.1	O
and	O
0.9	O
mg	O
RE	O
/	O
day	O
for	O
men	O
and	O
women	O
,	O
respectively	O
;	O
the	O
contributions	O
of	O
meat	O
,	O
fats	O
and	O
oils	O
,	O
vegetables	O
and	O
dairy	O
products	O
to	O
total	O
intake	O
were	O
35	O
%	O
,	O
24	O
%	O
,	O
16	O
%	O
,	O
and	O
16	O
%	O
,	O
respectively	O
.	O

The	O
Mig1	B
repressor	I
is	O
a	O
zinc	B
finger	I
protein	I
that	O
mediates	O
glucose	O
repression	O
in	O
yeast	O
.	O

Taken	O
together	O
,	O
our	O
results	O
indicate	O
that	O
the	O
FCR1	B
gene	I
behaves	O
as	O
a	O
negative	O
regulator	O
of	O
drug	O
resistance	O
in	O
C.	O
albicans	O
and	O
constitute	O
the	O
first	O
evidence	O
that	O
FCZ	O
resistance	O
can	O
result	O
from	O
the	O
inactivation	O
of	O
a	O
regulatory	O
factor	O
such	O
as	O
Fcr1p	B
.	O

These	O
findings	O
suggest	O
that	O
late	O
MYO	O
/	O
M	O
is	O
more	O
useful	O
than	O
washout	O
rate	O
to	O
assess	O
the	O
effect	O
of	O
treatment	O
on	O
heart	O
failure	O
due	O
to	O
DCM	O
.	O

With	O
regard	O
to	O
the	O
optimal	O
threshold	O
values	O
,	O
sensitivity	O
and	O
specificity	O
were	O
100%	O
/	O
97	O
%	O
and	O
95%	O
/	O
95	O
%	O
with	O
FDG	O
PET	O
,	O
compared	O
to	O
86%	O
/	O
92	O
%	O
and	O
77%	O
/	O
82	O
%	O
with	O
IS	O
,	O
respectively	O
.	O

Lead	O
fixation	O
in	O
dogs	O
achieved	O
with	O
RF	O
energy	O
.	O

The	O
percutaneous	O
absorption	O
of	O
clindamycin	O
was	O
studied	O
in	O
healthy	O
male	O
volunteers	O
,	O
comparing	O
two	O
investigative	O
clindamycin	O
(	O
%	O
w	O
/	O
v	O
)	O
/	O
tretinoin	O
(	O
0.025	O
%	O
w	O
/	O
v	O
)	O
gels	O
,	O
containing	O
clindamycin	O
phosphate	O
ester	O
and	O
clindamycin	O
HCl	O
,	O
respectively	O
,	O
relative	O
to	O
a	O
clindamycin	O
phosphate	O
lotion	O
(	O
1	O
%	O
clindamycin	O
;	O
Dalacin	O
T	O
)	O
.	O

The	O
orbitofrontal	O
,	O
cingulate	O
,	O
and	O
anteromedial	O
part	O
of	O
the	O
dorsal	O
premotor	O
areas	O
were	O
preferentially	O
activated	O
by	O
the	O
self	O
-	O
initiated	O
hand	O
movement	O
task	O
(	O
SELF	O
)	O
.	O

The	O
active	O
site	O
includes	O
the	O
acidic	O
triad	O
Asp53	O
(	O
the	O
site	O
of	O
phosphorylation	O
)	O
,	O
Asp10	O
and	O
Glu9	O
.	O

Epstein	B
-	I
Barr	I
virus	I
-	I
encoded	I
latent	I
membrane	I
protein	I
1	I
activates	O
the	O
JNK	B
pathway	O
through	O
its	O
extreme	O
C	O
terminus	O
via	O
a	O
mechanism	O
involving	O
TRADD	B
and	O
TRAF2	B
.	O

Furthermore	O
,	O
using	O
transgenic	O
mouse	O
technology	O
we	O
localized	O
independent	O
cis	O
-	O
regulatory	O
elements	O
controlling	O
the	O
tissue	O
-	O
specific	O
expression	O
of	O
Pax6	B
.	O

Interferon	B
-	I
alpha	I
treatment	O
of	O
posttransplant	O
lymphoproliferative	O
disorder	O
in	O
recipients	O
of	O
solid	O
organ	O
transplants	O
.	O

We	O
show	O
that	O
the	O
Sm	B
-	I
binding	I
site	I
and	O
stem	O
-	O
loop	O
III	O
structures	O
are	O
necessary	O
for	O
correct	O
3'-end	O
formation	O
.	O

Further	O
experiments	O
will	O
be	O
required	O
to	O
highlight	O
the	O
in	O
vivo	O
role	O
of	O
ELE1	B
in	O
nuclear	O
receptor	O
functioning	O
.	O

A	O
gapped	O
search	O
with	O
the	O
C	O
-	O
terminal	O
region	O
of	O
CDED	B
/	O
LIOR	B
revealed	O
a	O
36	O
-	O
41	O
%	O
similarity	O
to	O
several	O
proteins	O
related	O
to	O
signal	O
transduction	O
and	O
cell	O
replication	O
,	O
such	O
as	O
ORC1	B
and	O
KSR	B
.	O

Unitary	O
-	O
group	O
approach	O
to	O
spin	O
-	O
dependent	O
operators	O
.	O

C3	B
toxin	I
completely	O
inhibited	O
RhoA	B
function	O
,	O
partially	O
inhibited	O
SRE	O
:	O
Luc	B
activity	O
,	O
but	O
had	O
no	O
effect	O
on	O
LPA	O
-	O
stimulated	O
c	B
-	I
Fos	I
expression	O
.	O

Trinipatch	O
is	O
a	O
small	O
,	O
transparent	O
,	O
matricial	O
,	O
monolayer	O
patch	O
with	O
an	O
absorption	O
promoter	O
,	O
marketed	O
in	O
two	O
dose	O
-	O
strengths	O
(	O
5	O
mg	O
/	O
24	O
h	O
and	O
10	O
mg	O
/	O
24	O
h	O
)	O
by	O
Laboratoires	O
Synthelabo	O
.	O

The	O
starting	O
point	O
is	O
the	O
consideration	O
that	O
the	O
conceptions	O
underlying	O
the	O
ICIDH	O
are	O
not	O
suitable	O
to	O
serve	O
as	O
a	O
mainstay	O
of	O
a	O
model	O
for	O
diagnostics	O
in	O
rehabilitation	O
because	O
they	O
do	O
not	O
reflect	O
essential	O
characteristics	O
of	O
the	O
diagnostic	O
process	O
which	O
is	O
the	O
basis	O
for	O
intervention	O
.	O

Envelope	O
-	O
function	O
matching	O
conditions	O
for	O
GaAs	O
/	O
(	O
Al	O
,	O
Ga	O
)	O
As	O
heterojunctions	O
.	O

NMR	O
of	O
diffusing	O
atoms	O
in	O
a	O
periodic	O
porous	O
medium	O
in	O
the	O
presence	O
of	O
a	O
nonuniform	O
magnetic	O
field	O
.	O

Microstructure	O
and	O
conductivity	O
of	O
hierarchical	O
laminate	O
composites	O
.	O

Erratum	O
:	O
Absence	O
of	O
precursor	O
effects	O
above	O
the	O
martensitic	O
transformation	O
in	O
a	O
virgin	O
crystal	O
of	O
Li	O
metal	O

However	O
,	O
after	O
PRK	O
at	O
5	O
weeks	O
of	O
age	O
,	O
partial	O
retreatment	O
may	O
be	O
necessary	O
due	O
to	O
regression	O
of	O
the	O
PRK	O
effect	O
.	O

BACKGROUND	O
:	O
In	O
the	O
ubiquitin	B
-	O
dependent	O
proteolysis	O
pathway	O
,	O
a	O
ubiquitin	B
ligase	I
(	O
E3	B
)	O
is	O
responsible	O
for	O
substrate	O
selectivity	O
and	O
timing	O
of	O
degradation	O
.	O

Quantum	O
-	O
statistical	O
theory	O
of	O
high	O
-	O
field	O
transport	O
phenomena	O
.	O

NH3	O
and	O
NO	O
interaction	O
with	O
Si	O
(	O
100	O
)	O
-	O
(	O
2	O
x	O
1	O
)	O
surfaces	O
.	O

Temperature	O
dependence	O
of	O
the	O
sublattice	O
spontaneous	O
magnetization	O
of	O
YBa2Cu3O6	O
.	O

Depth	O
-	O
controlled	O
grazing	O
-	O
incidence	O
diffraction	O
of	O
synchrotron	O
x	O
radiation	O
.	O

Large	O
scale	O
electronic	O
structure	O
calculations	O
.	O

Band	O
structure	O
effects	O
of	O
transport	O
properties	O
in	O
icosahedral	O
quasicrystals	O
.	O

Nipponbare	O
as	O
well	O
as	O
O.	O
australiensis	O
.	O

KEY	O
WORDS	O
:	O

Melaleuca	O
;	O
Lake	O
Okeechobee	O
;	O
Littoral	O
zone	O
;	O
Water	O
level	O
;	O
Regulation	O
schedule	O

These	O
observations	O
of	O
elevated	O
serum	B
lipase	I
and	O
serum	O
CA	B
19	I
-	I
9	I
in	O
Sjogren	O
's	O
syndrome	O
without	O
evidence	O
of	O
malignancy	O
may	O
reflect	O
pancreatic	O
involvement	O
in	O
this	O
disorder	O
.	O

Calcinosis	O
cutis	O
following	O
intravenous	O
infusion	O
of	O
calcium	O
gluconate	O
.	O

Medicare	O
SNF	O
benefits	O
revised	O
--	O
again	O
.	O

BACKGROUND	O
:	O
The	O
MAZE	O
-	O
III	O
is	O
the	O
surgical	O
treatment	O
of	O
choice	O
for	O
medically	O
refractory	O
atrial	O
fibrillation	O
.	O

This	O
scFv	O
was	O
therefore	O
used	O
as	O
control	O
in	O
experiments	O
where	O
another	O
anti	B
-	I
Ras	I
scFv	I
(	O
Y259	B
scFv	I
,	O
derived	O
from	O
the	O
neutralizing	O
anti	B
-	I
Ras	I
mAb	I
Y13	I
-	I
259	I
)	O
blocked	O
the	O
Ras	B
pathway	O
in	O
vitro	O
and	O
led	O
to	O
tumor	O
regression	O
in	O
a	O
nude	O
mouse	O
model	O
[	O
Cochet	O
,	O
O.	O
,	O
Kenigsberg	O
,	O
M.	O
,	O
Delumeau	O
,	O
I.	O
,	O
Virone	O
-	O
Oddos	O
,	O
A.	O
,	O
Multon	O
,	O
M.C.	O
,	O
Fridman	O
,	O
W.H.	O
,	O
Schweighoffer	O
,	O
F.	O
,	O
Teillaud	O
,	O
J.L.	O
,	O
Tocque	O
,	O
B.	O
,	O
1998	O
.	O

The	O
responsive	O
region	O
of	O
the	O
alpha	B
2	I
(	I
V	I
)	I
collagen	I
gene	I
was	O
localized	O
to	O
a	O
fragment	O
including	O
100	O
bp	O
of	O
basal	O
promoter	O
and	O
150	O
bp	O
of	O
exon	O
1	O
sequences	O
,	O
which	O
contained	O
two	O
CRE	O
-	O
like	O
elements	O
.	O

OBJECTIVE	O
:	O
To	O
determine	O
whether	O
administration	O
of	O
misoprostol	O
prevents	O
gastric	O
hemorrhage	O
in	O
healthy	O
dogs	O
treated	O
with	O
high	O
doses	O
of	O
methylprednisolone	O
sodium	O
succinate	O
(	O
MPSS	O
)	O
.	O

(	O
i	O
)	O
Complete	O
Grb10	B
expression	O
from	O
cDNA	O
with	O
an	O
ecdysone	O
-	O
regulated	O
transient	O
expression	O
system	O
stimulated	O
PDGF	B
-	I
BB-	I
,	O
IGF	B
-	I
I	I
,	O
and	O
insulin-	B
but	O
not	O
epidermal	B
growth	I
factor	I
(	O
EGF	B
)	O
-induced	O
DNA	O
synthesis	O
in	O
an	O
ecdysone	O
dose	O
-	O
responsive	O
fashion	O
.	O

CONCLUSIONS	O
:	O
In	O
healthy	O
individuals	O
,	O
whole	O
body	O
insulin	B
sensitivity	O
is	O
related	O
,	O
or	O
""""	O
coupled	O
,	O
""""	O
to	O
the	O
anaerobic	O
threshold	O
.	O

The	O
intron	O
RNA	O
consists	O
of	O
2492	O
nucleotides	O
which	O
can	O
be	O
folded	O
into	O
a	O
secondary	O
structure	O
with	O
all	O
the	O
expected	O
sequence	O
motifs	O
of	O
subgroup	O
-	O
IIA1	O
introns	O
(	O
Michel	O
et	O
al.	O

272	O
,	O
1904	O
]	O
.	O

OBJECTIVE	O
:	O
1998	O
Surveillance	O
,	O
Epidemiology	O
,	O
and	O
End	O
Results	O
(	O
SEER	O
)	O
data	O
estimate	O
an	O
83.1	O
%	O
5-year	O
survival	O
rate	O
for	O
corpus	O
uteri	O
adenocarcinoma	O
FIGO	O
stage	O
II	O
.	O

Treatment	O
of	O
unstable	O
angina	O
:	O
role	O
of	O
antithrombotic	O
therapy	O
.	O

J.	O

Duch	O
,	O
and	O
F.	O

There	O
was	O
a	O
trend	O
toward	O
an	O
association	O
between	O
IENF	O
and	O
sural	O
nerve	O
unmyelinated	O
fiber	O
densities	O
(	O
r	O
=	O
0.32	O
,	O
p	O
=	O
0.054	O
)	O
.	O

In	O
addition	O
,	O
all	O
three	O
Opa	B
proteins	I
of	O
C751	O
bind	O
equally	O
well	O
to	O
HeLa	O
cells	O
transfected	O
with	O
cDNA	O
encoding	O
the	O
carcinoembryonic	B
antigen	I
[	O
CEA	B
(	O
CD66e	B
)	O
]	O
subgroup	O
of	O
the	O
CD66	B
family	I
,	O
but	O
show	O
distinct	O
tropism	O
for	O
CGM1-	B
(	O
CD66d	B
)	O
and	O
NCA	B
(	O
CD66c	B
)	O
-expressing	O
cells	O
.	O

The	O
proliferation	O
-	O
specific	O
HNF-3	B
/	O
fork	B
head	I
homolog-11B	I
protein	O
(	O
HFH-11B	B
;	O
also	O
known	O
as	O
Trident	B
and	O
Win	B
)	O
is	O
a	O
family	O
member	O
of	O
the	O
winged	B
helix	I
/	O
fork	B
head	I
transcription	O
factors	O
and	O
in	O
regenerating	O
liver	O
its	O
expression	O
is	O
reactivated	O
prior	O
to	O
hepatocyte	O
entry	O
into	O
DNA	O
replication	O
(	O
S	O
phase	O
)	O
.	O

The	O
role	O
of	O
transport	O
by	O
sea	O
ice	O
from	O
the	O
Kara	O
Sea	O
into	O
the	O
Arctic	O
Ocean	O
was	O
assessed	O
by	O
a	O
small	O
subgroup	O
at	O
GEOMAR	O
.	O

Results	O
confirmed	O
that	O
stress	O
produced	O
CA3	O
dendritic	O
atrophy	O
and	O
tianeptine	O
prevented	O
it	O
.	O

Studies	O
have	O
substantiated	O
the	O
involvement	O
of	O
numerous	O
loci	O
on	O
certain	O
chromosomes	O
;	O
in	O
excess	O
of	O
10	O
chromosomes	O
are	O
thought	O
to	O
be	O
involved	O
.	O

Analysis	O
of	O
its	O
genomic	O
region	O
revealed	O
that	O
the	O
13-kb	O
Cdc6	B
gene	I
is	O
divided	O
into	O
12	O
exons	O
by	O
11	O
introns	O
.	O

The	O
availability	O
of	O
potent	O
regulatory	O
DNA	O
cassettes	O
harboring	O
the	O
murine	B
D1A	I
gene	I
promoter	I
could	O
aid	O
testing	O
the	O
neuronal	O
-	O
specific	O
expression	O
of	O
transgenes	O
in	O
vivo	O
.	O

Of	O
these	O
patients	O
,	O
46,164	O
were	O
placed	O
on	O
a	O
waiting	O
list	O
for	O
transplantation	O
,	O
23,275	O
of	O
whom	O
received	O
a	O
first	O
cadaveric	O
transplant	O
between	O
1991	O
and	O
1997	O
.	O

In	O
electrophoretic	O
mobility	O
shift	O
assay	O
(	O
EMSA	O
)	O
,	O
this	O
GLUT4	B
repressor	I
element	I
(	O
G4RE	B
)	O
generated	O
specific	O
bands	O
with	O
nuclear	O
extracts	O
from	O
preadipocytes	O
,	O
but	O
not	O
from	O
adipocytes	O
.	O

We	O
show	O
here	O
that	O
the	O
third	O
SH3	B
domain	I
binds	O
to	O
Sos	B
,	O
a	O
guanine	B
nucleotide	I
exchange	I
factor	I
for	O
Ras	B
and	O
Rac	B
,	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

They	O
are	O
subdivided	O
into	O
two	O
types	O
that	O
activate	O
transduction	O
pathways	O
via	O
different	O
cell	O
surface	O
receptors	O
.	O

Demyelinating	O
diseases	O
involving	O
the	O
grey	O
matter	O
were	O
very	O
rare	O
,	O
but	O
we	O
must	O
consider	O
the	O
presence	O
of	O
symmetrical	O
thalamic	O
involvement	O
in	O
patients	O
with	O
ADEM	O
.	O

In	O
part	O
as	O
a	O
result	O
of	O
its	O
inability	O
to	O
sustain	O
radiative	O
loses	O
,	O
the	O
BB	O
resonator	O
has	O
extremely	O
low	O
RF	O
power	O
requirements	O
.	O

In	O
addition	O
to	O
the	O
bZIP	B
protein	I
Opaque2	I
(	O
O2	B
)	O
,	O
there	O
are	O
other	O
maize	O
endosperm	O
nuclear	O
proteins	O
that	O
recognize	O
the	O
O2	B
box	I
in	O
22	O
kDa	O
zein	B
gene	O
promoters	O
.	O

The	O
signalling	O
molecules	O
Wnt1	B
and	O
Sonic	B
hedgehog	I
,	O
implicated	O
in	O
the	O
activation	O
of	O
Myf5	B
in	O
myogenic	O
progenitor	O
cells	O
in	O
the	O
somite	O
,	O
are	O
also	O
produced	O
in	O
the	O
viscinity	O
of	O
the	O
Myf5	B
expression	I
domain	I
in	O
the	O
mesencephalon	O
.	O

Overexpression	O
of	O
CDP	B
/	O
cut	B
in	O
ROS	O
17	O
/	O
2.8	O
osteosarcoma	O
cells	O
results	O
in	O
repression	O
of	O
OC	B
promoter	I
activity	O
;	O
this	O
repression	O
is	O
abrogated	O
by	O
mutating	O
OC	B
box	I
I.	I

Sequence	O
analysis	O
of	O
the	O
promoter	O
region	O
showed	O
no	O
TATA	O
box	O
but	O
identified	O
consensus	O
binding	O
motifs	O
for	O
Sp1	B
,	O
CREB	B
,	O
and	O
half	O
sites	O
of	O
the	O
estrogen	B
receptor	I
binding	I
site	I
.	O

Sak	B
kinase	I
gene	O
structure	O
and	O
transcriptional	O
regulation	O
.	O

These	O
data	O
indicate	O
that	O
the	O
interaction	O
of	O
eIF4A	B
with	O
the	O
middle	O
region	O
of	O
eIF4GI	B
is	O
necessary	O
for	O
translation	O
,	O
whereas	O
the	O
interaction	O
of	O
eIF4A	B
with	O
the	O
C	O
-	O
terminal	O
region	O
plays	O
a	O
modulatory	O
role	O
.	O

Northern	O
blot	O
and	O
reverse	O
transcription	O
-	O
PCR	O
analyses	O
of	O
human	O
mRNA	O
samples	O
demonstrate	O
that	O
RNR	B
is	O
expressed	O
exclusively	O
in	O
the	O
retina	O
,	O
with	O
transcripts	O
of	O
approximately	O
7.5	O
kb	O
,	O
approximately	O
3.0	O
kb	O
,	O
and	O
approximately	O
2.3	O
kb	O
by	O
Northern	O
blot	O
analysis	O
.	O

Maximum	O
induction	O
of	O
AP-1	B
was	O
reached	O
at	O
a	O
concentration	O
of	O
250	O
nmol	O
/	O
L	O
of	O
CalC.	O

CONCLUSION	O
:	O
In	O
Cdks	B
functioning	O
throughout	O
the	O
cell	O
cycle	O
,	O
tyrosine	O
phosphorylation	O
is	O
inhibitory	O
to	O
the	O
activation	O
of	O
kinase	O
,	O
whereas	O
the	O
phosphorylation	O
of	O
threonine	O
in	O
the	O
T	O
-	O
loop	O
is	O
essential	O
for	O
activation	O
.	O

We	O
also	O
report	O
that	O
AHR	B
interacts	O
with	O
COUP	B
-	I
TF	I
in	O
transfected	O
CV-1	O
cells	O
.	O

The	O
single	O
strandedness	O
is	O
manifested	O
as	O
a	O
terminal	O
extension	O
of	O
the	O
G	O
-	O
rich	O
strand	O
(	O
G	O
tails	O
)	O
that	O
can	O
occur	O
independently	O
of	O
telomerase	B
,	O
suggesting	O
that	O
cdc17	B
/	O
pol1	B
mutants	O
exhibit	O
defects	O
in	O
telomeric	O
lagging	O
-	O
strand	O
synthesis	O
.	O

An	O
ASIC	O
-	O
chip	O
for	O
stereoscopic	O
depth	O
analysis	O
in	O
video	O
-	O
real	O
-	O
time	O
based	O
on	O
visual	O
cortical	O
cell	O
behavior	O
.	O

The	O
concomitant	O
interaction	O
of	O
mSTI1	B
with	O
hsp70	B
and	O
hsp90	B
at	O
its	O
N-	O
and	O
C	O
-	O
termini	O
respectively	O
is	O
mediated	O
by	O
the	O
tetratricopeptide	O
repeat	O
(	O
TPR	O
)	O
motifs	O
in	O
these	O
regions	O
.	O

Characterization	O
of	O
a	O
human	B
alternatively	I
spliced	I
truncated	I
reduced	I
folate	I
carrier	I
increasing	O
folate	O
accumulation	O
in	O
parental	O
leukemia	O
cells	O
.	O

Desmethylferrochloroquine	O
1a	O
and	O
didesmethylferrochloroquine	O
2	O
would	O
be	O
more	O
potent	O
against	O
schizontocides	O
than	O
CQ	O
in	O
vitro	O
against	O
two	O
strains	O
(	O
HB3	O
and	O
Dd2	O
)	O
of	O
Plasmodium	O
falciparum	O
.	O

Zebrafish	O
cyclops	B
(	O
cyc	B
)	O
encodes	O
a	O
Transforming	B
Growth	I
Factor	I
beta	I
(	O
TGFbeta	B
)	O
signaling	O
factor	O
closely	O
related	O
to	O
mouse	O
Nodal	B
.	O

CONCLUSION	O
:	O
Presence	O
of	O
APOE	B
epsilon4	I
/	I
*	I
seems	O
to	O
increase	O
the	O
risk	O
for	O
dementia	O
and	O
AD	O
independently	O
of	O
its	O
effect	O
on	O
dyslipidemia	O
and	O
atherogenesis	O
.	O

There	O
was	O
a	O
2.4-fold	O
difference	O
in	O
CAT	B
produced	O
from	O
these	O
transcripts	O
in	O
HeLa	O
cells	O
,	O
which	O
contain	O
a	O
greater	O
natural	O
abundance	O
of	O
PTB	B
.	O

Multiple	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
signaling	O
pathways	O
connect	O
the	O
cot	B
oncoprotein	I
to	O
the	O
c	B
-	I
jun	I
promoter	I
and	O
to	O
cellular	O
transformation	O
.	O

Protein	O
sequence	O
analysis	O
reveals	O
that	O
MAN1	B
shares	O
a	O
conserved	O
globular	O
domain	O
of	O
approximately	O
40	O
amino	O
acids	O
,	O
which	O
we	O
term	O
the	O
LEM	B
module	I
,	O
with	O
inner	O
nuclear	O
membrane	O
proteins	O
lamina	B
-	I
associated	I
polypeptide	I
2	I
and	O
emerin	B
.	O

In	O
vitro	O
expression	O
of	O
four	O
different	O
naturally	O
occurring	O
nonsense	O
and	O
missense	O
mutations	O
revealed	O
a	O
dramatically	O
altered	O
subcellular	O
location	O
of	O
the	O
protein	O
in	O
cultured	O
cells	O
.	O

As	O
no	O
complete	O
PPARgamma	B
antagonists	O
have	O
been	O
described	O
hitherto	O
,	O
we	O
have	O
constructed	O
a	O
dominant	O
-	O
negative	O
mutant	O
receptor	O
to	O
inhibit	O
wild	O
-	O
type	O
PPARgamma	B
action	O
.	O

EMSA	O
showed	O
that	O
nuclear	O
proteins	O
from	O
PC12	O
but	O
not	O
C6	O
or	O
Rat2	O
cells	O
bind	O
the	O
CRE	O
as	O
a	O
complex	O
containing	O
activating	B
transcription	I
factor	I
(	I
ATF	I
)	I
-4	I
and	O
CCAAT	B
enhancer	I
-	I
binding	I
protein	I
beta	I
,	O
while	O
both	O
PC12	O
and	O
C6	O
cell	O
nuclear	O
extracts	O
were	O
recruited	O
by	O
the	O
CCAAT	O
-	O
box	O
as	O
a	O
complex	O
containing	O
nuclear	B
factor	I
Y.	I

National	O
abortion	O
laws	O
usually	O
do	O
not	O
allow	O
abortion	O
when	O
a	O
foetus	O
is	O
independently	O
viable	O
,	O
i.e.	O
from	O
a	O
gestational	O
age	O
of	O
about	O
24	O
weeks	O
.	O

The	O
variations	O
were	O
caused	O
by	O
opposite	O
shifts	O
in	O
TSH	B
frequency	O
distribution	O
in	O
mothers	O
and	O
neonates	O
.	O

Antipyretic	O
therapy	O
:	O
physiologic	O
rationale	O
,	O
diagnostic	O
implications	O
,	O
and	O
clinical	O
consequences	O
.	O

Cross	O
-	O
reaction	O
between	O
a	O
monoclonal	O
antibody	O
and	O
two	O
alpha	B
beta	I
T	I
cell	I
receptors	I
.	O

Thus	O
,	O
patients	O
with	O
metastatic	O
melanoma	O
are	O
not	O
tolerant	O
to	O
gp100	B
Ag	I
based	O
on	O
the	O
detection	O
of	O
CD8	B
+	I
T	O
cells	O
specific	O
for	O
multiple	O
HLA	B
-	I
A*0201-restricted	I
,	O
gp100-derived	B
epitopes	O
.	O

Following	O
the	O
observation	O
that	O
non	O
-	O
organ	O
-	O
specific	O
antibodies	O
are	O
related	O
with	O
pregnancy	O
loss	O
and	O
preeclampsia	O
,	O
the	O
role	O
of	O
organ	O
-	O
specific	O
antibodies	O
is	O
currently	O
being	O
extensively	O
investigated	O
.	O

As	O
assessed	O
by	O
a	O
genetic	O
assay	O
that	O
measures	O
AAI	O
-	O
dependent	O
DNA	O
binding	O
,	O
TraM	B
inhibited	O
TraR	B
function	O
before	O
and	O
after	O
the	O
transcription	O
factor	O
had	O
bound	O
to	O
its	O
DNA	O
recognition	O
site	O
.	O

Gene	O
silencing	O
associated	O
with	O
repeated	O
DNA	O
sequences	O
has	O
been	O
reported	O
for	O
many	O
eukaryotes	O
,	O
including	O
plants	O
.	O

Thus	O
,	O
while	O
the	O
genomic	O
organization	O
of	O
mHuA	B
is	O
similar	O
to	O
the	O
neural	O
-	O
restricted	O
members	O
of	O
the	O
Elav	B
family	I
,	O
the	O
promoter	O
element	O
differs	O
substantially	O
both	O
by	O
sequence	O
analysis	O
and	O
transcriptional	O
activity	O
in	O
non	O
-	O
neural	O
cell	O
types	O
.	O

Analysis	O
of	O
the	O
5	O
'	O
end	O
of	O
the	O
mouse	B
Elavl1	I
(	O
mHuA	B
)	O
gene	O
reveals	O
a	O
transcriptional	O
regulatory	O
element	O
and	O
evidence	O
for	O
conserved	O
genomic	O
organization	O
.	O

mHuA	B
(	O
Elavl1	B
)	O
belongs	O
to	O
a	O
highly	O
conserved	O
family	O
of	O
genes	O
encoding	O
RNA	O
-	O
binding	O
proteins	O
and	O
has	O
been	O
linked	O
to	O
cell	O
growth	O
and	O
proliferation	O
through	O
its	O
regulation	O
of	O
mRNA	O
stability	O
.	O

Here	O
we	O
review	O
progress	O
to	O
date	O
in	O
this	O
area	O
.	O

Therefore	O
the	O
binding	O
sites	O
for	O
liver	O
-	O
enriched	O
factors	O
,	O
present	O
in	O
the	O
hamster	B
CYP7A1	I
proximal	I
promoter	I
in	O
close	O
vicinity	O
and	O
conserved	O
between	O
species	O
,	O
constitute	O
a	O
regulatory	O
unit	O
important	O
for	O
basal	O
hepatic	O
expression	O
and	O
tissue	O
restriction	O
of	O
the	O
action	O
of	O
hormones	O
such	O
as	O
insulin	B
.	O

Molecule	O
(	O
s	O
)	O
secreted	O
by	O
neuronal	O
cultures	O
contribute	O
to	O
this	O
induction	O
of	O
GLT-1	B
,	O
but	O
little	O
is	O
known	O
about	O
the	O
signaling	O
pathways	O
mediating	O
this	O
regulation	O
.	O

In	O
the	O
icosahaedral	O
MVMi	O
capsid	O
,	O
this	O
sequence	O
forms	O
the	O
carboxy	O
end	O
of	O
the	O
amphipathic	O
beta	O
-	O
strand	O
I	O
(	O
betaI	O
)	O
,	O
and	O
all	O
its	O
basic	O
residues	O
are	O
contiguously	O
positioned	O
at	O
the	O
face	O
that	O
in	O
the	O
unassembled	O
subunit	O
would	O
be	O
exposed	O
to	O
solvent	O
.	O

Advanced	O
adenoma	O
was	O
defined	O
as	O
an	O
adenoma	O
larger	O
than	O
10	O
mm	O
or	O
an	O
adenoma	O
of	O
any	O
size	O
with	O
villous	O
component	O
,	O
high	O
-	O
grade	O
dysplasia	O
or	O
invasive	O
carcinoma	O
.	O

In	O
transient	O
assays	O
,	O
using	O
rice	O
suspension	O
-	O
cultured	O
cells	O
transformed	O
by	O
particle	O
bombardment	O
,	O
we	O
showed	O
previously	O
that	O
Oshox1	B
can	O
transcriptionally	O
repress	O
the	O
activity	O
of	O
reporter	O
gene	O
constructs	O
with	O
upstream	O
HD	B
-	I
Zip	I
binding	O
sites	O
.	O

Electrophile	O
Response	O
Elements	O
(	O
EpREs	O
)	O
,	O
located	O
in	O
5'-flanking	O
sequences	O
of	O
both	O
the	O
GCSh	B
and	O
GCSl	B
subunit	I
genes	I
,	O
are	O
hypothesized	O
to	O
at	O
least	O
partially	O
mediate	O
gene	O
induction	O
following	O
xenobiotic	O
exposure	O
.	O

TbRAB31	B
behaviour	O
was	O
also	O
studied	O
during	O
the	O
cell	O
cycle	O
;	O
TbRAB31	B
always	O
localised	O
to	O
a	O
discrete	O
structure	O
that	O
duplicated	O
very	O
early	O
in	O
mitosis	O
and	O
relocated	O
to	O
daughter	O
cells	O
in	O
a	O
coordinate	O
manner	O
with	O
the	O
basal	O
body	O
and	O
kinetoplast	O
,	O
suggesting	O
the	O
involvement	O
of	O
microtubules	O
.	O

The	O
human	B
T	I
cell	I
leukemia	I
/	I
lymphotropic	I
virus	I
type	I
1	I
Tax	I
protein	I
represses	O
MyoD	B
-	O
dependent	O
transcription	O
by	O
inhibiting	O
MyoD	B
-	O
binding	O
to	O
the	O
KIX	B
domain	I
of	O
p300	B
.	O

Inhibitor-1	B
(	O
I-1	B
)	O
and	O
inhibitor-2	B
(	O
I-2	B
)	O
selectively	O
inhibit	O
type	B
1	I
protein	I
serine	I
/	I
threonine	I
phosphatases	I
(	O
PP1	B
)	O
.	O

A	O
variety	O
of	O
professional	O
and	O
self	O
-	O
applied	O
fluoride	O
products	O
are	O
available	O
and	O
new	O
fluoride	O
delivery	O
systems	O
have	O
recently	O
entered	O
the	O
market	O
.	O

CONCLUSION	O
:	O
More	O
than	O
50	O
%	O
of	O
patients	O
with	O
perennial	O
rhinitis	O
and	O
CRS	O
do	O
not	O
improve	O
after	O
surgery	O
,	O
a	O
response	O
that	O
may	O
be	O
predicted	O
by	O
more	O
cells	O
expressing	O
IL-5	B
mRNA	I
in	O
the	O
ethmoid	O
sinuses	O
.	O

Here	O
we	O
report	O
on	O
the	O
isolation	O
of	O
ICK2	B
,	O
and	O
show	O
that	O
it	O
interacts	O
with	O
Cdc2aAt	B
,	O
but	O
not	O
with	O
a	O
second	O
CDK	B
from	I
Arabidopsis	I
,	O
Cdc2bAt	B
.	O

Recombination	O
,	O
replication	O
,	O
repair	O
:	O
from	O
complexity	O
to	O
harmony	O
.	O

The	O
C	B
-	I
terminal	I
Cdk2	I
truncations	O
,	O
however	O
,	O
were	O
non	O
-	O
functional	O
in	O
these	O
strains	O
and	O
thus	O
dependent	O
for	O
activity	O
on	O
the	O
pho85	B
coding	I
region	I
which	O
remained	O
in	O
the	O
mutant	B
pho85::HIS3	I
chromosomal	B
locus	I
.	O

Antibodies	O
raised	O
against	O
a	O
C	O
-	O
terminal	O
portion	O
of	O
Sec31A	B
co	O
-	O
precipitate	O
Sec13	B
and	O
inhibit	O
ER	O
-	O
Golgi	O
transport	O
of	O
temperature	O
-	O
arrested	O
vesicular	O
stomatitis	B
G	I
protein	I
in	O
a	O
semi	O
-	O
intact	O
cell	O
assay	O
.	O

This	O
tendency	O
is	O
likely	O
due	O
to	O
the	O
biased	O
nucleotide	O
composition	O
of	O
the	O
asparagus	O
genome	O
,	O
rather	O
than	O
to	O
the	O
translational	O
selection	O
for	O
specific	O
codons	O
.	O

Regulation	O
of	O
pituitary	O
vasopressin	B
V1b	I
receptors	I
plays	O
a	O
critical	O
role	O
in	O
regulating	O
pituitary	B
adrenocorticotropic	I
hormone	I
(	O
ACTH	B
)	O
secretion	O
during	O
adaptation	O
to	O
stress	O
.	O

SELECTION	O
CRITERIA	O
:	O
Randomised	O
trials	O
comparing	O
children	O
undergoing	O
systematic	O
therapy	O
focusing	O
on	O
the	O
family	O
in	O
conjunction	O
with	O
asthma	O
medication	O
,	O
with	O
children	O
taking	O
asthma	O
medication	O
only	O
.	O

The	O
models	O
were	O
tested	O
by	O
studying	O
their	O
response	O
to	O
disturbances	O
of	O
the	O
afferent	O
signal	O
from	O
the	O
bladder	O
.	O

Our	O
data	O
show	O
also	O
that	O
phagocytic	O
killing	O
of	O
meningococci	O
is	O
probably	O
a	O
more	O
consistent	O
assay	O
than	O
antibody	O
titer	O
levels	O
for	O
antimeningococcal	O
immunity	O
,	O
especially	O
in	O
LCC	O
-	O
deficient	O
patients	O
.	O

Vancomycin	O
data	O
were	O
analyzed	O
according	O
to	O
a	O
one	O
-	O
compartment	O
open	O
model	O
with	O
use	O
of	O
NONMEM	O
population	O
pharmacokinetic	O
software	O
.	O

Interestingly	O
,	O
a	O
decreased	O
transcription	O
from	O
the	O
endogenous	O
c	B
-	I
Myb	I
promoter	I
was	O
observed	O
in	O
several	O
HTLV	O
-	O
I	O
transformed	O
T	O
-	O
cell	O
lines	O
.	O

H19	B
and	O
Igf2	B
monoallelic	O
expression	O
is	O
regulated	O
in	O
two	O
distinct	O
ways	O
by	O
a	O
shared	O
cis	O
acting	O
regulatory	O
region	O
upstream	O
of	O
H19	B
.	O

The	O
gene	O
amplification	O
model	O
of	O
Coquelle	O
et	O
al.	O

Up	O
to	O
95	O
%	O
of	O
the	O
total	O
UV	O
exposure	O
received	O
is	O
in	O
the	O
UV	O
-	O
A	O
waveband	O
(	O
320	O
-	O
400	O
nm	O
)	O
.	O

Among	O
genes	O
induced	O
by	O
added	O
pMesogenin1	B
is	O
Xwnt-8	B
,	O
a	O
signaling	O
factor	O
that	O
induces	O
a	O
similar	O
repertoire	O
of	O
marker	O
genes	O
and	O
a	O
similar	O
cellular	O
phenotype	O
.	O

Accordingly	O
,	O
no	O
Ha	B
-	I
ras	I
codon	I
12	I
mutations	O
are	O
found	O
in	O
the	O
EtNU	O
-	O
induced	O
mammary	O
tumors	O
.	O

The	O
cellular	O
part	O
of	O
the	O
third	O
chimeric	O
clone	O
shows	O
significant	O
homology	O
to	O
an	O
exon	O
of	O
the	O
human	B
tyrosine	I
phosphatase	I
1	I
gene	I
,	O
although	O
oriented	O
in	O
the	O
antisense	O
direction	O
compared	O
to	O
the	O
adjacent	O
LTR	O
.	O

Phosphorylation	O
of	O
tyrosine	O
residues	O
in	O
the	O
kinase	O
domain	O
and	O
juxtamembrane	O
region	O
regulates	O
the	O
biological	O
and	O
catalytic	O
activities	O
of	O
Eph	B
receptors	I
.	O

Taken	O
together	O
,	O
these	O
results	O
indicate	O
that	O
MAP	B
kinase	I
stimulates	O
the	O
hPL	B
-	I
B	I
enhancer	I
by	O
an	O
NF	B
-	I
IL-6-dependent	I
pathway	O
.	O

The	O
effect	O
of	O
acute	O
,	O
mid	O
-	O
cervical	O
spinal	O
cord	O
lesions	O
on	O
neuronal	O
and	O
reflex	O
activity	O
evoked	O
by	O
the	O
noxious	O
visceral	O
stimulus	O
,	O
colorectal	O
distension	O
(	O
CRD	O
;	O
80	O
mmHg	O
,	O
20	O
s	O
)	O
,	O
was	O
determined	O
in	O
halothane	O
-	O
anesthetized	O
rats	O
.	O

The	O
administration	O
of	O
the	O
GnRH	B
agonist	O
reduced	O
the	O
bone	O
mineral	O
density	O
in	O
the	O
whole	O
femur	O
to	O
91.0	O
%	O
of	O
that	O
in	O
the	O
control	O
group	O
.	O

When	O
the	O
LCx	O
was	O
partially	O
occluded	O
,	O
mild	O
PM	O
-	O
induced	O
tachycardia	O
resulted	O
in	O
decreased	O
AoP	O
(	O
P=0.045	O
)	O
as	O
well	O
as	O
in	O
decreased	O
SV	O
(	O
P=0.048	O
)	O
;	O
the	O
LVEDP	O
remained	O
high	O
(	O
P=0.002	O
)	O
.	O

GAP	O
JUNCTIONS	O
IN	O
THE	O
BRAIN	O
:	O
PREFACE	O
.	O

In	O
hemodialyzed	O
patients	O
(	O
Epo	B
and	O
Non	O
-	O
Epo	B
group	O
)	O
leptin	B
levels	O
were	O
significantly	O
higher	O
when	O
compared	O
to	O
CAPD	O
patients	O
(	O
Epo	B
and	O
Non	O
-	O
Epo	B
group	O
,	O
respectively	O
)	O
.	O

Screening	O
,	O
counseling	O
,	O
and	O
treatment	O
for	O
alcohol	O
and	O
illicit	O
drug	O
use	O
should	O
be	O
essential	O
components	O
in	O
comprehensive	O
HBP	O
care	O
.	O

This	O
is	O
the	O
first	O
example	O
of	O
a	O
eukaryotic	O
transcription	O
factor	O
complex	O
containing	O
both	O
a	O
MADS	B
-	I
box	I
and	O
a	O
forkhead	B
protein	I
,	O
and	O
it	O
has	O
important	O
implications	O
for	O
the	O
regulation	O
of	O
mammalian	O
gene	O
expression	O
.	O

The	O
present	O
study	O
was	O
designed	O
to	O
evaluate	O
the	O
sensitivity	O
and	O
specificity	O
of	O
AMP	O
CT	O
(	O
Gen	O
-	O
Probe	O
Incorporated	O
,	O
San	O
Diego	O
,	O
CA	O
,	O
USA	O
)	O
on	O
urogenital	O
specimens	O
taken	O
from	O
symptomatic	O
patients	O
and	O
on	O
first	O
void	O
urine	O
(	O
FVU	O
)	O
specimens	O
from	O
asymptomatic	O
patients	O
.	O

The	O
repetitive	O
ETn	B
(	O
early	B
transposon	I
)	O
family	O
of	O
sequences	O
represents	O
an	O
active	O
""""	O
mobile	O
mutagen	O
""""	O
in	O
the	O
mouse	O
genome	O
.	O

The	O
two	O
main	O
experimental	O
variables	O
were	O
the	O
attended	O
hemifield	O
(	O
left	O
or	O
right	O
)	O
and	O
the	O
proportion	O
of	O
trials	O
requiring	O
a	O
shift	O
within	O
that	O
hemifield	O
(	O
20	O
%	O
or	O
80	O
%	O
)	O
.	O

Pharmacoeconomic	O
assessment	O
of	O
HMG	B
-	I
CoA	I
reductase	I
inhibitor	O
therapy	O
:	O
an	O
analysis	O
based	O
on	O
the	O
CURVES	O
study	O
.	O

SELECTION	O
CRITERIA	O
:	O
All	O
controlled	O
trials	O
where	O
adults	O
with	O
schizophrenia	O
or	O
similar	O
illnesses	O
were	O
randomised	O
to	O
quetiapine	O
,	O
placebo	O
or	O
other	O
neuroleptic	O
drugs	O
and	O
where	O
clinically	O
relevant	O
outcomes	O
were	O
reported	O
.	O

Twenty	O
eligible	O
patients	O
with	O
cirrhosis	O
were	O
randomized	O
into	O
two	O
groups	O
:	O
10	O
patients	O
treated	O
with	O
6	O
million	O
units	O
of	O
natural	O
IFN	B
-	I
beta	I
twice	O
a	O
week	O
for	O
36	O
months	O
and	O
10	O
patients	O
without	O
IFN	B
therapy	O
.	O

VaI	O
and	O
VaII	O
co	O
-	O
immunoprecipitated	O
with	O
ErbB2	B
,	O
but	O
not	O
with	O
ErbB1	B
,	O
ErbB3	B
,	O
or	O
ErbB4	B
.	O

In	O
contrast	O
to	O
full	B
-	I
length	I
E2F-3	I
,	O
which	O
is	O
expressed	O
only	O
at	O
the	O
G1	O
/	O
S	O
boundary	O
,	O
E2F-3B	B
is	O
detected	O
throughout	O
the	O
cell	O
cycle	O
with	O
peak	O
levels	O
in	O
GO	O
where	O
it	O
is	O
associated	O
with	O
Rb	B
.	O

Five	O
of	O
the	O
PDP1	B
isoforms	I
differ	O
by	O
the	O
substitution	O
or	O
insertion	O
of	O
amino	O
acids	O
at	O
or	O
near	O
the	O
N	O
-	O
terminal	O
of	O
the	O
protein	O
.	O

To	O
analyze	O
the	O
regulatory	O
activity	O
of	O
Gtx	B
,	O
we	O
first	O
identified	O
the	O
optimal	O
Gtx	B
-	I
binding	I
sequence	I
using	O
an	O
in	O
vitro	O
DNA	O
-	O
binding	O
assay	O
.	O

The	O
loss	O
of	O
avirulence	O
activity	O
because	O
of	O
mutations	O
in	O
the	O
acidic	O
transcriptional	O
activation	O
domain	O
was	O
restored	O
by	O
addition	O
of	O
the	O
activation	O
domain	O
from	O
the	O
herpes	B
simplex	I
viral	I
protein	I
VP16	I
.	O

Although	O
there	O
is	O
little	O
evidence	O
that	O
diet	O
composition	O
plays	O
a	O
clinically	O
important	O
role	O
in	O
the	O
absorption	O
or	O
expenditure	O
of	O
energy	O
,	O
it	O
does	O
appear	O
to	O
play	O
a	O
role	O
in	O
food	O
intake	O
.	O

DATA	O
SYNTHESIS	O
:	O
Intracoronary	O
ultrasound	O
has	O
been	O
shown	O
to	O
improve	O
upon	O
demonstrated	O
weaknesses	O
of	O
coronary	O
angiography	O
.	O

TB	O
bone	O
area	O
(	O
p	O
<	O
0.001	O
)	O
,	O
height	O
(	O
p	O
<	O
0.01	O
)	O
,	O
years	O
in	O
present	O
colony	O
(	O
p	O
=	O
0.03	O
)	O
,	O
and	O
menses	O
(	O
p	O
<	O
0.01	O
)	O
predicted	O
TB	O
BMC	O
.	O

Viruses	O
were	O
isolated	O
from	O
9	O
lungs	O
:	O
7	O
with	O
PI-3V	O
,	O
1	O
with	O
NCP	O
BVDV	O
type	O
1	O
,	O
and	O
1	O
with	O
both	O
BVHV-1	O
and	O
BVDV	O
.	O

In	O
addition	O
,	O
the	O
ketamine	O
-	O
treated	O
rats	O
had	O
more	O
neurons	O
and	O
glial	O
cells	O
surrounding	O
the	O
ventricles	O
.	O

The	O
differences	O
were	O
as	O
follows	O
:	O
for	O
overall	O
response	O
rate	O
p	O
=	O
0.004	O
;	O
power	O
(	O
for	O
p	O
=	O
0.05	O
)	O
85	O
%	O
;	O
for	O
survival	O
p	O
=	O
0.09	O
;	O
for	O
grade	O
IV	O
granulocytopenia	O
p	O
=	O
0.3	O
;	O
and	O
for	O
febrile	O
neutropenia	O
p	O
=	O
0.61	O
.	O

These	O
regions	O
may	O
be	O
differentially	O
involved	O
in	O
tissue	O
-	O
specificity	O
,	O
and/or	O
circadian	O
regulation	O
,	O
of	O
the	O
human	B
hPer1	I
gene	I
transcription	O
.	O

Genomic	O
and	O
functional	O
characterization	O
of	O
the	O
oas	B
gene	I
family	I
encoding	O
O	B
-	I
acetylserine	I
(	I
thiol	I
)	I
lyases	I
,	O
enzymes	O
catalyzing	O
the	O
final	O
step	O
in	O
cysteine	O
biosynthesis	O
in	O
Arabidopsis	O
thaliana	O
.	O

Further	O
characterization	O
of	O
these	O
putative	O
Hoxa-1	B
target	I
genes	I
will	O
aid	O
in	O
delineating	O
the	O
functions	O
of	O
the	O
Hoxa-1	B
protein	I
in	O
the	O
differentiation	O
processes	O
which	O
occur	O
during	O
embryogenesis	O
.	O

The	O
ability	O
of	O
U6-U57	B
mutants	O
to	O
influence	O
the	O
fidelity	O
of	O
both	O
branch	O
site	O
and	O
3	O
'	O
splice	O
site	O
recognition	O
suggests	O
that	O
this	O
nucleotide	O
may	O
participate	O
in	O
the	O
formation	O
of	O
the	O
active	O
site	O
(	O
s	O
)	O
of	O
the	O
spliceosome	O
.	O

Only	O
two	O
of	O
27	O
participants	O
(	O
7.4	O
%	O
)	O
with	O
definite	O
POAG	O
had	O
been	O
previously	O
diagnosed	O
and	O
treated	O
,	O
and	O
66.7	O
%	O
of	O
the	O
previously	O
undiagnosed	O
had	O
IOP	O
less	O
than	O
22	O
mmHg	O
.	O

Because	O
GH	B
-	O
induced	O
Akt	B
activation	O
was	O
completely	O
inhibited	O
in	O
both	O
cells	O
by	O
the	O
same	O
concentration	O
of	O
LY294002	O
,	O
these	O
findings	O
indicate	O
that	O
the	O
wortmannin	O
sensitivity	O
of	O
both	O
the	O
IRS-1-independent	B
and	O
-dependent	O
GH	B
-	O
induced	O
MAP	B
kinase	I
activation	O
may	O
reflect	O
the	O
activity	O
of	O
another	O
wortmannin	O
-	O
sensitive	O
target	O
(	O
s	O
)	O
in	O
addition	O
to	O
PI3	B
K	I
in	O
mediation	O
of	O
GH	B
-	O
induced	O
MAP	B
kinase	I
activation	O
in	O
these	O
cells	O
.	O

These	O
results	O
support	O
a	O
model	O
in	O
which	O
p53	B
protein	I
contributes	O
to	O
the	O
maintenance	O
of	O
genomic	O
integrity	O
through	O
recombinational	O
repair	O
.	O

Mutating	O
the	O
Fcp1p	B
-	O
binding	O
motif	O
KEFGK	O
in	O
the	O
RAP74	B
(	O
Tfg1p	B
)	O
subunit	O
of	O
TFIIF	B
to	O
EEFGE	O
led	O
to	O
both	O
synthetic	O
phenotypes	O
in	O
certain	O
fcp1	B
tfg1	B
double	O
mutants	O
and	O
a	O
reduced	O
ability	O
of	O
Fcp1p	B
to	O
activate	O
transcription	O
when	O
it	O
is	O
artificially	O
tethered	O
to	O
a	O
promoter	O
.	O

Recombinant	O
AROM	B
-	O
p64	B
displayed	O
high	O
binding	O
to	O
single	O
-	O
stranded	O
DNA	O
and	O
poly	O
(	O
A	O
)	O
homopolymers	O
suggesting	O
that	O
this	O
protein	O
could	O
play	O
a	O
role	O
in	O
mRNA	O
maturation	O
/	O
metabolism	O
.	O

It	O
is	O
now	O
estimated	O
that	O
inactivation	O
mutants	O
of	O
PTEN	B
exist	O
in	O
60	O
%	O
of	O
all	O
forms	O
of	O
solid	O
tumors	O
.	O

Src	B
activation	O
induced	O
by	O
FGF1	B
was	O
blocked	O
by	O
the	O
SH2	B
domain	I
of	O
Src	B
and	O
PP2	B
,	O
a	O
specific	O
inhibitor	O
of	O
Src	B
.	O

The	O
use	O
of	O
the	O
PLCgamma	B
inhibitory	I
peptide	I
,	O
neomycin	O
and	O
the	O
calcium	O
chelator	O
BAPTA	O
-	O
AM	O
on	O
oocytes	O
expressing	O
FGFR1	B
or	O
the	O
stimulation	O
by	O
PDGF	B
-	I
BB	I
of	O
oocytes	O
expressing	O
PDGFR	B
-	O
FGFR1	B
mutated	O
on	O
the	O
PLCgamma	B
binding	I
site	I
,	O
prevented	O
GVBD	O
and	O
ERK2	B
phosphorylation	O
.	O

HYPOTHESIS	O
:	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
oxidative	O
susceptibility	O
of	O
apolipoprotein	B
B	I
-	I
containing	I
lipoproteins	I
and	O
antioxidant	O
status	O
in	O
patients	O
with	O
acute	O
coronary	O
syndromes	O
and	O
chronic	O
stable	O
angina	O
pectoris	O
.	O

We	O
cloned	O
a	O
DNA	O
fragment	O
encoding	O
the	O
N	O
-	O
terminal	O
part	O
of	O
a	O
protein	O
with	O
significant	O
similarity	O
to	O
members	O
of	O
the	O
LysR	B
family	I
of	I
transcriptional	I
regulators	I
(	O
LTTRs	B
)	O
.	O

Expression	O
of	O
a	O
dominant	B
negative	I
Smad2	I
significantly	O
reduces	O
the	O
level	O
of	O
luciferase	B
reporter	I
activity	O
induced	O
by	O
nodal	O
treatment	O
.	O

The	O
Drosophila	B
melanogaster	I
suppressor	I
of	I
sable	I
gene	I
,	O
su	B
(	I
s	I
)	I
,	O
encodes	O
a	O
novel	O
,	O
150-kDa	O
nuclear	O
RNA	O
binding	O
protein	O
,	O
SU	B
(	I
S	I
)	I
,	O
that	O
negatively	O
regulates	O
RNA	O
accumulation	O
from	O
mutant	O
alleles	O
of	O
other	O
genes	O
that	O
have	O
transposon	O
insertions	O
in	O
the	O
5	O
'	O
transcribed	O
region	O
.	O

As	O
a	O
result	O
,	O
we	O
have	O
defined	O
two	O
arginine	O
-	O
rich	O
motifs	O
(	O
ARM1	O
and	O
ARM2	O
)	O
that	O
mediate	O
the	O
RNA	O
binding	O
activity	O
of	O
SU	B
(	I
S	I
)	I
.	O

This	O
interaction	O
inhibits	O
the	O
histone	B
acetyltransferase	I
activity	O
of	O
p300	B
,	O
resulting	O
in	O
drastic	O
reduction	O
of	O
nucleosomal	O
histone	B
acetylation	O
and	O
alteration	O
of	O
chromatin	O
structure	O
.	O

Both	O
the	O
Cmax	O
and	O
AUC	O
values	O
were	O
almost	O
doubled	O
with	O
doubling	O
the	O
dose	O
.	O

Diary	O
.	O

In	O
transient	O
analysis	O
using	O
particle	O
bombardment	O
of	O
tobacco	O
leaf	O
sections	O
,	O
a	O
tetramer	O
of	O
the	O
distB	O
ABRE	O
(	O
abscisic	O
acid	O
-	O
responsive	O
element	O
)	O
mediated	O
transactivation	O
by	O
ABI3	B
and	O
ABI3-dependent	B
response	O
to	O
ABA	O
,	O
whereas	O
a	O
tetramer	O
of	O
the	O
composite	O
RY	O
/	O
G	O
complex	O
,	O
containing	O
RY	O
repeats	O
and	O
a	O
G	O
-	O
box	O
,	O
mediated	O
only	O
ABA	O
-	O
independent	O
transactivation	O
by	O
ABI3	B
.	O

METHODS	O
AND	O
RESULTS	O
:	O
Studies	O
were	O
undertaken	O
in	O
9	O
isolated	O
guinea	O
pig	O
hearts	O
,	O
which	O
demonstrated	O
reverse	O
use	O
-	O
dependent	O
prolongation	O
of	O
cardiac	O
repolarization	O
by	O
100	O
nmol	O
/	O
L	O
domperidone	O
.	O

CONCLUSIONS	O
:	O
LSCC	O
malformation	O
,	O
like	O
other	O
inner	O
ear	O
malformations	O
such	O
as	O
large	O
vestibular	O
aqueduct	O
and	O
X	O
-	O
linked	O
mixed	O
deafness	O
with	O
perilymph	O
gusher	O
,	O
can	O
be	O
associated	O
with	O
CHL	O
,	O
SNHL	O
,	O
or	O
normal	O
hearing	O
.	O

Thus	O
,	O
methylation	O
of	O
Pph21p	B
is	O
important	O
for	O
formation	O
of	O
PP2A	B
trimeric	I
and	I
dimeric	I
complexes	I
,	O
and	O
consequently	O
,	O
for	O
PP2A	B
function	O
.	O

Thus	O
,	O
diamide	O
treatment	O
of	O
nuclear	O
extracts	O
strongly	O
reduces	O
the	O
binding	O
of	O
NFI	B
proteins	I
,	O
and	O
the	O
addition	O
of	O
higher	O
concentrations	O
of	O
dithiothreitol	O
to	O
nuclear	O
extracts	O
from	O
TG	B
-	O
treated	O
cells	O
restores	O
NFI	B
-	I
DNA	I
binding	O
to	O
levels	O
in	O
extracts	O
from	O
untreated	O
cells	O
.	O

Further	O
,	O
Tax	B
-	O
mediated	O
apoptosis	O
was	O
effectively	O
prevented	O
by	O
ectopic	O
expression	O
of	O
the	O
p300	B
coactivator	I
.	O

There	O
were	O
no	O
instances	O
of	O
major	O
flap	O
necrosis	O
although	O
two	O
flaps	O
showed	O
tip	O
ischaemia	O
.	O

One	O
of	O
these	O
factors	O
,	O
IRF-2	B
,	O
was	O
initially	O
cloned	O
as	O
an	O
antagonistic	O
counterpart	O
to	O
IRF-1	B
with	O
oncogenic	O
potential	O
.	O

Exon	O
A	O
is	O
located	O
approximately	O
7	O
kb	O
5	O
'	O
to	O
the	O
HSL	B
translation	I
start	I
site	I
.	O

Cardiovascular	O
risk	O
factors	O
and	O
antihypertensive	O
treatment	O
.	O

These	O
two	O
mAbs	O
used	O
the	O
same	O
V	O
(	O
H	O
)	O
and	O
J	O
(	O
H	O
)	O
gene	O
segments	O
,	O
but	O
different	O
D	O
,	O
Vkappa	O
,	O
and	O
Jkappa	O
genes	O
.	O

Patients	O
had	O
to	O
have	O
adequate	O
liver	O
,	O
renal	O
,	O
and	O
marrow	O
functions	O
.	O

In	O
15	O
ventilator	O
-	O
dependent	O
,	O
SB	O
,	O
and	O
actively	O
expiring	O
patients	O
,	O
we	O
found	O
that	O
the	O
difference	O
PEEP	O
(	O
i	O
)	O
,dyn	O
-	O
Pga	O
,	O
total	O
decay	O
(	O
mean	O
+	O
/-	O

SD	O
,	O
5.7	O
+	O
/-	O

1.9	O
cm	O
H	O
(	O
2	O
)	O
O	O
)	O
was	O
quite	O
similar	O
to	O
PEEP	O
(	O
i	O
)	O
,dyn	O
ref	O
(	O
5.3	O
+	O
/-	O

1.9	O
cm	O
H	O
(	O
2	O
)	O
O	O
)	O
.	O

Of	O
208	O
eligible	O
subjects	O
,	O
82	O
received	O
supervised	O
IPT	O
at	O
a	O
dose	O
of	O
900	O
mg	O
twice	O
weekly	O
for	O
6	O
mo	O
(	O
Regimen	O
A	O
)	O
,	O
73	O
received	O
unsupervised	O
IPT	O
900	O
mg	O
twice	O
weekly	O
for	O
6	O
mo	O
(	O
Regimen	O
B	O
)	O
,	O
and	O
53	O
received	O
unsupervised	O
IPT	O
300	O
mg	O
daily	O
for	O
6	O
mo	O
(	O
Regimen	O
C	O
)	O
.	O

This	O
dynamic	O
response	O
strongly	O
suggests	O
that	O
the	O
p53	B
and	O
Rb	B
tumor	O
suppressor	O
pathways	O
are	O
intact	O
in	O
HeLa	O
cells	O
and	O
that	O
repression	O
of	O
HPV	B
E6	I
and	O
E7	B
mobilizes	O
these	O
pathways	O
in	O
an	O
orderly	O
fashion	O
to	O
deliver	O
growth	O
inhibitory	O
signals	O
to	O
the	O
cells	O
.	O

Thus	O
,	O
blocks	O
in	O
the	O
RARalpha	B
-	O
specific	O
pathway	O
of	O
retinoid	O
-	O
induced	O
differentiation	O
may	O
be	O
bypassed	O
during	O
retinoid	O
induction	O
of	O
FR	B
-	I
beta	I
expression	O
.	O

To	O
test	O
whether	O
or	O
not	O
SOCS-3	B
also	O
binds	O
to	O
the	O
IGFIR	B
,	O
we	O
cloned	O
human	B
SOCS-3	I
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
from	O
human	O
skeletal	O
muscle	O
mRNA	O
.	O

Interestingly	O
,	O
this	O
mutant	O
cell	O
line	O
lacks	O
expression	O
of	O
the	O
IKK	B
regulatory	I
protein	I
,	O
IKKgamma	B
.	O

RESULTS	O
:	O
The	O
main	O
effect	O
of	O
muscle	O
pain	O
,	O
compared	O
to	O
non	O
-	O
painful	O
stimulation	O
,	O
was	O
a	O
significant	O
and	O
long	O
-	O
lasting	O
increase	O
of	O
delta	O
(	O
1	O
-	O
3	O
Hz	O
)	O
power	O
and	O
an	O
alpha-1	O
(	O
9	O
-	O
11	O
Hz	O
)	O
power	O
increase	O
over	O
the	O
contralateral	O
parietal	O
locus	O
.	O

This	O
transcriptional	O
regulation	O
occurs	O
through	O
modulation	O
of	O
the	O
forkhead	B
transcription	I
factor	I
FKHR	B
-	I
L1	I
,	O
and	O
IL-3	B
inhibited	O
FKHR	B
-	I
L1	I
activity	O
in	O
a	O
PI3K	B
-	O
dependent	O
manner	O
.	O

Unlike	O
the	O
mammalian	O
proteins	O
,	O
XFGF3	B
is	O
efficiently	O
secreted	O
as	O
a	O
Mr	O
31,000	O
glycoprotein	O
,	O
gp31	B
,	O
which	O
undergoes	O
proteolytic	O
cleavage	O
to	O
produce	O
an	O
NH2-terminally	O
truncated	O
product	O
,	O
gp27	B
.	O

Characterization	O
of	O
the	O
microtubule	O
binding	O
domain	O
of	O
microtubule	B
actin	I
crosslinking	I
factor	I
(	O
MACF	B
)	O
:	O
identification	O
of	O
a	O
novel	O
group	O
of	O
microtubule	B
associated	I
proteins	I
.	O

Four	O
cases	O
of	O
synovial	O
chondromatosis	O
are	O
presented	O
.	O

These	O
cells	O
produced	O
P2Y	B
(	I
11	I
)	I
mRNA	I
during	O
culture	O
.	O

Coexpression	O
studies	O
indicate	O
that	O
insulin	B
and	O
PKB	B
suppress	O
transactivation	O
by	O
C	B
/	I
EBPbeta	I
,	O
but	O
not	O
C	B
/	I
EBPalpha	I
,	O
and	O
that	O
N	O
-	O
terminal	O
transactivation	O
domains	O
in	O
C	B
/	I
EBPbeta	I
are	O
required	O
.	O

Therefore	O
,	O
in	O
our	O
in	O
vitro	O
model	O
,	O
the	O
localization	O
of	O
the	O
mutation	O
in	O
the	O
K	B
-	I
ras	I
gene	I
predisposes	O
to	O
a	O
different	O
level	O
of	O
aggressiveness	O
in	O
the	O
transforming	O
phenotype	O
.	O

One	O
of	O
the	O
sequelae	O
of	O
the	O
antiphospholipid	O
-	O
antibodies	O
is	O
an	O
impaired	O
uteroplacental	O
circulation	O
.	O

PM	O
12	O
or	O
18	O
mg	O
/	O
kg	O
daily	O
plus	O
a	O
standard	O
dose	O
of	O
SB	O
for	O
21	O
days	O
was	O
statistically	O
more	O
effective	O
than	O
SB	O
in	O
producing	O
a	O
final	O
cure	O
for	O
patients	O
with	O
VL	O
in	O
Bihar	O
,	O
India	O
.	O

In	O
whole	O
sardine	O
,	O
domoic	O
acid	O
was	O
detected	O
in	O
levels	O
exceeding	O
sometimes	O
the	O
regulatory	O
limit	O
.	O

We	O
demonstrate	O
that	O
the	O
protein	O
is	O
a	O
murine	B
homologue	I
of	I
SAF	I
-	I
A	I
which	O
has	O
been	O
shown	O
to	O
bind	O
selectively	O
to	O
MARs	O
and	O
is	O
responsible	O
for	O
the	O
satMa	B
-	O
binding	O
activity	O
in	O
the	O
chromatographic	O
fractions	O
.	O

The	O
molecular	O
associations	O
dictating	O
INCENP	B
behavior	O
during	O
mitosis	O
are	O
currently	O
unknown	O
.	O

Termination	O
of	O
induced	O
VT	O
on	O
the	O
first	O
attempt	O
was	O
comparable	O
with	O
BV	O
pacing	O
(	O
87.4	O
%	O
)	O
versus	O
RV	O
pacing	O
(	O
89.6	O
%	O
)	O
.	O

Perfusion	O
technique	O
for	O
perfusion	O
-	O
assisted	O
direct	O
coronary	O
artery	O
bypass	O
(	O
PADCAB	O
)	O
.	O

To	O
account	O
for	O
this	O
observation	O
,	O
other	O
possible	O
causes	O
include	O
increased	O
CSF	O
pulsation	O
in	O
children	O
creating	O
motion	O
artifact	O
,	O
changes	O
in	O
arterial	O
oxygen	O
concentration	O
intrinsic	O
to	O
propofol	O
or	O
related	O
to	O
the	O
supplemental	O
oxygen	O
normally	O
administered	O
,	O
or	O
changes	O
in	O
CSF	O
protein	O
levels	O
related	O
to	O
propofol	O
binding	O
to	O
proteins	O
for	O
uptake	O
into	O
CSF	O
.	O

In	O
three	O
cases	O
(	O
21.4	O
%	O
)	O
,	O
the	O
MR	O
imaging	O
was	O
interpreted	O
as	O
negative	O
,	O
but	O
microscopic	O
tumor	O
was	O
shown	O
around	O
seroma	O
on	O
reexcision	O
.	O

This	O
interaction	O
is	O
reciprocal	O
,	O
since	O
C	B
/	I
EBP	I
dimer	I
binding	O
to	O
a	O
strong	O
C	B
/	I
EBP	I
site	I
leads	O
to	O
enhanced	O
CREB-1	B
recruitment	O
to	O
ATF	B
/	O
CREB	B
sites	O
that	O
are	O
weakly	O
bound	O
by	O
CREB	B
.	O

Quantitative	O
PCR	O
studies	O
indicated	O
that	O
synthesis	O
and	O
transport	O
of	O
vector	O
DNA	O
into	O
the	O
nucleus	O
were	O
similar	O
for	O
macrophages	O
infected	O
with	O
the	O
clone	O
239	O
and	O
316	O
pseudotypes	O
,	O
suggesting	O
that	O
the	O
restriction	O
for	O
SIVmac239	O
infection	O
is	O
after	O
reverse	O
transcription	O
and	O
nuclear	O
import	O
of	O
viral	O
DNA	O
.	O

Interestingly	O
,	O
the	O
similarities	O
with	O
the	O
endophilin	B
proteins	I
cover	O
the	O
entire	O
sequence	O
of	O
the	O
SH3GLB	B
family	I
,	O
suggesting	O
a	O
common	O
fold	O
and	O
presumably	O
a	O
common	O
mode	O
of	O
action	O
.	O

To	O
study	O
the	O
in	O
vivo	O
role	O
of	O
p16.7	B
,	O
a	O
phi29	O
mutant	O
containing	O
a	O
suppressible	O
mutation	O
in	O
gene	B
16.7	I
was	O
constructed	O
.	O

In	O
contrast	O
,	O
we	O
did	O
not	O
detect	O
a	O
significant	O
correlation	O
between	O
plasma	B
TNFalpha	I
and	O
radiation	O
pneumonitis	O
.	O

METHODS	O
:	O
Sixteen	O
pigs	O
were	O
assigned	O
randomly	O
to	O
control	O
and	O
shock	O
groups	O
.	O

Serial	O
US	O
images	O
were	O
obtained	O
before	O
and	O
20	O
,	O
30	O
,	O
40	O
,	O
50	O
,	O
60	O
,	O
90	O
,	O
120	O
,	O
150	O
,	O
180	O
,	O
240	O
,	O
and	O
300	O
s	O
after	O
intravenous	O
injection	O
of	O
2	O
g	O
of	O
contrast	O
agent	O
using	O
conventional	O
and	O
harmonic	O
PD	O
US	O
.	O

This	O
supports	O
previous	O
arguments	O
for	O
the	O
improbability	O
of	O
biological	O
effects	O
at	O
UHF	O
frequencies	O
unless	O
a	O
mechanism	O
can	O
be	O
found	O
for	O
accumulating	O
energy	O
over	O
time	O
and	O
space	O
and	O
focussing	O
it	O
.	O

To	O
assess	O
the	O
maximum	O
oxygen	O
uptake	O
(	O
V'O2	O
max	O
)	O
of	O
Hong	O
Kong	O
Chinese	O
children	O
and	O
to	O
explore	O
its	O
association	O
with	O
respiratory	O
illnesses	O
,	O
we	O
conducted	O
the	O
Multistage	O
Fitness	O
Test	O
(	O
MFT	O
)	O
,	O
a	O
20-m	O
shuttle	O
run	O
test	O
,	O
in	O
1,427	O
schoolchildren	O
aged	O
between	O
8	O
-	O
12	O
years	O
.	O

The	O
corresponding	O
genotype	O
was	O
determined	O
with	O
a	O
restriction	O
enzyme	O
-	O
based	O
assay	O
.	O

The	O
regulation	O
of	O
PGHS-2	B
mRNA	I
and	O
protein	O
was	O
studied	O
in	O
primary	O
cultures	O
of	O
bovine	O
uterine	O
stromal	O
cells	O
stimulated	O
with	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
;	O
100	O
nM	O
)	O
.	O

Functional	O
analysis	O
of	O
various	O
PTP	B
-	O
deficient	O
DT40	O
B	O
cell	O
lines	O
stably	O
expressing	O
wild	O
-	O
type	O
chimeric	O
Fc	B
gamma	I
RIIB1-PECAM-1	I
receptor	I
indicated	O
that	O
cytoplasmic	B
Src	I
homology	I
2-domain	I
-	I
containing	I
phosphatases	I
,	O
SHP-1	B
and	O
SHP-2	B
,	O
were	O
both	O
necessary	O
and	O
sufficient	O
to	O
deliver	O
inhibitory	O
negative	O
regulation	O
upon	O
coligation	O
of	O
BCR	B
complex	I
with	O
inhibitory	O
receptor	O
.	O

In	O
contrast	O
,	O
the	O
failure	O
of	O
the	O
QKTT	O
motif	O
and	O
TGN46	O
cytoplasmic	O
tail	O
to	O
induce	O
steady	O
-	O
state	O
ER	O
localization	O
of	O
vesicular	B
stomatitis	I
virus	I
glycoprotein	I
(	O
VSVG	B
)	O
chimeras	O
in	O
HeLa	O
and	O
NRK	O
cells	O
indicates	O
that	O
significant	O
differences	O
in	O
early	O
secretory	O
trafficking	O
also	O
exist	O
.	O

Consistent	O
with	O
the	O
specificity	O
observed	O
for	O
the	O
interaction	O
of	O
DmCKIIalpha	B
with	O
these	O
bHLH	B
proteins	I
,	O
sequence	O
alignment	O
suggests	O
that	O
only	O
m5	B
,	O
m7	B
,	O
and	O
m8	B
contain	O
a	O
consensus	O
site	O
for	O
phosphorylation	O
by	O
CKII	B
within	O
a	O
subdomain	O
unique	O
to	O
these	O
three	O
proteins	O
.	O

Sevelamer	O
hydrochloride	O
(	O
Renagel	O
)	O
is	O
a	O
nonabsorbed	O
phosphate	O
-	O
binding	O
polymer	O
marketed	O
for	O
the	O
treatment	O
of	O
hyperphosphatemia	O
in	O
adult	O
patients	O
receiving	O
hemodialysis	O
.	O

The	O
Genescan	O
program	O
predicted	O
an	O
open	O
reading	O
frame	O
of	O
a	O
novel	O
,	O
intron	O
-	O
less	O
gene	O
adjacent	O
to	O
the	O
B236	O
spot	O
that	O
encodes	O
a	O
putative	O
493-amino	O
acid	O
protein	O
containing	O
the	O
SNAG	O
repressor	O
motif	O
in	O
the	O
NH2-terminal	O
region	O
and	O
five	O
C2H2-type	O
zinc	O
finger	O
motifs	O
in	O
the	O
COOH	O
-	O
terminal	O
half	O
.	O

The	O
BFA	O
System	O
reads	O
a	O
text	O
file	O
with	O
flows	O
,	O
measured	O
with	O
fluorescent	O
microsphere	O
technique	O
,	O
and	O
constructs	O
the	O
lung	O
anatomy	O
with	O
volumetric	O
pixels	O
showing	O
the	O
flows	O
with	O
a	O
color	O
schema	O
.	O

Managing	O
HIV	O
.	O

Cells	O
containing	O
alpha	O
subunits	O
that	O
lacked	O
a	O
distal	O
domain	O
(	O
term-3	O
)	O
or	O
had	O
the	O
alternatively	O
spliced	O
alpha-2	O
distal	O
domain	O
showed	O
markedly	O
decreased	O
ability	O
to	O
support	O
tyrosine	O
phosphorylation	O
of	O
Jak-2	B
and	O
its	O
substrates	O
or	O
to	O
up	O
-	O
regulate	O
CD86	B
.	O

For	O
this	O
purpose	O
,	O
the	O
immediate	O
and	O
the	O
final	O
(	O
after	O
swelling	O
)	O
fixation	O
strengths	O
of	O
two	O
variations	O
of	O
the	O
swellable	O
bone	O
anchor	O
designs	O
(	O
a	O
smooth	O
anchor	O
and	O
a	O
screw	O
anchor	O
)	O
were	O
measured	O
in	O
two	O
different	O
foams	O
(	O
used	O
to	O
simulate	O
bone	O
)	O
with	O
different	O
densities	O
.	O

RESULTS	O
:	O
Within	O
7	O
days	O
,	O
all	O
groups	O
re	O
-	O
acquired	O
responding	O
for	O
heroin	O
under	O
CRF	O
at	O
rates	O
similar	O
to	O
their	O
pre	O
-	O
lesion	O
performance	O
.	O

A	O
novel	O
growth	O
-	O
related	O
nuclear	O
protein	O
binds	O
and	O
inhibits	O
rat	O
aldolase	B
B	I
gene	I
promoter	O
.	O

Mechanism	O
in	O
the	O
sequential	O
control	O
of	O
cell	O
morphology	O
and	O
S	O
phase	O
entry	O
by	O
epidermal	B
growth	I
factor	I
involves	O
distinct	O
MEK	B
/	O
ERK	B
activations	O
.	O

3D	O
image	O
-	O
processing	O
permits	O
to	O
analyse	O
ultrasound	O
data	O
interactively	O
in	O
three	O
orthogonal	O
planes	O
(	O
section	O
mode	O
)	O
or	O
in	O
realistic	O
3D	O
views	O
(	O
rendering	O
mode	O
)	O
.	O

Sequence	O
analysis	O
revealed	O
significant	O
differences	O
between	O
the	O
5	O
'	O
region	O
of	O
the	O
beta	O
subunit	O
gene	O
and	O
the	O
corresponding	O
regions	O
of	O
the	O
homologous	B
GlyR	I
alpha	I
subunit	I
genes	I
;	O
it	O
also	O
identified	O
a	O
novel	O
exon	O
(	O
exon	O
0	O
)	O
that	O
encodes	O
most	O
of	O
the	O
5'-untranslated	O
portion	O
of	O
the	O
GlyR	B
beta	I
mRNA	I
.	O

Forskolin	O
treatment	O
(	O
10	O
microM	O
)	O
of	O
the	O
transfected	O
cells	O
for	O
3	O
-	O
-6	O
h	O
maximally	O
induced	O
luciferase	B
threefold	O
.	O

B	B
-	I
myb	I
is	O
essential	O
for	O
G1	O
/	O
S	O
transition	O
and	O
has	O
been	O
shown	O
to	O
be	O
phosphorylated	O
by	O
the	O
cyclin	B
A2	I
/	O
cdk2	B
complex	O
.	O

The	O
flux	O
rates	O
of	O
p	O
-	O
toluidine	O
decreased	O
as	O
the	O
pH	O
value	O
in	O
the	O
donor	O
solution	O
increased	O
.	O

The	O
438	B
bp	I
EcoRI	I
fragment	I
,	O
which	O
was	O
detected	O
by	O
Southern	O
hybridization	O
,	O
reveals	O
an	O
open	O
reading	O
frame	O
which	O
encodes	O
a	O
protein	O
of	O
103	O
amino	O
acids	O
.	O

Nrf2	B
regulates	O
expression	O
of	O
genes	O
encoding	O
enzymes	O
with	O
antioxidant	O
(	O
e.g.	O
heme	B
oxygenase-1	I
(	O
HO-1	B
)	O
)	O
or	O
xenobiotic	O
detoxification	O
(	O
e.g.	O

These	O
results	O
indicate	O
that	O
ATF4	B
regulates	O
basal	O
and	O
CdCl	O
(	O
2	O
)	O
-induced	O
expression	O
of	O
the	O
ho-1	B
gene	I
in	O
a	O
cell	O
-	O
specific	O
manner	O
and	O
possibly	O
in	O
a	O
complex	O
with	O
Nrf2	B
.	O

This	O
effect	O
was	O
observed	O
in	O
the	O
absence	O
of	O
de	O
novo	O
protein	O
synthesis	O
and	O
was	O
independent	O
of	O
histone	B
deacetylase	I
activity	O
.	O

Corticosteroid	O
-	O
mediated	O
transcriptional	O
inhibition	O
was	O
greater	O
for	O
MR	B
/	O
GR	B
in	O
combination	O
than	O
for	O
MR	B
or	O
GR	B
alone	O
.	O

SV1	B
has	O
a	O
33-amino	O
acid	O
insert	O
in	O
the	O
S1	O
transmembrane	O
domain	O
that	O
does	O
not	O
alter	O
S1	O
overall	O
hydrophobicity	O
,	O
but	O
makes	O
the	O
S0-S1	O
linker	O
longer	O
.	O

Deterministic	O
effects	O
.	O

No	O
preferential	O
VH	B
/	O
VL	B
-	O
chains	O
correlated	O
with	O
any	O
of	O
the	O
12	O
different	O
antigen	O
reactivities	O
,	O
even	O
for	O
mAbs	O
with	O
nearly	O
identical	O
cross	O
-	O
reactivities	O
.	O

Recently	O
,	O
it	O
was	O
shown	O
that	O
purified	O
RAG1	B
/	I
2	I
proteins	I
can	O
cleave	O
DNA	O
hairpins	O
in	O
vitro	O
,	O
but	O
the	O
same	O
activity	O
was	O
also	O
described	O
for	O
a	O
protein	O
complex	O
of	O
the	O
DNA	O
repair	O
proteins	O
Nbs1	B
/	O
Mre11	B
/	O
Rad50	B
.	O

Instead	O
,	O
TRPS1	B
potently	O
and	O
specifically	O
represses	O
transcriptional	O
activation	O
mediated	O
by	O
other	O
GATA	B
factors	I
.	O

PABP	B
is	O
a	O
modular	O
protein	O
,	O
with	O
four	O
N	O
-	O
terminal	O
RNA	O
-	O
binding	O
domains	O
and	O
an	O
extensive	O
C	O
terminus	O
.	O

METHODS	O
:	O
126	O
patients	O
with	O
histologically	O
confirmed	O
MFH	O
were	O
analyzed	O
.	O

Their	O
numbers	O
have	O
regularly	O
increased	O
since	O
the	O
mid-1970s	O
.	O

In	O
contrast	O
,	O
the	O
ubiquitous	O
expression	O
of	O
p19	B
(	O
INK4d	B
)	O
has	O
not	O
been	O
previously	O
described	O
in	O
human	O
or	O
murine	O
B	O
-	O
lineage	O
cells	O
.	O

Cross	O
-	O
linking	O
FcalphaR	B
on	O
wt	B
-	I
ITAM	I
or	O
IIA	B
-	I
ITAM	I
cells	O
triggered	O
equivalent	O
PI	B
3-kinase	I
-	O
dependent	O
activation	O
of	O
PKBalpha	B
.	O

The	O
UBA	B
domains	I
of	O
RAD23	B
and	O
DDI1	B
are	O
required	O
for	O
these	O
interactions	O
.	O

Through	O
two	O
novel	O
mechanisms	O
,	O
Arf	B
inhibits	O
the	O
oncoprotein	B
Hdm2	I
,	O
a	O
negative	O
regulator	O
of	O
p53	B
.	O

Srb10	B
is	O
a	O
physiological	O
regulator	O
of	O
Gcn4	B
stability	O
because	O
both	O
phosphorylation	O
and	O
turnover	O
of	O
Gcn4	B
are	O
diminished	O
in	O
srb10	B
mutants	I
.	O

A	O
log	O
-	O
linear	O
dose	O
-	O
response	O
was	O
obtained	O
for	O
the	O
average	O
increase	O
in	O
FEV1	O
up	O
to	O
6	O
h	O
(	O
AUC0	O
-	O
6	O
h	O
)	O
and	O
peak	O
FEV1	O
across	O
the	O
dose	O
range	O
administered	O
by	O
Respimat	O
.	O

The	O
COD	O
and	O
color	O
removals	O
were	O
both	O
more	O
than	O
90	O
%	O
when	O
FeCl3	O
was	O
used	O
as	O
the	O
coagulation	O
(	O
dosages	O
of	O
two	O
-	O
step	O
coagulation	O
were	O
0.031	O
and	O
0.012	O
mol	O
/	O
L	O
respectively	O
)	O
after	O
a	O
ferrous	O
hydrogen	O
peroxide	O
oxidation	O
pretreatment	O
at	O
a	O
H2O2	O
dosage	O
of	O
0.06	O
mol	O
/	O
L.	O

It	O
is	O
useful	O
as	O
an	O
adjunct	O
to	O
mammography	O
in	O
those	O
patients	O
with	O
radiographically	O
dense	O
breasts	O
for	O
the	O
characterization	O
of	O
palpable	O
masses	O
.	O

Changes	O
of	O
the	O
DB	O
sequence	O
without	O
affecting	O
the	O
postulated	O
stem	O
structure	O
led	O
to	O
drastic	O
losses	O
of	O
translation	O
efficiency	O
.	O

Here	O
we	O
report	O
the	O
isolation	O
and	O
characterization	O
of	O
the	O
forkhead	B
homologue	I
in	I
rhabdomyosarcoma	I
(	O
FKHR	B
)	O
,	O
a	O
recently	O
described	O
member	O
of	O
the	O
hepatocyte	B
nuclear	I
factor	I
3	I
/	O
forkhead	B
homeotic	B
gene	I
family	I
,	O
as	O
a	O
nuclear	B
hormone	I
receptor	I
(	O
NR	B
)	O
intermediary	O
protein	O
.	O

Saccharomyces	O
cerevisiae	O
activates	O
a	O
regulatory	O
network	O
called	O
""""	O
general	O
control	O
""""	O
that	O
provides	O
the	O
cell	O
with	O
sufficient	O
amounts	O
of	O
protein	O
precursors	O
during	O
amino	O
acid	O
starvation	O
.	O

Mutation	O
analyses	O
identified	O
the	O
cobalt	O
-	O
responsive	O
sequences	O
as	O
the	O
stress	O
-	O
response	O
elements	O
(	O
StREs	O
)	O
.	O

During	O
most	O
of	O
the	O
cell	O
cycle	O
,	O
separase	B
is	O
kept	O
inactive	O
by	O
binding	O
to	O
an	O
inhibitory	O
protein	O
called	O
securin	B
.	O

Mechanical	O
ventilation	O
in	O
control	O
lungs	O
produced	O
a	O
47	O
%	O
decrease	O
in	O
chord	O
compliance	O
,	O
an	O
increase	O
in	O
lung	O
lavage	O
levels	O
of	O
tumor	B
necrosis	I
factor	I
(	I
TNF	I
)	I
-alpha	I
(	O
722	O
+	O
/-	O

306	O
pg	O
/	O
ml	O
)	O
,	O
interleukin	B
(	I
IL	I
)	I
-1beta	I
(	O
902	O
+	O
/-	O

322	O
pg	O
/	O
ml	O
)	O
,	O
and	O
macrophage	B
inflammatory	I
protein-2	I
(	O
MIP-2	B
)	O
(	O
363	O
+	O
/-	O

104	O
pg	O
/	O
ml	O
)	O
as	O
compared	O
with	O
low	O
levels	O
of	O
cytokines	O
detected	O
in	O
preventilation	O
data	O
,	O
and	O
no	O
change	O
in	O
percentage	O
of	O
surfactant	O
large	O
aggregates	O
(	O
LA	O
)	O
.	O

In	O
conclusion	O
,	O
USPIO	O
-	O
enhanced	O
MRI	O
data	O
were	O
capable	O
to	O
characterize	O
tumor	O
microvessel	O
properties	O
in	O
this	O
breast	O
cancer	O
model	O
:	O
microvascular	O
permeability	O
(	O
determined	O
using	O
USPIO	O
)	O
correlated	O
significantly	O
with	O
tumor	O
grade	O
.	O

Inhibition	O
of	O
constitutive	O
NF	B
-	I
kappaB	I
activity	O
results	O
in	O
cell	O
death	O
of	O
TT	O
cells	O
and	O
blocks	O
focus	O
formation	O
induced	O
by	O
oncogenic	O
forms	O
of	O
RET	B
in	O
NIH	O
3T3	O
cells	O
.	O

The	O
described	O
results	O
show	O
that	O
DTD	O
is	O
fast	O
,	O
simple	O
,	O
and	O
easy	O
to	O
automate	O
;	O
requires	O
only	O
a	O
small	O
amount	O
of	O
sample	O
(	O
approximately	O
50	O
mg	O
)	O
;	O
and	O
affords	O
quantitative	O
information	O
about	O
the	O
main	O
groups	O
of	O
compounds	O
present	O
in	O
cheeses	O
.	O

Newcastle	B
disease	I
antibody	I
titre	O
is	O
dependent	O
on	O
serum	O
calcium	O
concentration	O
.	O

10.0	O
+	O
/-	O

2.0	O
pmol	O
/	O
24	O
h	O
,	O
P	O
<	O
0.01	O
)	O
and	O
remained	O
elevated	O
.	O

CONCLUSIONS	O
:	O
Ketamine	O
-	O
induced	O
dissociative	O
anesthesia	O
produces	O
persistently	O
elevated	O
BIS	O
index	O
which	O
is	O
different	O
from	O
thiamylal	O
and	O
those	O
reported	O
with	O
other	O
conventional	O
anesthetic	O
agents	O
.	O

Positive	O
and	O
significant	O
correlations	O
were	O
found	O
between	O
the	O
weeks	O
of	O
pregnancy	O
and	O
Se	O
levels	O
in	O
kidney	O
(	O
r=0.433	O
,	O
P=0.023	O
)	O
and	O
heart	O
(	O
r=0.313	O
,	O
P=0.030	O
)	O
.	O

STAT5A	B
mutations	O
in	O
the	O
Src	B
homology	I
2	I
(	O
SH2	B
)	O
and	O
SH3	B
domains	I
did	O
not	O
alter	O
the	O
BTK	B
-	O
mediated	O
tyrosine	O
phosphorylation	O
.	O

Among	O
individuals	O
,	O
however	O
,	O
changes	O
were	O
strongly	O
correlated	O
with	O
ACR	O
levels	O
at	O
baseline	O
.	O

The	O
other	O
inhibitor	O
was	O
a	O
single	O
TAR	B
decoy	O
,	O
driven	O
by	O
the	O
U6	B
small	I
nuclear	I
RNA	I
promoter	I
(	O
U6-P	B
)	O
.	O

In	O
contrast	O
to	O
MPc3	B
,	O
data	O
indicate	O
that	O
the	O
Pc	B
protein	I
M33	B
does	O
not	O
interact	O
with	O
AF9	B
.	O

The	O
amount	O
of	O
drained	O
effusion	O
was	O
measured	O
,	O
and	O
fluid	O
was	O
sent	O
for	O
diagnostic	O
assessment	O
.	O

A	O
rare	O
case	O
of	O
primary	O
group	O
A	O
streptococcal	O
peritonitis	O
.	O

Statistical	O
Analysis	O
included	O
ANOVA	O
,	O
the	O
Pearson	O
Product	O
Moment	O
Correlation	O
Coefficient	O
,	O
Principal	O
Components	O
Analysis	O
and	O
Discriminant	O
Function	O
Analysis	O
and	O
the	O
calculation	O
of	O
Cronbach	O
's	O
alpha	O
(	O
alpha	O
)	O
RESULTS	O
:	O
Both	O
Sensitivity	O
and	O
specificity	O
exceed	O
90.00	O
at	O
23	O
/	O
24	O
,	O
Chronbach	O
's	O
alpha	O
for	O
the	O
total	O
scale	O
was	O
equal	O
to	O
0.95	O
.	O

The	O
telomerase	B
RNA	I
-	I
protein	I
complex	I
responsible	O
for	O
maintenance	O
of	O
telomeric	O
DNA	O
at	O
chromosome	O
ends	O
,	O
is	O
usually	O
inactive	O
in	O
most	O
primary	O
somatic	O
human	O
cells	O
,	O
but	O
is	O
specifically	O
activated	O
with	O
in	O
vitro	O
immortalization	O
and	O
during	O
tumorigenesis	O
.	O

Altogether	O
,	O
we	O
confirm	O
that	O
all	O
genes	O
of	O
the	O
Rad52	B
recombinational	O
repair	O
pathway	O
are	O
required	O
for	O
the	O
survival	O
of	O
rad27	B
Delta	I
strains	O
at	O
both	O
permissive	O
(	O
23	O
degrees	O
C	O
)	O
and	O
semipermissive	O
(	O
30	O
degrees	O
C	O
)	O
temperatures	O
for	O
growth	O
.	O

We	O
report	O
the	O
results	O
of	O
a	O
detailed	O
policy	O
analysis	O
comparing	O
2	O
CJD	O
-	O
related	O
decisions	O
:	O
a	O
1995	O
recall	O
of	O
blood	O
from	O
a	O
donor	O
with	O
classic	O
CJD	O
and	O
the	O
1999	O
decision	O
to	O
defer	O
donations	O
from	O
individuals	O
with	O
a	O
6-month	O
travel	O
history	O
to	O
the	O
UK	O
between	O
1980	O
and	O
1996	O
due	O
to	O
concerns	O
related	O
to	O
variant	O
CJD	O
.	O

The	O
novel	O
approach	O
to	O
insulin	B
administration	O
known	O
as	O
chronic	O
intermittent	O
intravenous	O
insulin	B
therapy	O
(	O
CIIIT	O
)	O
delivers	O
insulin	B
in	O
a	O
pulsatile	O
fashion	O
and	O
achieves	O
physiological	O
insulin	B
concentration	O
in	O
the	O
portal	O
vein	O
.	O

Breast	O
cancer	O
risk	O
assessment	O
:	O

Who	O
holds	O
the	O
magic	O
crystal	O
ball	O
?	O

In	O
addition	O
,	O
these	O
patients	O
show	O
both	O
quantitative	O
and	O
qualitative	O
differences	O
in	O
their	O
infectious	O
microbiological	O
spectrum	O
,	O
mainly	O
in	O
clean	O
-	O
contaminated	O
,	O
contaminated	O
and	O
dirty	O
surgical	O
procedures	O
.	O

RESULTS	O
:	O
In	O
vivo	O
,	O
there	O
was	O
a	O
wide	O
distribution	O
with	O
the	O
coefficient	O
of	O
variation	O
(	O
SD	O
/	O
mean	O
x	O
100	O
%	O
)	O
for	O
different	O
valve	O
sizes	O
ranging	O
from	O
21	O
%	O
to	O
39	O
%	O
in	O
the	O
St	O
Jude	O
Medical	O
valve	O
and	O
from	O
25	O
%	O
to	O
33	O
%	O
in	O
the	O
Omnicarbon	O
valve	O
.	O

Even	O
if	O
the	O
electrocardiographic	O
signs	O
are	O
subdued	O
,	O
the	O
underlying	O
blockade	O
of	O
I	O
(	O
Kr	O
)	O
current	O
may	O
precipitate	O
the	O
occurrence	O
of	O
arrhythmia	O
.	O

The	O
production	O
of	O
ceramide	O
is	O
emerging	O
as	O
a	O
fixture	O
of	O
programmed	O
cell	O
death	O
.	O

In	O
the	O
further	O
development	O
of	O
bladder	O
neck	O
suspension	O
according	O
to	O
Stamey	O
-	O
Pereyra	O
,	O
the	O
use	O
of	O
miniature	O
bone	O
anchors	O
received	O
considerable	O
support	O
.	O

Moreover	O
,	O
elderly	O
men	O
with	O
bioavailable	O
estradiol	O
levels	O
below	O
the	O
median	O
[	O
40	O
pmol	O
/	O
liter	O
(	O
11	O
pg	O
/	O
ml	O
)	O
]	O
had	O
significantly	O
higher	O
rates	O
of	O
bone	O
loss	O
and	O
levels	O
of	O
bone	O
resorption	O
markers	O
than	O
men	O
with	O
bioavailable	O
estradiol	O
levels	O
above	O
40	O
pmol	O
/	O
liter	O
.	O

Forced	O
expression	O
of	O
BZAP45	B
strongly	O
stimulates	O
H4	B
promoter	I
(	O
nt	O
-215	O
to	O
-1	O
)	O
/	O
CAT	B
reporter	O
gene	O
activity	O
.	O

No	O
mutation	O
of	O
the	O
NRL	B
gene	I
was	O
found	O
in	O
any	O
of	O
the	O
two	O
families	O
.	O

The	O
deubiquitinating	O
enzyme	O
DUB-2	B
is	O
induced	O
in	O
response	O
to	O
IL-2	B
but	O
as	O
yet	O
its	O
function	O
has	O
not	O
been	O
determined	O
.	O

Cardiac	O
output	O
at	O
anaerobic	O
threshold	O
(	O
COAT	O
)	O
<	O
or	O
=	O
7.3	O
L	O
/	O
min	O
was	O
the	O
best	O
cutoff	O
value	O
for	O
identifying	O
multivessel	O
coronary	O
artery	O
disease	O
(	O
relative	O
risk	O
,	O
3.1	O
)	O
.	O

In	O
conclusion	O
,	O
NF	B
-	I
Y	I
and	O
Sp1	B
binding	O
sites	O
play	O
a	O
decisive	O
role	O
in	O
the	O
basal	O
expression	O
of	O
the	O
rat	B
mrp2	I
gene	I
,	O
while	O
the	O
human	B
MRP2	I
gene	I
is	O
regulated	O
differently	O
.	O

NB-506	O
completely	O
inhibits	O
the	O
capacity	O
of	O
topoisomerase	B
I	I
to	O
phosphorylate	O
,	O
in	O
vitro	O
,	O
the	O
human	B
splicing	I
factor	I
2	I
/	O
alternative	B
splicing	I
factor	I
(	O
SF2	B
/	O
ASF	B
)	O
.	O

A	O
split	O
motor	O
domain	O
in	O
a	O
cytoplasmic	B
dynein	I
.	O

In	O
hypertensive	O
nephrosclerosis	O
,	O
therapy	O
containing	O
an	O
ACEI	O
alone	O
or	O
in	O
combination	O
significantly	O
reduces	O
the	O
incidence	O
of	O
renal	O
events	O
.	O

Body	O
weight	O
reduction	O
increases	O
insulin	B
sensitivity	O
and	O
improves	O
both	O
blood	O
glucose	O
and	O
blood	O
pressure	O
control	O
.	O

The	O
best	O
regression	O
model	O
for	O
predicting	O
changes	O
in	O
the	O
WCXR	O
included	O
time	O
to	O
first	O
positive	O
culture	O
and	O
antibody	O
titer	O
for	O
Pa	B
elastase	I
.	O

This	O
paper	O
describes	O
the	O
results	O
of	O
an	O
initial	O
study	O
on	O
the	O
application	O
of	O
linear	O
solvation	O
energy	O
relationships	O
(	O
LSERs	O
)	O
to	O
the	O
prediction	O
of	O
internal	O
standard	O
compounds	O
in	O
reversed	O
-	O
phase	O
liquid	O
chromatographic	O
(	O
RPLC	O
)	O
method	O
development	O
.	O

In	O
the	O
TVD	O
-	O
patients	O
decreases	O
in	O
skin	O
blood	O
flow	O
were	O
similar	O
compared	O
with	O
the	O
healthy	O
controls	O
.	O

In	O
Exp	O
.	O

Several	O
distinct	O
apoptotic	O
stimuli	O
induce	O
the	O
expression	O
and	O
caspase	B
-	O
dependent	O
cleavage	O
of	O
hTAF	B
(	I
II	I
)	I
80	I
delta	I
.	O

hTAF	B
(	I
II	I
)	I
80	I
delta	I
,	O
unlike	O
hTAF	B
(	I
II	I
)	I
80	I
,	O
forms	O
a	O
TFIID	B
-	I
like	I
complex	I
lacking	O
hTAF	B
(	I
II	I
)	I
31	I
.	O

Paul	O
Monagle	O
addresses	O
the	O
epidemiology	O
of	O
neonatal	O
thrombosis	O
outside	O
of	O
the	O
central	O
nervous	O
system	O
in	O
both	O
arterial	O
and	O
venous	O
locations	O
,	O
and	O
those	O
that	O
occur	O
in	O
utero	O
.	O

Saunders	O
Company	O
.	O

Effects	O
of	O
activating	O
blood	O
circulation	O
to	O
remove	O
blood	O
stasis	O
on	O
barrier	O
action	O
of	O
gastric	O
wall	O
in	O
chronic	O
atrophic	O
gastritis	O

Schistosoma	O
mansoni	O
schistosomiasis	O
]	O

Schistosomosis	O
are	O
parasitic	O
diseases	O
caused	O
by	O
blood	O
flukes	O
of	O
the	O
Schistosoma	O
genus	O
.	O

